Development of a Medical Cyclotron Production Facility

Science.gov (United States)

Allen, Danny R.

2003-08-01

Development of a Cyclotron manufacturing facility begins with a business plan. Geographics, the size and activity of the medical community, the growth potential of the modality being served, and other business connections are all considered. This business used the customer base established by NuTech, Inc., an independent centralized nuclear pharmacy founded by Danny Allen. With two pharmacies in operation in Tyler and College Station and a customer base of 47 hospitals and clinics the existing delivery system and pharmacist staff is used for the cyclotron facility. We then added cyclotron products to contracts with these customers to guarantee a supply. We partnered with a company in the process of developing PET imaging centers. We then built an independent imaging center attached to the cyclotron facility to allow for the use of short-lived isotopes.

Development of a Medical Cyclotron Production Facility

International Nuclear Information System (INIS)

Allen, Danny R.

2003-01-01

Development of a Cyclotron manufacturing facility begins with a business plan. Geographics, the size and activity of the medical community, the growth potential of the modality being served, and other business connections are all considered. This business used the customer base established by NuTech, Inc., an independent centralized nuclear pharmacy founded by Danny Allen. With two pharmacies in operation in Tyler and College Station and a customer base of 47 hospitals and clinics the existing delivery system and pharmacist staff is used for the cyclotron facility. We then added cyclotron products to contracts with these customers to guarantee a supply. We partnered with a company in the process of developing PET imaging centers. We then built an independent imaging center attached to the cyclotron facility to allow for the use of short-lived isotopes

Radiation protection of cyclotron vault with maze in PET Cyclotron Center

International Nuclear Information System (INIS)

Fueloep, Marko

2003-01-01

The PET Cyclotron center (PCC) is a complex for production, research and application of positron radiopharmaceuticals for PET (Positron Emission Tomography), which was commissioned this year (2004) in Bratislava, Slovak Republic. Positron radionuclides are produced by 18/9 MeV proton/deuteron cyclotron CYCLONE 18/9. Radiation protection of personnel and inhabitants against ionizing radiation in the PCC is solved with regard to the ICRP recommendations and Slovak regulatory system, protection rules and criteria and optimization of radiation protection. In the article comparisons of calculated and measured neutron and gamma dose equivalent rates around the CYCLONE 18/9 and at various points behind the shielding of cyclotron vault with maze are presented. Description of the CYCLONE 18/9 as a source of angular distribution of neutron energy spectra (production of 18 F was considered) was simulated by Monte Carlo code MCNPX. Code MCNP4B was used for shielding calculation of cyclotron vault with maze. Neutron energy spectra behind the shielding were measured by Bonner spectrometer. The values of neutron dose equivalent, which were calculated and measured around the CYCLONE 18/9 and at various points behind the shielding of cyclotron vault with maze, are within the range of factor 2. (authors)

Development of PET in Latin America. Experience of the first PET-Cyclotron Center

International Nuclear Information System (INIS)

Tutor, C.A.; Frias, L.

2002-01-01

Aim: Describe the experience of the first PET-Cyclotron Center in Latin America. Demonstrate the viability of running a PET Center in Argentina despite the economic crisis. Materials and Methods: For this study, we used a UGM/GE Quest 250 PET scan, a RDS 112 cyclotron and a Radiosynthesis Laboratory installed at the (FUESMEN) Nuclear Medicine School Foundation, located in Mendoza City, in the middle-west of Argentina. From January 1999 to March 2002, 741 studies were obtained, 731 were 18 FluorDeoxyGlucose-PET studies and 10 phantoms for calibration purposes. We used acquisition and imaging processing standard protocols, as well as research protocols designed according to the pathology under investigation. To better correlate anatomical and functional images, we used fusion techniques with (CT) Computed Tomography in some (WB) whole-body PET scans. Results: A total of 731 patients were retrospectively analyzed and classified according to statistics variables such as: 1-sex: 317 women and 414 men, 2-type of scan: 439 WB cases, 267 brain studies and 25 cardiac. From this data we divided them as PET indications and resulted in 17 cases as healthy volunteers, 422 oncological cases, 267 neurological studies and 25 cardiac for myocardial viability. According to the origin they were classified as patients coming from Mendoza 544, Buenos Aires 112, other argentine provinces 60 and foreign (Chile, Brazil and Uruguay) 15 cases. In terms of billing, 181 studies were done free of charge, 95 under research protocols were also done free of charge and 451 were charged. Conclusion: Not only the economical and political factors play an important role limiting the advances of PET Imaging in Latin America, but also the lack of a neighboring cyclotron that circumscribe many hospitals to have access to the radiopharmaceutical agent. FUESMEN was established in 1991 by three governmental entities: the (CONEA) National Commission of Atomic Energy, the (UNC) National University of Cuyo and

Operational experience and recent developments at the National Medical Cyclotron, Sydney

International Nuclear Information System (INIS)

Conard, E.M.; Arnott, D.W.

1996-01-01

The National Medical Cyclotron, Sydney, Australia commenced operation in mid 1991, with a mission to provide PET and SPECT radionuclides throughout Australia. The realization of the present production capacity has been synonymous with the development of the facility's industrial cyclotron (IBA Cyclone 30). The choice of cyclotron was based on the Cyclone 30's virtues as a compact, user-friendly, energy efficient cyclotron, offering the beam quality characteristic of negative ion technology. Development of the cyclotron has improved reliability and increased beam capacity, while improvements to targetry have increased production reliability. More recently, the installation and commissioning of a new solid target irradiation facility has provided much needed redundancy. This paper describes the major cyclotron and targetry developments carried out to date. (orig.)

Evolution of PET and SPECT tracers from cyclotrons: production and application

International Nuclear Information System (INIS)

Stoecklin, G.

1992-01-01

Small cyclotrons play an increasing role in the production of medically useful isotopes. Positron Emission Tomography (PET) and Single Photon Emission Computed Tomography (SPECT) are major tools in modern nuclear medicine for monitoring regional physiological and pharmacological functions at a molecular level. This requires physiological substrates or drugs labeled with suitable positron emitters or single photon emitters. Short-lived neutron deficient radioisotopes of high specific activity and high radionuclidic purity are needed. Some examples of radionuclide production, the development of radiopharmaceuticals for PET and SPECT, and their applications is presented with special emphasis on fluorine-18 and iodine-123. (author)

Operational experience and recent developments at the National Medical Cyclotron

International Nuclear Information System (INIS)

Conard, E.; Pac, B.; Arnott, D.W.

1994-01-01

The National Medical Cyclotron is a radioisotope production facility run by ANSTO and located on the grounds of the Royal Prince Alfred Hospital in Sydney, Australia. A CYCLONE 30 (IBA) cyclotron is used in the production of short-lived PET radiopharmaceuticals required by the hospital's PET Scanner and also to produce a number of bulk radiochemicals for processing and distribution throughout Australasia. Following commissioning of the cyclotron and beam lines in October 1991, and the overcoming of a number of early open-quote teething close-quote problems especially relating to the reliability of the r.f. and solid target transport systems, a steady program of improvements has been pursued. These improvements have included development of new beam diagnostics and the design and installation of a new beam line for SPECT radioisotope production. The current operations schedule includes the production of 18 FDG, 13 NH 3 , 15 O 2 and 201 Tl, 67 Ga and 123 I. This paper will discuss the process of development of the cyclotron to ably meet the present demands on it, and the problems resolved in the pursuit of this goal

Trends in cyclotrons for radionuclide production

International Nuclear Information System (INIS)

Vera Ruiz, H.; Lambrecht, R.M.

1999-01-01

The IAEA recently concluded a worldwide survey of the cyclotrons used for radionuclide production. Most of the institutions responded to the questionnaire. The responses identified technical, utilisation and administrative information for 206 cyclotrons. Compiled data includes the characteristics, performance and popularity of each of the different commercial cyclotrons. Over 20 cyclotrons are scheduled for installation in 1998. The expansion in the number of cyclotron installations during the last decade was driven by the advent of advances in medical imaging instrumentation (namely, positron emission tomography (PET), and more recently by 511 KeV emission tomography); introduction of user friendly compact medical cyclotrons; and recent governmental decisions that permit reimbursement for cyclotron radiopharmaceutical studies by the government or insurance companies. The priorities for the production of clinical, commercial and research radionuclides were identified. The emphasis is on radionuclides used for medical diagnosis with SPET (e.g. 123 I, 201 Tl) and PET (e.g. 11 C, 13 N, 15 O, 18 F) radiopharmaceuticals, and for individualized patient radiation treatment planning (e.g. 64 Cu, 86 Y, 124 I) with PET. There is an emerging trend to advance the cyclotron as an alternative method to nuclear reactors for the production of neutron-rich radionuclides (e.g. 64 Cu, 103 Pd, 186 Re) needed for therapeutic applications. (authors)

The National Medical Cyclotron - An Australian experience in technology

International Nuclear Information System (INIS)

Barnes, R. K.

1997-01-01

The establishment of the National Medical Cyclotron (NMC) in the early 1990's was the practical outcome of a vision, held by nuclear medicine professionals, to complement the available neutron-rich radionuclides produced in Australia, with neutron-deficient radionuclides. The NMC is operated by the Australian Nuclear Science and Technology Organisation (ANSTO) in collaboration with the Royal Prince Alfred Hospital (RPAH) in Sydney where the PET department is able to use the short-lived radiotracers to good advantage. Neutron-deficient radionuclides, are also produced by the NMC laboratories. The cyclotron-generated radionuclides are used in over 70,000 patient studies per year

Review of Cyclotrons for the Production of Radioactive Isotopes for Medical and Industrial Applications

Science.gov (United States)

Schmor, Paul

2011-02-01

Radioactive isotopes are used in a wide range of medical, biological, environmental and industrial applications. Cyclotrons are the primary tool for producing the shorter-lived, proton-rich radioisotopes currently used in a variety of medical applications. Although the primary use of the cyclotron-produced short-lived radioisotopes is in PET/CT (positron emission tomography/computed tomography) and SPECT (single photon emission computed tomography) diagnostic medical procedures, cyclotrons are also producing longer-lived isotopes for therapeutic procedures as well as for other industrial and applied science applications. Commercial suppliers of cyclotrons are responding by providing a range of cyclotrons in the energy range of 3-70MeV for the differing needs of the various applications. These cyclotrons generally have multiple beams servicing multiple targets. This review article presents some of the applications of the radioisotopes and provides a comparison of some of the capabilities of the various current cyclotrons. The use of nuclear medicine and the number of cyclotrons supplying the needed isotopes are increasing. It is expected that there will soon be a new generation of small "tabletop" cyclotrons providing patient doses on demand.

Health physics and quality control management of a cyclotron-based PET facility

International Nuclear Information System (INIS)

Jerabek, P.A.

1995-01-01

This paper provides an overview of the operation and management of a Positron Emission Tomography (PET) facility at the University of Texas. The facility components are discussed from an operations perspective with an emphasis on devices, and on practices and procedures which are implemented to ensure that personnel exposures are as low as reasonably achievable. The cyclotron-based PET facility uses in-house production of PET radioisotopes for preparation of radiopharmaceuticals. A combination of specially designed cyclotron equipped devices, radiopharmaceutical preparation devices, and shielded devices along with health physics practices have helped to make PET operations become routine

The National Medical Cyclotron - An Australian experience in technology

Energy Technology Data Exchange (ETDEWEB)

Barnes, R K [Australian Nuclear Science and Technology Organisation (ANSTO), Lucas Heights, NSW (Australia). National Medical Cyclotron

1998-12-31

The establishment of the National Medical Cyclotron (NMC) in the early 1990`s was the practical outcome of a vision, held by nuclear medicine professionals, to complement the available neutron-rich radionuclides produced in Australia, with neutron-deficient radionuclides. The NMC is operated by the Australian Nuclear Science and Technology Organisation (ANSTO) in collaboration with the Royal Prince Alfred Hospital (RPAH) in Sydney where the PET department is able to use the short-lived radiotracers to good advantage. Neutron-deficient radionuclides, are also produced by the NMC laboratories. The cyclotron-generated radionuclides are used in over 70,000 patient studies per year. 7 refs., 1 tab.

Development of a low-level RF control system for PET cyclotron CYCIAE-14

Energy Technology Data Exchange (ETDEWEB)

Li, Pengzhan, E-mail: lipengzhan@ciae.ac.cn; Yin, Zhiguo; Ji, Bin; Zhang, Tianjue; Zhao, Zhenlu

2014-01-21

The project of a 14 MeV PET cyclotron aiming at medical diagnosis and treatment was proposed and started at CIAE in 2010. The low-level RF system is designed to stabilize acceleration voltage and control the resonance of the cavity. Based on the experience of the existing CRM Cyclotron in CIAE, a new start-up sequence is developed and tested. The frequency sweeping is used to activate the RF system. Before the tuner is put into use, a new state called “DDS tuning” is applied to trace the resonance frequency to the designed value. This new option state helps to cover the tuning range, if a large frequency variation occurs because of a thermal cavity deformation. The logic control unit detects the spark, reflection, Pulse/CW state and the frequency of the RF source to perform all kinds of protection and state operations. The test bench and on-line test are carried out to verify the initial design. -- Highlights: • The low-level RF system is designed and verified for PET cyclotron CYCIAE-14. • The frequency sweeping is used to activate the RF system. • A new state called “DDS tuning” is applied to trace the resonance frequency. • This new option state helps to cover the tuning range. • Protection module allows a quick restart after an alarm and improves cyclotron's efficiency.

Rise of the machines : cyclotrons and radiopharmaceuticals in the PET-CT-MR golden age

International Nuclear Information System (INIS)

Price, Roger

2011-01-01

Full text: One particularly inspiring narrative in the evolution of medical imaging over 35 years begins with the introduction of quassi-routine production of 18F, enabled by advances in reliability of (medical) cyclotrons; invention of the 'molecule of the century' [18F]FOG and its robust synthesis; comprehending betrayal of major tumour-cell types by their glucose avidity; astounding advances in PET scanners (recently, time-of-flight); and marriage of anatomic with functional 3-D imaging as PET/CT or (recently) PET/MR. Though the explosion in PET is identified historically with diagnostic oncology plus quantitation of nuclear medicine, plus the collateral leverage of advances in CT and MR, other potentially transformative opportunities (pre-diagnosis or quantifying treatment response) are emerging in dementia and diabetes-as exemplars of PET-addressable mass afflictions-driven by advances in specificity/sensitivity of targeting molecules. PET delivers femto-M functional sensitivity (e.g.; receptor-targeting)-several magnitude-orders of narrow-context superiority over MR or CT-exemplified by the rapid rise of solid-targetry metallo-PET (64Cu, 89Zr), and concomitantly, preclinical radioimmuno micro-PET/CT/SPECT imaging. Though [11 C ] PET has elucidated brain, prostate and other cell +/- tumour mechanisms, realistic clinical rollout demands longer halflife [18F]-labelling. [18F] innovations beyond [18F]FDG elucidate numerous metabolisms, including choline, hypoxia, apoptosis and amino-acid, and notably will soon provide a routine-clinical [18F]-alternative to [11 C] based beta-amyloid dementia diagnosis. Frontier PET is constrained by cost/dose, shackled to 'twentieth century' technologies-cyclotron, hotcell and synthesis unit. Example is [18F] bone scintigraphy; acknowledged as clinically superior to [99mTc]MOP, its widespread implementation awaits cheaper isotope, accessible PET/CT scanners, and maybe 'true' shortage of [99mTc]. Generator-sourced 68 Ga-PET is

Neutron spectra due 13N production in a PET cyclotron

International Nuclear Information System (INIS)

Benavente, J.A.; Vega-Carrillo, H.R.; Lacerda, M.A.S.; Fonseca, T.C.F.; Faria, F.P.; Silva, T.A. da

2015-01-01

Monte Carlo and experimental methods have been used to characterize the neutron radiation field around PET (Positron Emission Tomography) cyclotrons. In this work, the Monte Carlo code MCNPX was used to estimate the neutron spectra, the neutron fluence rates and the ambient dose equivalent (H*(10)) in seven locations around a PET cyclotron during 13 N production. In order to validate these calculations, H*(10) was measured in three sites and were compared with the calculated doses. All the spectra have two peaks, one above 0.1 MeV due to the evaporation neutrons and another in the thermal region due to the room-return effects. Despite the relatively large difference between the measured and calculated H*(10) for one point, the agreement was considered good, compared with that obtained for 18 F production in a previous work. - Highlights: • MCNPX code was used to estimate the neutron spectra in a PET cyclotron. • Neutrons were estimated when 13 N is produced. • Neutron spectra show evaporation and room-return neutrons. • Calculated H*(10) were compared with measured H*(10)

Medical applications of cyclotrons

International Nuclear Information System (INIS)

Jean, R.; Fauchet, M.

1978-01-01

Isochronous cyclotrons used to accelerate different charged particles (protons, deuterons, alphas...) at variable energies, have important medical applications, for neutron teletherapy, in vivo or in vitro activation analysis or production of short-lived radioisotopes for nuclear medicine. The characteristics of the cyclotron presently available are described for these three applications (low energy 'compact' cyclotrons, cyclotrons of intermediate and high energies), and their advantages are discussed from the points of view of the medical requirements, the financial investments and the results obtained. (orig.) [de

Concepts and strategies to establish a cyclotron/PET center

International Nuclear Information System (INIS)

Hernan Vera Ruiz; D, Ph.

2004-01-01

Cyclotron accelerators are prolific sources of charged particle for the production of radionuclides and have become an essential tool in the practice of modern nuclear medicine by providing reliably radiotracers for SPECT and PET studies. In a recent survey conducted by the IAEA in 2001 (1) , the growth in the number of cyclotron facilities installed in laboratories and hospitals in developed as well as developing nations was put into evidence This trend, which started in the late 70's, continues up to the present time, and all indications are that it will continue in the next future. The reasons for this growth are several, amongst them it can be mentioned the fact that the technology involved has became more user or 'hospital friendly', third party reimbursement for several of clinical studies based on F-18 PET radiopharmaceuticals at least in some of the advanced countries starting with F-18FDG in 1998, and above all, the clear, irrefutable and demonstrable Conclusion of the positive cost/benefit outcomes of PET studies in the field of oncology and to a lesser degree, thus far, for cardiology and neurology. It is however recognized that the overall financial cost of the technology, which comprises the premises to house the facility, the cyclotron accelerator, the corresponding radiochemistry and quality control equipment and the PET camera can nevertheless be an expensive proposition that requires careful advance planning. This fact is even more relevant when the facility is planed for installation in a developing country which frequently, in addition to having a lack of sufficient financial resources, do have shortages of qualify human resources for advance planning and later, to run efficiently the facility. Several are the steps that needs consideration when planning a cyclotron facility, the most critical ones are a careful definition of the mission and scope of the facility including the utilization programme of the facility as a whole, followed by a

Clinical diagnostic system using a small cyclotron for medical use

International Nuclear Information System (INIS)

Yonekura, Y.; Magata, Y.; Konishi, J.

1990-01-01

Since a small cyclotron and a positron emission tomography (PET) scanner have been installed at the Kyoto University Hospital in 1983, a great deal of effort has been directed to the clinical application of the PET-cyclotron system. This paper outlines the experience with PET in the clinical setting, including the facility, equipments and staff involved, weekly schedule, typical clinical protocols, and some results from the patients. The system consists of small cyclotron for production of the short-lived positron emitting radionuclides, fully automated synthesis system for labeling various compounds, scanning for measurement of radioactivities, and data analysis system for calculating physiological parameters. A resolving cylinder target system with eight smaller cylinders is equipped for production of C-11, N-13, O-15, and F-18. Labeled compounds are quickly delivered to the PET scanner room by two systems--the continuous delivery system for the labeled gas and the rapid delivery system for the liquid compounds by compressed air. A PET scanner devoted for clinical studies is a multislice whole-body PET scanner. Ten PET studies are performed weekly on the average for measuring blood flow and oxygen and glucose metabolism in the brain, blood flow and glucose and fatty acid metabolism in the heart, blood flow and amino acid uptake in the pancreas, lung ventilation, and tumor glucose metabolism. The availability of PET-cyclotron system is still limited in view of cost. The previous clinical studies suggest the contribution of PET to the the understanding of the mechanism of disease pathophysiology. (N.K.)

Radiation shielding analysis of medical cyclotron at Radiation Medicine Centre, Parel

International Nuclear Information System (INIS)

Gathibandhe, M.V.; Agrawal, R.A.; Utge, C.G.

2003-01-01

Full text: PET (Positron Emission Tomography) is a diagnostic method to obtain 3-D functional images of the distribution of radio-nuclides introduced in the human body as tracers for specific biological processes. Tracers are produced by bombardment of different target nuclides by protons and deuterons of high energy produced in the cyclotron. A Wipro-GE medical cyclotron was installed in the basement of RMC, Parel. Shielding around the cyclotron is provided in the form of borated concrete walls of required thickness to limit dose rates to design values as per AERB criteria. The roof of the cyclotron room is made of heavy concrete. Entry in to the room is through a maze. Shielding analysis for the cyclotron room has been carried out using computer code ANISN. The maze has been analyzed using code MCNP. Based on the analysis carried out additional shielding was recommended to meet the design requirements. The paper discusses the shielding analysis carried out for the cyclotron room and the maze. Dose rate estimated at various locations are highlighted

Gaseous radioactive effluent restrictions, measurement, and minimization at a PET/cyclotron facility

International Nuclear Information System (INIS)

Plascjak, P.S.; Kim, K.K.; Googins, S.W.; Meyer, W.C. Jr.

1993-01-01

In the US, restrictions on the release of radioactive effluents from PET (positron emission tomography)/cyclotron facilities are typically imposed by State regulatory agencies and may be based on various methodologies and limits published by numerous agencies. This work presents suitable effluent concentration limits for various chemical forms of radioisotopes routinely produced in PET/cyclotron facilities. They were determined by application of metabolic models defined by ICRP 53 and ICRP 26/30 which will result in compliance with effective dose equivalent limits of 100 mrem per year at the release point. The NIH Cyclotron Facility effluent air monitoring system, environmental dosimetry program, and simple, effective systems for radioactive effluent minimization are also described. (orig.)

Evaluation of the production capabilities of 18F, 11C, 13N and 15O PET isotopes at the PET-cyclotron-radiochemistry site of Messina University

Directory of Open Access Journals (Sweden)

Lucrezia Auditore

2017-02-01

Full Text Available The production of 18F, 11C, 13N, and 15O positron emitting radionuclides for PET imaging is usually accomplished in Nuclear Medicine Departments through direct nuclear reactions induced by protons accelerated by compact medical cyclotrons on liquid or gaseous targets. Messina University has funded the construction of a PET-cyclotron-radio-chemistry plant at the Messina University Hospital, equipped with a 11 MeV self-shielded cyclotron. We estimated the expected production yields of these nuclides, accounting for target thickness, production of other radioactive nuclides, and time effects on the irradiated target purity. To this aim, both TALYS code (v. 1.8 and an analytical approach based on EXFOR experimental data were used. The general agreement between the two approaches, and with the available literature data, allows to assess the expected yields at the End of Bombardment, and relative target purities, to be used for further radiopharmaceutical preparation steps.

Development of Medical Cyclotron in KIRAMS

International Nuclear Information System (INIS)

Chai, Jong Seo; Jung, In Su; An, Dong Hyun

2005-01-01

This paper is presented on the development and status of medical cyclotron at the Korea Institute of Radiological and Medical Sciences (KIRAMS) at present. We have developed medical cyclotron which is KIRAMS-13. And the improvement of KIRAMS-13 is presented. Furthermore, the design of new cyclotrons, such as KIRAMS-5 and KIRAMS-30 cyclotron, are presented, and R and D studies for future plan of heavy ion accelerator are discussed

Directory of cyclotrons used for radionuclide production in Member States

International Nuclear Information System (INIS)

1998-03-01

The directory of cyclotrons used for radionuclide production is an update of the data base on cyclotrons that was compiled in 1983 by the International Atomic Energy Agency. The directory contains technical, utilization and administrative information supplied to the IAEA as of October 1997. The directory was prepared through information collected by questionnaires sent to institutions that either have a cyclotron, or that were identified to be in the process of installation of a cyclotron. The directory contains 206 entries for cyclotrons operating in 34 Member States. The largest concentration of cyclotrons for radionuclide production are located in the United States of America (66), Japan (33) and Germany (22). The largest number of cyclotrons for a single country is the United States of America. The expansion in number of cyclotrons during the last decade has been driven by the advent of advances in medical imaging instrumentation (PET, SPET and more recently 511 KeV emission tomography); introduction of user friendly compact medical cyclotrons from several companies that manufacture cyclotrons; and recent decisions that 15 O-oxygen PET studies in Japan, and 18 F-FDG PET studies in Germany are eligible for reimbursement by government or insurance companies

Directory of cyclotrons used for radionuclide production in Member States

Energy Technology Data Exchange (ETDEWEB)

NONE

1998-03-01

The directory of cyclotrons used for radionuclide production is an update of the data base on cyclotrons that was compiled in 1983 by the International Atomic Energy Agency. The directory contains technical, utilization and administrative information supplied to the IAEA as of October 1997. The directory was prepared through information collected by questionnaires sent to institutions that either have a cyclotron, or that were identified to be in the process of installation of a cyclotron. The directory contains 206 entries for cyclotrons operating in 34 Member States. The largest concentration of cyclotrons for radionuclide production are located in the United States of America (66), Japan (33) and Germany (22). The largest number of cyclotrons for a single country is the United States of America. The expansion in number of cyclotrons during the last decade has been driven by the advent of advances in medical imaging instrumentation (PET, SPET and more recently 511 KeV emission tomography); introduction of user friendly compact medical cyclotrons from several companies that manufacture cyclotrons; and recent decisions that {sup 15}O-oxygen PET studies in Japan, and {sup 18}F-FDG PET studies in Germany are eligible for reimbursement by government or insurance companies.

'Serial review on clinical PET tracers'. Manufacturing and quality control of positron emitting radiopharmaceuticals produced by in-house cyclotron

International Nuclear Information System (INIS)

Saji, Hideo

2009-01-01

In order to establish PET diagnosis as a routine clinical tool, manufacture's compliance with regulations under the Good Manufacturing Practice (GMP) principle for PET radiopharmaceuticals is necessary. For this purpose, the Sub-committee on Medical Application of Positron Emitting Radionuclides, Medical Science and Pharmaceutical Committee of Japan Radioisotopes Association has proposed 'Standards for Compounds Labeled with Emitting Radionuclides Approved as Established Techniques for Medical Use'. This guideline includes the general notices, general rules for preparations, general tests for the quality control, quality of each PET agents, guideline for manufacturing environment and manufacturing process at manufacturing facilities of PET agents. Each facility should have a committee and establish an internal system to account for manufacturing compounds labeled with positron emitting radionuclides produced in the facility, and compile standards by referring to the 'Established Standard Techniques of Labeling Compounds with Emitting Radionuclides for use as Radiopharmaceuticals: approved by the Subcommittee on Medical Application of Cyclotron-Produced Radionuclides (revised in 2009)', in order to maintain the quality of radiopharmaceuticals. (author)

Radiation exposure to the staff working in PET/CT and Cyclotron Facility

International Nuclear Information System (INIS)

Ivanova, S.D.

2016-01-01

Positron Emission Tomography (PET) has been available in number of centers for more than 25 years, but its use was not wide spread until 10 years ago. In Bulgarian PET/CT was installed for the first time in 2009 and the dose on demand cyclotron also for the first time – in 2013 in Nuclear Medicine Department in University Hospital St. Marina in Varna, Bulgaria. Responsibility of every radiation protection officer is to educate the stuff how to protect their selves from radioactive exposure and to observe and calculate the dose to the people and the stuff. The purpose of this paper is to show how big the doses of the stuff working in Nuclear Medicine Center including PET/CT and Cyclotron facilities situated in University Hospital St. Marina in Varna, Bulgaria are. The Department is working now with about 15 patients every day. The dose rates measured with personal TLD’s and personal dose rate meters for the last 5 years for the stuff are under 3 mSv. As the average dose is under 1 mSv, and the doses over 1mSv are only for nurses who injected the FDG. Keywords: radiation exposure, effective dose, PET/CT, Cyclotron, FDGbf

Performance characterization of the PET-CT tomograph at the PET-cyclotron-radiochemistry site of Messina University

OpenAIRE

Amato, Ernesto; Baldari, Sergio; Tomasello, Francesco

2015-01-01

A PET-cyclotron-radiochemistry plant was built at Messina University Hospital, whose diagnostics section was equipped with a PET-CT scanner composed by a time of flight PET and a 16-slice CT. The present note reports about the results of tomograph's acceptance tests, which had been planned and carried out in order to verify the correspondence of the specific scanner's performances declared by the firm and the fulfillment of Italian law's minimal criteria of acceptability. Acceptance tests...

A compact cost-effective beamline for a PET Cyclotron

International Nuclear Information System (INIS)

Dehnel, M.P.; Jackle, P.; Roeder, M.; Stewart, T.; Theroux, J.; Brasile, J.P.; Sirot, P.; Buckley, K.R.; Bedue, M.

2007-01-01

Most commercial PET Cyclotrons have targets mounted on or near the main cyclotron vacuum chamber. There is often little or no system capability for centering or focusing the extracted beam on target to achieve maximum production. This paper describes the ion-optics, design and development of a compact cost-effective beamline comprised of low activation and radiation resistant materials. The beamline, complete with suitable diagnostic devices, permits the extracted proton beam to be centered (X-Y steering magnet), and focused (quadrupole doublet) on target eliminating unnecessary beamspill and ensuring high production

Medical cyclotron: why, where, how

International Nuclear Information System (INIS)

Scheer, Kurt; Comar, Dominique; Kellershohn, Claude

1976-01-01

Cyclotrons for medical purposes are particularly useful for the production of radioactive isotopes of elements normally constituting organic matter ( 15 O, 13 N, 11 C). The short half-life and positron emission of those elements are of great interest in medical diagnosis. Many others carrier-free radioisotopes can be produced by cyclotrons. Three categories of cyclotrons are mentioned. Desk top cyclotron only adapted to the production of short-lived radioisotopes in a hospital; low energy and average energy cyclotrons which require well-entrained personnel for their operation and are best adapted to the production of radioelements on a regional or even national scale. Examples relative to the interest of short-lived radioisotopes in lung and brain investigations and tumor detection are given

Effective dose to immuno-PET patients due to metastable impurities in cyclotron produced zirconium-89

Science.gov (United States)

Alfuraih, Abdulrahman; Alzimami, Khalid; Ma, Andy K.; Alghamdi, Ali; Al Jammaz, Ibrahim

2014-11-01

Immuno-PET is a nuclear medicine technique that combines positron emission tommography (PET) with radio-labeled monoclonal antibodies (mAbs) for tumor characterization and therapy. Zirconium-89 (89Zr) is an emerging radionuclide for immuno-PET imaging. Its long half-life (78.4 h) gives ample time for the production, the administering and the patient uptake of the tagged radiopharmaceutical. Furthermore, the nuclides will remain in the tumor cells after the mAbs are catabolized so that time series studies are possible without incurring further administration of radiopharmarceuticals. 89Zr can be produced in medical cyclotrons by bombarding an yttrium-89 (89Y) target with a proton beam through the 89Y(p,n)89Zr reaction. In this study, we estimated the effective dose to the head and neck cancer patients undergoing 89Zr-based immune-PET procedures. The production of 89Zr and the impurities from proton irradiation of the 89Y target in a cyclotron was calculated with the Monte Carlo code MCNPX and the nuclear reaction code TALYS. The cumulated activities of the Zr isotopes were derived from real patient data in literature and the effective doses were estimated using the MIRD specific absorbed fraction formalism. The estimated effective dose from 89Zr is 0.5±0.2 mSv/MBq. The highest organ dose is 1.8±0.2 mSv/MBq in the liver. These values are in agreement with those reported in literature. The effective dose from 89mZr is about 0.2-0.3% of the 89Zr dose in the worst case. Since the ratio of 89mZr to 89Zr depends on the cooling time as well as the irradiation details, contaminant dose estimation is an important aspect in optimizing the cyclotron irradiation geometry, energy and time.

A mobile superconducting cyclotron for PET and neutron radiography

International Nuclear Information System (INIS)

Griffiths, R.

1988-01-01

The report addresses the development of a mobile superconducting cyclotron for PET (positron emission tomography) and neutron radiography. Proposals for an ultralight cyclotron were made by Finlan et al., who suggested a novel technique of utilising a superconducting magnet with RF acceleration and iron sectors contained within the room temperature bore of the magnet. Detailed design of a cyclotron based on this concept has progressed well at Oxford Instruments. The main design priorities were to minimise the weight and power consumption of the cyclotron. The cyclotron required a large amount of shielding to reduce either radiation background levels or stray magnetic field. Thus low background levels of radiation and magnetic field are key design criteria. The superconducting magnet has a mean field of 2.35 Tesla and a room temperature bore diameter of 500 mm. Three pairs of profiled iron sectors placed in the center of the warm bore of the magnet provide an azimuthally varying magnetic field. This permits the use of high beam currents with low background. A novel technique is incorporated to reduce the stray magnetic field and radiation from the cyclotron. The RF system consists of three pairs of resonators mounted within the warm bore of the magnet between the iron sectors. (Nogami, K.)

H-superconducting cyclotron for PET isotope production

International Nuclear Information System (INIS)

Smirnov, V.L.; Vorozhtsov, S.B.; Vincent, J.

2014-01-01

The scientific design of a 14-MeV H - compact superconducting cyclotron for producing of the 18 F and 13 N isotopes has been developed. Main requirements to the facility as a medical accelerator are met in the design. In particular, the main requirement for the cyclotron was the smallest possible size due to the superconducting magnet. The calculations show that the proposed cyclotron allows extracted beam intensity over 500 μA. To increase system reliability and production rates, an external H - ion source is applied. The choice of the cyclotron concept, design of the structure elements, calculation of the electromagnetic fields and beam dynamics from the ion source to the extraction system were performed.

A national medical cyclotron facility: report to the Minister of Health by the Medical Cyclotron Committee

International Nuclear Information System (INIS)

1985-01-01

Research and training in nuclear medicine in Australia are both limited by the lack of a medical cyclotron facility. The Committee recommends the establishment of a national medical cyclotron to provide a supply of short-lived radioisotopes for research in relevant fields of medicine, and for diagnostic use in nuclear medicine

Five Years of Cyclotron Radioisotope Production Experiences at the First PET-CT in Venezuela

International Nuclear Information System (INIS)

Colmenter, L.; Coelho, D.; Esteves, L. M.; Ruiz, N.; Morales, L.; Lugo, I.; Sajo-Bohus, L.; Liendo, J. A.; Greaves, E. D.; Barros, H.; Castillo, J.

2007-01-01

Five years operation of a compact cyclotron installed at PET-CT facility in Caracas, Venezuela is given. Production rate of 18 F labeled FDG, operation and radiation monitoring experience are included. We conclude that 18 FDG CT-PET is the most effective technique for patient diagnosis

Survey on radionuclide producing using cyclotron method in Malaysia

International Nuclear Information System (INIS)

Mohd Fadli Mohammad Noh

2008-01-01

This research discuss about basic design and systems of medical cyclotron that Malaysia currently have, its applications in radionuclide production and upcoming technologies of cyclotron. Surveys have been carried out on cyclotron facilities at Hospital Putrajaya and Wijaya International Medical Center, WIMC as well as reactor facility at Malaysia Nuclear Agency. The sources in this research also involves on-line and library searches. Information obtained are recorded, categorized, synthesized and discussed. systems of cyclotron of Hospital Putrajaya are further discussed in details. Based from the surveys carried out, it is found out that cyclotron facilities both in Hospital Putrajaya and WIMC only produce ( 18 F)FDG with radioactivity of 18 F produced in 2007 are 16479 mCi and 92546 mCi respectively. Survey also revealed that radioisotope production at Nuclear Malaysia has had its operation been ceased. A new radiopharmaceutical, namely CHOL is suggested to be synthesized by both facilities as a new PET tracer. Latest developments concerning technologies of cyclotron as well as other accelerators such as laser for future medical accelerator, prospect of boron neutron capture and the potential of hadron therapy in Malaysia are discussed here. Radioisotope production in Malaysia is expected to keep booming in future due to increase in usage of PET techniques and the construction of more compact, easy to handle and less costly cyclotrons. (author)

National Medical Cyclotron

International Nuclear Information System (INIS)

Boyd, Rex.

1991-01-01

The National Medical Cyclotron, under construction at Sydney's Royal Prince Alfred Hospital(RPAH) is to be operated by the Australian Nuclear Science and Technology Organization in collaboration with the hospital. Its main purpose is to produce radioisotopes on commercial basis for distribution to hospitals through Australia as well as short-lived radioisotopes (2 minutes to 2 hours) for immediate application at RPAH in Positron Emission Tomography, to study the dynamics of human physiology and metabolism in organs, bones and soft tissues. A list of the principal cyclotron-produced radionuclides is provided. ills

Cyclotron vault design for PET complex of C CSR

International Nuclear Information System (INIS)

Fiilop, M.

2004-01-01

The Cyclotron center of the Slovak Republic will be built in two building (pavilion I and J), In the pavilion I there is planed to build up a complex for production, research and application of positron radiopharmaceuticals for PET (Positron Emission Tomography). Production of radiopharmaceuticals for SPECT (Single Photon Emission Computerized Tomography) and radiotherapy is situated in the pavilion J of Slovak Institute of Metrology. The radiation protection of personal and inhabitants against ionizing radiation in the PET Complex is solved with regard to the International Basic Safety Standards for Protection against Ionizing Radiation and for the Safety of Radiation Sources [1], ICRP recommendations [2] and Slovak regulatory system, protection rules and criteria and optimization of radiation protection

Neutron transport calculation for Activation Evaluation for Decommissioning of PET cyclotron Facility

Science.gov (United States)

Nobuhara, Fumiyoshi; Kuroyanagi, Makoto; Masumoto, Kazuyoshi; Nakamura, Hajime; Toyoda, Akihiro; Takahashi, Katsuhiko

2017-09-01

In order to evaluate the state of activation in a cyclotron facility used for the radioisotope production of PET diagnostics, we measured the neutron flux by using gold foils and TLDs. Then, the spatial distribution of neutrons and induced activity inside the cyclotron vault were simulated with the Monte Calro calculation code for neutron transport and DCHAIN-SP for activation calculation. The calculated results are in good agreement with measured values within factor 3. Therefore, the adaption of the advanced evaluation procedure for activation level is proved to be important for the planning of decommissioning of these facilities.

New design for a medical cyclotron

Energy Technology Data Exchange (ETDEWEB)

Wilson, M

1985-12-01

The Oxford Instruments Group PLC, have designed a 30 MeV energy proton cyclotron incorporating a super-conducting magnet and a novel RF accelerating cavity. The energy range is suitable for the production of isotopes such as /sup 67/Ga, /sup 111/In, /sup 123/I and /sup 201/Tl, and the short lived isotopes of carbon, nitrogen, oxygen and fluorine for use in Positron Emmission Tomography (PET). A new magnet and RF cavity design permit a considerable power and weight reduction and a compact size (1.5m dia x 1.9m high), allowing the cyclotron to be transported to a shielded site as an assembly after factory testing. A method of beam extraction has been adopted which minimises activation of the accelerator components and so allows hands on maintenance to be carried out when required.

Regulatory Compliance to Assure the Safety of the Operation of a Medical Cyclotron

International Nuclear Information System (INIS)

Dela Cruz, Joselito

2015-01-01

Khealth Corporation, in Partnership with the National Kidney and Transplant Institute, has established a medical cyclotron facility to accommodate the up-and-coming needs of tracers for PET/CT in different centers and hospitals all over the country. This facility houses a 16.5 MeV GE PET trace 880 particle accelerator that can produce 14 Ci (518 GBq) of Fluorine-18. Its structure has adopted global standard designs in meeting the safety during its use, radiopharmaceutical production and distribution. Compliances were remarkably fulfilled from the building construction, machine acquisition, commissioning, operations up to the quality control and assurance. Furthermore, various regulatory challenges during the current standardization of radiopharmaceutical utilization were encountered however time dedication and efforts were wielded until all have been successfully justified and acquired. (author)

Safety and protection problems in the management of a plant with cyclotron, radiopharmacy laboratory and PET/CT equipment

Energy Technology Data Exchange (ETDEWEB)

Russo, A.; Speranza, A.; Panico, M. [University Federico-2, National Research Council - Institute of Biostructures and Bioimaging and Dept. of Bio-morphological and Functional Sciences, Napoli (Italy); Delia, R. [University La Sapienza - sez. Rieti, Faculty of Medicine, Rome (Italy); Casale, M. [University Federico-2, Dept. of Physics - Health Physics School, Napoli (Italy); Salvatore, M. [University Federico-2 and National Research Council - Institute of Biostructures and Bioimaging, Dept. of Bio-morphological and Functional Sciences, Napoli (Italy)

2006-07-01

The importance of Positron Emission Tomography (PET) is spreading and increasing in many clinical diagnostic fields, as well as the oncology, the cardiology, the neurology and so on. A strong input to the diffusion of this imaging technique from the research field to clinical one has been given either by the development of knowledge about PET or the modern technologies, which allow to set up at very suitable prices and in very little volumes, like in an hospital site, complete systems, which consist of: Cyclotron; Radiopharmacy Laboratory; one or more either PET or PET/CT. Such set-up arrangement allows to carry out highly innovative diagnostic examinations with a remarkable achievement of diagnostic quality and large number of daily examinations. In this paper the authors show the achieved know-how with respect to radioprotection for the set-up and running management of two systems such as PET/CT tomography unit, cyclotron and radiopharmacy laboratory, installed one in the Imaging Diagnostic Department of the Hospital of Naples University and used only for medical and research purposes, and the other one in A.C.O.M. (Advanced Center of Oncology in Macerata), used for commercial and research purposes. The following safety problems have been considered: the facility lay-out; the optimisation of the paths either for the operator, or the patients and the radiotracers; the guide lines for the protection and the safety of the patients, operators and general population, in relation to the utilization and the management of either the more common radiotracers (18 F and 11 C) or those in research progress, for example 64 Cu and 124 I; the protocol set up for the image quality control in relation to the patient protection and safety. The above problems have also been considered, taking into account the Italian regulation and the International Recommendations. (authors)

Safety and protection problems in the management of a plant with cyclotron, radiopharmacy laboratory and PET/CT equipment

International Nuclear Information System (INIS)

Russo, A.; Speranza, A.; Panico, M.; Delia, R.; Casale, M.; Salvatore, M.

2006-01-01

The importance of Positron Emission Tomography (PET) is spreading and increasing in many clinical diagnostic fields, as well as the oncology, the cardiology, the neurology and so on. A strong input to the diffusion of this imaging technique from the research field to clinical one has been given either by the development of knowledge about PET or the modern technologies, which allow to set up at very suitable prices and in very little volumes, like in an hospital site, complete systems, which consist of: Cyclotron; Radiopharmacy Laboratory; one or more either PET or PET/CT. Such set-up arrangement allows to carry out highly innovative diagnostic examinations with a remarkable achievement of diagnostic quality and large number of daily examinations. In this paper the authors show the achieved know-how with respect to radioprotection for the set-up and running management of two systems such as PET/CT tomography unit, cyclotron and radiopharmacy laboratory, installed one in the Imaging Diagnostic Department of the Hospital of Naples University and used only for medical and research purposes, and the other one in A.C.O.M. (Advanced Center of Oncology in Macerata), used for commercial and research purposes. The following safety problems have been considered: the facility lay-out; the optimisation of the paths either for the operator, or the patients and the radiotracers; the guide lines for the protection and the safety of the patients, operators and general population, in relation to the utilization and the management of either the more common radiotracers (18 F and 11 C) or those in research progress, for example 64 Cu and 124 I; the protocol set up for the image quality control in relation to the patient protection and safety. The above problems have also been considered, taking into account the Italian regulation and the International Recommendations. (authors)

Performance characterization of the PET-CT tomograph at the PET-cyclotron-radiochemistry site of Messina University

Directory of Open Access Journals (Sweden)

Ernesto Amato

2015-10-01

Full Text Available A PET-cyclotron-radiochemistry plant was built at Messina University Hospital, whose diagnostics section was equipped with a PET-CT scanner composed by a time of flight PET and a 16-slice CT. The present note reports about the results of tomograph's acceptance tests, which had been planned and carried out in order to verify the correspondence of the specific scanner's performances declared by the firm and the fulfillment of Italian law's minimal criteria of acceptability. Acceptance tests gave positive results for all the physical parameters measured. The assessment of CT slice thickness, with regard to the thinner slices of 0.75 and 0.6 mm, required the employment of a manual procedure exploiting a phantom equipped with low inclination ramps. These results allowed us to assess a baseline of performance parameters to be taken as a reference for periodic constance tests.

Emittance Measurement for Beamline Extension at the PET Cyclotron

Directory of Open Access Journals (Sweden)

Sae-Hoon Park

2016-01-01

Full Text Available Particle-induced X-ray emission is used for determining the elemental composition of materials. This method uses low-energy protons (of several MeV, which can be obtained from high-energy (of tens MeV accelerators. Instead of manufacturing an accelerator for generating the MeV protons, the use of a PET cyclotron has been suggested for designing the beamline for multipurpose applications, especially for the PIXE experiment, which has a dedicated high-energy (of tens MeV accelerator. The beam properties of the cyclotron were determined at this experimental facility by using an external beamline before transferring the ion beam to the experimental chamber. We measured the beam profile and calculated the emittance using the pepper-pot method. The beam profile was measured as the beam current using a wire scanner, and the emittance was measured as the beam distribution at the beam dump using a radiochromic film. We analyzed the measurement results and are planning to use the results obtained in the simulations of external beamline and aligned beamline components. We will consider energy degradation after computing the beamline simulation. The experimental study focused on measuring the emittance from the cyclotron, and the results of this study are presented in this paper.

The radioprotection management of a PET department with a cyclotron and radiopharmacy laboratory, in accordance with Italian legislation

International Nuclear Information System (INIS)

Russo, A. A.; Ferrari, P.; Casale, M.; Delia, R.

2011-01-01

The possibility of setting up a positron emission tomography (PET) facility with a cyclotron and radiopharmaceutical laboratory in situ, at a feasible price and in a very restricted space, has led to a steady increase both in the use of the PET technique in diagnostic clinical routine imaging and in the number of cyclotrons for drug production. Owing to the progress made in the PET procedures, it is now possible to have not only a highly innovative system of diagnostic examination, with a remarkable improvement in the diagnostic quality and patient care, but also a considerable increase in the number of daily examinations. In this paper, the authors show how the acquired know-how, with respect to radioprotection, has applied to the planning, running and management of the PET/CT unit, installed in the Imaging Diagnostic Dept. of the Policlinico Tor Vergata (PTV), at Tor Vergata Univ., Rome. (authors)

Radiation Protection in PET-CT

International Nuclear Information System (INIS)

2011-10-01

The presentation is based on the following areas: radiological monitoring installations in the production of PET radiopharmaceuticals, personal dose, dosage advertising, nuclear medicine, PET, radiation protection of patients, requirements for medical practice, regulatory aspects, dose calculation, shields, quantities, center Cudim, cyclotron and synthesis of radiopharmaceuticals, biological effects of radiation protection practices.

Design study of an ultra-compact superconducting cyclotron for isotope production

Science.gov (United States)

Smirnov, V.; Vorozhtsov, S.; Vincent, J.

2014-11-01

A 12.5 MeV, 25 μA, proton compact superconducting cyclotron for medical isotope production has been designed and is currently in fabrication. The machine is initially aimed at producing 13N ammonia for Positron Emission Tomography (PET) cardiology applications. With an ultra-compact size and cost-effective price point, this system will offer clinicians unprecedented access to the preferred radiopharmaceutical isotope for cardiac PET imaging. A systems approach that carefully balanced the subsystem requirements coupled to precise beam dynamics calculations was followed. The system is designed to irradiate a liquid target internal to the cyclotron and to minimize the need for radiation shielding. The main parameters of the cyclotron, its design, and principal steps of the development work are presented here.

Directory of cyclotrons used for radionuclide production in Member States [2006 update

International Nuclear Information System (INIS)

2006-10-01

The present directory of cyclotron facilities used for the production of radionuclides in Member States is an update of the one compiled by the International Atomic Energy Agency (IAEA) in late 2001 and published in 2002. This directory was prepared through information collected by questionnaires that the IAEA sent to known institutions operating cyclotrons for radionuclide production. Technical as well as administrative data supplied to the IAEA as of November 2005 were taken into account. The directory is considered to include most of the cyclotrons of the world that are used at least partially for radionuclide production. There are 262 entries for cyclotrons operating in 39 Member States of the IAEA. This is an increase of 7% over the 246 reported in the 2002 cyclotron directory. This can be compared to the 350 or so cyclotrons believed to be presently operating in the world, which are involved in some aspects of radionuclide production. The increase has been in the number of cyclotrons in developed countries, but even more so in the developing countries. The increase in number during the last four years was driven by several factors, i.e. advent of advances in medical imaging, introduction of compact, user friendly medical cyclotron, and a recent decision that costs for 15 O-oxygen position emission tomography (PET) studies in Japan and 18 F-FDG PET studies in Germany and the United States of America are eligible for reimbursement by government or health insurance companies. There is no doubt that the fastest growing segment of the market is in the commercial distribution of FDG to local hospitals. The IAEA is promoting cyclotron technology as applied to nuclear medicine. Requests for cyclotron technology is steadily increasing; many developing Member States are interested in this technology. There is need to stimulate, build and maintain consulting capability in interested developing Member States. There are good reasons to believe that the number of cyclotron

Building on TR-24 success. Advanced Cyclotron Systems Inc. launches a new cyclotron model

International Nuclear Information System (INIS)

Russell Watt; William Gyles; Alexander Zyuzin

2015-01-01

ACSI is designing a new 30 MeV cyclotron based on the TR-24. While minimizing changes from the proven TR-24, including maintaining the same outer dimensions, the energy of the cyclotron will be increased to 30 MeV, which will make it the most compact, non-superconducting, 30 MeV cyclotron design to date. Maximum beam current will match the TR-24 at 1 mA. With the size and footprint of a typical low energy PET cyclotron, this system will offer users a cost effective solution for a diversified facility capable of producing a wide spectrum of PET and SPECT radioisotopes for research and commercial distribution. (author)

Experimental monitoring of ozone production in a PET cyclotron facility

International Nuclear Information System (INIS)

Zanibellato, L.; Cicoria, G.; Pancaldi, D.; Boschi, S.; Mostacci, D.; Marengo, M.

2010-01-01

Ozone produced from radiolytic processes was investigated as a possible health hazard in the working environment at the University Hospital 'S.Orsola-Malpighi' PET facility. Intense radiation fields can generate ozone, known to be the most toxic gas produced by ionizing radiation around a particle accelerator. To evaluate ozone concentration in air, two different measurement campaigns were conducted with passive diffusion detectors. Comparison of the results with the concentration limits recommended by American Conference of Governmental Industrial Hygienists (ACGIH) demonstrated that ozone poses no health hazard to workers around a biomedical cyclotron.

Radiation monitoring in a self-shielded cyclotron installation

International Nuclear Information System (INIS)

Capaccioli, L.; Gori, C.; Mazzocchi, S.; Spano, G.

2002-01-01

As nuclear medicine is approaching a new era with the spectacular growth of PET diagnosis, the number of medical cyclotrons installed within the major hospitals is increasing accordingly. Therefore modern medical cyclotron are highly engineered and highly reliable apparatus, characterised with reduced accelerating energies (as the major goal is the production of fluorine 18) and often self-shielded. However specific dedicated monitors are still necessary in order to assure the proper radioprotection. At the Careggi University Hospital in Florence a Mini trace 10 MeV self-shielded cyclotron produced by General Electric has been installed in 2000. In a contiguous radiochemistry laboratory, the preparation and quality control of 1 8F DG and other radiopharmaceuticals takes place. Aim of this work is the characterisation and the proper calibration of the above mentioned monitors and control devices

Production of radiopharmaceuticals by cyclotrons

International Nuclear Information System (INIS)

Schmitz, F.; Van Naemen, J.; Monclus, M.; Van Gansbeke, B.; Kadiata, M.; Ekelmans, D.; Moray, M.; Penninckx, R.; Goldman, S.

2004-01-01

Companies specialized in the development and installation of accelerator-based systems dedicated to the medical applications brought on the market cyclotrons well fitted to the requests of the industrial community or universities and so covering every segment of the market. These machines are fully automatic, and need reduced maintenance; they are highly specialized for defined tasks. They can produce high beam intensity and realize dual beam irradiation. Also the prices are reducing considerably. The targets and the automatic system follow the same trend. Unfortunately, the flexibility of these devices for new area of research and development has been dramatically reduced. The growing number of PET cameras has increased the popularity of PET tracers used for nuclear imaging. Consequently, there is a growing demand for these radiopharmaceuticals compounds labeled with short-lived radioisotopes for clinical applications. From a research and development tool in the eighties, PET has now grown up to a clinical tool. Moreover, depending of the social welfare, reimbursement of some PET examinations is granted, which accelerates the trend for an extended use of PET tracers. Regulatory affairs try to establish and standardize the control on these radiopharmaceutical compounds produced in a growing number of local radio pharmacies owning a baby cyclotron. On the other hand, the attention of equipment suppliers was brought in the setting up of a total quality control follow up. These efforts were successively achieved by getting for instance the ISO 9001 certificate

NON-CONVENTIONAL PET NUCLIDES: PRODUCTION AND IMAGING

OpenAIRE

Laforest, Richard

2015-01-01

Abstract Medical cyclotrons are now commonly used for the production of PET nuclides by the (pn) reaction. These devices are typically capable of delivering 10-15 MeV protons beams at sufficiently high intensity for timely production of β+ decaying nuclides. Non-conventional PET nuclides have emerged recently and offers new opportunities for diagnostic and therapy drug discovery. In this paper, we will review the production capabilities for such nuclides at Washington University Medical Schoo...

ROKCY-12 (KCCH PET-dedicated cyclotron): main features and improvements

International Nuclear Information System (INIS)

Chai, J. S.; Kim, Y. S.; Yang, Y. T.; Jung, I. S.; Hong, S. S.; Lee, M. Y.; Jang, H. S.; Kim, J. H.

2002-01-01

In this paper, we describe the development of 13 MeV cyclotron (ROKCY-12) that can be used for a Position Emission Tomography(PET) purpose. This cyclotron with a maximum beam energy of 13 MeV can produce radio isotopes especially 18 F which has a relatively short half lifetime of 110 minutes. First, we show the beam characteristics can be used to carry out the operation of ROCKY-12. Based on this, a computer program has been developed to determine main cyclotron parameters such as cyclotron magnet, RF system, ion source, vacuum system and other cyclotron operation parameters. And then we show the result of design and manufacturing feature of ROKCY-12. By using this design program, one can determines magnet yoke geometry and the average magnetic fields etc. And then the three-dimensional computer program OPERA-3D has been invoked to determine magnet pole tips. Validity of the design can be seen by investigating magnetic fields, radial and vertical focusing frequencies as a function of the beam energy. In this paper, we show the results of cyclotron beam by ROCKY-12. We designed 77.3 MHz RF system and ion source system. We tested RF resonance each coupling methods. We show the result of RF design and prototype operation. Developed ion source is PIG type. We described our design methods and implementation. We report the result of getting negative hydrogen ion. Cyclotron controller asks inputs of every sensor and output of every instrument for notifying current condition to operator. It has independent controllers, for example DC power supply, vacuum system, beam profile system, beam extraction system, RF system, ion source, cooling unit and so on. Basically, each control system uses RS-485 for communication to main control computer. Consumers reward products and services that feature quality, originality, a distinct personality and charm. The International Standardization Organization (ISO) requires, as its mission, that we achieve competitive superiority by

Simulations of Beam Quality in a 13 MeV PET Cyclotron

Directory of Open Access Journals (Sweden)

A. Pramudita

2015-12-01

Full Text Available Simulation of the trajectories of negative hydrogen ion (H− beam in a 13 MeV PET cyclotron (DECY-13 were carried out by using the Runge-Kutta (RK4 approximation method and Scilab 5.4.1. The magnetic and electric fields were calculated using Opera-3d/TOSCA softwares at 1 mm resolution. The cyclotron is of a fourth-harmonics type, meaning that the acceleration occurs four times per cycle, with a radiofrequency (RF field of 77.66 MHz frequency and 40 kV amplitude. The calculations and simulations show that the maximum distance between the ion source and the puller is about 6 mm, while the maximum width of the beam at 13 MeV is about 10 mm, and the initial phase between the RF field and the beam ranges from -10° to 10°, with a yield of about 10% of the beam from the ion source getting accelerated to 13 MeV.

Radioisotope production with a medical cyclotron

International Nuclear Information System (INIS)

Silvester, D.J.

1974-01-01

The cyclotron of Hammersmith hospital in England was completed and started the operation in 1955. The feature is in its design operable at high beam current, reaching 500μA in internal beam and 300μA in external beam. In 1960's, twelve nuclides of radioactive pharmaceuticals were produced with the cyclotron. C-11, N-13 and O-15 have been used in the form of radioactive gases such as CO or H 2 O to test lung functions. F-18 has been used for bone scanning. K-43 is employed in the research of electrolyte balancing together with Na-24 and Br-77. Fe-52 is utilized in iron ion researches as a tracer. Cs-129 is highly evaluated as an isotope for imaging cardiac clogging part. Radioisotopes must be much more used in the examination of in vivo metabolic function. For this purpose, peculiarly labelled compounds should be further developed. It is welcome that the persons paying attention to the medical prospect of cyclotrons are increasing. The author hopes to continue his endeavour to find new products made with the cyclotron for human welfare. (Wakatsuki, Y.)

Solid targets and irradiation facilities for production of diagnostic and therapeutic radionuclides at the Debrecen cyclotron

International Nuclear Information System (INIS)

Tarkanyi, F.; Ando, L.; Szucs, Z.; Mahunka, I.; Kovacs, Z.

2000-01-01

The MGC-20E (NIIEFA, Leningrad, USSR) variable energy compact cyclotron (k=20) was installed in ATOMKI (Debrecen, Hungary) in 1985. Protons, deuterons, 3 He- and α-particles can be accelerated with currents up to 300 μA for internal irradiation and up to 50 μA for external beams. The establishment of the Cyclotron Laboratory was partly supported by the International Atomic Energy Agency. The application of the cyclotron is multipurpose: basic nuclear research, application of activation technique for analytical and wear studies, application of intense fast neutron source for agro-biological, bio-medical application and for radiation damage test of electronic components, and finally radioisotope production for medical diagnostics and for other scientific and applied fields. The cyclotron laboratory has six target rooms, a radiochemistry laboratory and a medical unit equipped with PET

Intelligent low-level RF system by non-destructive beam monitoring device for cyclotrons

Science.gov (United States)

Sharifi Asadi Malafeh, M. S.; Ghergherehchi, M.; Afarideh, H.; Chai, J. S.; Yoon, Sang Kim

2016-04-01

The project of a 10 MeV PET cyclotron accelerator for medical diagnosis and treatment was started at Amirkabir University of Technology in 2012. The low-level RF system of the cyclotron accelerator is designed to stabilize acceleration voltage and control the resonance frequency of the cavity. In this work an Intelligent Low Level Radio Frequency Circuit or ILLRF, suitable for most AVF cyclotron accelerators, is designed using a beam monitoring device and narrow band tunable band-pass filter. In this design, the RF phase detection does not need signal processing by a microcontroller.

General aspects of radiological protection to consider for the licensing a hospital cyclotron

International Nuclear Information System (INIS)

Andrada Contardi, F.A.; Fruttero, N.H.; Bozzo, R.H.; Moschella, E.G.

2010-01-01

The use of PET/PET-CT studies for a variety of diagnoses has increased significantly on a global scale. Modern medical cyclotrons must be placed in or near hospitals on account of the short radioactive half-life of the pharmaceuticals used in such studies. Many countries in Latin America are now licensing cyclotrons and laboratories for the production of radio-pharmaceuticals for the first time, and most are expected to have installations within the near future. This report outlines the general aspects of radiological protection important to consideration during the licensing of these facilities, and includes the following: general operation of the cyclotron and laboratory for the production of radiopharmaceuticals, safety systems (shielding, interlocks, ventilation, manual safety systems, alarms and monitors), and general aspects for licensing an installation (monitoring, accidental and incidental events, activation of components, etc.) and personnel. (authors) [es

Particle Accelerators for PET radionuclides

DEFF Research Database (Denmark)

Jensen, Mikael

2012-01-01

The requirements set for particle accelerators for production of radioactive isotopes for PET can easily be derived from first principles. The simple general need is for proton beams with energy in the region 10–20 MeV and current 20–100 microAmps. This is most reliably and cost-effectively achie......The requirements set for particle accelerators for production of radioactive isotopes for PET can easily be derived from first principles. The simple general need is for proton beams with energy in the region 10–20 MeV and current 20–100 microAmps. This is most reliably and cost......-effectively achieved by the well proven technology of the compact medical cyclotron, presently available from several companies. The main features of these cyclotrons are essential similar: resistive, sector focused iron magnets, internal negative ion sources and stripping extraction. The remaining differences between...... different manufacturers will be discussed the light of what is actually needed for a given PET site operation. Alternatives to the conventional cyclotron have been proposed and tested but have at present very limited use. These alternatives will be discussed, as well as the future possibilities of supplying...

Study of the neutron field in the vicinity of an unshielded PET cyclotron

International Nuclear Information System (INIS)

Mendez, R; Iniguez, M P; MartI-Climent, J M; Penuelas, I; Vega-Carrillo, H R; Barquero, R

2005-01-01

The neutron field in the proximity of an unshielded PET cyclotron was investigated during 18 F radioisotope production with an 18 MeV proton beam. Thermoluminescent detector (TLD) models TLD600 and TLD700 as well as Bonner moderating spheres were irradiated at different positions inside the vault room where the cyclotron is located to determine the thermal neutron flux, neutron spectrum and dose equivalent. Furthermore, from a combination of measurements and Monte Carlo simulations the neutron source intensity at the target was estimated. The resulting intensity is in good agreement with the IAEA recommendations. Neutron doses derived from the measured spectra were found to vary between 7 and 320 mSv per 1 μA h of proton-integrated current. Finally, gamma doses were determined from TLD700 readings and amounted to around 10% of the neutron doses

Study of the neutron field in the vicinity of an unshielded PET cyclotron

Energy Technology Data Exchange (ETDEWEB)

Mendez, R [Dpto. Fisica Teorica, Atomica y Optica, Universidad de Valladolid (Spain); Iniguez, M P [Dpto. Fisica Teorica, Atomica y Optica, Universidad de Valladolid (Spain); MartI-Climent, J M [Servicio de Medicina Nuclear, ClInica Universitaria de Navarra (Spain); Penuelas, I [Servicio de Medicina Nuclear, ClInica Universitaria de Navarra (Spain); Vega-Carrillo, H R [Dpto. Estudios Nucleares, IngenierIa Electrica, Matematicas, Universidad Autonoma de Zacatecas (Mexico); Barquero, R [Hospital Universitario RIo Hortega, Valladolid (Spain)

2005-11-07

The neutron field in the proximity of an unshielded PET cyclotron was investigated during {sup 18}F radioisotope production with an 18 MeV proton beam. Thermoluminescent detector (TLD) models TLD600 and TLD700 as well as Bonner moderating spheres were irradiated at different positions inside the vault room where the cyclotron is located to determine the thermal neutron flux, neutron spectrum and dose equivalent. Furthermore, from a combination of measurements and Monte Carlo simulations the neutron source intensity at the target was estimated. The resulting intensity is in good agreement with the IAEA recommendations. Neutron doses derived from the measured spectra were found to vary between 7 and 320 mSv per 1 {mu}A h of proton-integrated current. Finally, gamma doses were determined from TLD700 readings and amounted to around 10% of the neutron doses.

Seminar | Development of a PET Cyclotron Based Irradiation Setup for Proton Radiobiology | 25 June

CERN Multimedia

2015-01-01

Sharif Hasan Mahmoud Ghithan, a Palestinian postdoctoral researcher at the Laboratory of Instrumentation and Experimental Particle Physics (Portugal), will discuss the development of an out-of-yoke irradiation setup using the proton beam from a cyclotron that ordinarily produces radioisotopes for Positron Emission Tomography (PET). The speaker will also discuss possible future use of the results of this research for CERN’s new LEIR biomedical facility. The seminar will be proposed in the framework of a meeting of the CERN Medical Applications Study Group.   25 June, 2 p.m. to 3 p.m. Room 13-2-005 ABSTRACT: In this new irradiation setup, the current from a 20 mm thick aluminum transmission foil is read out by homemade transimpedance electronics, providing online dose information. The main monitoring variables, delivered in real-time, include beam current, integrated charge and dose rate. Hence the dose and integrated current delivered at a given instant to an experimental setu...

First-in-Human PET/CT Imaging of Metastatic Neuroendocrine Neoplasms with Cyclotron-Produced 44Sc-DOTATOC: A Proof-of-Concept Study.

Science.gov (United States)

Singh, Aviral; van der Meulen, Nicholas P; Müller, Cristina; Klette, Ingo; Kulkarni, Harshad R; Türler, Andreas; Schibli, Roger; Baum, Richard P

2017-05-01

44 Sc is a promising positron emission tomography (PET) radionuclide (T 1/2  = 4.04 hours, E β+average  = 632 keV) and can be made available, using a cyclotron production route, in substantial quantities as a highly pure product. Herein, the authors report on a first-in-human PET/CT study using 44 Sc-DOTATOC prepared with cyclotron-produced 44 Sc. The production of 44 Sc was carried out through the 44 Ca(p,n) 44 Sc nuclear reaction at Paul Scherrer Institut, Switzerland. After separation, 44 Sc was shipped to Zentralklinik Bad Berka, Germany, where radiolabeling was performed, yielding radiochemically pure 44 Sc-DOTATOC. Two patients, currently followed up after peptide receptor radionuclide therapy of metastatic neuroendocrine neoplasms, participated in this proof-of-concept study. Blood sampling was performed before and after application of 44 Sc-DOTATOC. PET/CT acquisitions, performed at different time points after injection of 44 Sc-DOTATOC, allowed detection of even very small lesions on delayed scans. No clinical adverse effects were observed and the laboratory hematological, renal, and hepatic profiles remained unchanged. In this study, cyclotron-produced 44 Sc was used in the clinic for the first time. It is attractive for theranostic application with 177 Lu, 90 Y, or 47 Sc as therapeutic counterparts. 44 Sc-based radiopharmaceuticals will be of particular value for PET facilities without radiopharmacy, to which they can be shipped from a centralized production site.

A light, superconducting H- cyclotron for medical diagnostics and neutron radiography

International Nuclear Information System (INIS)

Finlan, M.F.; Kruip, M.; Wilson, M.N.

1987-01-01

Oxford Instruments, working in close collaboration with Amersham International are developing a compact, lightweight, low radiation field superconducting cyclotron. The combination of superconductivity, H - acceleration and no internal yoke as such makes this possible. It is intended for use as a generator of short half lived isotopes for use in hospitals for PET and other imaging procedures, for use in industrial PET imaging, and as a neutron generator for neutron radiography. With a weight of 2000 kg, it is transportable and comparitively easy to handle and is capable in the 17 MeV version of generating 1.8 10 13 neutrons/second for neutron radiography. (author)

An investigation into the technical feasibility of cyclotron production of technetium-99m

International Nuclear Information System (INIS)

Egan, G.F.; Lagunas-Solar, M.C.

1994-01-01

The role of technetium-99m in nuclear medicine is well established with 80 per cent to 90 per cent of all nuclear medicine studies utilising this isotope. Technetium-99m is currently produced from nuclear reactors via production of the parent radionuclide molybdenum-99. The reactor production of 99m Tc has both significant financial and environmental costs, with unresolved problems in the areas of radioactive waste disposal and reactor decommissioning. Recent scientific publications have indicated that medical quality 99m Tc may be produced using cyclotrons without having the associated problems of waste disposal and decommissioning. Further scientific research is now required to demonstrate the feasibility of this cyclotron production technique. A collaboration between the Cyclotron and PET Centre, Austin Hospital, the National Medical Cyclotron, ANSTO, Sydney, and the Crocker Nuclear Laboratory, University of California, Davis, USA has been proposed. The general objective of the proposed collaboration is to acquire additional scientific data to evaluate the 99m Tc cyclotron production method and to determine the feasibility of cyclotron technology for Australian nuclear medicine. 16 refs., 2 tabs

Cyclotrons in developing countries

International Nuclear Information System (INIS)

Vera Ruiz, Hernan

2004-01-01

Cyclotron accelerators are prolific sources of charged particle for the production of radionuclides and have become an essential tool in the practice of modern nuclear medicine by providing reliable radiotracers for SPECT and PET studies. In a recent survey conducted by the IAEA in 2001, the growth in the number of cyclotron facilities installed in laboratories and hospitals in developed as well as developing countries was recorded. This trend, which started in the late 70's, continues in the present time also and all indications are that it will continue in the next five to ten years. The reasons for this growth are several: technology involved has become more user or 'hospital friendly', third party reimbursement for several clinical studies based on F-18 PET radiopharmaceuticals at least in some of the advanced countries started in 1998 and above all, the clear irrefutable and demonstrable conclusion of the positive cost/benefit outcomes of PET studies in the field of oncology to a lesser degree, thus far, for cardiology and neurology. It is however recognizable that the overall financial cost of the technology, which comprises the premises to house the facility, the cyclotron accelerator, the corresponding radiochemistry and quality control equipment and the PET cameras can be nevertheless an expensive proposition that requires careful advance planning. This fact is even more relevant when the facility is planned for installation in a developing country, which, frequently, in addition to having a lack of sufficient financial resources, do have shortage of qualified human resources to efficiently run the facility. In spite of the above, it is fact that more and more public as well as private organizations in the developing countries are setting up cyclotron/PET programmes or are seriously considering the installation of such a facility

Evaluation of Radiation Exposure to Staff and Environment Dose from [18F]-FDG in PET/CT and Cyclotron Center using Thermoluminescent Dosimetry.

Science.gov (United States)

Zargan, S; Ghafarian, P; Shabestani Monfared, A; Sharafi, A A; Bakhshayeshkaram, M; Ay, M R

2017-03-01

PET/CT imaging using [18F]-FDG is utilized in clinical oncology for tumor detecting, staging and responding to therapy procedures. Essential consideration must be taken for radiation staff due to high gamma radiation in PET/CT and cyclotron center. The aim of this study was to assess the staff exposure regarding whole body and organ dose and to evaluate environment dose in PET/CT and cyclotron center. 80 patients participated in this study. Thermoluminescence, electronic personal dosimeter and Geiger-Muller dosimeter were also utilized for measurement purpose. The mean annual equivalent organ dose for scanning operator with regard to lens of eyes, thyroid, breast and finger according to mean±SD value, were 0.262±0.044, 0.256±0.046, 0.257±0.040 and 0.316±0.118, respectively. The maximum and minimum estimated annual whole body doses were observed for injector and the chemist group with values of (3.98±0.021) mSv/yr and (1.64±0.014) mSv/yr, respectively. The observed dose rates were 5.67 µSv/h in uptake room at the distance of 0.5 meter from the patient whereas the value 4.94 and 3.08 µSv/h were recorded close to patient's head in PET/CT room and 3.5 meter from the reception desk. In this study, the injector staff and scanning operator received the first high level and second high level of radiation. This study confirmed that low levels of radiation dose were received by all radiation staff during PET/CT procedure using 18F-FDG due to efficient shielding and using trained radiation staff in PET/CT and cyclotron center of Masih Daneshvari hospital.

Optimization approach for saddling cost of medical cyclotrons with fuzziness

International Nuclear Information System (INIS)

Abass, S.A.; Massoud, E.M.A.

2007-01-01

Most radiation fields are combinations of different kinds of radiation. The radiations of most significance are fast neutrons, thermal neutrons, primary gammas and secondary gammas. Thermos's composite shielding materials are designed to attenuate these types of radiation. The shielding design requires an accurate cost-benefit analysis based on uncertainty optimization technique. The theory of fuzzy sets has been employed to formulate and solve the problem of cost-benefit analysis of medical cyclotron. This medical radioisotope production cyclotron is based in Sydney, Australia

The establishment of the Rossendorf PET Center

International Nuclear Information System (INIS)

Johannsen, B.; Steinbach, J.

1993-01-01

The objectives of the newly established Positron Emission Tomography (PET) Center at the Institut of Bioinorganic and Radiopharmaceutical Chemistry in Rossendorf are described, referring to medical research, development of tracers and radiochemicals developments, biochemistry and future prospects of PET in Rossendorf. The layout of the center is also described considering the cyclotron and targetry, the transport system, the radiopharmaceutical laboratories and the tomograph. A schedule for project development is going. (BBR)

Operational health and physics service during the maintenance of the Australian National Medical Cyclotron

International Nuclear Information System (INIS)

Mukherjee, B.

1994-01-01

Modern Medical Cyclotrons use intense beams of high energy protons or deuterons to produce large activities of short and medium lived radionuclides. After continuous operation for prolonged periods the Cyclotron components become activated through various nuclear interactions therefore, the risk of personal radiation hazard while handling such activated cyclotron components is high. This paper describes all operational aspects of the Health Physics service evolved during the first preventative maintenance program of the Australian National Medical Cyclotron, which took place in June 1993. 5 refs., 3 tabs., 2 figs

Cyclotrons and positron emitting radiopharmaceuticals

International Nuclear Information System (INIS)

Wolf, A.P.; Fowler, J.S.

1984-01-01

The state of the art of Positron Emission Tomography (PET) technology as related to cyclotron use and radiopharmaceutical production is reviewed. The paper discusses available small cyclotrons, the positron emitters which can be produced and the yields possible, target design, and radiopharmaceutical development and application. 97 refs., 12 tabs

Possibilities of 140Nd production by the VINCY cyclotron

International Nuclear Information System (INIS)

Comor, J.J.; Dakovic, M.

2000-01-01

Application of positron emission tomography (PET) in modern medical diagnosis relies on the application of short lived radionuclides 11 C, 13 N, 15 O and 18 F, presuming their production in the close vicinity of the PET camera. Application of long-lived positron emitters would enable the regional distribution of PET radiopharmaceuticals, which would significantly lower the price of PET diagnosis, as well as enable its application in fields currently inhibited by the short half-life of available positron emitters. One of the candidates for application in PET is the generator system 140 Nd/ 140 Pr, due to the long half-life of 140 Nd (3,37 days). Theoretical calculations confirm that this radionuclide can be produced with high yields by protons accelerated to energies bellow 30 MeV. Due to its optimal operating parameters, the VINCY Cyclotron could produce enough 140 Nd for its regional distribution to a number of PET centers (author)

Cyclotrons and positron emitting radiopharmaceuticals

Energy Technology Data Exchange (ETDEWEB)

Wolf, A.P.; Fowler, J.S.

1984-01-01

The state of the art of Positron Emission Tomography (PET) technology as related to cyclotron use and radiopharmaceutical production is reviewed. The paper discusses available small cyclotrons, the positron emitters which can be produced and the yields possible, target design, and radiopharmaceutical development and application. 97 refs., 12 tabs. (ACR)

Regulatory requirements for designing PET-CT facility in India

International Nuclear Information System (INIS)

Tandon, Pankaj

2010-01-01

In India, cyclotron-produced radionuclides are gaining importance in molecular imaging in Nuclear Medicine (NM) departments. The importance of this modality among others is due to the fact that it provides valuable clinical information, which was lacking in other available modalities. Presently, every well-established hospital would like to procure Medical Cyclotron or positron emission tomography-computed tomography (PET-CT) facility in their NM department. Because cyclotron-produced radionuclides have higher energy than the other routinely used radionuclides for diagnosis, it becomes essential for the user to know about the regulatory requirement and radiation safety precautions that one has to take for the installation of this new modality in their premises. The various stages of approval of PET-CT facility by the Atomic Energy Regulatory Board (AERB) and important steps that one has to know/follow before planning for this new facility are summarized

Medical cyclotrons

International Nuclear Information System (INIS)

Wolf, A.P.

1976-01-01

Cyclotrons as tools for therapy and for the production of radionuclides for use in nuclear medicine have been extensively reviewed in the literature. The current world status with respect to cyclotrons used primarily for research, development and application in nuclear medicine is reviewed here in the context of geographical distribution and type of use, presently available commercial types, machine characteristics and trends. Aspects of design requirements from a user perspective such as machine, beam and target characteristics are covered. Some special problems concerning many factors which can lead to effective production of the desired radionuclide or product are considered in light of machine characteristics. Consideration is also given to future directions for accelerators in nuclear medicine

Measurements and evaluation of the risks due to external radiation exposures and to intake of activated elements for operational staff engaged in the maintenance of medical cyclotrons.

Science.gov (United States)

Calandrino, R; del Vecchio, A; Parisi, R; Todde, S; De Felice, P; Savi, A; Pepe, A; Mrskova, A

2010-06-01

The aim of this paper is to assess the activation phenomena and to evaluate the risk of external exposure and intake doses for the maintenance staff of two medical cyclotrons. Two self-shielded cyclotrons are currently operating in the facility for the routine production of (11)C and (18)F. Four radiochemistry laboratories are linked to the cyclotrons by means of shielded radioisotope delivery lines. Radiopharmaceuticals are prepared both for the PET Diagnostic Department, where four CT-PET scanners are operating with a mean patient workload of 40 d(-1) and for [(18)F]FDG external distribution, to provide radiopharmaceuticals for other institutions. In spite of the fact that air contamination inside the radiochemistry laboratories during the synthesis represents the largest 'slice of the pie' in the evaluation of annual intake dose, potential contamination due to the activated particulate, generated during cyclotron irradiation by micro-corrosion of targets and other components potentially struck by the proton beam and generated neutrons, should be considered. In this regard, the most plausible long-lived (T(1/2) > 30 d) radioisotopes formed are: (97)Tc, (56)Co, (57)Co, (58)Co, (60)Co, (49)V, (55)Fe, (109)Cd, (65)Zn and (22)Na. The results for the operating personnel survey has revealed only low-level contamination for (65)Zn in one test, together with minor (18)F intake, probably due to the environmental dispersion of the radioisotope during the [(18)F]FDG synthesis.

Optimisation of the radiation shielding of medical cyclotrons using a genetic algorithm

International Nuclear Information System (INIS)

Mukherjee, Bhaskar

2000-01-01

Effective radiation shielding is imperative for safe operation of modern Medical Cyclotrons producing large activities of short-lived radioisotopes on a commercial basis. The optimal cyclotron shielding design demands a careful balance between the radiological, economical and often the sociopolitical factors. One is required to optimize the cost of radiation protection and the cost of radiological-health detriment. The cost of radiation protection depends explicitly on a) the nature of the radiation field produced by the cyclotron, b) the cyclotron operation condition, c) the cost of shielding material, d) the level of dose reduction, e) the projected net revenue from the sale of the radioisotopes, and f) the depreciation rate of the cyclotron facility. The Genetic Algorithm (GA) is used for a cost -benefit analysis of this problem. The GA is a mathematical technique that emulates the Darwinian Evolution paradigm. It is ideally suited to search for a global optimum in a large multi-dimensional solution space, having demonstrated strength compared to the classical analytical methods. Furthermore the GA method runs on a PC in a Windows environment. This paper highlights an interactive spreadsheet macro program for the cost benefit analysis of the optimize Medical Cyclotron shielding using a GA search engine. (author)

Cyclotron will not survive yet this year without state support

International Nuclear Information System (INIS)

Marcan, P.

2005-01-01

In this paper the project of the Cyclotron Center of the Slovak republic is described. On the basis of this project the state joint-stock company Biont was constituted. Small cyclotron is in operation; big cyclotron is in process of manufacture and it will be put in operation in 2007. Small cyclotron will be used for production of radiopharmaceuticals. Positron emission tomograph (PET) in Oncological Institute of St. Elizabeth (in Bratislava) and gamma camera in Central Military Hospital (in Ruzomberok) are constituents of the Biont. The PET will be also in Biont. The hadron therapy of ophthalmic tumors is planned. Financial plans of the Biont up to 2009 are presented

Study of the source term of radiation of the CDTN GE-PET trace 8 cyclotron with the MCNPX code

Energy Technology Data Exchange (ETDEWEB)

Benavente C, J. A.; Lacerda, M. A. S.; Fonseca, T. C. F.; Da Silva, T. A. [Centro de Desenvolvimento da Tecnologia Nuclear / CNEN, Av. Pte. Antonio Carlos 6627, 31270-901 Belo Horizonte, Minas Gerais (Brazil); Vega C, H. R., E-mail: jhonnybenavente@gmail.com [Universidad Autonoma de Zacatecas, Unidad Academica de Estudios Nucleares, Cipres No. 10, Fracc. La Penuela, 98068 Zacatecas, Zac. (Mexico)

2015-10-15

Full text: The knowledge of the neutron spectra in a PET cyclotron is important for the optimization of radiation protection of the workers and individuals of the public. The main objective of this work is to study the source term of radiation of the GE-PET trace 8 cyclotron of the Development Center of Nuclear Technology (CDTN/CNEN) using computer simulation by the Monte Carlo method. The MCNPX version 2.7 code was used to calculate the flux of neutrons produced from the interaction of the primary proton beam with the target body and other cyclotron components, during 18F production. The estimate of the source term and the corresponding radiation field was performed from the bombardment of a H{sub 2}{sup 18}O target with protons of 75 μA current and 16.5 MeV of energy. The values of the simulated fluxes were compared with those reported by the accelerator manufacturer (GE Health care Company). Results showed that the fluxes estimated with the MCNPX codes were about 70% lower than the reported by the manufacturer. The mean energies of the neutrons were also different of that reported by GE Health Care. It is recommended to investigate other cross sections data and the use of physical models of the code itself for a complete characterization of the source term of radiation. (Author)

Electroplating targets for production of unique PET radionuclides

International Nuclear Information System (INIS)

Bui, V.; Sheh, Y.; Finn, R.

1994-01-01

The past decade has witnessed the applications of Positron Emission Tomography (PET) evolving from a purely research endeavour to a procedure which has specific clinical applications in the areas of cardiology, neurology and oncology. The growth of PET has been facilitated by developments in medical instrumentation and radiopharmaceutical chemistry efforts. Included in this latter effort has been the low energy accelerator production and processing of unique PET radionuclides appropriate for the radiolabeling of biomolecules i.e. monoclonal antibodies and pepetides. The development and application of electroplated targets of antimony and copper for the production of iodine-124 and gallium-66 respectively, utilizing the Memorial Sloan-Kettering Cancer Center cyclotron are examples of target design and development applicable to many medical accelerators

Microeconomics of introduction of a PET system based on the revised Japanese national insurance reimbursement system

International Nuclear Information System (INIS)

Abe, Katsumi; Kosuda, Shigeru; Kusano, Shoichi; Nagata, Masayoshi

2003-01-01

It is crucial to evaluate an annual balance beforehand when an institution installs a PET system because the revised Japanese national insurance reimbursement system set the cost of a FDG PET study as 75,000 yen. A break-even point was calculated in an 8-hour or a 24-hour operation of a PET system, based on the total costs reported. The break-even points were as follows: 13.4, 17.7, 22.1 studies per day for the 1 cyclotron-1 PET camera, 1 cyclotron-2 PET cameras, 1 cyclotron-3 PET cameras system, respectively, in an ordinary PET system operation of 8 hours. The break-even points were 19.9, 25.5, 31.2 studies per day for the 1 cyclotron-1 PET camera, 1 cyclotron-2 PET cameras, 1 cyclotron-3 PET cameras system, respectively, in a full PET system operation of 24 hours. The results indicate no profit would accrue in an ordinary PET system operation of 8 hours. The annual profit and break-even point for the total cost including the initial investment would be respectively 530 million yen and 2.8 years in a 24-hour operation with 1 cyclotron-3 PET cameras system. (author)

[Microeconomics of introduction of a PET system based on the revised Japanese National Insurance reimbursement system].

Science.gov (United States)

Abe, Katsumi; Kosuda, Shigeru; Kusano, Shoichi; Nagata, Masayoshi

2003-11-01

It is crucial to evaluate an annual balance before-hand when an institution installs a PET system because the revised Japanese national insurance reimbursement system set the cost of a FDG PET study as 75,000 yen. A break-even point was calculated in an 8-hour or a 24-hour operation of a PET system, based on the total costs reported. The break-even points were as follows: 13.4, 17.7, 22.1 studies per day for the 1 cyclotron-1 PET camera, 1 cyclotron-2 PET cameras, 1 cyclotron-3 PET cameras system, respectively, in an ordinary PET system operation of 8 hours. The break-even points were 19.9, 25.5, 31.2 studies per day for the 1 cyclotron-1 PET camera, 1 cyclotron-2 PET cameras, 1 cyclotron-3 PET cameras system, respectively, in a full PET system operation of 24 hours. The results indicate no profit would accrue in an ordinary PET system operation of 8 hours. The annual profit and break-even point for the total cost including the initial investment would be respectively 530 million yen and 2.8 years in a 24-hour operation with 1 cyclotron-3 PET cameras system.

Standardized high current solid targets for cyclotron production of radionuclides

International Nuclear Information System (INIS)

Al-Jammaz, Ibrahim

2000-01-01

The Cyclotron and Radiopharmaceuticals Department (CRP) is an advanced and modern facility that encompasses two essential components: radioisotope research, and radiopharmaceuticals manufacturing. Radiopharmaceuticals manufacturing program is not only quite unique, but also an essential component of King Faisal Specialist Hospital and Research Center (KFSH and RC) in providing quality patient care for the population of the Kingdom. Accurate diagnosis and therapy with medical imaging equipment requires quality radiopharmaceuticals that are available readily and with reliability. The CRP Department provides that quality and reliability. Research activities of the CRP Department are focused on developing new radiotracers with potential usefulness in biomedical research and clinical applications. Research projects consist of: developing cyclotron targetry for radioisotope production; developing synthesis methods for radiolabeling biomolecules; and developing analytical methods for quality control. The CRP Department operates a semi-commercial radiopharmaceuticals manufacturing program that supplies the diagnostic radioactive products to several hospitals in the Kingdom and neighboring countries. These products for clinical applications are produced according to the international standards of Good Manufacturing Practices of quality and efficacy. At the heart of the radioisotope program is a medium energy cyclotron capable of accelerating a number of particles for transformation of non-radioactive atoms into radionuclides that are the primary sources for research and development activities, and for preparing radiopharmaceuticals. In addition to having the only cyclotron facility in the region, KFSH and RC also has the only Positron Emission Tomography Center (PET) in this part of the world. This combination of cyclotron and the ultra modern PET facility translates into advanced and specialized care for the patients at KFSH and RC

Neutron field inside a PET Cyclotron vault room

International Nuclear Information System (INIS)

Vega C, H.R.; Mendez, R.; Iniguez, M.P.; Climent, J.M.; Penuelas, I.; Barquero, R.

2006-01-01

The neutron field around a Positron Emission Tomography cyclotron was investigated during 18 F radioisotope production with an 18 MeV proton beam. In this study the Ion Beam Application cyclotron, model Cyclone 18/9, was utilized. Measurements were carried out with a Bonner sphere neutron spectrometer with pairs of thermoluminescent dosemeters (TLD600 and TLD700) as thermal neutron detector. The TLDs readouts were utilized to unfold the neutron spectra at three different positions inside the cyclotron's vault room. With the spectra the Ambient dose equivalent was calculated. Neutron spectra unfolding were performed with the BUNKIUT code and the UTA4 response matrix. Neutron spectra were also determined by Monte Carlo calculations using a detailed model of cyclotron and vault room. (Author)

Beam tracking simulation in the central region of a 13 MeV PET cyclotron

Science.gov (United States)

Anggraita, Pramudita; Santosa, Budi; Taufik, Mulyani, Emy; Diah, Frida Iswinning

2012-06-01

This paper reports the trajectories simulation of proton beam in the central region of a 13 MeV PET cyclotron, operating with negative proton beam (for easier beam extraction using a stripper foil), 40 kV peak accelerating dee voltage at fourth harmonic frequency of 77.88 MHz, and average magnetic field of 1.275 T. The central region covers fields of 240mm × 240mm × 30mm size at 1mm resolution. The calculation was also done at finer 0.25mm resolution covering fields of 30mm × 30mm × 4mm size to see the effects of 0.55mm horizontal width of the ion source window and the halted trajectories of positive proton beam. The simulations show up to 7 turns of orbital trajectories, reaching about 1 MeV of beam energy. The distribution of accelerating electric fields and magnetic fields inside the cyclotron were calculated in 3 dimension using Opera3D code and Tosca modules for static magnetic and electric fields. The trajectory simulation was carried out using Scilab 5.3.3 code.

Medical radioisotopes production at the isochronous cyclotron in Alma-Ata

International Nuclear Information System (INIS)

Arzumanov, A.A.; Batischev, V.N.; Gladun, V.K.; Kochetkov, V.L.

1988-01-01

High efficiency cyclotron operations (up to 5200 hours of beam time a year) considerably increased the possibility to perform both fundamental and applied scientific work. There appeared possibility to accelerate protons in a wide energy range from 6 to 30 MeV and realize correspondingly the nuclear reactions up to (A, 3n). This paper reports that among different applied tasks performed at the cyclotron the special program of cyclotron production of short-lived medical radioisotopes iodine-123, thallium-201, cadmium-109 in the first place and some others to satisfy clinic needs of Alma-Ata and its region has special importance. In accordance with this program the preparation to produce iodine-123 is being held and regular production of Thallium chloride, thallium-201 pharmaceptical is started

Cost benefit analysis of the radiological shielding of medical cyclotrons using a genetic algorithm

International Nuclear Information System (INIS)

Mukherjee, Bhaskar

2001-01-01

Adequate radiation shielding is vital to the safe operation of modern commercial medical cyclotrons producing large yields of short-lived radioisotopes. The radiological shielding constitutes a significant capital investment for any new cyclotron-based radioisotope production facility; hence, the shielding design requires an accurate cost-benefit analysis often based on a complex multi-variant optimization technique. This paper demonstrates the application of a Genetic Algorithm (GA) for the optimum design of the high yield target cave of a Medical Cyclotron radioisotope production facility based in Sydney, Australia. The GA is a novel optimization technique that mimics the Darwinian Evolution paradigm and is ideally suited to search for global optima in a large multi-dimensional solution space

Verification of effectiveness of borated water shield for a cyclotron type self-shielded; Verificacao da eficacia da blindagem de agua borada construida para um acelerador ciclotron do tipo autoblindado

Energy Technology Data Exchange (ETDEWEB)

Videira, Heber S.; Burkhardt, Guilherme M.; Santos, Ronielly S., E-mail: heber@cyclopet.com.br [Cyclopet Radiofarmacos Ltda., Curitiba, PR (Brazil); Passaro, Bruno M.; Gonzalez, Julia A.; Santos, Josefina; Guimaraes, Maria I.C.C. [Universidade de Sao Paulo (HCFMRP/USP), Sao Paulo, SP (Brazil). Faculdade de Medicina. Hospital das Clinicas; Lenzi, Marcelo K. [Universidade Federal do Parana (UFPR), Curitina (Brazil). Programa de Pos-Graduacao em Engenharia Quimica

2013-04-15

The technological advances in positron emission tomography (PET) in conventional clinic imaging have led to a steady increase in the number of cyclotrons worldwide. Most of these cyclotrons are being used to produce {sup 18}F-FDG, either for themselves as for the distribution to other centers that have PET. For there to be safety in radiological facilities, the cyclotron intended for medical purposes can be classified in category I and category II, ie, self-shielded or non-shielded (bunker). Therefore, the aim of this work is to verify the effectiveness of borated water shield built for a cyclotron accelerator-type Self-shielded PETtrace 860. Mixtures of water borated occurred in accordance with the manufacturer’s specifications, as well as the results of the radiometric survey in the vicinity of the self-shielding of the cyclotron in the conditions established by the manufacturer showed that radiation levels were below the limits. (author)

Decontamination of the activation product based on a legal revision of the cyclotron vault room on the non-self-shield compact medical cyclotron

International Nuclear Information System (INIS)

Komiya, Isao; Umezu, Yoshiyuki; Fujibuchi, Toshiou; Nakamura, Kazumasa; Baba, Shingo; Honda, Hiroshi

2016-01-01

The non-self-shield compact medical cyclotron and the cyclotron vault room were in operation for 27 years. They have now been decommissioned. We efficiently implemented a technique to identify an activation product in the cyclotron vault room. Firstly, the distribution of radioactive concentrations in the concrete of the cyclotron vault room was estimated by calculation from the record of the cyclotron operation. Secondly, the comparison of calculated results with an actual measurement was performed using a NaI scintillation survey meter and a high-purity germanium detector. The calculated values were overestimated as compared to the values measured using the Nal scintillation survey meter and the high-purity germanium detector. However, it could limit the decontamination area. By simulating the activation range, we were able to minimize the concrete core sampling. Finally, the appropriate range of radioactivated area in the cyclotron vault room was decontaminated based on the results of the calculation. After decontamination, the radioactive concentration was below the detection limit value in all areas inside the cyclotron vault room. By these procedures, the decommissioning process of the cyclotron vault room was more efficiently performed. (author)

Business administration of PET facilities. A nationwide survey for prices of PET screening and a cost analysis of three facilities

International Nuclear Information System (INIS)

Mitsutake, Naohiro; Fujii, Ryo; Oku, Shinya; Furui, Yuji; Yasunaga, Hideo

2007-01-01

The purpose of this study is to analyze the business administration of positron emission tomography (PET) facilities based on the survey of the price of PET cancer screening and cost analysis of PET examination. The questionnaire survey of the price of PET cancer screening was implemented for all PET facilities in Japan. Cost data of PET examination, including fixed costs and variable costs, were obtained from three different medical institutions. The marked price of the PET cancer screening was yen111,499 in average, and the most popular range of prices was between yen80,000 and yen90,000. Costs of PET per examination were accounted for yen110,675, yen79,158 and yen111,644 in facility A, B and C, respectively. The results suggested that facilities with two or more PET/CT per a cyclotron could only secure profits. In Japan, the boom in PET facility construction could not continue in accordance with increasing number of PET facilities. It would become more essential to analyze the appropriate distribution of PET facilities and the adequate amount of PET procedures from the perspective of efficient utilization of the PET equipments and supply of PET-related healthcare. (author)

Use of cyclotrons in medical research: Past, present, future

Science.gov (United States)

Smathers, James B.; Myers, Lee T.

1985-05-01

The use of cyclotrons in medical research started in the late 1930s with the most prominent use being neutron irradiation in cancer therapy. Due to a lack of understanding of the biological effect of neutrons, the results were less than encouraging. In the 1940s and 1950s, small cyclotrons were used for isotope production and in the mid 60s, the biological effect of neutrons was more thoroughly studied, with the result that a second trial of neutron therapy was initiated at Hammersmith Hospital, England. Concurrent with this, work on the use of high energy charged particles, initially protons and alphas, was initiated in Sweden and Russia and at Harvard and Berkeley. The English success in neutron therapy led to some pilot studies in the USA using physics cyclotrons of various energies and targets. These results in turn lead to the present series of machines presently being installed at M.D. Anderson Hospital (42 MeV), Seattle (50 MeV) and UCLA (46 MeV). The future probably bodes well for cyclotrons at the two extremes of the energy range. For nuclear medicine the shift is away from the use of multiple isotopes, which requires a large range of particles and energies to 11C, 13N, 15O, and 18F, which can be incorporated in metabolic specific compounds and be made with small 8-10 MeV p+ "table top" cyclotrons. For tumor therapy machines of 60 MeV or so will probably be the choice for the future, as they allow the treatment of deep seated tumors with neutrons and the charged particles have sufficient range to allow the treatment of ocular tumors.

77 FR 40355 - Workshop on Pet Medications Issues

Science.gov (United States)

2012-07-09

... veterinarians. Over the last ten years, brick-and-mortar and online retail and pharmacy entities (hereinafter... and therapeutic treatments for pets; pet medications have become available at some online and brick- and-mortar retail outlets; and veterinarians and others have increasingly emphasized preventative pet...

Evaluation of {sup 18}F radioactive concentration in exhaust at cyclotron facility at Chosun University

Energy Technology Data Exchange (ETDEWEB)

Jeong, Cheol Ki; Jang, Han; Lee, Goung Jin [Dept. of Nuclear Engineering, Chsoun University, Gwangju (Korea, Republic of)

2016-11-15

the recent prevalence of PET examinations in Korea has led to an increase in the number of cyclotrons. the medical isotope 18F produced in most cyclotron facilities currently operating in Korea is emitted into the environment during the production of [{sup 18}F]FdG, a cancerdiagnosis reagent. the amount of [{sup 18}F]FdG synthesized determines the radioactive concentration of {sup 18}F in the exhaust. at some facilities, this amount temporarily exceeds the emission limit. In this study, we evaluated the {sup 18}F radioactivity concentration in the exhaust from the cyclotron facility at chosun university. the {sup 18}F radioactivity concentration was measured using an air sampler and a hPGe semiconductor detector. the measurements showed that the radioactive concentration of {sup 18}F in the exhaust at the cyclotron facility at Chosun university was the highest during [{sup 18}F]FdG synthesis but remained under the legal limit of 2,000 Bq m{sup -3}.

The cyclotron laboratory and the RFQ accelerator in Bern

International Nuclear Information System (INIS)

Braccini, S.; Ereditato, A.; Kreslo, I.; Nirkko, M.; Weber, M.; Scampoli, P.; Bremen, K. von

2013-01-01

Two proton accelerators have been recently put in operation in Bern: an 18 MeV cyclotron and a 2 MeV RFQ linac. The commercial IBA 18/18 cyclotron, equipped with a specifically conceived 6 m long external beam line ending in a separate bunker, will provide beams for routine 18-F and other PET radioisotope production as well as for novel detector, radiation biophysics, radioprotection, radiochemistry and radiopharmacy developments. The accelerator is embedded into a complex building hosting two physics laboratories and four Good Manufacturing Practice (GMP) laboratories. This project is the result of a successful collaboration between the Inselspital, the University of Bern and private investors, aiming at the constitution of a combined medical and research centre able to provide the most cutting-edge technologies in medical imaging and cancer radiation therapy. The cyclotron is complemented by the RFQ with the primary goals of elemental analysis via Particle Induced Gamma Emission (PIGE), and the detection of potentially dangerous materials with high nitrogen content using the Gamma-Resonant Nuclear Absorption (GRNA) technique. In this context, beam instrumentation devices have been developed, in particular an innovative beam profile monitor based on doped silica fibres and a setup for emittance measurements using the pepper-pot technique. On this basis, the establishment of a proton therapy centre on the campus of the Inselspital is in the phase of advanced study

The cyclotron laboratory and the RFQ accelerator in Bern

Energy Technology Data Exchange (ETDEWEB)

Braccini, S.; Ereditato, A.; Kreslo, I.; Nirkko, M.; Weber, M. [Albert Einstein Center for Fundamental Physics, Laboratory for High Energy Physics (LHEP), University of Bern, Sidlerstrasse 5, CH-3012 Bern (Switzerland); Scampoli, P. [Albert Einstein Center for Fundamental Physics, Laboratory for High Energy Physics (LHEP), University of Bern, Sidlerstrasse 5, CH-3012 Bern, Switzerland and Department of Physical Sciences, University Federico II, Via Cintia, I-60126 Napoli (Italy); Bremen, K. von [SWAN Isotopen AG, Inselspital, CH-3010 Bern (Switzerland)

2013-07-18

Two proton accelerators have been recently put in operation in Bern: an 18 MeV cyclotron and a 2 MeV RFQ linac. The commercial IBA 18/18 cyclotron, equipped with a specifically conceived 6 m long external beam line ending in a separate bunker, will provide beams for routine 18-F and other PET radioisotope production as well as for novel detector, radiation biophysics, radioprotection, radiochemistry and radiopharmacy developments. The accelerator is embedded into a complex building hosting two physics laboratories and four Good Manufacturing Practice (GMP) laboratories. This project is the result of a successful collaboration between the Inselspital, the University of Bern and private investors, aiming at the constitution of a combined medical and research centre able to provide the most cutting-edge technologies in medical imaging and cancer radiation therapy. The cyclotron is complemented by the RFQ with the primary goals of elemental analysis via Particle Induced Gamma Emission (PIGE), and the detection of potentially dangerous materials with high nitrogen content using the Gamma-Resonant Nuclear Absorption (GRNA) technique. In this context, beam instrumentation devices have been developed, in particular an innovative beam profile monitor based on doped silica fibres and a setup for emittance measurements using the pepper-pot technique. On this basis, the establishment of a proton therapy centre on the campus of the Inselspital is in the phase of advanced study.

Laboratory and cyclotron requirements for PET research

International Nuclear Information System (INIS)

Schlyer, D.J.

1993-01-01

The requirements for carrying out PET research can vary widely depending on the type of basic research being carried out and the extent of a clinical program at a particular center. The type of accelerator and laboratory facilities will, of course, depend on the exact mix. These centers have been divided into four categories. 1. Clinical PET with no radionuclide production facilities, 2. clinical PET with some radionuclide production facilities, 3. clinical PET with research support, and 4. a PET research facility developing new tracers and exploring clinical applications. Guidelines for the choice of an accelerator based on these categories and the practical yields of the common nuclear reactions for production of PET isotopes have been developed and are detailed. Guidelines as to the size and physical layout of the laboratory space necessary for the synthesis of various radiopharmaceuticals have also been developed and are presented. Important utility and air flow considerations are explored

Current status and future perspective of PET

International Nuclear Information System (INIS)

Lee, Myung Chul

2002-01-01

Positron Emission Tomography (PET) is a nuclear medicine imaging modality that consists of systemic administration to a subject of a radiopharmaceutical labeled with a positron-emitting radionuclide. Following administration, its distribution in the organ or structure under study can be assessed as a function of time and space by (1) detecting the annihilation radiation resulting from the interaction of the positrons with matter, and (2) reconstructing the distribution of the radioactivity from a series of that used in computed tomography (CT). The nuclides most generally exhibit chemical properties that render them particularly desirable in physiological studies. The radionuclides most widely used in PET are F-18, C-11, O-15 and N-13. Regarding to the number of the current PET Centers worldwide (based on ICP data), more than 300 PET Centers were in operation in 2000. The use of PET technology grew rapidly compared to that in 1992 and 1996, particularly in the USA, which demonstrates a three-fold rise in PET installations. In 2001, 194 PET Centers were operating in the USA. In 1994, two clinical and research-oriented PET Centers at Seoul National University Hospital and Samsung Medical Center, was established as the first dedicated PET and Cyclotron machines in Korea, followed by two more PET facilities at the Korea Cancer Center Hospital, Ajou Medical Center, Yonsei University Medical Center, National Cancer Center and established their PET Center. Catholic Medical School and Pusan National University Hospital have finalized a plan to install PET machine in 2002, which results in total of nine PET Centers in Korea. Considering annual trends of PET application in four major PET centers in Korea in Asan Medical Center recent six years (from 1995 to 2000), a total of 11,564 patients have been studied every year and the number of PET studies has shown steep growth year upon year. We had, 1,020 PET patients in 1995. This number increased to 1,196, 1,756, 2,379, 3

Improved High Current Liquid and Gas Targets for Cyclotron Produced Radioisotopes (Turkey)

Energy Technology Data Exchange (ETDEWEB)

Kivrakdal, Deniz; Ustaoğlu, Özgur; Soylu, Ayfer [Eczacibasi Nuclear Products Inc. (Turkey)

2009-07-01

As positron emitting radiopharmaceuticals gain interest in nuclear medicine, more and more baby cyclotrons are installed. The number of cyclotrons in Turkey went up to nine whereas the number of PET or PET/CT cameras increased more than 50% within a year. At the moment there are 65 positron imaging cameras serving a population of around 70 million. Eczacıbası - Monrol Nuclear Products Industry and Trade Inc. has five cyclotrons three of them being of different brands. In this report production data collected with these cyclotrons using high current liquid targets of silver, tantalum and niobium will be presented. The data presented here covers the whole duration of the project. Another topic which will be discussed here is the work carried out about purification and analysis of used O-18 water for re-use purposes. (author)

Improved High Current Liquid and Gas Targets for Cyclotron Produced Radioisotopes (Turkey)

International Nuclear Information System (INIS)

Kivrakdal, Deniz; Ustaoğlu, Özgur; Soylu, Ayfer

2009-01-01

As positron emitting radiopharmaceuticals gain interest in nuclear medicine, more and more baby cyclotrons are installed. The number of cyclotrons in Turkey went up to nine whereas the number of PET or PET/CT cameras increased more than 50% within a year. At the moment there are 65 positron imaging cameras serving a population of around 70 million. Eczacıbası - Monrol Nuclear Products Industry and Trade Inc. has five cyclotrons three of them being of different brands. In this report production data collected with these cyclotrons using high current liquid targets of silver, tantalum and niobium will be presented. The data presented here covers the whole duration of the project. Another topic which will be discussed here is the work carried out about purification and analysis of used O-18 water for re-use purposes. (author)

Important radiation protection aspects of the operation of a commercial medical cyclotron

International Nuclear Information System (INIS)

Mukherjee, B.

1997-01-01

Since July 1991 the Radiopharmaceutical Division of the Australian Nuclear Science and Technology Organisation (ANSTO) operates a 30 MeV H'- ion Medical Cyclotron (Model; CYCLONE 30, Manufacturer: Ion Beam Applications, Louvain La Neuve, Belgium). During routine isotope production operations at the cyclotron a thick copper substrate plate electroplated with thin layer of selected enriched target material are bombarded with 30 MeV proton beam current up to 450 μA. The nuclear reaction of protons with the copper atoms result in the reduction of prompt evaporation neutrons with a peak energy of ∼ 1.8 MeV. These evaporation neutrons slow down via multiple collisions with the concrete shielding walls of the target cave, bounce back to the,interior space of the cave activating the cyclotron parts, beam tube components and other utilities installed in the irradiation cave. After the completion of 60 hour isotope production run, gamma dose equivalent rates of ∼10 5 μSvh -1 were measured at contact with the target irradiation stations and beam collimators. Evidently, these gamma rays emitted from the activated cyclotron components impose crucial radiation exposure hazard problems for the cyclotron maintenance technicians. Experiments had been carried out in order to identify the specific pathways of cyclotron component activation and to assess the probable personnel radiation exposure during handling of the activated cyclotron parts. The cool-down (radioactive decay) of the activated cyclotron components was estimated experimentally at different target bombardment conditions using the wall mounted gamma area monitors interfaced to the Health Physics Data Acquisition System. The gamma dose equivalent rates at contact with various locations of interest at the target irradiation station and at the typical work areas of the maintenance personnel were carefully recorded with a radiation (gamma) survey instrument during the three years operation period of the cyclotron. A

Present and future aspects of PET examinations

International Nuclear Information System (INIS)

Inoue, Tomio

2003-01-01

The PET examination gives the body distribution image of a compound labeled with the positron emitter manufactured by cyclotron. Recently, PET with F18-deoxyglucose (FDG) attracts considerable attention because the imaging is particularly useful for cancer detection. Since the technique was authorized by the United States (US) official health insurance in 1998, the number of the examination is increasing, which is also under similar situation in Japan due to the latest partial authorization for some malignant tumors. In Japan, about 30,000 examinations per year are carried out, half of which, in private hospitals. Their purpose is increasingly for cancer detection. For future PET examination, awaited are improvement of PET camera and development of a novel imaging agent. PET/CT imaging is for the former and F18-α-methyltyrosine, for the latter. Miniaturization of cyclotron, FDG delivery system, improved FDG synthetic method, popularization of PET/CT, development of PET camera for health examination, clinical trial of a novel imaging agent, and spread of PET health examination and operation of PET Center, are expected for future progress of PET technique. (N.I.)

THE CHARACTERISTICS OF EEC PET INSTRUMENTATION

NARCIS (Netherlands)

PAANS, AMJ

1991-01-01

As a result of a Guide-Questionnaire distributed among all European PET centers an inventory of the European PET instrumentation has become available in a data base. An overview and analysis of the European PET equipment, cyclotrons, scanners and software, together with some global information on

Linacs for medical isotope production

International Nuclear Information System (INIS)

Pramudita, A.

2012-01-01

This paper reviews efforts on using high energy (25-30 MeV) and high power (10-20 kW) electron linacs and lower energy (7 MeV) proton linacs for medical radioisotope production. Using high energy x-rays from the electron linacs, PET (Positron Emission Tomography) radioisotopes are produced through photonuclear reactions such as 19 F(γ,n) 18 F, which also allow production of other PET radionuclides 11 C, 13 N, and 15 O. Other mostly used medical radionuclides 99m Tc can also be obtained by using the electron linacs, through photofission or photonuclear reactions. Proton linacs for PET have also been recently developed and the product has been available in the market since 2005. The linacs have been tested for 18 F production. As a proton accelerator, the target systems and nuclear reactions are similar to the ones used in PET cyclotrons. (author)

Medical Isotope Production at TRIUMF - from Imaging to Treatment

Science.gov (United States)

Hoehr, C.; Bénard, F.; Buckley, K.; Crawford, J.; Gottberg, A.; Hanemaayer, V.; Kunz, P.; Ladouceur, K.; Radchenko, V.; Ramogida, C.; Robertson, A.; Ruth, T.; Zacchia, N.; Zeisler, S.; Schaffer, P.

TRIUMF has a long history of medical isotope production. For more than 40 years, the Life Sciences Division at TRIUMF has produced isotopes for Positron Emission Tomography (PET) for the local hospitals. Recently, the division has taken on the challenge to expand the facility's isotope repertoire to isotopes for imaging to treatment. At the smallest cyclotron at TRIUMF with energy of 13 MeV, radiometals are being produced in a liquid target which is typically used for PET isotope production. This effort makes radiometals available for early stage research and preclinical trials. At beam energy of 24 MeV, we produce 99mTc from 100Mo with a cyclotron, the most common isotope for Single-Photon-Emission-Computed-Tomography (SPECT) and the most common isotope for nuclear imaging. The use of a cyclotron bypasses the common production route via a nuclear reactor as well as enriched uranium. And finally, at our 500 MeV cyclotron we have demonstrated the production of α emitters useful for targeted alpha therapy. Herein, these efforts are summarized.

One year's experience of the WA medical cyclotron and radiopharmaceutical production facility

International Nuclear Information System (INIS)

DeRoach, J.; Tuchyna, T.; Jones, C.; Price, R.

2004-01-01

Full text: The WA PET Centre Medical Cyclotron, a facility novel in Western Australia, produced its first bolus of FDG for patient injection for PET scanning in August 2003. This paper describes the methodology and practices employed during the past 12 months for ensuring that reliable routine provision of FDG is maintained, in parallel with facilitating the development and production of achievable new radiopharmaceuticals. An FDG production team of six staff and, a maintenance and development team of 4 staff were created from the 3.4 staff specifically recruited for this service and from incumbent staff. Teams were also set up to carry out development projects related to the service. Training procedures were created under the department's ISO9001:2000 accreditation system for the certification of production and maintenance staff. Practices and documentation systems were put in place in anticipation of a pending cGMP audit. Several unplanned major changes to equipment and infrastructure were necessary post commissioning. These changes included purchase of a different FDG synthesis module from that originally supplied, and modifications to engineering services, including changes to air conditioning, changes to supply of vacuum and upgrading of drainage in the laboratory area. A device for the measurement of end of bombardment yield was built, so that the efficiencies of the various synthesis modules could be accurately determined. Strict radiation protection procedures were put in place. All staff were provided with luxels and finger TLDs for monthly reporting of their radiation levels, as well as electronic monitors for real-time monitoring. From August 2003 to June 2004 (11 months) 2229 FDG patient doses were produced and dispensed by this facility. An average of 8.0 patient doses per available working day were dispensed during the 2003 period, rising to 11.1 patient doses per day in 2004. Several 11 NH3 doses were also delivered. The cyclotron was unavailable for

Occupational radiation exposure at the self-shielded IBA CYCLONE 10/5, cyclotron of the Austin and Repatriation Medical Centre, Melbourne, Australia

International Nuclear Information System (INIS)

Tochon-Danguy, H.; Sachinidis, J.I.; U, P.; Egan, G.; Mukherjee, B.

1999-01-01

A series of health physics measurements was carried out at the IBA CYCLONE 10/5 Medical Cyclotron of the Austin and Repatriation Medical Centre, Melbourne. The neutron attenuation factor of the cyclotron shielding was estimated using the Superheated Bubble dosimeters. The neutron and gamma dose rates at various public access and radiation worker's area in the vicinity of the cyclotron facility were evaluated during the 11 C, 18 F, 13 N and 15 O production conditions. (authors)

Evaluating secondary neutron doses of a refined shielded design for a medical cyclotron using the TLD approach

International Nuclear Information System (INIS)

Lin, Jye-Bin; Tseng, Hsien-Chun; Liu, Wen-Shan; Lin, Ding-Bang; Hsieh, Teng-San; Chen, Chien-Yi

2013-01-01

An increasing number of cyclotrons at medical centers in Taiwan have been installed to generate radiopharmaceutical products. An operating cyclotron generates immense amounts of secondary neutrons from reactions such the 18 O(p, n) 18 F, used in the production of FDG. This intense radiation can be hazardous to public health, particularly to medical personnel. To increase the yield of 18 F-FDG from 4200 GBq in 2005 to 48,600 GBq in 2011, Chung Shan Medical University Hospital (CSMUH) has prolonged irradiation time without changing the target or target current to meet requirements regarding the production 18 F. The CSMUH has redesigned the CTI Radioisotope Delivery System shield. The lack of data for a possible secondary neutron doses has increased due to newly designed cyclotron rooms. This work aims to evaluate secondary neutron doses at a CTI cyclotron center using a thermoluminescent dosimeter (TLD-600). Two-dimensional neutron doses were mapped and indicated that neutron doses were high as neutrons leaked through self-shielded blocks and through the L-shaped concrete shield in vault rooms. These neutron doses varied markedly among locations close to the H 2 18 O target. The Monte Carlo simulation and minimum detectable dose are also discussed and demonstrated the reliability of using the TLD-600 approach. Findings can be adopted by medical centers to identify radioactive hot spots and develop radiation protection. - Highlights: • Neutron doses were verified using TLD approach. • Neutron doses were increased at cyclotron centers. • Revised L-shaped shield suppresses effectively the neutrons. • Neutron dose can be attenuated to 1.13×10 6 %

Development of the RF cavity for the SKKUCY-9 compact cyclotron

International Nuclear Information System (INIS)

Shin, Seungwook; Lee, Jongchul; LEE, Byeong-No; Ha, Donghyup; Namgoong, Ho; Chai, Jongseo

2015-01-01

A 9 MeV compact cyclotron, named SKKUCY-9, for a radiopharmaceutical compound especially fludeoxyglucose (FDG) production for a positron emission tomography (PET) machine was developed at Sungkyunkwan University. H − ions which are produced from a Penning Ionization Gauge(PIG) ion source, travel through a normal conducting radio frequency (RF) cavity which operates at 83.2 MHz for an acceleration and electro-magnet for a beam focusing until the ions acquire energy of about 9 MeV. For installation at a small local hospital, our SKKUCY-9 cyclotron is developed to be compact and light-weight, comparable to conventional medical purpose cyclotrons. For compactness, we adapted a deep valley and large angle hill type for the electro-magnet design. Normally a RF cavity is installed inside of the empty space of the magnet valley region, which is extremely small in our case. We faced problems such as difficulties of installing the RF cavity, low Q-value. Despite of those difficulties, a compact RF cavity and its system including a RF power coupler to feed amplified RF power to the RF cavity and a fine tuner to compensate RF frequency variations was successfully developed and tested

Development of the RF cavity for the SKKUCY-9 compact cyclotron

Science.gov (United States)

Shin, Seungwook; Lee, Jongchul; LEE, Byeong-No; Ha, Donghyup; Namgoong, Ho; Chai, Jongseo

2015-09-01

A 9 MeV compact cyclotron, named SKKUCY-9, for a radiopharmaceutical compound especially fludeoxyglucose (FDG) production for a positron emission tomography (PET) machine was developed at Sungkyunkwan University. H- ions which are produced from a Penning Ionization Gauge(PIG) ion source, travel through a normal conducting radio frequency (RF) cavity which operates at 83.2 MHz for an acceleration and electro-magnet for a beam focusing until the ions acquire energy of about 9 MeV. For installation at a small local hospital, our SKKUCY-9 cyclotron is developed to be compact and light-weight, comparable to conventional medical purpose cyclotrons. For compactness, we adapted a deep valley and large angle hill type for the electro-magnet design. Normally a RF cavity is installed inside of the empty space of the magnet valley region, which is extremely small in our case. We faced problems such as difficulties of installing the RF cavity, low Q-value. Despite of those difficulties, a compact RF cavity and its system including a RF power coupler to feed amplified RF power to the RF cavity and a fine tuner to compensate RF frequency variations was successfully developed and tested.

Management of radioactive waste gases from PET radiopharmaceutical synthesis using cost effective capture systems integrated with a cyclotron safety system.

Science.gov (United States)

Stimson, D H R; Pringle, A J; Maillet, D; King, A R; Nevin, S T; Venkatachalam, T K; Reutens, D C; Bhalla, R

2016-09-01

The emphasis on the reduction of gaseous radioactive effluent associated with PET radiochemistry laboratories has increased. Various radioactive gas capture strategies have been employed historically including expensive automated compression systems. We have implemented a new cost-effective strategy employing gas capture bags with electronic feedback that are integrated with the cyclotron safety system. Our strategy is suitable for multiple automated 18 F radiosynthesis modules and individual automated 11 C radiosynthesis modules. We describe novel gas capture systems that minimize the risk of human error and are routinely used in our facility.

CyberPET: a PET service distributed over a wide area

International Nuclear Information System (INIS)

Pilloy, W.J.; Hellwig, D.; Schaeffer, A.; Hoffmann, P.; Lens, V.

2002-01-01

Aim: Demonstration of bi-directional PET data transmission, interactive display and co-registration, for the purpose of correlative imaging, treatment planning and teaching. Material and Method: In the year 2000, the initial problem to attend was to provide an effective PET service to a hospital (in Luxemburg) which lies 150 km away from a PET center (in another country). Once this solved, the procedure was expanded (in 2001) to co-registration with CT/MRI scans performed locally, and with radiotherapy simulation CT performed in another center 25 km away (in 2002). Equipment from various vendors was used (Siemens, Adac, GE, Hermes). With preliminary agreement of the national medical aid, patients are sent from the Nuclear Medicine Dept of the Centre Hospitalier in Luxemburg (CHL) to the Dept NM of the Saarland University Medical Center for PET examination. The digital data are then sent from the Siemens PET camera to a PC connected to the LAN, and then to a FTP server (Healthnet). The data are similarly collected by a PC of the hospital network in Luxemburg, and transferred to a Hermes NM station. The Dicom PET data are converted on the fly to Interfile, displayed interactively as any other tomographic data, printed and available on the NM image server. Since 2001, the PET data are co-registered with whole-body CT data recorded at CHL according to a specific protocol (see other paper of this group). Now in 2002, we are busy implementing the co-registration of PET data and simulation CT data obtained from the Centre Baclesse (CFB, 25 km from CHL) for the treatment planning of brain tumours (input into an ADAC system). Furthermore, we plan to send the data (after deletion of their digital ID) to a (South African) university which does not yet dispose of a PET camera, to allow the training of their registrars. Results: For the end-user clinician at CHL and CFB , the PET data have the quality of 'live data', which can be examined interactively, along with other imaging

High Yield F-18 Target for KOTRON-13 Cyclotron

International Nuclear Information System (INIS)

Lee, W. K.; Song, J. Y.; Park, J. Y.; Jung, K. I.; Chae, S. K.

2009-01-01

Currently the domestic radiation market for medical diagnosis witnesses a high increase of the use of PET/CT for the purpose of cancer diagnosis, and the cases of cancer diagnosis using PET/CT increase by geometric progression every year. In case of domestic practice, full body scan is taken by using FDG medical isotope medicines mainly using F-18, but the necessity of various medical radioactive isotopes according to each medical purpose is increasing. F-18 output yield is directly proportional to energy of protons and beam current, and has correlation with heat production rate in case of target and decides the function of target in accordance with the efficiency of a cooling device. At present, in case of most F-18 target, when one irradiates beam in O-18 water of about 0.2∼5mL, one has to apply heat of over 300W, a high thermal energy per unit area is irradiated in target, which is easily damaged, and it has limitation in beam current. Currently, in case of commercial target, about 2,000W beam current is the maximum value, and in case of double-grid target developed by Korea Institute of Radiological and Medical Sciences in 2004, it was designed to stand up to about 1,000W theoretically, but in reality it can irradiate lower beam current than this because of the shortage of cooling efficiency. In general, the irradiation strength to produce radioactive isotopes given in the heat emission by target substance currently is limited to 50μA against target substance irradiated in 1.6mL. However, current KOTRON-13 cyclotron can accelerate proton beam with a high scope of strength marking 100μA thru 120μA by a continuous development. Therefore, it doesn't fully function compared with that of proton beam of KOTRON-13 cyclotron. The solution about this is to get over the problem of cooling target substance of cavity in the production system of radioactive isotopes. Especially, one has to develop the method to cool target substance, and provide higher F-18 yield than

Cyclotron production of Cu-61

Czech Academy of Sciences Publication Activity Database

Lebeda, Ondřej; Ráliš, Jan; Seifert, Daniel

2013-01-01

Roč. 40, 2 Supplement (2013), S323-S323 ISSN 1619-7070. [Annual Congress of the European Association of Nuclear Medicine (EANM). 19.10.2013-23.10.2013, Lyon] R&D Projects: GA TA ČR TA02010797 Institutional support: RVO:61389005 Keywords : cyclotron U-120M * PET * Cu-61 Subject RIV: BG - Nuclear, Atomic and Molecular Physics, Colliders

Commercial cyclotrons. Part I: Commercial cyclotrons in the energy range 10 30 MeV for isotope production

Science.gov (United States)

Papash, A. I.; Alenitsky, Yu. G.

2008-07-01

A survey of commercial cyclotrons for production of medical and industrial isotopes is presented. Compact isochronous cyclotrons which accelerate negative hydrogen ions in the energy range 10 30 MeV have been widely used over the last 25 years for production of medical isotopes and other applications. Different cyclotron models for the energy range 10 12 MeV with moderate beam intensity are used for production of 11C, 13N, 15O, and 18F isotopes widely applied in positron emission tomography. Commercial cyclotrons with high beam intensity are available on the market for production of most medical and industrial isotopes. In this work, the physical and technical parameters of different models are compared. Possibilities of improving performance and increasing intensity of H- beams up to 2 3 mA are discussed.

Direct production of ^99mTc using a small medical cyclotron

Energy Technology Data Exchange (ETDEWEB)

Lapi, Suzanne [Washington Univ., St. Louis, MO (United States)

2017-10-03

This project describes an investigation towards the production of ^99mTc with a small medical cyclotron. This endeavor addresses the current urgent problem of availability of ^99mTc due to the ongoing production reactor failures and the upcoming Canadian reactor shut down. Currently, ^99mTc is produced via nuclear fission using highly enriched uranium which is a concern due to nuclear proliferation risks. In addition to this, the United States is dependent solely on currently unreliable foreign sources of this important medical isotope. Clearly, a need exists to probe alternative production routes of ^99mTc. In the first year, this project measured cross-sections and production yields of potential pathways to ^99mTc and associated radionuclidic impurities produced via these pathways using a small 15 MeV medical cyclotron. During the second and third years target systems for the production of ^99mTc via the most promising reaction routes were developed and separation techniques for the isolation of ^99mTc from the irradiated target material will be investigated. Systems for the recycling of the enriched target isotopes as well as automated target processing systems were examined in years four and five. This project has the potential to alleviate some of the current crisis in the medical community by developing a technique to produce ^99mTc on location at a university hospital. This technology will be applicable at many other sites in the United States as many other similar, low energy (<20 MeV) cyclotrons (currently used for a few hours per day for the production of [¹⁸F]fluorodeoxyglucose) are available for production of ^99mTc though this method, thus leading to job creation and preservation.

Business administration of PET facilities. A cost analysis of three facilities utilizing delivery FDG

International Nuclear Information System (INIS)

Mitsutake, Naohiro; Oku, Shinya; Fujii, Ryo; Furui, Yuji; Yasunaga, Hideo

2008-01-01

PET (positron emission tomography) has been proved to be a powerful imaging tool in clinical oncology. The number of PET facilities in Japan has remarkably increased over the last decade. Furthermore, the approval of delivery fluorodeoxyglucose (FDG) in 2005 resulted in a tremendous expansion of the PET institutions without a cyclotron facility. The aim of this study was to conduct a cost analysis of PET institutions that utilized delivery FDG. Three PET facilities using delivery FDG were investigated about the costs for PET service. Fixed costs included depreciation costs for construction and medical equipments such as positron camera. Variable costs consisted of costs for medical materials including delivery FDG. The break-even point was analyzed in each of three institutions. In the three hospitals (A, B and C), the annual number of PET scan was 1,591, 1,637 and 914, while cost per scan was accounted as 110,262 yen, 111,091 yen, and 134,192 yen, respectively. The break-even point was calculated to be 2,583, 2,679 and 2,081, respectively. PET facilities utilizing delivery FDG seemed to have difficulty in business administration. Such a situation suggests the possibility that the current supply of PET facilities might exceed actual demand for the service. The efficiency of resource allocation should be taken into consideration in the future health service researches on PET. (author)

Physical and technical basis of positron emission tomography (PET)

International Nuclear Information System (INIS)

Bauer, R.

1994-01-01

Positron emission tomography utilizes the annihilation of positrons, generating pairs of gamma quanta which are emitted in opposing directions. 'Electronic collimation' is performed by coincident detection of both quanta. Thus, there is no need for mechanical collimators and no limiting connection between sensitivity and spatial resolution. Transversal tomograms are reconstructed from the projection data by means of highly sophisticated data processing. The half life of the most positron emitters used in medical applications is short and of the order of some minutes. Therefore, many positron emitters have to be produced on-side by means of a cyclotron. PET is superior to SPECT with respect to physical and technical aspects, but the high costs of PET limit its wide-spread use up to now. (orig.) [de

Cyclotrons for clinical and biomedical research with PET

International Nuclear Information System (INIS)

Wolf, A.P.

1987-01-01

The purpose of this commentary is to present some background material on cyclotrons and other particle accelerators particularly with a view toward the considerations behind acquiring and installing such a machine for purely clinical and/or biomedical research use

Report on the development and application of PET/CT in mainland China.

Science.gov (United States)

Chen, Yumei; Chen, Ruohua; Zhou, Xiang; Liu, Jianjun; Huang, Gang

2017-09-08

To examine the development and application of systems combining positron emission and x-ray-computed tomography systems (PET/CTs) in mainland China. Using a questionnaire, we surveyed Chinese medical institutions on a variety topics relating to their PET/CT systems and its use. The respondents had PET/CTs installed and in clinical use before 31 December 2015. We examined the clinical scenarios to which Chinese PET/CTs were applied by reviewing the related Chinese and international literature from the start of 1995 to the end of 2013; these papers were found by searching the Wanfang and PubMed databases, respectively. The data were then classified and analyzed statistically. At the end of 2015, there were 240 PET/CTs and 101 medical cyclotrons in mainland China. The total number of PET studies performed in 2015 was 469,364. The main clinical applications of PET were found to be diagnostic fludeoxyglucose ( 18 F-FDG) imaging and oncological imaging. A minority of PET/CT studies were performed using 11 C-choline and other imaging agents. The number of papers relating to clinical use of PET/CT in mainland China increased each year over the period of study, in both the Chinese and international literature. Despite this progress, important problems were also apparent, including unbalanced regional development and the limited quality of the research. This study provides detailed information for understanding the development PET/CT technology in mainland China, along with its geographical distribution and clinical application. It may thus prove a useful reference for all those involved in planning the future of PET/CT in China.

Neutron measurements at BRIT/BARC medical cyclotron facility of RMC, Parel

International Nuclear Information System (INIS)

Sathian, Deepa; Sathian, V.; Phandnis, U.V.; Soni, P.S.; Mohite, D.Y.

2005-01-01

Neutron leakage and its long distance propagation in the atmosphere from the intense neutron facilities such as high energy accelerators like Cyclotron are very important for the shielding design of the facilities and resulting dose reduction to nearby population, because of strong penetrability of high energy neutrons. The neutron interaction cross sections are highly energy dependent, so different methods are adopted for measuring different energy neutrons. The method also depends on the amount of neutron fluence rate expected at the location. When the fluence rate is very high, the foil activation is the best method for the measurement of neutron fluence rate. In foil activation technique an inactive material is activated by neutrons and the activity is measured and correlated to the neutron fluence rate. In this paper, neutron fluence rate measurement using different activation foils at medical cyclotron room of Radiation Medicine Centre (RMC) is discussed. (author)

THE ROLE OF THE CYCLOTRON IN MEDICAL RESEARCH

Energy Technology Data Exchange (ETDEWEB)

Hamilton, Joseph G.

1950-04-19

The uses of radioactive isotopes in medical research can be conveniently divided into three principal categories; namely, the applications as tracers for the study of metabolic phenomena, as diagnostic aids in clinical medicine, and finally their role in therapy. Frequently radioisotopes available from the chain-reacting pile do not have a sufficient degree of specific activity for satisfactory use. A number of radioisotopes which can be produced with high specific activity in the pile possess half-lives too short to be of any practical value. Then, there are a few cases in which the desired radioisotope may be made in the pile with high specific activity, but concomitantly there is formed another radioisotope of the same element whose half-life is of such duration as to render its use hazardous in man. Finally, there are several elements of biological and medical interest whose radioactive isotopes can be produced only by the cyclotron.

Positron emission tomography/computed tomography (PET/CT) in children.

Science.gov (United States)

Shore, Richard M

2008-06-01

Although PET imaging has been available for more than two decades, its use has greatly increased lately due to the advent of PET/CT, readily available sources of commercially supplied FDG, and mobile scanners. These features have enabled PET scanning to expand beyond select major university medical centers, with on-site cyclotron facilities to smaller institutions including free- standing children's hospitals. In these settings, imaging is generally limited to FDG, which suffices for most applications, with the majority of studies performed for tumor imaging. FDGI is being used for evaluation of many tumors in children, with its use in lymphoma being the most established. In lymphoma, it has proven quite useful in determining whether active tumor is present in residual masses following treatment, which may otherwise contain only residual fibrous tissue. For brain tumors, FDGI has some relation to tumor grade, although its more important role is distinguishing recurrent or residual tumor from the effects of treatment, particularly radiation necrosis. For neurological evaluation, interictal FDGI is helpful in localizing potential seizure foci for subsequent subdural EEG monitoring. Because of the relatively long uptake time of FDG, true ictal studies cannot be performed with FDG, and these remain within the domain of SPECT imaging of tracers such as Tc-99m HMPAO. Examinations utilizing radiopharmaceuticals other than FDG are significantly more limited in their availability and are limited to PET centers with on-site cyclotrons. However, these additional agents open the door to many additional studies, including more specific tumor-imaging agents of certain tumors such as neuroblastoma. Another neurotransmitter, F-18-fluoro-L-dopa, is of benefit outside of the central nervous system for evaluating infantile hyperinsulism. The use of PET/CT in children is increasing quickly, particularly FDGI imaging of tumors. It is expected that over the next few years, its role will

Cyclotron facilities in Brazil: Current status and licensing aspects

International Nuclear Information System (INIS)

Facure, A.; Carvalho, S.M.; Di Prinzio, R.; Silveira, C.S.; Gasparian, P.B.R.; Franca, W.F.

2017-01-01

Positron Emission Tomography (PET) is a highly sensitive and accurate nuclear medicine imaging technology but the major problem of this technique is the use of radioisotopes with short half-life, less than two hours. The production and selling of short half-life radioisotopes used to be monopoly of the Brazilian Government. In 2006, a Constitutional Amendment revoked the state monopoly due to the need for the use of short half-life radioisotopes in nuclear medicine centers very far from the government production facilities. The aim of this study is to describe the current status of short half-life radioisotopes production in Brazil and discuss some licensing process. In Brazil, as has been occurring worldwide, the number of nuclear medicine centers is increasing. Currently there are 123 services performing PET scans in Brazil. There are 14 cyclotrons operating in Brazil. The type of licensing process conducted in Brazil does not take into account the population density of each state, with a free competition model being adopted. Because of this there is a lot of equipment concentrated in the Southeast and no cyclotrons operating in the Northern part of the country. One of the biggest obstacles during the licensing process is the designation of qualified personnel as operation workers and radiation safety officers. The number of cyclotron accelerators and PET/CT equipment increased in recent years. However, a number of external factors such as the distance from the nuclear medicine centers, and qualified personnel have proved crucial for the economic viability of this type of facility. (author)

Cyclotron facilities in Brazil: Current status and licensing aspects

Energy Technology Data Exchange (ETDEWEB)

Facure, A.; Carvalho, S.M.; Di Prinzio, R.; Silveira, C.S.; Gasparian, P.B.R.; Franca, W.F., E-mail: facure@cnen.gov.br [Comissao Nacional de Energia Nuclear (CNEN), Rio de Janeiro, RJ (Brazil)

2017-09-01

Positron Emission Tomography (PET) is a highly sensitive and accurate nuclear medicine imaging technology but the major problem of this technique is the use of radioisotopes with short half-life, less than two hours. The production and selling of short half-life radioisotopes used to be monopoly of the Brazilian Government. In 2006, a Constitutional Amendment revoked the state monopoly due to the need for the use of short half-life radioisotopes in nuclear medicine centers very far from the government production facilities. The aim of this study is to describe the current status of short half-life radioisotopes production in Brazil and discuss some licensing process. In Brazil, as has been occurring worldwide, the number of nuclear medicine centers is increasing. Currently there are 123 services performing PET scans in Brazil. There are 14 cyclotrons operating in Brazil. The type of licensing process conducted in Brazil does not take into account the population density of each state, with a free competition model being adopted. Because of this there is a lot of equipment concentrated in the Southeast and no cyclotrons operating in the Northern part of the country. One of the biggest obstacles during the licensing process is the designation of qualified personnel as operation workers and radiation safety officers. The number of cyclotron accelerators and PET/CT equipment increased in recent years. However, a number of external factors such as the distance from the nuclear medicine centers, and qualified personnel have proved crucial for the economic viability of this type of facility. (author)

A comparative study on PET and SPECT image formation systems for a proper scanner choice in a considered PET center

International Nuclear Information System (INIS)

Santos, G.R. dos; Oliveira, A. de; Oliveira, C.L. de

2001-01-01

Full text: In the last twenty years, the conjunction of technology and research had provided exceptional conditions for improvements on the quality of life, specially on nuclear medicine. In this area, the developed technology is being applied, making available better diagnoses and therapy to a variety of diseases. Since then the short-lived radionuclides were available only in the large physics research centers. The increasing clinical applications have led to the rapid rise in the number of compact cyclotrons throughout the world. All medical cyclotrons currently are suitable for sustaining programs for PET research and clinical application. To date, up to 122 medical cyclotrons have been established worldwide, and Brazil is about to install a new dedicated cyclotron (RDS111 from CTI), to its first PET Center, in Rio de Janeiro. Also the number of scanners worldwide has increased, mainly those based on the positrons emission and annihilation. The better result gotten in the final contrast of the object imposes a comparative study and analysis of the image formation process, either in a system based on a Single Photon Emission Computerized Tomography (SPECT), as well as on Positron Emission Tomography (PET.) This comparative study should at least follow same increasing rates of the new devices with technological advances. That kind of study can be helpful on the decision of what type of scan should be the proper one, to a PET Center, on a specific region. Obviously, many other parameters are involved in that decision, and this discussion and analyses are the main subject of the present work. The objective is to make available a realistic comparative scenario. Many of the new devices have been introduced making progresses. As an example, in the new PET scanners, the reduction of examination time, and the remarkable improvement on the diagnoses based on images. As a consequence, we have a broadening on application, better performance, and making possible the

Opportunities for chemists in PET research

International Nuclear Information System (INIS)

Fowler, J.S.

1990-01-01

Advances in chemistry have played a key role in the evolution of positron emission tomography (PET) as a scientific and clinical research tool. For example, development in hot atom chemistry and in rapid synthetic organic chemistry over the past three decades has laid the foundation for the incorporation the short lived cyclotron-produced positron emitters such as flourine-18 (t 1/2 :110 minutes), carbon-11 (t 1/2 :20.4 minutes) and nitrogen-13 (t 1/2 :10 minutes) into several hundred different organic molecules. A number of these have proven to be exquisitely sensitive as probes for various metabolic processes and drug binding sites in normal and disease states. As a consequence, PET has recently been introduced into clinical medicine and the number of cyclotron-PET centers has grown from 4 in 1976 to several dozen worldwide in 1990. This rapid growth has created a demand for the synthetic chemists with advanced training in radiochemistry

A new generation of medical cyclotrons for the 90's

International Nuclear Information System (INIS)

Milton, B.F.

1995-08-01

Cyclotrons continue to be efficient accelerators for use in radio-isotope production. In recent years, developments in accelerator technology have greatly increased the practical beam current in these machines while also improving the overall system reliability. These developments combined with the development of new isotopes for medicine and industry, and a retiring of older machines indicates a strong future for commercial cyclotrons. In this paper the authors will survey recent developments in the areas of cyclotron technology as they relate to the new generation of commercial cyclotrons. Existing and potential markets for these cyclotrons will be presented. They will also discuss the possibility of systems capable of extracted energies up to 150 MeV and extracted beam currents of up to 2.0 mA

A new generation of medical cyclotrons for the 90's

International Nuclear Information System (INIS)

Milton, B.F.

1995-08-01

Cyclotrons continue to be efficient accelerators for use in radio-isotope production. In recent years, developments in accelerator technology have greatly increased the practical beam current in these machines while also improving the overall system reliability. These developments combined with the development of new isotopes for medicine and industry, and a retiring of older machines indicates a strong future for commercial cyclotrons. In this paper we will survey recent developments in the areas of cyclotron technology as they relate to the new generation of commercial cyclotrons. Existing and potential markets for these cyclotrons will be presented. We will also discuss the possibility of systems capable of extracted energies up to 150 MeV and extracted beam currents of up to 2.0 mA. (author)

A real-time intercepting beam-profile monitor for a medical cyclotron

Energy Technology Data Exchange (ETDEWEB)

Hendriks, C.; Uittenbosch, T.; Cameron, D.; Kellogg, S.; Gray, D.; Buckley, K.; Schaffer, P.; Verzilov, V.; Hoehr, C. [TRIUMF, 4004 Wesbrook Mall, Vancouver, British Columbia V6T 2A3 (Canada)

2013-11-15

There is a lack of real-time continuous beam-diagnostic tools for medical cyclotrons due to high power deposition during proton irradiation. To overcome this limitation, we have developed a profile monitor that is capable of providing continuous feedback about beam shape and current in real time while it is inserted in the beam path. This enables users to optimize the beam profile and observe fluctuations in the beam over time with periodic insertion of the monitor.

Solid targets for 99mTc production on medical cyclotrons

International Nuclear Information System (INIS)

Hanemaayer, V.; Buckley, K.R.; Klug, J.; Ruth, T.J.; Schaffer, P.; Zeisler, S.K.; Benard, F.; Kovacs, M.; Leon, C.

2014-01-01

Recent disruptions in the molybdenum-technetium generator supply chain prompted a review of non-reactor based production methods for both 99 Mo and 99m Tc. Small medical cyclotrons (E p ∼ 16-24 MeV) are capable of producing Curie quantities of 99m Tc from isotopically enriched 100 Mo using the 100 Mo(p,2n) 99m Tc reaction. Unlike most other metallic target materials for routine production of medical radioisotopes, molybdenum cannot be deposited by reductive electroplating from aqueous salt solutions. To overcome this issue, we developed a new process for solid molybdenum targets based on the electrophoretic deposition of fine 100 Mo powder onto a tantalum plate, followed by high temperature sintering. The targets obtained were mechanically robust and thermally stable when irradiated with protons at high power density. (author)

Comparison of the production of medical radioisotopes on reactor and cyclotron

International Nuclear Information System (INIS)

Vucina, J.; Vuksanovic, Lj.; Dobrijevic, R.; Karanfilov, E.

1997-01-01

The production of radioisotopes for nuclear-medical applications can be performed either on nuclear reactor or on cyclotron. According to the nuclear reactions applied the radioisotopes of different physical characteristics can be produced. In the paper a comparison of the radioisotopes production given. Compared are the main steps in the production: choice of the nuclear reaction, targetry, irradiation and radiochemical separations performed on the irradiated target to isolate the desired radioisotope. The main characteristics of the produced radioisotopes are given and discussed. (author)

Ion source and injection line for high intensity medical cyclotron

Science.gov (United States)

Jia, XianLu; Guan, Fengping; Yao, Hongjuan; Zhang, TianJue; Yang, Jianjun; Song, Guofang; Ge, Tao; Qin, Jiuchang

2014-02-01

A 14 MeV high intensity compact cyclotron, CYCIAE-14, was built at China Institute of Atomic Energy (CIAE). An injection system based on the external H- ion source was used on CYCIAE-14 so as to provide high intensity beam, while most positron emission tomography cyclotrons adopt internal ion source. A beam intensity of 100 μA/14 MeV was extracted from the cyclotron with a small multi-cusp H- ion source (CIAE-CH-I type) and a short injection line, which the H- ion source of 3 mA/25 keV H- beam with emittance of 0.3π mm mrad and the injection line of with only 1.2 m from the extraction of ion source to the medial plane of the cyclotron. To increase the extracted beam intensity of the cyclotron, a new ion source (CIAE-CH-II type) of 9.1 mA was used, with maximum of 500 μA was achieved from the cyclotron. The design and test results of the ion source and injection line optimized for high intensity acceleration will be given in this paper.

First PET Center in Mexico: the power of molecular imaging

International Nuclear Information System (INIS)

Avila R, M.A.

2001-01-01

Positron Emission Tomography (PET) is a non-invasive diagnostic imaging technique modality. It represents the forefront of medical images and was developed as a quantitative technique for imaging biochemical and physiological processes in the human body. PET is unique because it produces images of the body's basic biochemistry or function. Traditional diagnostic techniques such as x-rays, CT scans or MRI, produce images of the body's anatomy or structure. The premise with these techniques is that the change in anatomy or structure that occurs with disease can be seen. However, biochemical processes are also altered with disease and may occur before there is a change gross anatomy. PET is an imaging technique that is used to visualize some of these processes. The development of PET as we know it today began in 1974 with the development of a single ring detector system by Phelps et al. Today, over 350 PET scanners are in use in the world, mainly in the USA (over 140), Europe (particularly in the Anglo-Saxon countries and France) and Japan. Many of these facilities also have their own cyclotron to produce the positron emitters. In the Southern hemisphere, only Australia, Argentina. and recently Mexico, have a very small number of PET facilities. (Author)

First PET Center in Mexico: the power of molecular imaging

Energy Technology Data Exchange (ETDEWEB)

Avila R, M.A. [Unidad PET, Facultad de Medicina, UNAM (Mexico)

2001-09-01

Positron Emission Tomography (PET) is a non-invasive diagnostic imaging technique modality. It represents the forefront of medical images and was developed as a quantitative technique for imaging biochemical and physiological processes in the human body. PET is unique because it produces images of the body's basic biochemistry or function. Traditional diagnostic techniques such as x-rays, CT scans or MRI, produce images of the body's anatomy or structure. The premise with these techniques is that the change in anatomy or structure that occurs with disease can be seen. However, biochemical processes are also altered with disease and may occur before there is a change gross anatomy. PET is an imaging technique that is used to visualize some of these processes. The development of PET as we know it today began in 1974 with the development of a single ring detector system by Phelps et al. Today, over 350 PET scanners are in use in the world, mainly in the USA (over 140), Europe (particularly in the Anglo-Saxon countries and France) and Japan. Many of these facilities also have their own cyclotron to produce the positron emitters. In the Southern hemisphere, only Australia, Argentina. and recently Mexico, have a very small number of PET facilities. (Author)

Future cyclotron systems : an industrial perspective

International Nuclear Information System (INIS)

Stevenson, N.R.; Dickie, W.J.

1995-09-01

The use of commercial cyclotron systems for the production of radioisotopes continues to grow on a world-wide scale. Improvements in technology have significantly increased the production capabilities of modem cyclotron-based isotope production facilities. In particular, the change to negative ion acceleration and new high power systems have resulted in dramatic improvements in reliability, increases in capacity, and decreases in personnel radiation dose. As more and more older machines are retired decisions regarding their replacement are made based on several factors including the market's potential and the cyclotron system's abilities. Taking the case of the recently upgraded TR30 cyclotron at TRIUMF/Nordion, we investigate the requirements industrial/medical users are likely to impose on future commercial cyclotron systems and the impact this will have on cyclotron technology by the end of the century. (author)

Future cyclotron systems: An industrial perspective

International Nuclear Information System (INIS)

Stevenson, N.R.; Dickie, W.J.

1995-09-01

The use of commercial cyclotron systems for the production of radioisotopes continues to grow on a world-wide scale. Improvements in technology have significantly increased the production capabilities of modern cyclotron-based isotope production facilities. In particular, the change to negative ion acceleration and new high power systems have resulted in dramatic improvements in reliability, increases in capacity, and decreases in personnel radiation dose. As more and more older machines are retired, decisions regarding their replacement are made based on several factors including the market's potential and the cyclotron system's abilities. Taking the case of the recently upgraded TR30 cyclotron at TRIUMF/Nordion, the authors investigate the requirements industrial/medical users are likely to impose on future commercial cyclotron systems and the impact this will have on cyclotron technology by the end of the century

PET diagnosis. The decisive factor for early detection of the cancer

International Nuclear Information System (INIS)

Yonekura, Yoshiharu; Kusakabe, Kiyoko; Fukuda, Hiroshi; Inoue, Kentaro; Tanaka, Koichi; Murayama, Hideo; Amano, Masaharu; Oikawa, Koichi; Yamashita, Takashi

2007-01-01

The feature contains 8 articles concerned with the subject matter in the title. The first is a document of the interview with Dr. Yoshiharu Yonekura, the National Institute of Radiological Sciences (NIRS) President, by the editor in chief of the journal, entitled ''Twenty to Thirty years are Necessary for Development of Basic Technology''- discussed are progress of molecular imaging, present and future of positron emission tomography (PET) diagnosis. Lasting are the articles of: ''Recommendation for PET diagnosis'' by K. Kusakabe, Tokyo Women's Medical Univ.- the role of PET diagnosis in a mass examination; ''The present state and future development of PET diagnosis of cancer'' by H. Fukuda and K. Inoue, Tohoku Univ. Hospital- labeled compounds and others; ''Promotion of popularization of the diagnosis as a part of CSR (corporate social responsibility) in the local medicare- A participation of the Hospital of Chugoku Electric Power Co., Ltd. in the project'' by K. Tanaka; ''Trend of development of next generation PET equipment'' by H. Murayama, NIRS- equipments like PET/CT or PET/MRI, and with high system sensitivity (detector- and photo-elements, DOI detection, high performance circuit, etc.); ''Achievement and developing trend of the equipments in the manufacturer- Shimadzu Corp.'' by M. Amano- PET/CT; ''(the same title)- Sumitomo Heavy Industries, Ltd.'' by K. Oikawa- cyclotron and therapeutic heavy ion beam generator; and ''Research and development in Hamamatsu Photonics K.K.'' by T. Yamashita- high throughput PET and animal PET. (R.T.)

Radiation exposure to workers at cyclotron facilities

International Nuclear Information System (INIS)

Ribeiro, M.S.; Sanches, M.P.; Sanchez, A.S.; Rodrigues, D.L.

2001-01-01

Radiopharmaceuticals quickly furnish the information doctors need to establish a precise diagnosis of the patient's condition, and therefore to prescribe the most effective therapy. In cancerology, F18-FDG, the most widely used PET imaging tracer, excels in the early detection of cancer tumors, even very tiny ones, which it locates and clearly distinguishes from healthy surrounding tissues. IPEN-CNEN/SP has two cyclotron accelerators used mainly for radioisotope production to be utilized in nuclear medicine for diagnosis and therapy. The first is a CV-28 cyclotron, variable energy that came into operation in 1982, which was used to produce F18-FDG and Iodine 123 up to 1998. The second, a Cyclone 30 cyclotron, 30 MeV, commenced operation in 1998 for certification purpose, and due to increase demand for radiopharmaceuticals in Brazil, started F18-FDG production in 1999. Cyclotron Laboratory will be a reference Research and Developing Center in our country and will help the Brazilian and Latin-American community. It is necessary to have an adequate database to allow regular follow up and analysis of the individual dose distributions for each group involved in the cyclotron activities. These databases are also important means to assess the effectiveness of efforts in order to maintain doses ALARA and reduce inequalities. The official individual occupational dosimetry is provided by certified Laboratory of Thermoluminescent Dosimetry at IPEN-CNEN/SP. This paper describes the occupational doses distribution in Laboratory of Cyclotrons at IPEN-CNEN/SP from January, 1998 to July, 2000 and propose improvements for the future. (author)

New Cyclotron Targetry to Enhance F-18 clinical Position Emission Tomography

International Nuclear Information System (INIS)

Doster, J. Michael

2008-01-01

This project proposes to develop cyclotron targets that produce F-18 for clinical Positron Emission Tomography (PET) at significantly higher rates than that available from current targetry. This production rate of 18F is directly proportional to the beam current. Higher beam currents would result in increased 18F production but would be accompanied by higher heat loads to the target. The beam power available in most commercial cyclotrons exceeds the heat removal capacity of current target technology by a factor of two to four, significantly limiting the production rate of Fluorine-18

First PET scans in Estonia

International Nuclear Information System (INIS)

Nazarenko, Sergei

2003-01-01

First PET scans in Estonia were performed on 25th November 2002 in North Estonia Regional Hospital, Tallinn. Six patients with melanoma underwent scanning with FDG. This event was a result of thorough extensive preparations first started in 2000 during the European Association of Nuclear Medicine congress in Paris. During the congress first contacts were made with providers of mobile PET units. At the same time negotiations were begun with potential FDG suppliers. For the introduction of PET in Estonia mobile truckmounted scanning technology was chosen due to low level of initial investments. Of particular importance was also availability of maintenance personnel from the device providers. A significant prerequisite was potential availability of FDG from the neighbourhood - Finland and Sweden. The latter avoided the necessity for investments into local cyclotrons and local FDG production. For the first scanning experience the dedicated truckmounted PET-camera Accel, Siemens was brought by the International Hospital Group (IHG, Amersfoort, Netherlands). The device arrived by ferry from Stockholm to Tallinn harbour at 10 o'clock in the morning and left by ferry for Helsinki at 23 o'clock. The team-on-truck consisted of one technician for device operation, two drivers and two company representatives. North Estonia Regional Hospital provided three additional technicians for patient preparation and FDG injection, one nuclear medicine doctor and one specialist of biomedical engineering and medical physics. The FDG was provided by MAP Medical Technologies, Schering, Helsinki, Finland. The shipments were made by air. This was possible due to small distance between Tallinn and Helsinki of approximately 80 km due to the regular flight connections between the two cities. The FDG was shipped in two lots with a time interval of 4 hours. The patient selection was based on clinical and histopathology data. In all six patients the exam was justified for detailied staging and

How cyclotrons work

International Nuclear Information System (INIS)

Nolan, D.

1992-01-01

The operating principles of a cyclic accelerator are presented based on the IBA Cyclone 30 negative ion cyclotron, selected for the Australia's first medical cyclotron. Its main features are: acceleration with variable energy of between 15-30 million electron volts, the capability of extracting two beams simultaneously, low power consumption, easy maintenance. Other aspects not directly related to the principle of operation discussed include the vacuum and the radio-frequency systems as well as the complex computerized control system used to automatically control start-up and shut-down operations. ills

Activation of air and concrete in medical isotope production facilities

Science.gov (United States)

Dodd, Adam C.; Shackelton, R. J.; Carr, D. A.; Ismail, A.

2017-05-01

Medical isotope facilities operating in the 10 to 25 MeV proton energy range have long been used to generate radioisotopes for medical diagnostic imaging. In the last few years the beam currents available in commercially available cyclotrons have increased dramatically, and so the activation of the materials within cyclotron vaults may now pose more serious radiological hazards. This will impact the regulatory oversight of cyclotron operations, cyclotron servicing and future decommissioning activities. Air activation could pose a hazard to cyclotron staff. With the increased cyclotron beam currents it was necessary to examine the issue more carefully. Therefore the ways in which radioactivity may be induced in air by neutron reactions and neutron captures were considered and it was found that the dominant mechanism is neutron capture on Ar-40. A study of the activation of the air by neutron capture on Ar-40 within a cyclotron vault was performed using the MCNP Monte Carlo code. The neutron source energy spectrum used was from the production of the widely used F-18 PET isotope. The results showed that the activation of the air within a cyclotron vault does not pose a significant radiological hazard at the beam intensities currently in use and shows how ventilation affects the results. A second MCNP study on the activation of ordinary concrete in cyclotron vaults by neutron capture was made with a view to determining the optimum thickness of borated polyethylene to reduce neutron activation on both the inner surfaces of the vault and around production targets. This is of importance in decommissioning cyclotrons and therefore in the design of new cyclotron vaults. The distribution of activation on the walls as a function of the source position was also studied. Results are presented for both borated and regular polyethylene, and F-18 and Tc-99 neutron spectra.

New superconducting cyclotron driven scanning proton therapy systems

International Nuclear Information System (INIS)

Klein, Hans-Udo; Baumgarten, Christian; Geisler, Andreas; Heese, Juergen; Hobl, Achim; Krischel, Detlef; Schillo, Michael; Schmidt, Stefan; Timmer, Jan

2005-01-01

Since one and a half decades ACCEL is investing in development and engineering of state of the art particle-therapy systems. A new medical superconducting 250 MeV proton cyclotron with special focus on the present and future beam requirements of fast scanning treatment systems has been designed. The first new ACCEL medical proton cyclotron is under commissioning at PSI for their PROSCAN proton therapy facility having undergone successful factory tests especially of the closed loop cryomagnetic system. The second cyclotron is part of ACCEL's integrated proton therapy system for Europe's first clinical center, RPTC in Munich. The cyclotron, the energy selection system, the beamline as well as the four gantries and patient positioners have been installed. The scanning system and major parts of the control software have already been tested. We will report on the concept of ACCEL's superconducting cyclotron driven scanning proton therapy systems and the current status of the commissioning work at PSI and RPTC

Medical application of PET technology

International Nuclear Information System (INIS)

Lim, Sang Moo; Choi, C. W.; An, S. H.; Woo, K. S.; Chung, W. S.; Yang, S. D.; Jun, G. S. and others

1999-04-01

We performed following studies using PET technology: 1. Clinical usefulness of [ 18 F]FDG whole body PET in malignant disease 2. Clinical usefulness of quantitative evaluation of F-18-FDG 3. Pilot study of C-11 methionine PET in brain tumor 4. PET study in patients with Parkinson's disease 5. A study on the clinical myocardial PET image. PET gives various metabolic information for the living human body, and is very important, new diagnostic modality. The PET study will give us the information of cancer patients such as early detection of cancer, staging, recurrence detection and characterization of cancer. The quantitative analysis using PET could be applied to evaluate the pathophysiology of various diseases and develop new drugs and develop new radiopharmaceuticals

Medical application of PET technology

Energy Technology Data Exchange (ETDEWEB)

Lim, Sang Moo; Choi, C. W.; An, S. H.; Woo, K. S.; Chung, W. S.; Yang, S. D.; Jun, G. S. and others

1999-04-01

We performed following studies using PET technology: 1. Clinical usefulness of [{sup 18}F]FDG whole body PET in malignant disease 2. Clinical usefulness of quantitative evaluation of F-18-FDG 3. Pilot study of C-11 methionine PET in brain tumor 4. PET study in patients with Parkinson's disease 5. A study on the clinical myocardial PET image. PET gives various metabolic information for the living human body, and is very important, new diagnostic modality. The PET study will give us the information of cancer patients such as early detection of cancer, staging, recurrence detection and characterization of cancer. The quantitative analysis using PET could be applied to evaluate the pathophysiology of various diseases and develop new drugs and develop new radiopharmaceuticals.

Distribution of residual long-lived radioactivity in the inner concrete walls of a compact medical cyclotron vault room.

Science.gov (United States)

Fujibuchi, Toshioh; Nohtomi, Akihiro; Baba, Shingo; Sasaki, Masayuki; Komiya, Isao; Umedzu, Yoshiyuki; Honda, Hiroshi

2015-01-01

Compact medical cyclotrons have been set up to generate the nuclides necessary for positron emission tomography. In accelerator facilities, neutrons activate the concrete used to construct the vault room; this activation increases with the use of an accelerator. The activation causes a substantial radioactive waste management problem when facilities are decommissioned. In the present study, several concrete cores from the walls, ceiling and floor of a compact medical cyclotron vault room were samples 2 years after the termination of operations, and the radioactivity concentrations of radionuclides were estimated. Cylindrical concrete cores 5 cm in diameter and 10 cm in length were bored from the concrete wall, ceiling and floor. Core boring was performed at 18 points. The gamma-ray spectrum of each sample was measured using a high-purity germanium detector. The degree of activation of the concrete in the cyclotron vault room was analyzed, and the range and tendency toward activation in the vault room were examined. (60)Co and (152)Eu were identified by gamma-ray spectrometry of the concrete samples. (152)Eu and (60)Co are produced principally from the stable isotopes of europium and cobalt by neutron capture reactions. The radioactivity concentration did not vary much between the surface of the concrete and at a depth of 10 cm. Although the radioactivity concentration near the target was higher than the clearance level for radioactive waste indicated in IAEA RS-G-1.7, the mean radioactivity concentration in the walls and floor was lower than the clearance level. The radioactivity concentration of the inner concrete wall of the medical cyclotron vault room was not uniform. The areas exceeding the clearance level were in the vicinity of the target, but most of the building did not exceed the clearance levels.

Production, administration and disposal of cyclotron produced shortlived radioactive gases for positron emission tomography studies at the Austin Repatriation Medical Centre, Melbourne

Energy Technology Data Exchange (ETDEWEB)

Egan, G.F.; O`Keefe, G. [Austin Hospital, Heidelberg, VIC (Australia); Tochon-Danguy, H.J.; Midgley, S.; Phana, K.S.; Sachinidis, J.; Chan, J.G. [Melbourne Univ., Parkville, VIC (Australia). School of Physics

1995-01-01

Positron Emission Tomography (PET) Centre is operational at the Austin Repatriation Medical Centre, Melbourne. The major equipment consists of a 10 MeV cyclotron and a whole body PET scanner. Radioactive gases produced and used directly in clinical studies include [{sup 15}O]O{sub 2}, [{sup 15}O]CO, and [{sup 15}O]CO{sub 2}, whilst [{sup 11}C]CO{sub 2} is also produced for use in radiochemistry syntheses. Radioactivity delivery rates of 3.7, 3.3, and 1.6 GBq/min to the scanner suite have been achieved for [{sup 15}O]O{sub 2}, [{sup 15}O]CO{sub 2}, and [{sup 15}O]CO respectively, and batch productions of 36.3 GBq of [{sup 11}C]CO{sub 2} have been produced. The production. patient administration and disposal of the short-lived radioactive gases has been achieved in compliance with radiation protection principles. Radioactive gas doses of 1.7 GBq are administered to patients with less than 0.02 MBq/m{sup 3} leakage into the scanner suite. Less than 13 MBq of [ {sup 15}O]-labelled gases are released into the environment per patient study at a concentration of 0.018 MBq/m{sup 3}. Annually less than 2 GBq is expected to be released into the environment. The centre design and first four months` experience of radioactive gas production, administration and disposal is presented. 5 refs., 4 tab., 1 fig.

Nuclear medical technology

International Nuclear Information System (INIS)

Daga, Avinash; Sharma, Smita; Sharma, K.S.

2012-01-01

Nuclear medical technology helps to use radiopharmaceuticals (drugs that give off radiation) to diagnose and treat illness. A more recent development is Positron Emission Tomography (PET) which is a more precise and sophisticated technique that uses isotopes produced in a cyclotron. F-18 in FDG (fluorodeoxyglucose) is one such positron-emitting radionuclide. Chemically, it is 2-deoxy-2-( 18 F) fluoro-D-glucose, a glucose analog with the positron-emitting radioactive isotope fluorine-18 substituted for the normal hydroxyl group at the 2' position in the glucose molecule. It is introduced, usually by injection, and then it gets accumulated in the target tissue. As it decays it emits a positron, which promptly combines with a nearby electron resulting in the simultaneous emission of two identifiable gamma rays in opposite directions. These are detected by a PET camera when the patient is placed in the PET scanner for a series of one or more scans which may take from 20 minutes to as long as an hour. It gives very precise indication of their origin. 18 F in FDG (fluorodeoxyglucose) has become very important in detection of cancers and the monitoring of progress in their treatment, using PET. (author)

Research and investigation on medical usage of cyclotrons as a special research project

International Nuclear Information System (INIS)

1980-01-01

In the National Institute of Radiological Sciences, the special research project ''Research and investigation on the medical usage of cyclotrons'' had been carried out in the three years program from fiscal 1976 to 1978. Its purpose was to establish the methods of therapy using particle beam such as fast neutrons and the methods of diagnosis using short-lived radioisotopes and positron-emitting radioisotopes. The works were conducted comprehensively in cooperation of the personnel both in and outside the NIRS. Consequently, the purpose was able to be fulfilled satisfactorily. Following on this project, a new special research project ''Research and investigation on the medical usage of particle accelerators'' was started in fiscal 1979. These results are described on the effects of the therapy, diagnostic utilizations, and the medical usage of heavy ion accelerators. (J.P.N.)

Advances in superconducting cyclotrons at MSU

International Nuclear Information System (INIS)

Blosser, H.; Antaya, T.; Au, R.

1987-01-01

Intensive work on superconducting cyclotrons began at MSU in late 1973 (a brief earlier study had occurred in the early 1960's) and continues vigorously at present. One large cyclotron, the ''K500'', has been operating for a number of years, a second, the ''K800'', is nearing completion, the first operating tests of its magnet having occurred at the time of the previous conference, and a third, the ''medical cyclotron'', is now also nearing completion with first operation of its magnet expected just after the present conference. These cyclotrons like other superconducting cyclotrons are all dramatically smaller than comparable room temperature machines; overall weight is typically about 1/20th of that of room temperature cyclotrons of the same energy. This large reduction in the quantities of materials is partially offset by added complexity, but finally, a net overall cost savings of 50 to 70 % typically results; as a consequence the superconducting cyclotron is widely viewed as the cyclotron of the future. The thirteen years of experience at MSU involving three of these cyclotrons, together with much important work at other laboratories, gives a rather clear view of the advantages and disadvantages of various design approaches including by now a rather significant period of long term evaluation. This paper reviews highlights of this program. (author)

77 FR 58840 - Request for Comments and Announcement of Workshop on Pet Medications Issues

Science.gov (United States)

2012-09-24

... therapeutic treatments for pets; pet medications have become available at some online and brick- and-mortar... veterinarians. Over the last ten years, brick-and-mortar and online retail and pharmacy entities (hereinafter...

Medical isotope production experience at the V.G. Khlopin Radium Institute cyclotron

International Nuclear Information System (INIS)

Solin, L.M.

2000-01-01

Radium Institute cyclotron MGC-20 is used since 1990. There are four cyclotrons of such type in Russia and four abroad: in Finland, in Hungary, in North Korea and in Egypt. The Radium institute cyclotron was used in different fields, such as radioisotope production, nuclear physics, physics and engineering. For ten years some improvements of the Radium Institute cyclotron operation have been made. Those are: creation of the automatic control system based on IBM PC, development of a new power supply for the ion source, creation of the deflector electronic protection from discharges, change of the main elements of the cyclotron with high induced radioactivity. Moreover we investigated the possibility of the negative ions acceleration at the MGC-20 cyclotron without ion source exchange. The maximum value of the proton beam current reached was about 30 μA for 10 MeV H - beam energy. To extract the proton beam from the cyclotron after the stripping foil we made an additional output beam line. It was used for determination of the horizontal and vertical emittance. A special device was constructed and used for measurements of emittance. The latter amounted 30 π mm mrad for horizontal direction and 16 π mm mrad for vertical direction

NIRS report concerning the cyclotron usages. FY 2000

International Nuclear Information System (INIS)

2001-07-01

This report describes the National Institute of Radiological Sciences (NIRS) cyclotron usages concerning of: Operation and improvement-development of the cyclotrons in 2000 (total 1,302 hr operation, development of the insulating septum, renewal of the magnetic channel and radiofrequency (RF) pre-amplifier, and improvement of the magnetic interference); Development of neutron detectors in the cosmic environment (the phoswich detector, low-pressure proportional counter, bubble dosimeter and new type phoswich detector); Development of detectors of charged particle components in the cosmic radiation (Liulin-4J and position sensitive silicon detector); Measurement of the energy and angular distribution of secondary electrons from water vapor with heavy-ion impact; Phase II clinical trials of proton beam therapy for ophthalmological tumors (34 patients in 1996-2000 and survival rate 100% within 3 years); Application of cyclotrons for RI production (mainly, 11 C, 13 N, 15 O and 18 F for basic and clinical PET); Studies on the spread-out peak of proton beam (for radiotherapy); and Related materials to above (details). (N.I.)

PRODUCTION CONSIDERATIONS FOR THE CLASSICAL PET NUCLIDES.

Energy Technology Data Exchange (ETDEWEB)

FINN,R.; SCHLYER,D.

2001-06-25

Nuclear Medicine is the specialty of medical imaging, which utilizes a variety of radionuclides incorporated into specific compounds for diagnostic imaging and therapeutic applications. During recent years, research efforts associated with this discipline have concentrated on the decay characteristics of particular radionuclides and the design of unique radiolabeled tracers necessary to achieve time-dependent molecular images. The specialty is expanding with specific Positron emission tomography (PET) and SPECT radiopharmaceuticals allowing for an extension from functional process imaging in tissue to pathologic processes and nuclide directed treatments. PET is an example of a technique that has been shown to yield the physiologic information necessary for clinical oncology diagnoses based upon altered tissue metabolism. Most PET drugs are currently produced using a cyclotron at locations that are in close proximity to the hospital or academic center at which the radiopharmaceutical will be administered. In November 1997, a law was enacted called the Food and Drug Administration Modernization Act of 1997 which directed the Food and Drug Administration (FDA) to establish appropriate procedures for the approval of PET drugs in accordance with section 505 of the Federal Food, Drug, and Cosmetic Act and to establish current good manufacturing practice requirements for such drugs. At this time the FDA is considering adopting special approval procedures and cGMP requirements for PET drugs. The evolution of PET radiopharmaceuticals has introduced a new class of ''drugs'' requiring production facilities and product formulations that must be closely aligned with the scheduled clinical utilization. The production of the radionuclide in the appropriate synthetic form is but one critical component in the manufacture of the finished radiopharmaceutical.

PRODUCTION CONSIDERATIONS FOR THE CLASSICAL PET NUCLIDES

International Nuclear Information System (INIS)

FINN, R.; SCHLYER, D.

2001-01-01

Nuclear Medicine is the specialty of medical imaging, which utilizes a variety of radionuclides incorporated into specific compounds for diagnostic imaging and therapeutic applications. During recent years, research efforts associated with this discipline have concentrated on the decay characteristics of particular radionuclides and the design of unique radiolabeled tracers necessary to achieve time-dependent molecular images. The specialty is expanding with specific Positron emission tomography (PET) and SPECT radiopharmaceuticals allowing for an extension from functional process imaging in tissue to pathologic processes and nuclide directed treatments. PET is an example of a technique that has been shown to yield the physiologic information necessary for clinical oncology diagnoses based upon altered tissue metabolism. Most PET drugs are currently produced using a cyclotron at locations that are in close proximity to the hospital or academic center at which the radiopharmaceutical will be administered. In November 1997, a law was enacted called the Food and Drug Administration Modernization Act of 1997 which directed the Food and Drug Administration (FDA) to establish appropriate procedures for the approval of PET drugs in accordance with section 505 of the Federal Food, Drug, and Cosmetic Act and to establish current good manufacturing practice requirements for such drugs. At this time the FDA is considering adopting special approval procedures and cGMP requirements for PET drugs. The evolution of PET radiopharmaceuticals has introduced a new class of ''drugs'' requiring production facilities and product formulations that must be closely aligned with the scheduled clinical utilization. The production of the radionuclide in the appropriate synthetic form is but one critical component in the manufacture of the finished radiopharmaceutical

The guideline for in-hospital manufactured FDG for PET examinations

International Nuclear Information System (INIS)

2001-01-01

The guideline made by the three working groups of Japan Society of Nuclear Medicine, of subcommittee on Medical Application of Cyclotron-Produced Radionuclides in Medical and Pharmaceutical Science Committee of Japan Radioisotope Association (JRA) and of Radiopharmaceuticals Committee of JRA, deals with working environment and management system of FDG ( 18 F-2-deoxy-2-fluoro-D-glucose) manufacturing, standards for FDG synthetic equipment and its installation, quality and methods of synthesis and assay, PET apparatus and clinical application, for the purpose of safe and effective use of the FDG made in-hospital for its future application into public health insurance. FDG is synthesized in-hospital from 18 F generated from either 20 Ne irradiated by deuteron or 18 O, by proton. For the confirmation in the quality standard, the peaks only at 511 and 1022 keV should be observed by gamma-spectrometry with the half life of 105-115 min. The PET apparatus usable must be a defined one in the Pharmaceutical Affairs Law like that for positron CT, positron camera and PET camera. In clinical application, FDG is formulated for injection and used for examinations of brain/myocardium and cerebral/myocardial glucose consumption, of tumor and tumor FDG uptake and so on. Precautions involve general contraindications and usage in pregnancy, aged people and infants. (K.H.)

Physical and Chemical Aspects of PET Radiopharmaceuticals

International Nuclear Information System (INIS)

2004-09-01

On the Workshop 23 contributions were presented. This proceedings includes 21 presentations delivered at the workshop. The topics discussed included: Cyclotron and Target Constructions; Target Chemistry; Radiopharmaceuticals Synthesis; Quality Control of Radiopharmaceuticals; GLP-GMP Design; PET Imaging. Each presentation has been indexed separately

Proposed full automatic control system for the Medical Small Cyclotron C-30 at the Institute of Nuclear Studies, Poland

International Nuclear Information System (INIS)

Jankowski, A.

1987-01-01

The computer control system for the C-30 Medical Small Cyclotron, which is currently under construction at the Institute of Nuclear Studies will be presented. The features of this simple and secure system are briefly discussed. Some efforts have been done to make a conversational system easily understandable for operators. The keystone of the control system is an fibre optical link (wireless) between the cyclotron and the computer. The control system is based on the use of an extended configuration of the IBM PC/AT computer. A new system software is used to execute multitask hierarchical programs to control the cyclotron. The comercial adapters for control and data aquisition, connected with the fibre optic communication channels are used to transmit data and control codes. Two colour graphic CRT displays the ongoing status and function of each controlled units so that the operator can monitor the whole system conditions at a glance. The paper gives a general description of the programs which are executed on the computer. It also shows how the cyclotron is controlled by dedicated computer practically without special electronic equipment except of the hardware safety cutout switch. The cyclotron is protected against operating incidents and mistakes by a complex system of interlocks. (author)

JSW's baby cyclotron

International Nuclear Information System (INIS)

Toda, Y.; Kaneda, Y.; Satoh, Y.; Suzukawa, I.; Yamada, T.

1983-01-01

Designed by The Japan Steel Works, Ltd., specially for installation in a hospital's medical department and nuclear research laboratory, '' JSW BABY CYCLOTRON '' has been developed to produce short-lived radioisotopes such as 11C, 13N, 15O and 18F. JSW's Baby Cyclotron has some design features. 1) Fixed energy and four sector azimuthally varying field. 2) Compact figure desired for hospital's nuclear medical department 3) A bitter type magnet yoke shielding activity 4) Simple control and operation 5) Easy maintenance without skilled personnel. Type BC105 (P:10MeV, d:5MeV), BC107 (P:10MeV, d:7MeV), BC168 (P:16MeV, d:8MeV) and BC1710 (P:17MeV, d:10MeV) are available according to required amount of radioisotopes. In our radioisotope production test, yield and purity of 11C, 13N, 15O and 18F are usable to clinical diagnosis

Cyclotron produced radiopharmaceuticals

International Nuclear Information System (INIS)

Kopicka, K.; Fiser, M.; Hradilek, P.; Hanc, P.; Lebeda, O.

2003-01-01

Some of the cyclotron-produced radionuclides may serve as important materials for the production of radiopharmaceuticals. This lecture deals with basic information relating to various aspects of these compounds. In comparison with radionuclides /compounds used for non-medical purposes, radiopharmaceuticals are subject to a broader scale of regulations, both from the safety and efficacy point of view; besides that, there are both radioactive and medical aspects that must be taken into account for any radiopharmaceutical. According to the regulations and in compliance with general rules of work with radioactivity, radiopharmaceuticals should only be prepared/manufactured under special conditions, using special areas and special equipment and applying special procedures (e.g. sterilisation, disinfection, aseptic work). Also, there are special procedures for cleaning and maintenance. Sometimes the requirements for the product safety clash with those for the safety of the personnel; several examples of solutions pertaining to these cases are given in the lecture. Also, the specific role of cyclotron radiopharmaceuticals is discussed. (author)

General aspects of meteorology and wind flow patterns at the National Medical Cyclotron site, Camperdown, NSW, Australia

International Nuclear Information System (INIS)

Clark, G.H.; Bartsch, F.J.K.

1994-06-01

As part of an assessment into the consequences of a potential accident at the National Medical Cyclotron, Camperdown, NSW., Australia, two meteorological stations were installed to monitor the winds, temperatures and atmospheric dispersion conditions. The data will be used to assess environmental impacts of the Cyclotron's operation. In spite of the relatively poor performance of the stations, the wind data indicated significant effects of local buildings and the general urban surface roughness features. The prevailing winds during the study were from the north-north-west at night and south-south-west or north-east sea breezes during the day. Atmospheric stability/dispersion categories were typical of an urban heat island location. 11 refs., 10 tabs, 6 figs

Pet in Clinical oncology

International Nuclear Information System (INIS)

Hunsche, A.; Grossman, G.; Santana, M.; Santana, C.; Halkar, R.; Garcia, E.

2003-01-01

The utility of the PET (positron emission tomography in clinical oncology has been recognized for more than two decades, locating it as a sensible technique for the diagnosis and the prognosis stratification of the oncology patients. The sensitivity and specificity of the PET in comparation to other image studies have demonstrated to be greater. For some years, there was a restriction of PET because of the high cost of the equipment and the cyclotrons. Nevertheless, the relation of cost/benefits is considered as a priority as this technique offers important clinical information. In this article the results observed when using it in diverse types of cancer, as well as the effectiveness shown in the pre-operating evaluation, the evaluation of residual disease, diagnosis of recurrences, pursuit and prognosis stratification of the patients with cancer. (The author)

Estimation of the thermal neutron flux in a PET cyclotron room via radioactive analysis of the bolts of a wall socket in the room

International Nuclear Information System (INIS)

Ogata, Y.; Ishigure, N.; Mochizuki, S.; Ito, K.; Hatano, K.; Abe, J.; Miyahara, H.; Masumoto, K.; Nakamura, H.; Matsumura, H.

2008-01-01

Full text: Since positron emission nuclides for PET (Positron Emission Tomography) have short half-lives, they are mainly produced by on-site cyclotrons. Significant amounts of neutrons are generated together with the operating of the cyclotron, and then materials in the room are activated. To quantify the neutron flux density will lead the prediction of the extent of the activation. We tried to estimate the neutron flux of the room via the radioactive analysis of bolts in the room. The cyclotron (Cypris HM-18, Sumitomo Heavy Industry) is able to accelerate protons and deuterons up to 18 and 10 MeV, respectively. The routine charge current is 20μA. The cyclotron is housed in a room with 1 m thickness concrete wall. A couple of bolts of a wall socket were removed to investigate the components and the radioactivities, which were analyzed by fluorescent X-ray spectroscopy and by gamma-ray spectroscopy, respectively. We compared the neutron flux estimated by the bolts analysis with the results measured by the gold foil activation method. The weight sum of the bolts was 1.257 g. They were made of nickel plated brass, and predominantly consisted of Cu (63%) and Zn (34%). Four nuclides, 69m Zn, 65 Zn, 64 Cu, and 60 Co, were detected in the bolts. The activity of 64 Cu half-life of 12.7 h, led the last few days history of neutron flux, and the activity of 65 Zn, 244 d, led the last few years history. The analysis of the bolts activity estimated the thermal neutron flux at 4∼6x10 5 cm -2 s -1 . This figure agreed with the value, 6∼9x10 5 cm -2 s -1 , computed from the activated gold foil near the bolts. Bolts are quite generally installed in such a room. Therefore, the radioactive analysis of the bolts leads convenient and effective estimation of neutron flux there. Consequently, the radioactive analysis of the bolts in the cyclotron room allowed us to estimate the neutron flux in the room. (author)

Recent development and progress of IBA cyclotrons

Energy Technology Data Exchange (ETDEWEB)

Kleeven, W., E-mail: Willem.Kleeven@iba-group.com [Ion Beam Applications s.a. Chemin du Cyclotron 3, Louvain-la-Neuve (Belgium); Abs, M., E-mail: Michel.Abs@iba-group.com [Ion Beam Applications s.a. Chemin du Cyclotron 3, Louvain-la-Neuve (Belgium); Delvaux, J.L., E-mail: Jean-Luc.Delvaux@iba-group.com [Ion Beam Applications s.a. Chemin du Cyclotron 3, Louvain-la-Neuve (Belgium); Forton, E., E-mail: Eric.Forton@iba-group.com [Ion Beam Applications s.a. Chemin du Cyclotron 3, Louvain-la-Neuve (Belgium); Jongen, Y., E-mail: Yves.Jongen@iba-group.com [Ion Beam Applications s.a. Chemin du Cyclotron 3, Louvain-la-Neuve (Belgium); Medeiros Romao, L., E-mail: Luis.MedeirosRomao@iba-group.com [Ion Beam Applications s.a. Chemin du Cyclotron 3, Louvain-la-Neuve (Belgium); Nactergal, B., E-mail: Benoit.Nactergal@iba-group.com [Ion Beam Applications s.a. Chemin du Cyclotron 3, Louvain-la-Neuve (Belgium); Nuttens, V., E-mail: Vincent.Nuttens@iba-group.com [Ion Beam Applications s.a. Chemin du Cyclotron 3, Louvain-la-Neuve (Belgium); Servais, T., E-mail: Thomas.Servais@iba-group.com [Ion Beam Applications s.a. Chemin du Cyclotron 3, Louvain-la-Neuve (Belgium); Vanderlinden, T., E-mail: Thierry.Vanderlinden@iba-group.com [Ion Beam Applications s.a. Chemin du Cyclotron 3, Louvain-la-Neuve (Belgium); Zaremba, S., E-mail: Simon.Zaremba@iba-group.com [Ion Beam Applications s.a. Chemin du Cyclotron 3, Louvain-la-Neuve (Belgium)

2011-12-15

Several cyclotron development projects were recently realized by Ion Beam Applications S.A. (IBA). This contribution presents three of them: (i) the intensity enhancement of the Cyclone 30 cyclotron, a machine mainly used for the production of SPECT isotopes. This project is related with the increased demand for {sup 201}Tl because of the shortage of Mo/Tc generators from nuclear reactors, (ii) development of a new versatile multiple-particle K = 30 isotope-production cyclotron (the Cyclone 30XP) being able to accelerate H{sup -}, D{sup -} and also {alpha}-particles. The {alpha}-beam of this cyclotron will allow the production of new therapeutic isotopes (e.g. {sup 211}At) and (iii) commissioning of the Cyclone 70 cyclotron installed for Arronax in France. This machine is similar to the C30XP but provides higher energy (K = 70) and allows research on new types of medical isotopes.

Manufacturing on the radiopharmaceuticals produced by cyclotron

International Nuclear Information System (INIS)

Ueda, Nobuo

1994-01-01

Radiopharmaceutical (RP) produced by cyclotrons are widely used for the in vivo diagnosis of various diseases such as cancer, cerebral vascular disorders and cardiac diseases. The nuclides used as RPs and their nuclear reactions, and the quantity of RPs supplied in Japan in the last five years are shown. These RPs are delivered to about 1,100 hospitals in Japan. Thallium-201 and iodine-123 showed very high growth rate. Recently, two new I-123 RPs, BMIPP and MIBG which are heart-imaging agents, have been supplied. It suggests that the quantity of I-123 will increase much more in future. The image diagnostic method using RPs is called in vivo nuclear medicine, and has become the indispensable means for medical institutions together with X-ray CT, nuclear magnetic resonance imaging and ultrasonic diagnosis. The RPs for in vivo diagnosis generally used at present are classified into those labeled with the RIs produced with cyclotrons and those labeled with Tc-99m formed by the decay of Mo-99. The quantity being used is overwhelmingly more in the latter, but the former shows the tendency of growth. The commercial production of cyclotron RIs for medical use, the chemical forms and the diagnostic purposes of the RPs using cyclotron RIs, and the state of use of the cyclotron-produced RPs are reported. (K.I.)

Recent achievements in Tc-99m radiopharmaceutical direct production by medical cyclotrons.

Science.gov (United States)

Boschi, Alessandra; Martini, Petra; Pasquali, Micol; Uccelli, Licia

2017-09-01

99m Tc is the most commonly used radionuclide in the field of diagnostic imaging, a noninvasive method intended to diagnose a disease, assess the disease state and monitor the effects of treatments. Annually, the use of 99m Tc, covers about 85% of nuclear medicine applications. This isotope releases gamma rays at about the same wavelength as conventional X-ray diagnostic equipment, and owing to its short half-life (t ½  = 6 h) is ideal for diagnostic nuclear imaging. A patient can be injected with a small amount of 99m Tc and within 24 h almost 94% of the injected radionuclide would have decayed and left the body, limiting the patient's radiation exposure. 99m Tc is usually supplied to hospitals through a 99 Mo/ 99m Tc radionuclide generator system where it is produced from the β decay of the parent nuclide 99 Mo (t ½  = 66 h), which is produced in nuclear reactors via neutron fission. Recently, the interruption of the global supply chain of reactor-produced 99 Mo, has forced the scientific community to investigate alternative production routes for 99m Tc. One solution was to consider cyclotron-based methods as potential replacement of reactor-based technology and the nuclear reaction 100 Mo(p,2n) 99m Tc emerged as the most worthwhile approach. This review reports some achievements about 99m Tc produced by medical cyclotrons. In particular, the available technologies for target design, the most efficient extraction and separation procedure developed for the purification of 99m Tc from the irradiated targets, the preparation of high purity 99m Tc radiopharmaceuticals and the first clinical studies carried out with cyclotron produced 99m Tc are described.

Improving cancer treatment with cyclotron produced radionuclides

International Nuclear Information System (INIS)

Larson, S.M.; Finn, R.D.

1992-01-01

Our goal is to improve the scientific basis for tumor diagnosis, treatment and treatment follow-up based on the use of cyclotron produced radiotracers in oncology. The grant includes 3 interactive components: Radiochemistry/Cyclotron; Pharmacology; and Immunology. The radiochemistry group seeks to develop innovative cyclotron targetry, radiopharmaceuticals, and radiolabeled antibodies, which are then used to assess important unanswered questions in tumor pharmacology and immunology. Examples include selected positron emitting radionuclides, such as Iodine-124, and Ga-66; I-124, I-123, I-131 labeled iododeoxyuridine, C-11 colchicine, and antimetabolites, like C-11 methotrexate; and radiolabeled antibodies, 3F8, M195, A33, and MRK16 for application in the pharmacology and immunology projects. The pharmacology program studies tumor resistance to chemotherapy, particularly the phenomenon of multidrug resistance and the relationship between tumor uptake and retention and the tumor response for anti-metabolite drugs. The immunology program studies the physiology of antibody localization at the tissue level as the basis for novel approaches to improving tumor localization such as through the use of an artificial lymphatic system which mechanically reduces intratumoral pressures in tumors in vivo. Quantitative imaging approaches based on PET and SPECT in radioimmunotherapy are studied to give greater insight into the physiology of tumor localization and dosimetry

Next customers to cyclotron center meanwhile are not entered

International Nuclear Information System (INIS)

Bato, R.; Zackova, K.

2004-01-01

In this paper the financial aspects of construction of the Cyclotron Centre of the Slovak Republic (CC SR) are analysed. This building represents the problems of exploitation of commodity deblocation of Russian Federation debt to Slovakia. The estimated expenses have risen from original planned 2 billion Slovak crowns to 6 billion Slovak crowns. Devices which should be part of centre - a cyclotron used for radiopharmaceuticals production for oncological purposes and a big cyclotron for industrial purposes, a centre of positron emissive tomography (PET), a laboratory of nano-technologies, a source of heavy ions - they indicates that the oncological institutes, departments of health service, of education, of economy, of defence, of environment, also Nuclear Regulatory Authority of Slovak Republic and Slovak Academy of Sciences should become the customers principally. Around 2.2 billion of Slovak crowns from deblocation have been spent for a construction of Cyclotron Centre of SR yet. The national budget has contributed by 95 million Slovak crowns; 90.5 million USD will be obtained from deblocation of Russian debt yet. IAEA has supported this centre by grant of almost 800 thousand USD. Budget of Cyclotron Centre of SR is still rising also because of rising of VAT from 10 percent to 19 percent. VAT will be paid also for goods imported within the framework of deblocation after integration of Slovak Republic to European Union; besides also 10 percent duty is paid. Project of CC SR has not passed the state expert opinion. Agreement for construction of Cyclotron Centre of SR was issued by State Health Institute of Bratislava, therefore it was confirmed also by the main hygienist of Slovak Republic

Cyclotrons at the Institute of Physical and Chemical Research

International Nuclear Information System (INIS)

Imamura, Masashi.

1989-01-01

In this article the destruction by American forces, during World War II, of the Japanese cyclotrons and the subsequent construction of new cyclotrons at the Institute of Physical and Chemical Research, Japan is described. Their use for biological and medical radiation chemistry studies is summarized. (UK)

Status of Simulations for the Cyclotron Laboratory at the Institute for Nuclear Research and Nuclear Energy

Science.gov (United States)

Asova, G.; Goutev, N.; Tonev, D.; Artinyan, A.

2018-05-01

The Institute for Nuclear Research and Nuclear Energy is preparing to operate a high-power cyclotron for production of radioisotopes for nuclear medicine, research in radiochemistry, radiobiology, nuclear physics, solid state physics. The cyclotron is a TR24 produced by ASCI, Canada, capable to deliver proton beams in the energy range of 15 to 24 MeV with current as high as 400 µA. Multiple extraction lines can be fed. The primary goal of the project is the production of PET and SPECT isotopes as 18F, 67,68Ga, 99mTc, etc. This contribution reports the status of the project. Design considerations for the cyclotron vault will be discussed for some of the target radioisotopes.

Diagnostic system for the nuclear medicine with baby cyclotron

International Nuclear Information System (INIS)

Kashihara, Masao; Wakasa, Shyuichiro

1982-01-01

The system of cyclotron nuclear medicine consists of ''RI-production by using the cyclotron'', ''production of radio-pharmaceuticals labeled with RI'', ''positron tomography''. On the other hand, Ultra compact cyclotron (Baby cyclotron) itself, RI production technique and positron tomography have been rapidly developed and advanced. We think that these three functions must be balance in the development in order to spread this system into the routine work in the hospital. However, since the technology of the synthesis for the labeled compounds is not so developed so far, more advance can be strongly expected. In this report, construction of the cyclotron nuclear medicine, utility for the practical use of RI produced by using the cyclotron, technique of RI production, and the studies on automated and efficient productions of radio-pharmaceuticals labeled with short-lived positron emitters for medical diagnostic use are described. (author)

Clinical blood flow measurements with O-15 water and Positron Emission Tomography (PET)

International Nuclear Information System (INIS)

Hichwa, R.D.; Watkins, G.L.; Boles Ponto, L.L.

1993-01-01

Traditionally PET chemists have been primarily involved in development and synthesis of radiopharmaceuticals for imaging. If greater clinical utility and research productivity are to be achieved in the PET field, then this role must be expanded to include not just the synthesis of the end product, but also the efficient and timely delivery of the radiopharmaceutical. Hence, the chemist must also consider (1) more automation of synthesis and QC procedures, (2) reduced radiopharmaceutical preparation time with emphasis towards on-line syntheses whenever feasible, (3) integrated cyclotron/chemistry operations, (4) dose delivery schemes to minimize staff exposure while maintaining purity, sterility and apyrogenicity, and (5) technologist/technician operability of all procedures. At the University of Iowa, techniques have been employed to stream-line the production synthesis, delivery, and imaging of O-15 labelled water for determination of tissue blood flow. Automated cyclotron and PET tomograph operation, as well as steady-state production of O-15 water permit a single PET technologist to conduct qualitative blood flow studies on demand for routine or emergency procedures

Lung PET scan

Science.gov (United States)

... Chest PET scan; Lung positron emission tomography; PET - chest; PET - lung; PET - tumor imaging; ... Grainger & Allison's Diagnostic Radiology: A Textbook of Medical Imaging . 6th ed. Philadelphia, ...

The Medical Imaging & Technology Alliance conference on research endpoints appropriate for Medicare coverage of new PET radiopharmaceuticals.

Science.gov (United States)

Hillman, Bruce J; Frank, Richard A; Abraham, Brian C

2013-09-01

The outcomes of a 2011 Medical Imaging & Technology Alliance (MITA) conference helped shape considerations about what might be the most appropriate pathways for the regulatory and payment considerations of new PET radiopharmaceuticals. As follow-up to that conference, MITA convened a second conference of stakeholders to advise payers on what might be acceptable endpoints for clinical trials to support the coverage of novel PET agents. The conference involved experts on imaging and clinical research, providers of PET services, as well as representatives of interested medical societies, the PET industry, and the regulatory and payer communities. The principal outcome of their deliberations was that it was unrealistic to expect trials of new PET radiopharmaceuticals to directly demonstrate a health benefit. Rather, intermediate outcomes, such as a positive change in patient management, would be more efficient and appropriate.

82 Rubidium-PET kan blive den nye myokardieskintigrafi

DEFF Research Database (Denmark)

Hasbak, Philip; Kjær, Andreas

2011-01-01

-lived isotopes at centres with access to a cyclotron, and only including a very limited number of patients. The number of PET scanners has increased markedly in Denmark and with the introduction of generator-produced 82-Rubidium, this modality may replace the traditional cardial single photon emission computed...

Comparison of short-lived medical isotopes activation by laser thin target induced protons and conventional cyclotron proton beams

Science.gov (United States)

Murray, Joseph; Dudnikova, Galina; Liu, Tung-Chang; Papadopoulos, Dennis; Sagdeev, Roald; Su, J. J.; UMD MicroPET Team

2014-10-01

Production diagnostic or therapeutic nuclear medicines are either by nuclear reactors or by ion accelerators. In general, diagnostic nuclear radioisotopes have a very short half-life varying from tens of minutes for PET tracers and few hours for SPECT tracers. Thus supplies of PET and SPECT radiotracers are limited by regional production facilities. For example 18F-fluorodeoxyglucose (FDG) is the most desired tracer for positron emission tomography because its 110 minutes half-life is sufficient long for transport from production facilities to nearby users. From nuclear activation to completing image taking must be done within 4 hours. Decentralized production of diagnostic radioisotopes will be idea to make high specific activity radiotracers available to researches and clinicians. 11 C, 13 N, 15 O and 18 F can be produced in the energy range from 10-20 MeV by protons. Protons of energies up to tens of MeV generated by intense laser interacting with hydrogen containing targets have been demonstrated by many groups in the past decade. We use 2D PIC code for proton acceleration, Geant4 Monte Carlo code for nuclei activation to compare the yields and specific activities of short-lived isotopes produced by cyclotron proton beams and laser driven protons.

Use of maze in cyclotron hoppers

International Nuclear Information System (INIS)

Fernandes, Fernando A.; Alves, Juliano S.; Fochesatto, Cintia; Cerioli, Luciane; Borges, Joao Alfredo; Gonzalez, Delfin; Silva, Daniel C.

2013-01-01

Introduction: the increasing number of cyclotrons in Brazil due to constitutional amendment 49 /06 that enabled the production of radiopharmaceuticals with a short half - life by private companies. The radionuclides used for PET - CT require production centers near or within the diagnostic centers. In order to minimize maintenance and operating risks, gaining efficiency, our facility was the first in Brazil to use the access to a cyclotron bunker via maze, rather than armored door stopper type. Materials: the design calculations were based on the Monte Carlo method (MCNP5 - Monte Carlo N-Particletransportcode version 5). At the ends of the labyrinth are installed a door of polyethylene, for thermalization of neutrons, and other of wood for limiting access. Both legs of the maze have wall thickness of 100cm. In inspection Brazilian CNEN realize measures of dose rate for neutrons and gamma 9 points: 7 around the bunker, 1 over the bunker and 1 in the exhaust with the cyclotron operating with maximum load, double beam of 50uA for 2 hours. After commissioning were carried out around the bunker, the following measures: cumulative dose in three months with dosimeters for neutron rate dose with a gas proportional detector type filled with 3 He and polyethylene neutron moderator and dose rate with a Geiger - Mueller detector for gamma radiation. Readings with neutron detectors were classified as background radiation and dose rates were always below the limits established in standard EN 3.01, and the calculation of the predicted regardless of the intensity of irradiation inside the bunker. Conclusion: the use of labyrinths as a way to access the bunkers cyclotron has been shown to be effective as the radiation shielding and efficient by allowing quick and easy access, virtually eliminating the maintenance

Shielding of medically used proton accelerators; Abschirmung von medizinisch genutzten Protonenbeschleunigern

Energy Technology Data Exchange (ETDEWEB)

Ewen, Klaus

2014-10-01

In several standards of the standards committee radiology (NRA) the shielding of proton accelerators (cyclotrons) for medical utilization is described. Proton beams can be used in nuclear medicine for PET (proton emission tomography) isotope production or for radiotherapeutic use. The dominating radiation from proton induced nuclear reactions is fast neutron radiation. The calculation procedure for appropriate shielding measures according to the NAR standards is described step-by-step. AN adequate shielding of fast neutrons is also sufficient for the generated gamma radiation.

Future perspective of medical radionuclide production and related educational problems in developing countries

International Nuclear Information System (INIS)

Uenak, Turan

1999-01-01

The radionuclide applications are continuously escalation in nuclear medicine. Especially, the development of positron emission tomography (PET) technique has increased very rapidly the use of short-lived radioisotopes in this field, and this has caused the development of compact medical cyclotrons. About 30 cyclotrons operated in the world wide are actually found in the developing countries. In parallel of this progress, the basic nuclear sciences, especially nuclear chemistry and radiopharmaceutical chemistry will probably very important fields in the next new century for nuclear science and technology applications in health care sector. For this reason, the developing countries should eventually revise their academic educational and training programs aiming to ensure the formation of qualified basic nuclear scientists such as nuclear chemist, nuclear physicist, radiopharmacist, etc. (author)

Development of cyclotron solid targetry

International Nuclear Information System (INIS)

D'Souza, J.; Deans, T.; Cryer, D.; Price, R.

2004-01-01

Full text: Western Australia's first medical cyclotron was recently installed in the Department of Medical Technology and Physics at Sir Charles Gairdner Hospital. The cyclotron is routinely used for 18 F production using a liquid target, and now research is being undertaken into solid target bombardment for production of novel isotopes such as 124 I, 64 Cu and 96 Tc. The IBA Cyclone 18/9 has a maximum proton beam energy of 18MeV and maximum beam current of 80μA. A proton beam is generated by the acceleration of H- ions in the evacuated cyclotron (10 -6 bar) which are then stripped of 2 electrons just prior to exiting a target port. Each port has two strippers which are made of 10μm thick carbon with dimensions 12mmxl3mm. Due to their thinness, the strippers are easily ruptured. The Cyclone 18/9 has 8 target ports. In order to fit a target onto the cyclotron when the cyclotron is already evacuated the target is first evacuated to 10 -3 bar by a roughing pump before an isolation valve at the port is opened. This stops any damage that may occur by the flow of air from the target reservoir to the cyclotron eg to the strippers. The first step in the project to develop solid targetry is to build a beam line in order to measure the beam profile. If successful, this design will be improved in order to have a beam line and target holder that are suitable for use in solid target bombardment. A 40cm beam line with an internal diameter of 3.6cm was built to fit onto the IBA Cyclone 18/9. The beam line, made out of aluminium, incorporates a step 5cm from the end at which a target material can be fitted. A cover fits onto the beam line, behind the target in order to maintain vacuum. The cover is held in place by the vacuum within the beam line. At the end of bombardment, the beam line can be isolated from the vacuum of the target and normal air pressure restored. In doing so the cover plate falls open and the target falls into a lead pot, ready for removal from the cyclotron

The problems of high efficient extraction from the isochronous cyclotron

International Nuclear Information System (INIS)

Schwabe, J.

1994-06-01

The problem of high efficient extraction (η ≥ 50%) from isochronous cyclotrons (with the exception of the stripping method) is not completely solved up to this day. This problem is specifically important, because these cyclotrons are being also applied in the production of medical radioisotopes, labeled pharmaceuticals as well as in neutron therapy (oncology), machine industry, agriculture (plant mutagenesis), etc. The aim of the proposed topic is to solve this problem on the AIC-144 isochronous cyclotron in the INP (Institute of Nuclear Physics). Lately, a beam of 20 MeV deuterons with an efficiency of ca. 15% was extracted from this cyclotron. (author). 25 refs, 14 figs

Influence of the initial guess spectrum in the unfolding of Bss data obtained inside a bunker of a PET cyclotron

Energy Technology Data Exchange (ETDEWEB)

Benavente C, J. A.; Lacerda, M. A. S.; Guimaraes, A. M.; Da Silva, T. A. [Universidade Federal de Minas Gerais, Departamento de Engenharia Nuclear, Programa de Pos-graduacao em Ciencias e Tecnicas Nucleares, Pte. Antonio Carlos 6627, Belo Horizonte 31270-901, Minas Gerais (Brazil); Vega C, H. R. [Universidad Autonoma de Zacatecas, Unidad Academica de Estudios Nucleares, Cipres No. 10, Fracc. La Penuela, 98060 Zacatecas, Zac. (Mexico)

2015-10-15

In a cyclotron facility is strongly advised the use of spectrometry techniques to support workplace neutron dosimetry. Bonner sphere spectrometer (Bss) is the most used for radiation protection applications. Bss data must be unfolded to determine the spectral particle fluence. Some computer codes have been utilized for this purpose. These codes allow unfolding the spectrum from the Bss count rates through different algorithms. Some iterative routines need an initial guess spectrum to start the unfolding. The adequate choice of this initial spectrum is a critical part of the process and can affect the final solution. In this work, we evaluate the influence of the initial guess spectrum in the unfolding of Bss data obtained in four points inside the bunker of a PET cyclotron. The measurements were done utilizing a modified Bss system with thermoluminescent detectors (TLDs). Codes BUNKIUT and NSDUAZ were utilized to unfold the Bss data. For the NSDUAZ the starting spectrum is automatically obtained from a library initial guess spectra. For the BUNKIUT code were utilized two different initial guess spectra: (a) a Maxwellian spectrum with temperature of 1.4 MeV and shape factor of 0.1, created with the MAXIET algorithm and; (b) the spectra obtained through simulation with the MCNPX code version 2.7. Spectra obtained with both unfold codes and with the different initial guess spectra presented epithermal and thermal neutrons due to room-return effects. However, the contribution of the fast neutron to the total fluence were quite different for the different cases studied. These differences highlight the importance of an appropriate choice of an initial guess spectra for the quality of the results. (Author)

Influence of the initial guess spectrum in the unfolding of Bss data obtained inside a bunker of a PET cyclotron

International Nuclear Information System (INIS)

Benavente C, J. A.; Lacerda, M. A. S.; Guimaraes, A. M.; Da Silva, T. A.; Vega C, H. R.

2015-10-01

In a cyclotron facility is strongly advised the use of spectrometry techniques to support workplace neutron dosimetry. Bonner sphere spectrometer (Bss) is the most used for radiation protection applications. Bss data must be unfolded to determine the spectral particle fluence. Some computer codes have been utilized for this purpose. These codes allow unfolding the spectrum from the Bss count rates through different algorithms. Some iterative routines need an initial guess spectrum to start the unfolding. The adequate choice of this initial spectrum is a critical part of the process and can affect the final solution. In this work, we evaluate the influence of the initial guess spectrum in the unfolding of Bss data obtained in four points inside the bunker of a PET cyclotron. The measurements were done utilizing a modified Bss system with thermoluminescent detectors (TLDs). Codes BUNKIUT and NSDUAZ were utilized to unfold the Bss data. For the NSDUAZ the starting spectrum is automatically obtained from a library initial guess spectra. For the BUNKIUT code were utilized two different initial guess spectra: (a) a Maxwellian spectrum with temperature of 1.4 MeV and shape factor of 0.1, created with the MAXIET algorithm and; (b) the spectra obtained through simulation with the MCNPX code version 2.7. Spectra obtained with both unfold codes and with the different initial guess spectra presented epithermal and thermal neutrons due to room-return effects. However, the contribution of the fast neutron to the total fluence were quite different for the different cases studied. These differences highlight the importance of an appropriate choice of an initial guess spectra for the quality of the results. (Author)

Thermal Stabilization of Cryogenic System in Superconducting Cyclotron

International Nuclear Information System (INIS)

Shin, Seung Jae; Kim, Kyung Min; Cho, Hyung Hee; Hong, Bong Hwan; Kang, Joon Sun; Ahn, Dong Hyun

2011-01-01

Radiology has some useful applications for medical purpose. For cancer therapy, the superconducting cyclotron should generate heavy ion beams. It radiates heavy ion beams to cancer patients. In order to make cyclotron system stable, the cryogenic system which makes superconducting state should work constantly. However, radiation heat transfer of cryogenic system should be considered because liquid helium's boiling point is extremely low and there is huge temperature difference between the cryogenic system and ambient temperature. Accordingly, thermal analysis should be carried out. In this paper, the numerical analysis of the cryogenic system in practical superconducting cyclotron show temperature distribution and suggest the number of coolers using ANSYS Workbench program

Magnet design and test of positron emission tomography cyclotron

International Nuclear Information System (INIS)

Wei Tao; Yang Guojun; He Xiaozhong; Pang Jian; Zhao Liangchao; Zhang Kaizhi

2012-01-01

An 11 MeV H - compact cyclotron used for medical radioactive isotope production is under construction in Institute of Fluid Physics, CAEP. The cyclotron magnet adopts the design of small valley gaps and coulee structure which can provide high average magnetic field and strong focus ability. To achieve 5 × 10 -4 measuring accuracy, a magnetic field mapping system has been developed. After iterative correction using field measurement data, the total phase excursion of the cyclotron is within ± 9° and the first harmonic is less than 10 -3 T, which are all acceptable. Furthermore, the beam testing declares the successful construction of the cyclotron magnet. Besides, some magnetic field influence factors were discussed, including the magnetic field distortion and measurement error. (authors)

Advances in intense beams, beam delivery, targetry, and radiochemistry at advanced cyclotron systems

Energy Technology Data Exchange (ETDEWEB)

Johnson, R.R. [Advanced Cyclotron Systems Inc., 7851 Alderbridge Way, Richmond, BC, V6X 2A4 (Canada)]. E-mail: djohnson@advancedcyclotron.com; Watt, R. [Advanced Cyclotron Systems Inc., 7851 Alderbridge Way, Richmond, BC, V6X 2A4 (Canada); Kovac, B. [Advanced Cyclotron Systems Inc., 7851 Alderbridge Way, Richmond, BC, V6X 2A4 (Canada); Zyuzin, A. [Advanced Cyclotron Systems Inc., 7851 Alderbridge Way, Richmond, BC, V6X 2A4 (Canada); Van Lier, E. [Advanced Cyclotron Systems Inc., 7851 Alderbridge Way, Richmond, BC, V6X 2A4 (Canada); Erdman, K.L. [Advanced Cyclotron Systems Inc., 7851 Alderbridge Way, Richmond, BC, V6X 2A4 (Canada); Gyles, Wm. [Advanced Cyclotron Systems Inc., 7851 Alderbridge Way, Richmond, BC, V6X 2A4 (Canada); Sabaiduc, V. [Advanced Cyclotron Systems Inc., 7851 Alderbridge Way, Richmond, BC, V6X 2A4 (Canada); McQuarrie, S.A. [Faculty of Medicine and Dentistry, University of Alberta, Edmonton, AB, T6G 1Z2 (Canada); Wilson, J. [Faculty of Medicine and Dentistry, University of Alberta, Edmonton, AB, T6G 1Z2 (Canada); Backhouse, C. [Department of Electrical Engineering, University of Alberta, Edmonton, AB (Canada); Gelbart, Wm. [Advanced System Design, C22, S6, RR1, Garden Bay, BC, V0N 1S0 (Canada); Kuo, T. [4654 N. Larwin Ave., Concorde, CA 94521 United States (United States)

2007-08-15

The increasing demand for radionuclides for PET and SPECT has resulted in ACSI system improvements starting from the cyclotron and proceeding to the Radiochemistry Modules. With more TR30 cyclotrons installed and operating at full capacity, emphasis has been placed on improving the operational components to reduce both the incidence of failure and subsequent maintenance time. A cyclotron system has been developed that meets the needs of a regional radiopharmacy that supplies both positron and single photon emitters that would not otherwise be available. This new system has been named the TR24. In order to deal with some of the challenges of high currents, a method has been developed for passivating the entrance window foil during high current irradiation of a water target used to produce F-18. A method has been developed for passivating the entrance window foil to reduce unwanted chemical species that interfere with radiopharmaceutical production. Preliminary results for novel radioiodine production technique using the TR19/9 are also discussed.

Advances in intense beams, beam delivery, targetry, and radiochemistry at advanced cyclotron systems

Science.gov (United States)

Johnson, R. R.; Watt, R.; Kovac, B.; Zyuzin, A.; Van Lier, E.; Erdman, K. L.; Gyles, Wm.; Sabaiduc, V.; McQuarrie, S. A.; Wilson, J.; Backhouse, C.; Gelbart, Wm.; Kuo, T.

2007-08-01

The increasing demand for radionuclides for PET and SPECT has resulted in ACSI system improvements starting from the cyclotron and proceeding to the Radiochemistry Modules. With more TR30 cyclotrons installed and operating at full capacity, emphasis has been placed on improving the operational components to reduce both the incidence of failure and subsequent maintenance time. A cyclotron system has been developed that meets the needs of a regional radiopharmacy that supplies both positron and single photon emitters that would not otherwise be available. This new system has been named the TR24. In order to deal with some of the challenges of high currents, a method has been developed for passivating the entrance window foil during high current irradiation of a water target used to produce F-18. A method has been developed for passivating the entrance window foil to reduce unwanted chemical species that interfere with radiopharmaceutical production. Preliminary results for novel radioiodine production technique using the TR19/9 are also discussed.

Advances in intense beams, beam delivery, targetry, and radiochemistry at advanced cyclotron systems

International Nuclear Information System (INIS)

Johnson, R.R.; Watt, R.; Kovac, B.; Zyuzin, A.; Van Lier, E.; Erdman, K.L.; Gyles, Wm.; Sabaiduc, V.; McQuarrie, S.A.; Wilson, J.; Backhouse, C.; Gelbart, Wm.; Kuo, T.

2007-01-01

The increasing demand for radionuclides for PET and SPECT has resulted in ACSI system improvements starting from the cyclotron and proceeding to the Radiochemistry Modules. With more TR30 cyclotrons installed and operating at full capacity, emphasis has been placed on improving the operational components to reduce both the incidence of failure and subsequent maintenance time. A cyclotron system has been developed that meets the needs of a regional radiopharmacy that supplies both positron and single photon emitters that would not otherwise be available. This new system has been named the TR24. In order to deal with some of the challenges of high currents, a method has been developed for passivating the entrance window foil during high current irradiation of a water target used to produce F-18. A method has been developed for passivating the entrance window foil to reduce unwanted chemical species that interfere with radiopharmaceutical production. Preliminary results for novel radioiodine production technique using the TR19/9 are also discussed

Atmospheric tracer tests and assessment of a potential accident at the National Medical Cyclotron, Camperdown, NSW, Australia

International Nuclear Information System (INIS)

Clark, G.H.; Bartsch, F.J.K.; Stone, D.J.M.

1994-08-01

In order to assess the impact of a potential atmospheric release of radionuclides from the National Medical Cyclotron facility, in Camperdown, an atmospheric tracer release, sampling and analysis system using SF 6 was developed. During eight experiments conducted in a variety of meteorological conditions, ten samplers were located in the vicinity of the Cyclotron building and other nearby buildings on the rapid downward movement of the tracer gas plume. The atmospheric dilution factors which lead to the highest observed air concentrations were then applied to the releases of I 123 and Xe 123 from a potential accident scenario in order to assess the impact on nearby receptors. Even given the conservative assumptions about the release of I 123 , the estimated radiation doses were at least an order of magnitude below the international standards for doses to member of the public. 27 refs., 8 tabs., 5 figs

Atmospheric tracer tests and assessment of a potential accident at the National Medical Cyclotron, Camperdown, NSW, Australia

Energy Technology Data Exchange (ETDEWEB)

Clark, G H; Bartsch, F J.K.; Stone, D J.M.

1994-08-01

In order to assess the impact of a potential atmospheric release of radionuclides from the National Medical Cyclotron facility, in Camperdown, an atmospheric tracer release, sampling and analysis system using SF{sub 6} was developed. During eight experiments conducted in a variety of meteorological conditions, ten samplers were located in the vicinity of the Cyclotron building and other nearby buildings on the rapid downward movement of the tracer gas plume. The atmospheric dilution factors which lead to the highest observed air concentrations were then applied to the releases of I{sup 123} and Xe{sup 123} from a potential accident scenario in order to assess the impact on nearby receptors. Even given the conservative assumptions about the release of I{sup 123}, the estimated radiation doses were at least an order of magnitude below the international standards for doses to member of the public. 27 refs., 8 tabs., 5 figs.

The Midwest Proton Radiation Institute project at the Indiana University Cyclotron Facility

Energy Technology Data Exchange (ETDEWEB)

Anferov, V; Broderick, B; Collins, J C; Friesel, D L; Jenner, D; Jones, W P; Katuin, J; Klein, S B; Starks, W; Self, J; Schreuder, N [IUCF, Bloomington, Indiana 47408 (United States)

2001-12-12

The IUCF cyclotrons ceased delivering particle beams for physics research and became dedicated medical proton beam accelerators in 1999. Removal of the beam lines and nuclear research facilities associated with the cyclotrons to make room for the new medical beam delivery systems was completed in October, 2000. A new achromatic beam line was completed, extending from the main stage cyclotron and ending at a temporary research platform. This beam line is being commissioned during ongoing applied research. The achromatic line will deliver 0.5 {mu}A of 205 MeV protons from which the treatment room technician may draw current at any time via fast switching, laminated magnets located at the entrances to the energy selection systems upstream of each of the treatment rooms. Three treatment rooms are planned, one containing two fixed horizontal lines and two gantry rooms. The cyclotrons will also support full time research in radiation effects, single event upset, radiation biology and pre-clinical research. This contribution describes the status of the medical construction project.

Cyclotron production of {sup 64}Cu by deuteron irradiation of {sup 64}Zn

Energy Technology Data Exchange (ETDEWEB)

Abbas, K. [Institute for Health and Consumer Protection, Joint Research Centre, European Commission, TP 500, I-21020 Ispra (Vatican City State, Holy See,) (Italy)]. E-mail: kamel.abbas@jrc.it; Kozempel, J. [Institute for Health and Consumer Protection, Joint Research Centre, European Commission, TP 500, I-21020 Ispra (VA) (Italy); Charles University Prague, Faculty of Science, Department of Organic and Nuclear Chemistry, 128 43 Prague (Czech Republic); Bonardi, M. [LASA, Radiochemistry Laboratory, University and INFN, via F.lli Cervi 201, I-20090 Segrate (MI) (Italy); Groppi, F. [LASA, Radiochemistry Laboratory, University and INFN, via F.lli Cervi 201, I-20090 Segrate (MI) (Italy); Alfarano, A. [Institute for Health and Consumer Protection, Joint Research Centre, European Commission, TP 500, I-21020 Ispra (VA) (Italy); Holzwarth, U. [Institute for Health and Consumer Protection, Joint Research Centre, European Commission, TP 500, I-21020 Ispra (VA) (Italy); Simonelli, F. [Institute for Health and Consumer Protection, Joint Research Centre, European Commission, TP 500, I-21020 Ispra (VA) (Italy); Hofman, H. [Institute for Health and Consumer Protection, Joint Research Centre, European Commission, TP 500, I-21020 Ispra (VA) (Italy); Horstmann, W. [Institute for Health and Consumer Protection, Joint Research Centre, European Commission, TP 500, I-21020 Ispra (VA) (Italy); Menapace, E. [ENEA, Applied Physics Division, Bologna (Italy); Leseticky, L. [Charles University Prague, Faculty of Science, Department of Organic and Nuclear Chemistry, 128 43 Prague (Czech Republic); Gibson, N. [Institute for Health and Consumer Protection, Joint Research Centre, European Commission, TP 500, I-21020 Ispra (VA) (Italy)

2006-09-15

The short-lived (12.7 h half-life) {sup 64}Cu radioisotope is both a {beta} {sup +} and a {beta} {sup -} emitter. This property makes {sup 64}Cu a promising candidate for novel medical applications, since it can be used simultaneously for therapeutic application of radiolabelled biomolecules and for diagnosis with PET. Following previous work on {sup 64}Cu production by deuteron irradiation of natural zinc, we report here the production of this radioisotope by deuteron irradiation of enriched {sup 64}Zn. In addition, yields of other radioisotopes such as {sup 61}Cu, {sup 67}Cu, {sup 65}Zn, {sup 69m}Zn, {sup 66}Ga and {sup 67}Ga, which were co-produced in this process, were also measured. The evaporation code ALICE-91 and the transport code SRIM 2003 were used to determine the excitation functions and the stopping power, respectively. All the nuclear reactions yielding the above-mentioned radioisotopes were taken into account in the calculations both for the natural and enriched Zn targets. The experimental and calculated yields were shown to be in reasonable agreement. The work was carried out at the Scanditronix MC-40 Cyclotron of the Institute for Health and Consumer Protection of the Joint Research Centre of the European Commission (Ispra site, Italy). The irradiations were carried out with 19.5 MeV deuterons, the maximum deuteron energy obtainable with the MC-40 cyclotron.

Design study of the KIRAMS-430 superconducting cyclotron magnet

International Nuclear Information System (INIS)

Kim, Hyun Wook; Kang, Joonsun; Hong, Bong Hwan; Jung, In Su

2016-01-01

Design study of superconducting cyclotron magnet for the carbon therapy was performed at the Korea Institute of Radiological and Medical Science (KIRAMS). The name of this project is The Korea Heavy Ion Medical Accelerator (KHIMA) project and a fixed frequency cyclotron with four spiral sector magnet was one of the candidate for the accelerator type. Basic parameters of the cyclotron magnet and its characteristics were studied. The isochronous magnetic field which can guide the "1"2C"6"+ ions up to 430 MeV/u was designed and used for the single particle tracking simulation. The isochronous condition of magnetic field was achieved by optimization of sector gap and width along the radius. Operating range of superconducting coil current was calculated and changing of the magnetic field caused by mechanical deformations of yokes was considered. From the result of magnetic field design, structure of the magnet yoke was planned.

Design study of the KIRAMS-430 superconducting cyclotron magnet

Energy Technology Data Exchange (ETDEWEB)

Kim, Hyun Wook; Kang, Joonsun, E-mail: genuinei@kirams.re.kr; Hong, Bong Hwan; Jung, In Su

2016-07-01

Design study of superconducting cyclotron magnet for the carbon therapy was performed at the Korea Institute of Radiological and Medical Science (KIRAMS). The name of this project is The Korea Heavy Ion Medical Accelerator (KHIMA) project and a fixed frequency cyclotron with four spiral sector magnet was one of the candidate for the accelerator type. Basic parameters of the cyclotron magnet and its characteristics were studied. The isochronous magnetic field which can guide the {sup 12}C{sup 6+} ions up to 430 MeV/u was designed and used for the single particle tracking simulation. The isochronous condition of magnetic field was achieved by optimization of sector gap and width along the radius. Operating range of superconducting coil current was calculated and changing of the magnetic field caused by mechanical deformations of yokes was considered. From the result of magnetic field design, structure of the magnet yoke was planned.

An analytical approach of thermodynamic behavior in a gas target system on a medical cyclotron.

Science.gov (United States)

Jahangiri, Pouyan; Zacchia, Nicholas A; Buckley, Ken; Bénard, François; Schaffer, Paul; Martinez, D Mark; Hoehr, Cornelia

2016-01-01

An analytical model has been developed to study the thermo-mechanical behavior of gas targets used to produce medical isotopes, assuming that the system reaches steady-state. It is based on an integral analysis of the mass and energy balance of the gas-target system, the ideal gas law, and the deformation of the foil. The heat transfer coefficients for different target bodies and gases have been calculated. Excellent agreement is observed between experiments performed at TRIUMF's 13 MeV cyclotron and the model. Copyright © 2015 Elsevier Ltd. All rights reserved.

PIXE analysis by baby cyclotron

International Nuclear Information System (INIS)

Yoshida, Hyogo; Tanaka, Teruaki; Ito, Takashi; Toda, Yohjiro; Wakasa, Hideichiro

1988-01-01

The Japan Steel Works, Ltd. has been supplying a very small sized cyclotron (Baby Cyclotron) to hospitals and research facilities. The cyclotron is designed to produce short-lived radioisotopes for medical use. In the present study, this cyclotron is modified so that it can serve for PIXE analysis. The PIXE (particle induced X-ray emission) technique has the following features: (1) Down to 1 ng of trace material in a sample (mg - μg) can be detected, (2) An analysis run is completed in one to ten minutes, permitting economical analysis for a large number of samples, (3) Several elements can be analyzed simultaneously, with an almost constant sensitivity for a variety of elements ranging from aluminum to heavy metals, (4) Analysis can be performed nondestructively without a chemical process, and (5) The use of microbeam can provide data on the distribution of elements with a resolution of several μm. Software for analysis is developed to allow the modified equipment to perform peak search, background fitting, and identification and determination of peaks. A study is now being conducted to examine the performance of the equipment for PIXE analysis of thin samples. Satisfactory results have been obtained. The analysis time, excluding the background correction, is 5-10 min. (Nogami, K.)

Technical Note: Building a combined cyclotron and MRI facility: Implications for interference

Energy Technology Data Exchange (ETDEWEB)

Hofman, Mark B. M.; Kuijer, Joost P. A.; Ridder, Jan Willem de; Perk, Lars R.; Verdaasdonk, Rudolf M. [Physics and Medical Technology, VU University Medical Center, Amsterdam 1007 MB (Netherlands) and BV Cyclotron VU, Amsterdam 1081HV (Netherlands)

2013-01-15

Purpose: With the introduction of hybrid PET/MRI systems, it has become more likely that the cyclotron and MRI systems will be located close to each other. This study considered the interference between a cyclotron and a superconducting MRI system. Methods: Interactions between cyclotrons and MRIs are theoretically considered. The main interference is expected to be the perturbation of the magnetic field in the MRI due to switching on or off the magnetic field of the cyclotron. MR imaging is distorted by a dynamic spatial gradient of an external inplane magnetic field larger than 0.5-0.04 {mu}T/m, depending on the specific MR application. From the design of a cyclotron, it is expected that the magnetic fringe field at large distances behaves as a magnetic dipolar field. This allows estimation of the full dipolar field and its spatial gradients from a single measurement. Around an 18 MeV cyclotron (Cyclone, IBA), magnetic field measurements were performed on 5 locations and compared with calculations based upon a dipolar field model. Results: At the measurement locations the estimated and measured values of the magnetic field component and its spatial gradients of the inplane component were compared, and found to agree within a factor 1.1 for the magnetic field and within a factor of 1.5 for the spatial gradients of the field. In the specific case of the 18 MeV cyclotron with a vertical magnetic field and a 3T superconducting whole body MR system, a minimum distance of 20 m has to be considered to prevent interference. Conclusions: This study showed that a dipole model is sufficiently accurate to predict the interference of a cyclotron on a MRI scanner, for site planning purposes. The cyclotron and a whole body MRI system considered in this study need to be placed more than 20 m apart, or magnetic shielding should be utilized.

Accurate Monte Carlo modeling of cyclotrons for optimization of shielding and activation calculations in the biomedical field

Science.gov (United States)

Infantino, Angelo; Marengo, Mario; Baschetti, Serafina; Cicoria, Gianfranco; Longo Vaschetto, Vittorio; Lucconi, Giulia; Massucci, Piera; Vichi, Sara; Zagni, Federico; Mostacci, Domiziano

2015-11-01

Biomedical cyclotrons for production of Positron Emission Tomography (PET) radionuclides and radiotherapy with hadrons or ions are widely diffused and established in hospitals as well as in industrial facilities and research sites. Guidelines for site planning and installation, as well as for radiation protection assessment, are given in a number of international documents; however, these well-established guides typically offer analytic methods of calculation of both shielding and materials activation, in approximate or idealized geometry set up. The availability of Monte Carlo codes with accurate and up-to-date libraries for transport and interactions of neutrons and charged particles at energies below 250 MeV, together with the continuously increasing power of nowadays computers, makes systematic use of simulations with realistic geometries possible, yielding equipment and site specific evaluation of the source terms, shielding requirements and all quantities relevant to radiation protection. In this work, the well-known Monte Carlo code FLUKA was used to simulate two representative models of cyclotron for PET radionuclides production, including their targetry; and one type of proton therapy cyclotron including the energy selection system. Simulations yield estimates of various quantities of radiological interest, including the effective dose distribution around the equipment, the effective number of neutron produced per incident proton and the activation of target materials, the structure of the cyclotron, the energy degrader, the vault walls and the soil. The model was validated against experimental measurements and comparison with well-established reference data. Neutron ambient dose equivalent H*(10) was measured around a GE PETtrace cyclotron: an average ratio between experimental measurement and simulations of 0.99±0.07 was found. Saturation yield of 18F, produced by the well-known 18O(p,n)18F reaction, was calculated and compared with the IAEA recommended

Radioisotope production in the I. Ph. P. E. cyclotron for medical application

Energy Technology Data Exchange (ETDEWEB)

Krasnov, N.N.; Dmitriyev, P.P.; Konjakhin, N.A.; Ognev, A.A. (Gosudarstvennyj Komitet po Ispol' zovaniyu Atomnoj Ehnergii SSSR, Obninsk. Fiziko-Ehnergeticheskij Inst.)

1982-01-01

The production methods for seven radioisotopes, Ga-67, Sr-85, Pd-103, In-111, Tm-167, Hg-197 and Pb-203, by using a classical 1.5m cyclotron in the Institute of Physics and Power Engineering, Obninsk, USSR, are described. At present, more than 50 cyclotrons in different countries are used for the production of radioisotopes applied to medicine. Radioisotopes are produced with the cyclotron in the I.Ph.P.E. in the form of irradiated targets, which are delivered to Moscow radiopharmaceutical factory, where radiopharmaceuticals are produced on the base of these targets. The cyclotron is operated in two regimes providing the acceleration of protons, deuterons and alpha -particles. Two types of target assemblies are used for irradiation, the one is intended for the internal beam, and the other is for the external beam. The reactions used for the production of seven radioisotopes described above, the types of targets, particle energy, respective irradiated materials, beam current, thick target yield and the amount of respective radioisotopes produced per year are reported. Metals have large heat conductivity, therefore the use of metal targets increases beam current, and increases the production rate of radioisotopes.

Review on PET radiopharmaceuticals: from isotopes and molecules to medical applications

International Nuclear Information System (INIS)

Seimbille, Yann

2014-01-01

Molecular imaging of living subjects is an emerging field that aims to study molecular and cellular events in the intact living animal and human. Unlike classical biology, molecular imaging allows to study biological processes with cells residing in their native environment in the living subjects. Positron Emission Tomography (PET) is actually one of the preferred molecular imaging tool for its high sensitivity and its capability to non-invasively and quantitatively visualize in vivo cellular events in the non- or sub-pharmacologic concentration (nano to picomolar) without affecting biological processes. An overview of the principles of this imaging technique and a comparison with other imaging modalities will be presented. Combination of PET technology with conventional anatomical imaging (computed tomography (CT), magnetic resonance imaging (MRI)) or with another molecular imaging technique is getting more and more relevant, and such hybrid imaging is often best suited to answer specific biological or medical question. PET imaging requires the injection of a radioactive tracer, which is made of a positron-emitting isotope that allows signal detection and a chemically specific pharmacophore that interacts with the intended molecular target. Infrastructure, methods and regulation about the production of the different radionuclides of interest and the synthesis of PET tracers will be discussed. Recent novel radiolabelling strategies, as well as new technologies (i.e. micro fluidic), to generate libraries of PET radiopharmaceuticals will also be covered in this presentation

National cyclotron centre at the Institute for Nuclear Research and Nuclear Energy

Science.gov (United States)

Tonev, D.; Goutev, N.; Asova, G.; Artinyan, A.; Demerdjiev, A.; Georgiev, L. S.; Yavahchova, M.; Bashev, V.; Genchev, S. G.; Geleva, E.; Mincheva, M.; Nikolov, A.; Dimitrov, D. T.

2018-05-01

An accelerator laboratory is presently under construction in Sofia at the Institute for Nuclear Research and Nuclear Energy. The laboratory will use a TR24 type of cyclotron, which provides a possibility to accelerate a proton beam with an energy of 15 to 24 MeV and current of up to 0.4 mA. An accelerator with such parameters allows to produce a large variety of radioisotopes for development of radiopharmaceuticals. The most common radioisotopes that can be produced with such a cyclotron are PET isotopes like: 11C, 13N, 15O, 18F, 124I, 64Cu, 68Ge/68Ga, and SPECT isotopes like: 123I, 111In, 67Ga, 57Co, 99mTc. Our aim is to use the cyclotron facility for research in the fields of radiopharmacy, radiochemistry, radiobiology, nuclear physics, materials sciences, applied research, new materials and for education in all these fields including nuclear energy. Presently we perform investigations in the fields of target design for production of radioisotopes, shielding and radioprotection, new ion sources etc.

Modern compact cyclotrons for nuclear medicine designed and manufactured in NIIEFA

International Nuclear Information System (INIS)

Bogdanov, P.V.; Vasilchenko, I.N.; Gavrish, Yu.N.; Galchuk, A.V.; Grigorenko, S.V.; Kuzhlev, A.N.; Menshov, Yu.D.; Mudroyubov, V.G.; Ponomarenko, V.I.; Strokach, A.P.

2012-01-01

A series of compact cyclotrons, the CC-12, CC-18/9 and MCC-30/15, intended for the production of radionuclides for diagnostics and therapy directly in medical institutions has been designed and manufactured in NIIEFA. These cyclotrons provide the acceleration of negative hydrogen and deuterium ions injected from external sources. Beams of accelerated particles are extracted by stripping negative ions to protons and deuterons by carbon foils. Shielding-type electromagnets with the vertically located median plane are applied in these cyclotrons.

Performance test of electron cyclotron resonance ion sources for the Hyogo Ion Beam Medical Center

Science.gov (United States)

Sawada, K.; Sawada, J.; Sakata, T.; Uno, K.; Okanishi, K.; Harada, H.; Itano, A.; Higashi, A.; Akagi, T.; Yamada, S.; Noda, K.; Torikoshi, M.; Kitagawa, A.

2000-02-01

Two electron cyclotron resonance (ECR) ion sources were manufactured for the accelerator facility at the Hyogo Ion Beam Medical Center. H2+, He2+, and C4+ were chosen as the accelerating ions because they have the highest charge to mass ratio among ion states which satisfy the required intensity and quality. The sources have the same structure as the 10 GHz ECR source at the Heavy Ion Medical Accelerator in Chiba except for a few improvements in the magnetic structure. Their performance was investigated at the Sumitomo Heavy Industries factory before shipment. The maximum intensity was 1500 μA for H2+, 1320 μA for He2+, and 580 μA for C4+ at the end of the ion source beam transport line. These are several times higher than required. Sufficient performance was also observed in the flatness and long-term stability of the pulsed beams. These test results satisfy the requirements for medical use.

PET or PET-CT with cancer screening

International Nuclear Information System (INIS)

Wang Taisong; Zhao Jinhua; Song Jianhua

2007-01-01

At present, cancer screening remains a lot of debate in contemporary medical practice. Many constitutes have done a lot of experiments in cancer screening. The same version is that recommendations and decisions regarding cancer screening should be based on reliable data, not self- approbation. Now, some institutes advocate 18 F-FDG PET or 18 F-FDG PET-CT for cancer screening, here, discussed status quo, potential financial, radiation safety and statistical data in 18 F-FDG PET or 18 F-FDG PET- CT cancer screening. (authors)

PET / MRI vs. PET / CT. Indications Oncology

International Nuclear Information System (INIS)

Oliva González, Juan P.

2016-01-01

Hybrid techniques in Nuclear Medicine is currently a field in full development for diagnosis and treatment of various medical conditions. With the recent advent of PET / MRI much it speculated about whether or not it is superior to PET / CT especially in oncology. The Conference seeks to clarify this situation by dealing issues such as: State of the art technology PET / MRI; Indications Oncology; Some clinical cases. It concludes by explaining the oncological indications of both the real and current situation of the PET / MRI. (author)

A simple thick target for production of ⁸⁹Zr using an ¹¹MeV cyclotron

Energy Technology Data Exchange (ETDEWEB)

Link, Jeanne M.; Krohn, Kenneth A.; O' Hara, Matthew J.

2017-04-01

The growing interest but limited availability of ⁸⁹Zr for PET led us to test targets for the ⁸⁹(p,n) reaction. The goal was an easily constructed target for an 11 MeV Siements cyclotron. Yttrium foils were tested at different thicknesses, angles and currents. A 90 degree foil tolerated 41 microAmp without damage and produced ~800 MBq/hr, >20 mCi, an amount adequate for radiochemistry research and human doses in a widely available accelerator. This method should translate to higher energy cyclotrons.

Comprehensive Approach for Monitoring and Analyzing the Activity Concentration Level of PET Isotopes

International Nuclear Information System (INIS)

Osovizky, A.; Paran, J.; Ankry, N.; Vulasky, E.; Ashkenazi, B.; Tal, N.; Dolev, E.; Gonen, E.

2004-01-01

A comprehensive approach for measuring and analyzing low concentration levels of positron emitter isotopes is introduced. The solution is based on a Continuous Air Monitoring Sampler (CAMS), Stack Monitoring System (SMS) and software package. Positron Emission Tomography (PET) is a major tool for both, biochemical research and non-invasive diagnostics for medicine imaging. The PET method utilizes short half life β + radioisotopes that are produced in cyclotron sites built especially for this purpose. The growing need for β + isotopes brought about a commonly wide use of cyclotrons next to populated areas. Isotopes production involves two possible radiation hazards deriving from the activity concentration; one refers to the nearby population by the activity released through the ventilation system and the other refers to the personnel working in the nuclear facility. A comprehensive system providing solution for both radiation hazards is introduced in this work

In-beam PET at clinical proton beams with pile-up rejection

Energy Technology Data Exchange (ETDEWEB)

Helmbrecht, Stephan; Fiedler, Fine; Iltzsche, Marc [Helmholtz-Zentrum Dresden-Rossendorf, Dresden (Germany). Inst. of Radiation Physics; Enghardt, Wolfgang [Helmholtz-Zentrum Dresden-Rossendorf, Dresden (Germany). Inst. of Radiation Physics; OncoRay - National Center for Radiation Research in Oncology, Dresden (Germany); Helmholtz-Zentrum Dresden-Rossendorf, Dresden (Germany). Inst. of Radiooncology; German Cancer Research Center (DKFZ), Heidelberg (Germany); German Cancer Consortium (DKTK), Dresden (Germany); Pausch, Guntram [OncoRay - National Center for Radiation Research in Oncology, Dresden (Germany); Tintori, Carlo [CAEN S.p.A., Viareggio (Italy); Kormoll, Thomas [OncoRay - National Center for Radiation Research in Oncology, Dresden (Germany); Technische Univ. Dresden (Germany). AG Radiation Physics

2017-10-01

Positron emission tomography (PET) is a means of imaging the β{sup +}-activity produced by the radiation field in ion beam therapy and therefore for treatment verification. Prompt γ-rays that are emitted during beam application challenge the detectors and electronics of PET systems, since those are designed for low and medium count rates. Typical PET detectors operated according to a modified Anger principle suffer from multiple events at high rates. Therefore, in-beam PET systems using such detectors rely on a synchronization of beam status and measurement to reject deteriorated data. In this work, a method for pile-up rejection is applied to conventional Anger logic block detectors. It allows for an in-beam data acquisition without further synchronization. Though cyclotrons produce a continuous wave beam, the radiation field shaping technique introduces breaks in the application. Time regimes mimicking synchrotrons as well as cyclotron based ones using double-scattering or pencil beam scanning field shaping at dose rates of 0.5, 1.0 and 2.0 Gy/min were investigated. Two types of inhomogeneous phantoms were imaged. The first one simulates cavity structures, the other one mimics a static lung irradiation. It could be shown that, depending on the dose rate and the beam time structure, in-beam measurement including a few seconds decay time only, yield images which revealed all inhomogeneities in the phantoms. This technique can be the basis for the development of an in-beam PET system with traditional detectors and off-the-shelf electronics.

Superconducting cyclotrons

International Nuclear Information System (INIS)

Blosser, H.G.; Johnson, D.A.; Burleigh, R.J.

1976-01-01

Superconducting cyclotrons are particularly appropriate for acceleration of heavy ions. A review is given of design features of a superconducting cyclotron with energy 440 (Q 2 /A) MeV. A strong magnetic field (4.6 tesla average) leads to small physical size (extraction radius 65 cm) and low construction costs. Operating costs are also low. The design is based on established technology (from present cyclotrons and from large bubble chambers). Two laboratories (in Chalk River, Canada and in East Lansing, Michigan) are proceeding with construction of full-scale prototype components for such cyclotrons

Oncology PET imaging

International Nuclear Information System (INIS)

Inubushi, Masayuki

2014-01-01

At the beginning of this article, likening medical images to 'Where is Waldo?' I indicate the concept of diagnostic process of PET/CT imaging, so that medical physics specialists could understand the role of each imaging modality and infer our distress for image diagnosis. Then, I state the present situation of PET imaging and the basics (e.g. health insurance coverage, clinical significance, principle, protocol, and pitfall) of oncology FDG-PET imaging which accounts for more than 99% of all clinical PET examinations in Japan. Finally, I would like to give a wishful prospect of oncology PET that will expand to be more cancer-specific in order to assess therapeutic effects of emerging molecular targeted drugs targeting the 'hallmarks of cancer'. (author)

Decommissioning analyzis of a university cyclotron

International Nuclear Information System (INIS)

Eggermont, G.X.; Buls, N.; Hermanne, A.

1996-01-01

In the widespread use of some medical nuclear facilities, such as cyclotrons for isotope production, Life cycle analyzis, including decommissioning, was not taken into account. The structural materials of an accelerator and the concrete shielding of the bunker are activated by neutrons. This could yield a considerable volume of nuclear waste and needs radiation protection concern for occupational workers and the environment during some decennia. At the university of Brussels (WB) a prospective radiation protection and waste analyzis is being made for the later decommissioning of their cyclotron. Only few similar studies have been published. In Belgium future nuclear dismantling operations will be submitted to a radiation protection authorization procedure. Meanwhile the nuclear waste authorities insist on dismantling planning, including financial provisioning. An optimization exercise was made at the VUB-cyclotron, taking into account international trends to clearance levels for low level nuclear waste. Conceptual prevention opportunities e.g. selective material choice could be identified for future accelerator constructions. (author)

Design features and operating characteristics of the MC-50 cyclotron

International Nuclear Information System (INIS)

Bak, Hae Ill; Bak, Joo Shik

1989-01-01

The MC-50 cyclotron at Korean Cancer Center Hospital is now operational for neutron therapy and medical radioisotope production. Design features, mechanical structures and operating characteristics of the MC-50 are described in this paper. Optimum operating condition for this cyclotron has been determined by the repetitive running, and the performances of the internal beam have been investigated through the measurements of intensity and spatial distribution of the internal beam as a function of the radius of the cyclotron. Routinely, the 40 μA of 50 MeV protons have been obtained at first Faraday cup with a extraction efficiency of 61%. (Author)

Potential medical applications of the plasma focus in the radioisotope production for PET imaging

International Nuclear Information System (INIS)

Roshan, M.V.; Razaghi, S.; Asghari, F.; Rawat, R.S.; Springham, S.V.; Lee, P.; Lee, S.; Tan, T.L.

2014-01-01

Devices other than the accelerators are desired to be investigated for generating high energy particles to induce nuclear reaction and positron emission tomography (PET) producing radioisotopes. The experimental data of plasma focus devices (PF) are studied and the activity scaling law for External Solid Target (EST) activation is established. Based on the scaling law and the techniques to enhance the radioisotopes production, the feasibility of generating the required activity for PET imaging is studied. - Highlights: • Short lived radioisotopes for PET imaging are produced in plasma focus device. • The scaling law of the activity induced with plasma focus energy is established. • The potential medical applications of plasma focus are studied

Radiation protection problems by the operation of the cyclotron facility

International Nuclear Information System (INIS)

Durcik, M.; Nikodemova, D.

1998-01-01

The Cyclotron Center in Bratislava will consist of two cyclotrons. First - cyclotron DC-72 with maximal energy of 72 MV for protons for making experiments, for teaching process, for radioisotope production as 123 I and for neutron and proton therapy. Second - compact cyclotron with maximal proton energy of 18 MeV will be used for radioisotopes production for medical diagnosis as 1 *F (fluorodeoxyglucose), 81 Rb/ 81 Kr generator. This paper deals with the radiation protection problems by the operation of tis cyclotron facility as radiation protection of workers, monitoring plan, ventilation, safety lock and limitation and radiation monitoring. For proposed and continuing practices at the accelerator facility, the following general principles have to be fulfilled: (1) practices should produce sufficient benefit to offset the radiation detriment they case (justification); (2) the magnitude of the individual doses should be kept as low as achievable (optimization of protection); (3) individual exposures are subject to dose limits and some control of risk from potential exposures (dose and risk limits)

Fluorine-18-labelled molecules: synthesis and application in medical imaging

International Nuclear Information System (INIS)

Dolle, F.; Perrio, C.; Barre, L.; Lasne, M.C.; Le Bars, D.

2006-01-01

Positron emission tomography (PET) is one of the more powerful available techniques for medical imaging. It relies on the use of molecules labelled with a positron emitter (β + ). Among those emitters, fluorine-18, available from a cyclotron, is a radionuclide of choice because of its relatively long-half-life (109.8 min) and the relatively low energy of the emitted-positron. The electrophilic form of fluorine-18 ([ 18 F]F 2 or reagents derived from [ 18 F]F 2 ) is mainly used for hydrogen or metal substitutions on aromatic or vinylic carbons. The presence of the stable isotope (fluorine-19) in the radiotracers limits their use in medical imaging. The nucleophilic form of fluorine-18 (alkaline mono-fluoride, K[ 18 F]F, the most used), obtained from irradiation of enriched water, is widely used in aliphatic and (hetero)aromatic substitutions for the synthesis of radiotracers with high specific radioactivity. Some examples of radio-fluorinated tracers used in PET are presented, as well as some of their in vivo applications in human. (authors)

Final report of the group research. Advanced Technology for Medical Imaging Research. 1996-2000 FY

Energy Technology Data Exchange (ETDEWEB)

NONE

2002-03-01

This report involves the organization of the research groups (4 units of radiopharmaceutical chemistry, radiotracer and radiopharmacology, clinical imaging, and molecular informative research), 5 research reports and 38 published research papers. The research reports concern Fundamental researches on the availability and production of PET radiopharmaceuticals using the National Institute of Radiological Sciences (NIRS) cyclotron, Design and evaluation of in vivo radiopharmaceuticals for PET measurement (kinetics and metabolism in small animals and primates), Fundamental studies on development of technique radiation measurement, Clinical application of medical imaging technology in the fields of neuroscience, cardiovascular, cancer diagnosis and others, and A study to establish and evaluate a lung cancer screening system using spiral CT units which is in pilot-progress in Kanto and Kansai regions. (N.I.)

Vancouver Cyclotron Conference

International Nuclear Information System (INIS)

Clark, David J.

1993-01-01

Although no longer on the high energy frontier, the cyclotron field is still a major scientific growth area. Its progress is highlighted at the international conference on cyclotron design, development and utilization held at intervals of about three years, under the auspices of the International Union of Pure and Applied Physics (IUPAP). Vancouver, surrounded by mountains, water and some cyclotrons, provided a pleasant setting for the 13th Conference, held last summer. With over 200 cyclotrons in operation around the world, the attendance, 241 delegates and 26 industrial exhibitors, was a near record, reflecting the flourishing state of the field. The early sessions covered the initial operation of new or upgraded cyclotron facilities. Major facilities completed since the previous Conference in Berlin in May 1989 included the 400 MeV ring cyclotron at Osaka, the U400M cyclotron at Dubna which will be coupled to the U400 to give 20 MeV nucléon uranium beams, the 130 MeV cyclotron at Jyvaskyla (in Finland, the furthest north!), the 110 MeV JAERI machine in Japan, and the 65 MeV proton therapy cyclotron in Nice. Among the facility upgrades were the KFA cyclotron at Julich which will inject the 2.5 GeV storage ring COSY, and the addition of an FM mode to the K=200 CW mode at Uppsala to give protons up to 180 MeV. The impressive current of 1.5 mA at 72 MeV obtained from the PSI Injector II will soon be injected into the 590 MeV ring

[Nationwide survey on radioactive waste management related to positron emission tomography in Japan].

Science.gov (United States)

Nagaoka, Hiroaki; Watanabe, Hiroshi; Yamaguchi, Ichiro; Fujibuchi, Toshioh; Kida, Tetsuo; Tanaka, Shinji

2009-12-20

A clearance system for medical radioactive solid waste has not yet been implemented in Japan. Since 2004 new regulations have allowed institutions using positron emission tomography(PET)to handle totally decayed radioactive waste as non-radioactive waste after decay-in-storage. It was expected that this new regulation would mediate the installation of clearance systems in Japan. In order to assess the current situation of radiation safety management in PET institutions, we conducted a nationwide survey. The study design was a cross-sectional descriptive study conducted by questionnaire. The subjects of this survey were all the PET institutions in Japan. Among 224 institutes, 128 institutes are equipped with cyclotrons and 96 institutes are not. The number of returned questionnaires was 138. Among institutes that are using delivered radiopharmaceuticals, 80% treat their waste as non-radioactive according to the new regulation. The impact of new regulations for reducing radioactive waste in PET institutes without a cyclotron was estimated at about $400 thousand per year. The main concern of medical institutes was assessment of the contamination caused by by-products of radioactive nuclides generated in target water during the operation of a cyclotron. It was thought that a rational rule based on scientific risk management should be established because these by-products of radioactive nuclides are negligible for radiation safety. New regulation has had a good influence on medical PET institutes, and it is expected that a clearance system for medical radioactive waste will be introduced in the near future, following these recent experiences in PET institutes.

Solid targets for production of radioisotopes with cyclotron

International Nuclear Information System (INIS)

Paredes G, L.; Balcazar G, M.

1999-01-01

The design of targets for production of radioisotopes and radiopharmaceuticals of cyclotron to medical applications requires a detailed analysis of several variables such as: cyclotron operation conditions, choice of used materials as target and their physicochemical characteristics, activity calculation, the yielding of each radioisotope by irradiation, the competition of nuclear reactions in function of the projectiles energy and the collision processes amongst others. The objective of this work is to determine the equations for the calculation for yielding of solid targets at the end of the proton irradiation. (Author)

Theoretical estimation of "6"4Cu production with neutrons emitted during "1"8F production with a 30 MeV medical cyclotron

International Nuclear Information System (INIS)

Auditore, Lucrezia; Amato, Ernesto; Baldari, Sergio

2017-01-01

Purpose: This work presents the theoretical estimation of a combined production of "1"8F and "6"4Cu isotopes for PET applications. "6"4Cu production is induced in a secondary target by neutrons emitted during a routine "1"8F production with a 30 MeV cyclotron: protons are used to produce "1"8F by means of the "1"8O(p,n)"1"8F reaction on a ["1"8O]-H_2O target (primary target) and the emitted neutrons are used to produce "6"4Cu by means of the "6"4Zn(n,p)"6"4Cu reaction on enriched zinc target (secondary target). Methods: Monte Carlo simulations were carried out using Monte Carlo N Particle eXtended (MCNPX) code to evaluate flux and energy spectra of neutrons produced in the primary (Be+["1"8O]-H_2O) target by protons and the attenuation of neutron flux in the secondary target. "6"4Cu yield was estimated using an analytical approach based on both TENDL-2015 data library and experimental data selected from EXFOR database. Results: Theoretical evaluations indicate that about 3.8 MBq/μA of "6"4Cu can be obtained as a secondary, ‘side’ production with a 30 MeV cyclotron, for 2 h of irradiation of a proper designed zinc target. Irradiating for 2 h with a proton current of 120 μA, a yield of about 457 MBq is expected. Moreover, the most relevant contaminants result to be "6"3","6"5Zn, which can be chemically separated from "6"4Cu contrarily to what happens with proton irradiation of an enriched "6"4Ni target, which provides "6"4Cu mixed to other copper isotopes as contaminants. Conclusions: The theoretical study discussed in this paper evaluates the potential of the combined production of "1"8F and "6"4Cu for medical purposes, irradiating a properly designed target with 30 MeV protons. Interesting yields of "6"4Cu are obtainable and the estimation of contaminants in the irradiated zinc target is discussed. - Highlights: • "6"4Cu production with secondary neutrons from "1"8F production with protons was investigated. • Neutron reactions induced in enriched "6"4Zn

Positron Emission Tomography (PET)

International Nuclear Information System (INIS)

Welch, M.J.

1990-01-01

Positron emission tomography (PET) assesses biochemical processes in the living subject, producing images of function rather than form. Using PET, physicians are able to obtain not the anatomical information provided by other medical imaging techniques, but pictures of physiological activity. In metaphoric terms, traditional imaging methods supply a map of the body's roadways, its, anatomy; PET shows the traffic along those paths, its biochemistry. This document discusses the principles of PET, the radiopharmaceuticals in PET, PET research, clinical applications of PET, the cost of PET, training of individuals for PET, the role of the United States Department of Energy in PET, and the futures of PET. 22 figs

Positron Emission Tomography (PET)

Science.gov (United States)

Welch, M. J.

1990-01-01

Positron emission tomography (PET) assesses biochemical processes in the living subject, producing images of function rather than form. Using PET, physicians are able to obtain not the anatomical information provided by other medical imaging techniques, but pictures of physiological activity. In metaphoric terms, traditional imaging methods supply a map of the body's roadways, its, anatomy; PET shows the traffic along those paths, its biochemistry. This document discusses the principles of PET, the radiopharmaceuticals in PET, PET research, clinical applications of PET, the cost of PET, training of individuals for PET, the role of the United States Department of Energy in PET, and the futures of PET.

Positron Emission Tomography (PET)

Energy Technology Data Exchange (ETDEWEB)

Welch, M.J.

1990-01-01

Positron emission tomography (PET) assesses biochemical processes in the living subject, producing images of function rather than form. Using PET, physicians are able to obtain not the anatomical information provided by other medical imaging techniques, but pictures of physiological activity. In metaphoric terms, traditional imaging methods supply a map of the body's roadways, its, anatomy; PET shows the traffic along those paths, its biochemistry. This document discusses the principles of PET, the radiopharmaceuticals in PET, PET research, clinical applications of PET, the cost of PET, training of individuals for PET, the role of the United States Department of Energy in PET, and the futures of PET. 22 figs.

A prediction model for the radiation safety management behavior of medical cyclotrons

International Nuclear Information System (INIS)

Jung, Ji Hye; Han, Eun Ok; Kim, Ssang Tae

2008-01-01

This study attempted to provide reference materials for improving the behavior level in radiation safety managements by drawing a prediction model that affects the radiation safety management behavior because the radiation safety management of medical Cyclotrons, which can be used to produce radioisotopes, is an important factor that protects radiation caused diseases not only for radiological operators but average users. In addition, this study obtained follows results through the investigation applied from January 2 to January 30, 2008 for the radiation safety managers employed in 24 authorized organizations, which have already installed Cyclotrons, through applying a specific form of questionnaire in which the validity was guaranteed by reference study, site investigation, and focus discussion by related experts. The radiation safety management were configured as seven steps: step 1 is a production preparation step, step 2 is an RI production step, step 3 is a synthesis step, step 4 is a distribution step, step 5 is a quality control step, step 6 is a carriage container packing step, and step 7 is a transportation step. It was recognized that the distribution step was the most exposed as 15 subjects (62.5%), the items of 'the sanction and permission related works' and 'the guarantee of installation facilities and production equipment' were the most difficult as 9 subjects (37.5%), and in the trouble steps in such exposure, the item of 'the synthesis and distribution' steps were 4 times, respectively (30.8%). In the score of the behavior level in radiation safety managements, the minimum and maximum scores were 2.42 and 4.00, respectively, and the average score was 3.46 ± 0.47 out of 4. Prosperity and well-being programs in the behavior and job in radiation safety managements (r=0.529) represented a significant correlation statistically. In the drawing of a prediction model based on the factors that affected the behavior in radiation safety managements, general

Unit Cost Analysis of PET-CT at an Apex Public Sector Health Care Institute in India.

Science.gov (United States)

Gajuryal, S H; Daga, A; Siddharth, V; Bal, C S; Satpathy, S

2017-01-01

PET/CT scan service is one of the capital intensive and revenue-generating centres of a tertiary care hospital. The cost associated with the provisioning of PET services is dependent upon the unit costs of the resources consumed. The study aims to determine the cost of providing PET/CT Scan services in a hospital. This descriptive and observational study was conducted in the Department of Nuclear Medicine at a tertiary apex teaching hospital in New Delhi, India in the year 2014-15. Traditional costing methodology was used for calculating the unit cost of PET/CT scan service. The cost was calculated under two heads that is capital and operating cost. Annualized cost of capital assets was calculated using methodology prescribed by WHO and operating costs was taken on an actual basis. Average number of PET/CT scan performed in a day is 30. The annual cost of providing PET/CT scan services was calculated to be 65,311,719 Indian Rupees (INR) (US$ 1,020,496), while the unit cost of PET scan was calculated to be 9625.92 INR (US$ 150). 3/4th cost was spent on machinery and equipment (75.3%) followed by healthcare personnel (11.37%), electricity (5%), consumables and supplies (4%) engineering maintenance (3.24%), building, furniture and HVAC capital cost (0.76%), and manifold cost (0.05%). Of the total cost, 76% was capital cost while the remaining was operating cost. Total cost for establishing PET/CT scan facility with cyclotron and chemistry module and PET/CT scan without cyclotron and chemistry module was calculated to be INR 610,873,517 (US$9944899) and 226,745,158 (US$3542893), respectively. (US$ 1=INR 64).

Automated radiochemical processing for clinical PET

International Nuclear Information System (INIS)

Padgett, H.C.; Schmidt, D.G.; Bida, G.T.; Wieland, B.W.; Pekrul, E.; Kingsbury, W.G.

1991-01-01

With the recent emergence of positron emission tomography (PET) as a viable clinical tool, there is a need for a convenient, cost-effective source of the positron emitter-labeled radiotracers labeled with carbon-11, nitrogen-13, oxygen-15, and fluorine-18. These short-lived radioisotopes are accelerator produced and thus, require a cyclotron and radiochemistry processing instrumentation that can be operated 3 in a clinical environment by competant technicians. The basic goal is to ensure safety and reliability while setting new standards for economy and ease of operation. The Siemens Radioisotope Delivery System (RDS 112) is a fully automated system dedicated to the production and delivery of positron-emitter labeled precursors and radiochemicals required to support a clinical PET imaging program. Thus, the entire RDS can be thought of as an automated radiochemical processing apparatus

Cyclotron Production of Radionuclides for Nuclear Medicine at Academic Centers

Science.gov (United States)

Lapi, Suzanne

2016-09-01

The increase in use of radioisotopes for medical imaging has led to the development of new accelerator targetry and separation techniques for isotope production. For example, the development of longer-lived position emitting radionuclides has been explored to allow for nuclear imaging agents based on peptides, antibodies and nanoparticles. These isotopes (64Cu, 89Zr, 86Y) are typically produced via irradiation of solid targets on smaller cyclotrons (10-25 MeV) at academic or hospital based facilities. Recent research has further expanded the toolbox of PET tracers to include additional isotopes such as 52Mn, 55Co, 76Br and others. The smaller scale of these types of facilities can enable the straightforward involvement of students, thus adding to the next generation of nuclear science leaders. Research pertaining to development of robust and larger scale production technologies including solid target systems and remote systems for transport and purification of these isotopes has enabled both preclinical and clinical imaging research for many diseases. In particular, our group has focused on the use of radiolabeled antibodies for imaging of receptor expression in preclinical models and in a clinical trial of metastatic breast cancer patients.

Neutron radiography by using JSW baby cyclotron

International Nuclear Information System (INIS)

Toda, Yojiro

1995-01-01

At present, JSW baby cyclotrons are mostly used for the production of the radioisotopes for medical use. The attempt to use this baby cyclotron for neutron radiography began already in 1981. The feasibility of the neutron radiography for the explosives in metallic cases which are used for H1 rockets was investigated. In 1983, it was shown that the neutron radiography by using the baby cyclotron in Muroran Works, Japan Steel Works, Ltd. was able to be carried out as a routine work. Since then, the nondestructive inspection by neutron radiography has been performed for rocket pyrotechnic articles, and contributed to heighten their reliability. Further, the radiography by using fast neutrons was developed and put to practical use for recent large H2 rockets. The JSW baby cyclotron BC 168 which has been used for neutron radiography can accelerate 16 MeV protons or 8 MeV deuterons up to 50 μA. The principle of thermal neutron radiography is the generation of fast neutrons by irradiating a Be target with the proton beam accelerated by a baby cyclotron, the moderation of the fast neutrons, the formation of the thermal neutron flux of uniform distribution with a collimator, the thermal neutron flux hitting the Gd plate in a film cassette through an object, and the exposure of an X-ray film to electrons from the Gd plate. Fast neutron radiography apparatus, and commercial neutron radiography are described. (K.I.)

MICHIGAN: Cyclotron conference

Energy Technology Data Exchange (ETDEWEB)

Anon.

1984-10-15

A sense of excitement was in the air as cyclotron physicists and engineers from 17 countries convened on 30 April for the opening of the Tenth International Conference on Cyclotrons and Their Applications. Some 50 years after its invention, the redoubtable cyclotron remains a topic of compelling current interest. Cyclotron experts gathered at Michigan State University's Kellogg Center to hear of latest developments, of progress and successes on new machines which had come into operation, of new projects which were underway, and of dreams which lay ahead.

Modeling of a cyclotron target for the production of 11C with Geant4.

Science.gov (United States)

Chiappiniello, Andrea; Zagni, Federico; Infantino, Angelo; Vichi, Sara; Cicoria, Gianfranco; Morigi, Maria Pia; Marengo, Mario

2018-04-12

In medical cyclotron facilities, 11C is produced according to the 14N(p,α)11C reaction and widely employed in studies of prostate and brain cancers by Positron Emission Tomography. It is known from literature [1] that the 11C-target assembly shows a reduction in efficiency during time, meaning a decrease of activity produced at the end of bombardment. This effect might depend on aspects still not completely known. Possible causes of the loss of performance of the 11C-target assembly were addressed by Monte Carlo simulations. Geant4 was used to model the 11C-target assembly of a GE PETtrace cyclotron. The physical and transport parameters to be used in the energy range of medical applications were extracted from literature data and 11C routine productions. The Monte Carlo assessment of 11C saturation yield was performed varying several parameters such as the proton energy and the angle of the target assembly with respect to the proton beam. The estimated 11C saturation yield is in agreement with IAEA data at the energy of interest, while is about the 35% greater than experimental value. A more comprehensive modeling of the target system, including thermodynamic effect, is required. The energy absorbed in the inner layer of the target chamber was up to 46.5 J/mm2 under typical irradiation conditions. This study shows that Geant4 is potentially a useful tool to design and optimize targetry for PET radionuclide productions. Tests to choose the Geant4 physics libraries should be performed before using this tool with different energies and materials. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.

Electromagnetic cyclotron harmonic waves

International Nuclear Information System (INIS)

Ohnuma, T.; Watanabe, T.; Hamamatsu, K.

1981-09-01

Electromagnetic electron cyclotron harmonic waves just below the electron cyclotron harmonics are investigated numerically and experimentally. Backward waves which are observed to propagate nearly perpendicular to the magnetic field just below the electron cyclotron frequency in a high density magnetoplasma are confirmed to be in accord with the theoretical electromagnetic cyclotron waves. (author)

MICHIGAN: Cyclotron conference

International Nuclear Information System (INIS)

Anon.

1984-01-01

A sense of excitement was in the air as cyclotron physicists and engineers from 17 countries convened on 30 April for the opening of the Tenth International Conference on Cyclotrons and Their Applications. Some 50 years after its invention, the redoubtable cyclotron remains a topic of compelling current interest. Cyclotron experts gathered at Michigan State University's Kellogg Center to hear of latest developments, of progress and successes on new machines which had come into operation, of new projects which were underway, and of dreams which lay ahead

Automated cyclotron tuning using beam phase measurements

International Nuclear Information System (INIS)

Timmer, J.H.; Roecken, H.; Stephani, T.; Baumgarten, C.; Geisler, A.

2006-01-01

The ACCEL K250 superconducting cyclotron is specifically designed for the use in proton therapy systems. The compact medical 250 MeV proton accelerator fulfils all present and future beam requirements for fast scanning treatment systems and is delivered as a turn key system; no operator is routinely required. During operation of the cyclotron heat dissipation of the RF system induces a small drift in iron temperature. This temperature drift slightly detunes the magnetic field and small corrections must be made. A non-destructive beam phase detector has been developed to measure and quantify the effect of a magnetic field drift. Signal calculations were made and the design of the capacitive pickup probe was optimised to cover the desired beam current range. Measurements showed a very good agreement with the calculated signals and beam phase can be measured with currents down to 3 nA. The measured phase values are used as input for a feedback loop controlling the current in the superconducting coil. The magnetic field of the cyclotron is tuned automatically and online to maintain a fixed beam phase. Extraction efficiency is thereby optimised continuously and activation of the cyclotron is minimised. The energy and position stability of the extracted beam are well within specification

Investigation of radiation protection of medical staff performing medical diagnostic examinations by using PET/CT technique

International Nuclear Information System (INIS)

Wrzesień, Małgorzata; Napolska, Katarzyna

2015-01-01

Positron emission tomography (PET) is now one of the most important methods in the diagnosis of cancer diseases. Due to the rapid growth of PET/CT centres in Poland in less than a decade, radiation protection and, consequently, the assessment of worker exposure to ionising radiation, emitted mainly by the isotope 18 F, have become essential issues. The main aim of the study was to analyse the doses received by workers employed in the Medical Diagnostic Centre. The analysis comprises a physicist, three nurses, three physicians, three technicians, as well as two administrative staff employees. High-sensitivity thermoluminescent detectors (TLDs) were used to measure the doses for medical staff. The personnel was classified into categories, among them employees having direct contact with the ‘source of radiation’— 18 FDG. The TLDs were placed on the fingertips of both hands and they were also attached at the level of eye lenses, thyroid and gonads depending on the assigned category. The highest dose of radiation was observed during the administration of the 18 FDG to the patients. In the case of the physicist, the highest dose was recorded during preparation of the radiopharmaceutical— 18 FDG. The body parts most exposed to ionizing radiation are the fingertips of the thumb, index and middle finger. (paper)

Investigation of radiation protection of medical staff performing medical diagnostic examinations by using PET/CT technique.

Science.gov (United States)

Wrzesień, Małgorzata; Napolska, Katarzyna

2015-03-01

Positron emission tomography (PET) is now one of the most important methods in the diagnosis of cancer diseases. Due to the rapid growth of PET/CT centres in Poland in less than a decade, radiation protection and, consequently, the assessment of worker exposure to ionising radiation, emitted mainly by the isotope (18)F, have become essential issues. The main aim of the study was to analyse the doses received by workers employed in the Medical Diagnostic Centre. The analysis comprises a physicist, three nurses, three physicians, three technicians, as well as two administrative staff employees. High-sensitivity thermoluminescent detectors (TLDs) were used to measure the doses for medical staff. The personnel was classified into categories, among them employees having direct contact with the 'source of radiation'-(18)FDG. The TLDs were placed on the fingertips of both hands and they were also attached at the level of eye lenses, thyroid and gonads depending on the assigned category. The highest dose of radiation was observed during the administration of the (18)FDG to the patients. In the case of the physicist, the highest dose was recorded during preparation of the radiopharmaceutical-(18)FDG. The body parts most exposed to ionizing radiation are the fingertips of the thumb, index and middle finger.

Risk assessment of 30 MeV cyclotron facilities

Energy Technology Data Exchange (ETDEWEB)

Jeong, Gyo Seong; Lee, Jin Woo [Advanced Radiation Technology Institute, Korea Atomic Energy Research Institute, Jeongeup (Korea, Republic of); Kim, Chong Yeal [Dept. of Radiation Science and Technology, Chonbuk National University, Jeonju (Korea, Republic of)

2017-03-15

A cyclotron is a kind of particle accelerator that produces a beam of charged particles for the production of medical, industrial, and research radioisotopes. More than 30 cyclotrons are operated in Korea to produce 18F, an FDG synthesis at hospitals. A 30-MeV cyclotron was installed at ARTI (Advanced Radiation Technology Institute, KAERI) mainly for research regarding isotope production. In this study, we analyze and estimate the items of risk such as the problems in the main components of the cyclotron, the loss of radioactive materials, the leakage of coolant, and the malfunction of utilities, fres and earthquakes. To estimate the occurrence frequency in an accident risk assessment, five levels, i.e., Almost certain, Likely, Possible, Unlikely, and Rare, are applied. The accident consequence level is classified under four grades based on the annual permissible dose for radiation workers and the public in the nuclear safety law. The analysis of the accident effect is focused on the radioactive contamination caused by radioisotope leakage and radioactive material leakage of a ventilation filter due to a free. To analyze the risks, Occupation Safety and Health Acts is applied. In addition, action plans against an accident were prepared after a deep discussion among relevant researchers. In this acts, we will search for hazard and introduce the risk assessment for the research 30-MeV cyclotron facilities of ARTI.

Risk assessment of 30 MeV cyclotron facilities

International Nuclear Information System (INIS)

Jeong, Gyo Seong; Lee, Jin Woo; Kim, Chong Yeal

2017-01-01

A cyclotron is a kind of particle accelerator that produces a beam of charged particles for the production of medical, industrial, and research radioisotopes. More than 30 cyclotrons are operated in Korea to produce 18F, an FDG synthesis at hospitals. A 30-MeV cyclotron was installed at ARTI (Advanced Radiation Technology Institute, KAERI) mainly for research regarding isotope production. In this study, we analyze and estimate the items of risk such as the problems in the main components of the cyclotron, the loss of radioactive materials, the leakage of coolant, and the malfunction of utilities, fres and earthquakes. To estimate the occurrence frequency in an accident risk assessment, five levels, i.e., Almost certain, Likely, Possible, Unlikely, and Rare, are applied. The accident consequence level is classified under four grades based on the annual permissible dose for radiation workers and the public in the nuclear safety law. The analysis of the accident effect is focused on the radioactive contamination caused by radioisotope leakage and radioactive material leakage of a ventilation filter due to a free. To analyze the risks, Occupation Safety and Health Acts is applied. In addition, action plans against an accident were prepared after a deep discussion among relevant researchers. In this acts, we will search for hazard and introduce the risk assessment for the research 30-MeV cyclotron facilities of ARTI

International conference on clinical PET and molecular nuclear medicine (IPET 2007). Book of abstracts

Energy Technology Data Exchange (ETDEWEB)

NONE

2007-07-01

unique among all diagnostic and therapeutic procedures because nuclear medicine techniques are increasingly based on molecular targeting. Molecular nuclear medicine and radiopharmacology are central to the growth of nuclear medicine. The targeting models include the receptor-ligand model, antigen-antibody model, transporter-substrate model (FDG and Glut-1 transporter), enzyme-substrate model and complex or hybrid models. Numerous developments in these areas e.g. antisense targeting, mutation detection, aptamers, tumour antigens, tumour receptors, tumour metabolism, tumour hypoxia, tumour proliferation, apoptosis, angiogenesis, neuroreceptors and neurotransmitters, abnormal proteins in brain, response to infection, multiple drug resistance, reporter genes - all employing radioactive labels and being specific to a disease - provide strategic advantages. There is a very significant growth in the installation of cyclotrons and with a few exceptions, these new cyclotrons cater for the production of radionuclides for medical application. Research into other 18F labelled molecules including peptides and agents for tracking gene therapy has resulted in new radiopharmaceuticals such as 18F-FLT, 18F-FET etc. The quest for newer and more specific 18F labelled radiopharmaceuticals keeps PET chemists busy all over the world. Other short-lived PET radionuclides such as 11C, 13N and 15O, despite the logistical disadvantage of their short half lives, are increasingly used in neurology and in new pharmaceutical developments. The short half life of most of these radioisotopes makes it essential that the process is automated from irradiation to the dispensing stage so that the final radiopharmaceuticals are in compliance with the approved guidelines of Good Manufacturing Practices (GMP). There is a need to evolve appropriate guidelines for short shelf life radiopharmaceuticals. The conference will cover developments in the entire spectrum of activities related to molecular imaging. This

International conference on clinical PET and molecular nuclear medicine (IPET 2007). Book of abstracts

International Nuclear Information System (INIS)

2007-01-01

unique among all diagnostic and therapeutic procedures because nuclear medicine techniques are increasingly based on molecular targeting. Molecular nuclear medicine and radiopharmacology are central to the growth of nuclear medicine. The targeting models include the receptor-ligand model, antigen-antibody model, transporter-substrate model (FDG and Glut-1 transporter), enzyme-substrate model and complex or hybrid models. Numerous developments in these areas e.g. antisense targeting, mutation detection, aptamers, tumour antigens, tumour receptors, tumour metabolism, tumour hypoxia, tumour proliferation, apoptosis, angiogenesis, neuroreceptors and neurotransmitters, abnormal proteins in brain, response to infection, multiple drug resistance, reporter genes - all employing radioactive labels and being specific to a disease - provide strategic advantages. There is a very significant growth in the installation of cyclotrons and with a few exceptions, these new cyclotrons cater for the production of radionuclides for medical application. Research into other 18F labelled molecules including peptides and agents for tracking gene therapy has resulted in new radiopharmaceuticals such as 18F-FLT, 18F-FET etc. The quest for newer and more specific 18F labelled radiopharmaceuticals keeps PET chemists busy all over the world. Other short-lived PET radionuclides such as 11C, 13N and 15O, despite the logistical disadvantage of their short half lives, are increasingly used in neurology and in new pharmaceutical developments. The short half life of most of these radioisotopes makes it essential that the process is automated from irradiation to the dispensing stage so that the final radiopharmaceuticals are in compliance with the approved guidelines of Good Manufacturing Practices (GMP). There is a need to evolve appropriate guidelines for short shelf life radiopharmaceuticals. The conference will cover developments in the entire spectrum of activities related to molecular imaging. This

Cyclotron waves in plasma

CERN Document Server

Lominadze, D G

2013-01-01

Cyclotron Waves in Plasma is a four-chapter text that covers the basic physical concepts of the theory of cyclotron waves and cyclotron instabilities, brought about by the existence of steady or alternating plasma currents flowing perpendicular to the magnetic field.This book considers first a wide range of questions associated with the linear theory of cyclotron oscillations in equilibrium plasmas and in electron plasmas in metals and semiconductors. The next chapter deals with the parametric excitation of electron cyclotron oscillations in plasma in an alternating electric field. A chapter f

Cyclotron waves in plasma

International Nuclear Information System (INIS)

Lominadse, D.G.

1975-01-01

The book deals with fundamental physical concepts of the theory of cyclotron waves and cyclotron instabilities conditioned by the presence in plasma of direct or alternating electric currents passing in it perpendicularily to a magnetic field. A great variety of problems is considered connected with the linear theory of cyclotron oscillations in equilibrium and electron plasma of metals and semiconductors. Parametric excitations of electron cyclotron oscillations of plasma in an alternating electric field are studied. Particular attention is paid to the investigation of plasma turbulence arising as a result of development of cyclotron instabilities. Experimental data are discussed and compared with theoretical results

Cyclotrons: 1978

International Nuclear Information System (INIS)

Martin, J.A.

1978-01-01

A compilation is presented of the experimental facilities of the world's cyclotrons including history and status, staff and operation, research staff, target facilities, magnet, acceleration system, vacuum system, characteristic beams, beam properties, and a plan view of the facility for each cyclotron

Fluorine-18 radiopharmaceuticals beyond [F-18]FDG for use in oncology and neurosciences

NARCIS (Netherlands)

Coenen, H. H.; Elsinga, P. H.; Iwata, R.; Kilbourn, M. R.; Pillai, M. R. A.; Rajan, M. G. R.; Wagner, H. N.; Zaknun, J. J.

2010-01-01

Positron emission tomography (PET) is a rapidly expanding clinical modality worldwide thanks to the availability of compact medical cyclotrons and automated chemistry for the production of radiopharmaceuticals. There is an armamentarium of fluorine-18 (F-18) tracers that can be used for PET studies

A prediction model for the radiation safety management behavior of medical cyclotrons

Energy Technology Data Exchange (ETDEWEB)

Jung, Ji Hye; Han, Eun Ok [Daegu Health College, Daegu (Korea, Republic of); Kim, Ssang Tae [CareCamp Inc., Seoul (Korea, Republic of)

2008-06-15

This study attempted to provide reference materials for improving the behavior level in radiation safety managements by drawing a prediction model that affects the radiation safety management behavior because the radiation safety management of medical Cyclotrons, which can be used to produce radioisotopes, is an important factor that protects radiation caused diseases not only for radiological operators but average users. In addition, this study obtained follows results through the investigation applied from January 2 to January 30, 2008 for the radiation safety managers employed in 24 authorized organizations, which have already installed Cyclotrons, through applying a specific form of questionnaire in which the validity was guaranteed by reference study, site investigation, and focus discussion by related experts. The radiation safety management were configured as seven steps: step 1 is a production preparation step, step 2 is an RI production step, step 3 is a synthesis step, step 4 is a distribution step, step 5 is a quality control step, step 6 is a carriage container packing step, and step 7 is a transportation step. It was recognized that the distribution step was the most exposed as 15 subjects (62.5%), the items of 'the sanction and permission related works' and 'the guarantee of installation facilities and production equipment' were the most difficult as 9 subjects (37.5%), and in the trouble steps in such exposure, the item of 'the synthesis and distribution' steps were 4 times, respectively (30.8%). In the score of the behavior level in radiation safety managements, the minimum and maximum scores were 2.42 and 4.00, respectively, and the average score was 3.46 {+-} 0.47 out of 4. Prosperity and well-being programs in the behavior and job in radiation safety managements (r=0.529) represented a significant correlation statistically. In the drawing of a prediction model based on the factors that affected the behavior in

Positron emission tomography

International Nuclear Information System (INIS)

Marchenkov, N.S.

2000-01-01

The foundations of the positron emission tomography (PET), widely used for the medical diagnostics, are considered. The brief description of the cyclotron for production of radionuclides, applied in the PET, the target devices for manufacturing the position emitters, the moduli for the radiopharmaceuticals synthesis (RPS) for the PET is presented. The necessity and concept of complete automation of the RPS for the PET are discussed [ru

Radionuclide production for PET with a linear electrostatic accelerator

International Nuclear Information System (INIS)

Shefer, R.E.; Hughey, B.J.; Klinkowstein, R.E.; Welch, M.J.

1993-01-01

A new type of linear electrostatic accelerator for the production of short-lived radionuclides for PET has been developed at Science Research Laboratory. The tandem cascade accelerator (TCA) is a low energy (3.7 MeV) proton and deuteron accelerator which can generate the four short-lived PET radionuclides in the quantities required for clinical use. The compact size, low weight, low power consumption and reduced radiation shielding requirements of the TCA result in a significant reduction in capital and operating costs when compared with higher energy cyclotron-based systems. Radioisotope target for the production of O-15, F-18, N-13 and C-11 have been designed specifically for use with the low energy TCA beam. A simple to use PC-based computer control system allows fully automated system operation and advanced scheduling of isotope production. Operating experience with the TCA and its PET radionuclide targets is described

Radioisotope production by reactors and cyclotrons in Japan

International Nuclear Information System (INIS)

Murakami, Yukio

1978-01-01

Present status of radioisotope production in Japan and the increasing demand from various fields are generally reviewed. Future problems associated with the shortage of economical supply are also discussed. The first half of this report is devoted to general review of the increasing demand for various radioisotopes from increasing number of users. The present status and future trends of the distribution of users of specific radioisotopes and their demands are shown. The remaining half of this report reviews the production with reactors and cyclotrons. The Japanese reactors producing radioisotopes are limited to low flux (10 13 ) research reactors at JAERI. Some problems associated with the improvement of availability and with the organizational structure are discussed. As for the production with cyclotrons, available facilities and the method of production are explained in detail. For clinical use, especially for the production of short lived radioisotopes, the advantage of a small special purpose cyclotron at each medical organization is emphasized. (Aoki, K.)

LIBO - boosting medical cyclotron facilities for cancer therapy Exhibition LEPFest 2000

CERN Multimedia

2000-01-01

Length : Energy boost : From 62 to 200 MeVAccelerating gradient : 10 MeV/metreAccelerating frequency : 3 GHz Collaboration : CERN, INFN and University of Milan, INFN and University of Naples and TERA foundation Prototype test in 2001 : SC cyclotron Catania

The Study of 99mTc Production Using Medical Cyclotrons in Ukraine

Directory of Open Access Journals (Sweden)

Borys M. Bondar

2017-12-01

Conclusions. The obtained results showed satisfied 99mTс tracer yields and feasibility of further development of this method, which will significantly improve the efficiency of cyclotron installations.

Cyclotrons as mass spectrometers

International Nuclear Information System (INIS)

Clark, D.J.

1984-04-01

The principles and design choices for cyclotrons as mass spectrometers are described. They are illustrated by examples of cyclotrons developed by various groups for this purpose. The use of present high energy cyclotrons for mass spectrometry is also described. 28 references, 12 figures

CAS CERN Accelerator School: Cyclotrons, linacs and their applications. Proceedings

International Nuclear Information System (INIS)

Turner, S.

1996-01-01

These proceedings present the lectures given at the eighth specialized course organized by the CERN Accelerator School (CAS), the topic this time being 'Cyclotrons, Linacs and Their Applications'. Following an introductory lecture on linacs, the fundamental features of electron, ion and induction linacs are described together with their RF systems and particle sources. Cyclotrons are then introduced followed by details of their different types, their magnet and RF design, and their injection and extraction systems, with a glance towards exotic and possible future machines. Chapters are then presented on the use of linacs and cyclotrons for medical, fission, fusion and material applications, as well as for isotope production. Finally, descriptions of the design of a radioisotope facility, the matching of accelerators to their task and the computational tools used in their design are included. (orig.)

CAS CERN Accelerator School: Cyclotrons, linacs and their applications. Proceedings

Energy Technology Data Exchange (ETDEWEB)

Turner, S [ed.

1996-03-04

These proceedings present the lectures given at the eighth specialized course organized by the CERN Accelerator School (CAS), the topic this time being `Cyclotrons, Linacs and Their Applications`. Following an introductory lecture on linacs, the fundamental features of electron, ion and induction linacs are described together with their RF systems and particle sources. Cyclotrons are then introduced followed by details of their different types, their magnet and RF design, and their injection and extraction systems, with a glance towards exotic and possible future machines. Chapters are then presented on the use of linacs and cyclotrons for medical, fission, fusion and material applications, as well as for isotope production. Finally, descriptions of the design of a radioisotope facility, the matching of accelerators to their task and the computational tools used in their design are included. (orig.).

Comparison Between In-Beam and Offline Positron Emission Tomography Imaging of Proton and Carbon Ion Therapeutic Irradiation at Synchrotron- and Cyclotron-Based Facilities

International Nuclear Information System (INIS)

Parodi, Katia; Bortfeld, Thomas; Haberer, Thomas

2008-01-01

Purpose: The benefit of using dedicated in-beam positron emission tomography (PET) detectors in the treatment room instead of commercial tomographs nearby is an open question. This work quantitatively compares the measurable signal for in-beam and offline PET imaging, taking into account realistic acquisition strategies at different ion beam facilities. Both scenarios of pulsed and continuous irradiation from synchrotron and cyclotron accelerators are considered, because of their widespread use in most carbon ion and proton therapy centers. Methods and Materials: A mathematical framework is introduced to compare the time-dependent amount and spatial distribution of decays from irradiation-induced isotope production. The latter is calculated with Monte Carlo techniques for real proton treatments of head-and-neck and paraspinal tumors. Extrapolation to carbon ion irradiation is based on results of previous phantom experiments. Biologic clearance is modeled taking into account available data from previous animal and clinical studies. Results: Ratios between the amount of physical decays available for in-beam and offline detection range from 40% to 60% for cyclotron-based facilities, to 65% to 110% (carbon ions) and 94% to 166% (protons) at synchrotron-based facilities, and increase when including biologic clearance. Spatial distributions of decays during irradiation exhibit better correlation with the dose delivery and reduced influence of biologic processes. Conclusions: In-beam imaging can be advantageous for synchrotron-based facilities, provided that efficient PET systems enabling detection of isotope decays during beam extraction are implemented. For very short (<2 min) irradiation times at cyclotron-based facilities, a few minutes of acquisition time after the end of irradiation are needed for counting statistics, thus affecting patient throughput

'PET -Compton' system. Comparative evaluation with PET system using Monte Carlo simulation

International Nuclear Information System (INIS)

Diaz Garcia, Angelina; Arista Romeu, Eduardo; Abreu Alfonso, Yamiel; Leyva Fabelo, Antonio; Pinnera Hernandez, Ibrahin; Bolannos Perez, Lourdes; Rubio Rodriguez, Juan A; Perez Morales, Jose M.; Arce Dubois, Pedro; Vela Morales, Oscar; Willmott Zappacosta, Carlos

2011-01-01

Positron Emission Tomography (PET) in small animals has actually achieved spatial resolution round about 1 mm and currently there are under study different approaches to improve this spatial resolution. One of them combines PET technology with Compton Cameras. This paper presents the idea of the so called 'PET-Compton' systems and includes comparative evaluation of spatial resolution and global efficiency in both PET and PET-Compton system by means of Monte Carlo simulations using Geant4 code. Simulation is done on a PET-Compton system consisting of LYSO-LuYAP scintillating detectors of particular small animal PET scanner named 'Clear-PET' and for Compton detectors based on CdZnTe semiconductor. A group of radionuclides that emits a positron (e + ) and γ quantum almost simultaneously and fulfills some selection criteria for their possible use in PET-Compton systems for medical and biological applications were studied under simulation conditions. (Author)

Cancer screening with FDG-PET

International Nuclear Information System (INIS)

Ide, M.

2006-01-01

Aim: This study is based on medical health check-up and cancer screening on of a medical health club using PET, MRI, spiral CT and other conventional examinations. Methods: Between October 1994 and June 2005, 9357 asymptomatic members of the health club participated in 24772 screening session (5693 men and 3664 women, mean age 52.2±10.4 years). Results: Malignant tumors were discovered in 296 of the 9357 participants (3.16%) and 24772 screening sessions (1.19%). The detection rate of our program is much higher than that of mass screening in Japan. The thyroid, lung, colon and breast cancers were PET positive, but the prostate, renal and bladder cancers were generally PET negative. Conclusion: FDG-PET has the potential to detect a wide variety of cancers at curable stages in asymptomatic individuals. To reduce false-positive and false-negative results of PET examination, there is a need of experienced radiologist and/or oncologists who had training in the wide aspect of FDG-PET. FDG-PET has limitations in the detection of urological cancers, cancers of low cell density, small cancers and hypo metabolic or FDG non-avid cancers. Therefore, conventional examinations and/or PET/CT are also needed for cancer screening in association with FDG-PET

SPECT and PET imaging in epilepsy

International Nuclear Information System (INIS)

Semah, F.

2007-01-01

Positron emission tomography (PET) and single photon emission computed tomography (SPECT) imaging are very useful for the management of patients with medically refractory partial epilepsy. Presurgical evaluation of patients with medically refractory partial epilepsy often included PET imaging using FDG. The use of SPECT in these patients adds some more information and gives the clinicians the possibility of having ictal imaging. Furthermore, PET and SPECT imaging are performed to better understand the pathophysiology of epilepsy. (authors)

Radiation monitoring of PET staff

International Nuclear Information System (INIS)

Trang, A.

2004-01-01

Full text: Positron emission tomography (PET) is becoming a common diagnostic tool in hospitals, often located in and employing staff from the Nuclear Medicine or Radiology departments. Although similar in some ways, staff in PET departments are commonly found to have the highest radiation doses in the hospital environment due to unique challenges which PET tracers present in administration as well as production. The establishment of a PET centre with a dedicated cyclotron has raised concerns of radiation protection to the staff at the WA PET Centre and the Radiopharmaceutical Production and Development (RAPID) team. Since every PET centre has differing designs and practices, it was considered important to closely monitor the radiation dose to our staff so that improvements to practices and design could be made to reduce radiation dose. Electronic dosimeters (MGP DMC 2000XB), which have a facility to log time and dose at 10 second intervals, were provided to three PET technologists and three PET nurses. These were worn in the top pocket of their lab coats throughout a whole day. Each staff member was then asked to note down their duties throughout the day and also note the time they performed each duty. The duties would then correlate with the dose with which the electronic monitor recorded and an estimate of radiation dose per duty could be given. Also an estimate of the dose per day to each staff member could be made. PET nurses averaged approximately 20 μ8v per day getting their largest dose from caring for occasional problematic patients. Smaller doses of a 1-2 μ8v were recorded for injections and removing cannulas. PET technologists averaged approximately 15 μ8v per day getting their largest dose of 1-5μ8v mainly from positioning of patients and sometimes larger doses due to problematic patients. Smaller doses of 1-2 μ5v were again recorded for injections and removal of cannulas. Following a presentation given to staff, all WA PET Centre and RAPID staff

Calculation of the neutrons shielding in cyclotron accelerator

International Nuclear Information System (INIS)

Ribeiro, Martha S.; Sanches, Matias P.; Rodrigues, Demerval L.

2000-01-01

The objective of radioprotection in cyclotron facilities is to reduce the dose levels in the workplaces to classify them like supervised areas. In this way, the radiation dose rates in areas occupied by workers during cyclotron operations should not exceed 7,5 μSv/h. In controlled areas these levels are not observed and some rigorous controls must be exerted by administrative procedures or protection mechanisms. The Cyclotron Laboratory at IPEN-CNEN/SP has a cyclotron model Cyclone 30, 30 MeV, used for research and it is also used for radioisotopes production for medical diagnosis and therapeutical applications. Among them, 123 I, 67 Ga and 18 F can be pointed. When accelerator is operating, failures in perforations and paths that conduce to room accelerator can be occur and thus, the dose levels are higher than that established by law. For this reason, a review for shielding structure was necessary in order to optimize radiation dose. The purpose of this work was to determine the shielding thickness and adequate material to diminish the dose rates in workplaces to a value below 7,5 μSv/h. It was used a method to employ the equivalent dose value in the facility areas for neutrons fluency rate for the principal reactions in target irradiation processes. The purposed shielding for the vault doors ensures dose levels lower than established limits to supervised areas. (author)

Detection of Cancer with PET and PET/CT in Asymptomatic Volunteers

International Nuclear Information System (INIS)

Chung, Ji In; Choi, Joon Young; Lee, Kyung Han; Kim, Byung Tae; Choi, Yoon Ho; Cho, Han Byoul; Shim, Jae Yong

2009-01-01

We retrospectively investigated the diagnostic performance of 18 F-fluorodeoxyglucose positron emission tomography (PET) and PET/CT for cancer detection in asymptomatic health-check examinees. This study consisted of 5091 PET or PET/CT conducted as part of annual health examination at one hospital from March 1998 to February 2008. To find the incidence of cancers, medical records of the subjects were thoroughly reviewed for a follow-up period of one year. The patterns of formal readings of PET and PET/CT were analyzed to assess the sensitivity and specificity for cancer detection. The histopathology and stage of the cancers were evaluated in relation to the results of PET. Eighty-six cancers (1.7%) were diagnosed within one year after PET or PET/CT. When PET and PET/CT results were combined, the sensitivity was 48.8% and specificity was 81.1% for cancer detection. PET only had a sensitivity of 46.2% and a specificity of 81.4%, and PET/CT only had a sensitivity of 75.0% and a specificity of 78.5% respectively. There were no significant differences in cancer site, stage and histopathology between PET positive and PET negative cancers. In 19.3% of formal readings of PET and PET/CT, further evaluation to exclude malignancy or significant disease was recommended. Head and neck area and upper gastrointestinal tract were commonly recommended sites for further evaluation. PET and PET/CT showed moderate performance for detecting cancers in asymptomatic adults in this study. More experience and further investigation are needed to overcome limitations of PET and PET/CT for cancer screening

Repository National Institutes for Quantum and Radiological Science and Technology (QST)

International Nuclear Information System (INIS)

Maeda, Takamasa

2016-01-01

This paper introduces the facilities of National Institute of Radiological Sciences (NIRS). It was established as an auxiliary organ of the Science and Technology Agency in 1957. In April 2016, it became a comprehensive radiology research and development department of the Quantum Science and Technology Research Organization, and has been performing 'research for medical use of radiation' and 'research for radiation safety and emergency radiation medical care' as the two pillars of research. The laboratory hospital is a sole monotechnic radiation hospital in Japan specializing in radiotherapy. Heavy particle accelerator for medical use has been constructed, and advancement of heavy particle therapy using rotating gantry is expected. At the clinical nuclear medicine department, research facilities involved in molecular imaging are cyclotron building, positron building, imaging diagnostic building, and exploratory research building, and they are equipped with are three large and small cyclotrons, clinical PET device, animal-specialized PET device, 7-tesla MRI. The nuclear medicine laboratory is equipped with four PET/CT devices, one PET device, and one gamma camera, and performing tumor examination and clinical research on psychiatric and neurological diseases. (A.O.)

Application of PET and PET/CT imaging for cancer screening

International Nuclear Information System (INIS)

Chen Yenkung; Hu Fenglan; Shen Yehyou; Liao, A.C.; Hung, T.Z.; Su, Chentau; Chen Liangkuang

2004-01-01

The aim of this study was to evaluate the potential application of 18F-fluorodeoxyglucose (FDG) Positron Emission Tomography (PET) and PET/CT for cancer screening in asymptomatic individuals. Methods: The subjects consisted of 3631 physical check up examinees (1947 men, 1684 women; mean age ±SD, 52.1±8.2 y) with non-specific medical histories. Whole-body FDG PET (or PET/CT), ultrasound and tumor markers were performed on all patients. Focal hypermetabolic areas with intensities equal to or exceeding the level of FDG uptake in the brain and bladder were considered abnormal and interpreted as neoplasia. Follow-up periods were longer than one year. Results: Among the 3631 FDG PET (including 1687 PET/CT), ultrasound and tumor markers examinations, malignant tumors were discovered in 47 examinees (1.29%). PET findings were true-positive in 38 of the 47 cancers (80.9%). In addition, 32 of the 47 cancers were performed with the PET-CT scan. PET detected cancer lesions in 28 of the 32 examinees. However, the CT detected cancer lesions in only 15 of 32 examinees. Conclusion: The sensitivity of FDG PET in the detection of a wide variety of cancers is high. Most cancer can be detected with FDG PET in a resectable stage. CT of the PET/CT for localization and characteristics of the lesion shows an increased specificity of the PET scan. Using ultrasound and tumor markers may complement the PET scan in cancer screening for hepatic and urologic neoplasms. (authors)

Compact superconducting 250 MeV proton cyclotron for the PSI PROSCAN proton therapy project

International Nuclear Information System (INIS)

Schillo, M.; Geisler, A.; Hobl, A.; Klein, H.U.; Krischel, D.; Meyer-Reumers, M.; Piel, C.; Blosser, H.; Kim, J.-W.; Marti, F.; Vincent, J.; Brandenburg, S.; Beijers, J.P.M.

2001-01-01

A cyclotron for proton therapy has to fulfill many requirements set by the specific operational and safety needs of a medical facility and the medical environment. These are for instance high extraction efficiency, high availability and reliability, simple and robust operation. ACCEL Instruments GmbH has refined the design concept of a medical cyclotron for the PSI PROSCAN project with the objective to use this cyclotron as the standard accelerator in complete proton therapy facilities, which ACCEL intends to market. Starting from the design, we have carried out further detail clarifications, optimizations and adaptations to the needs of PSI. The work was performed in a collaboration between ACCEL, NSCL and KVI in view of the requirements from the PSI PROSCAN project. An overview on the design will be given touching on subjects such as the 3D structural analysis of the coil, detailed magnetic modeling for optimization of the inner region and the spiral, optimization of the RF power, optimization of the cryogenic design based on available cryocoolers instead of a liquefaction plant and Monte Carlo simulations to estimate the heat balance produced by neutrons at 4K components

Injection and extraction for cyclotrons

International Nuclear Information System (INIS)

Heikkinen, P.

1994-01-01

External ion sources for cyclotrons are needed for polarised and heavy ions. This calls for injection systems, either radial or axial. Radial injection is also needed when a cyclotron works as a booster after another cyclotron or a linear accelerator (usually tandem). Requirements for injection differ from separated sector cyclotrons where there is plenty of room to house inflectors and/or strippers, to superconducting cyclotrons where the space is limited by a small magnet gap, and high magnetic field puts other limitations to the inflectors. Several extraction schemes are used in cyclotrons. Stripping injection is used for H - and also for heavy ions where the q/m ratio is usually doubled. For other cases, electric and magnetic deflection has to be used. To increase the turn separation before the first deflector, both resonant and non-resonant schemes are used. In this lecture, external injection systems are surveyed and some rules to thumb for injection parameters are given. Extraction schemes are also reviewed. (orig.)

Focusing and bunching of ion beam in axial injection channel of IPHC cyclotron TR24

Science.gov (United States)

Adam, T.; Ivanenko, I.; Kazarinov, N.; Osswald, F.; Traykov, E.

2017-07-01

The CYRCe cyclotron (CYclotron pour la ReCherche et l’Enseignement) is used at IPHC (Institut Pluridisciplinaire Hubert Curien) for the production of radio-isotopes for diagnostics, medical treatments and fundamental research in radiobiology. The TR24 cyclotron produced and commercialized by ACSI (Canada) delivers a 16-25 MeV proton beam with intensity from few nA up to 500 μA. The solenoidal focusing instead of existing quadrupole one is proposed in this report. The changing of the focusing elements will give the better beam matching with the acceptance of the spiral inflector of the cyclotron. The parameters of the focusing solenoid are found. Additionally, the main parameters of the bunching system are evaluated in the presence of the beam space charge. This system consists of the buncher installed in the axial injection beam line of the cyclotron. The using of the grid-less multi harmonic buncher may increase the accelerated beam current and will give the opportunity to new proton beam applications.

Readout and characterisation of new silicon pixel photodiode array for use in PET

International Nuclear Information System (INIS)

Hooper, P.; Ward, G.; Lerch, R.; Rozenfeld, A.

2002-01-01

Full text: Positron emission tomography (PET) is a functional imaging tool, which is able to quantify physiological, and biochemical processes in vivo using short-lived cyclotron-produced radiotracers. The main physical principle of PET is the simultaneous measurement of two 511 keV photons which are emitted in opposite directions following the annihilation of a positron in tissue. The accuracy of tracking these photons determines the accuracy of localising the radiotracer in the body, which is referred to as the spatial resolution of the system. Compared with conventional single photon imaging with gamma cameras, PET provides superior spatial resolution and sensitivity. However, compared with anatomical imaging techniques, the spatial resolution remains relatively poor at approximately 4-6 mm full width at half maximum (FWHM), compared with 1 mm FWHM for MRI. The Centre for Medical Radiation Physics at the University of Wollongong is developing a new Positron Emission Tomography (PET) detection sub-module that will significantly improve the spatial resolution of PET. The new sub-module design is simple and robust to minimise module assembly complications and is completely independent of photomultiplier tubes. The new sub-module has also been designed to maximise its flexibility for easy sub-module coupling so as to form a complete, customised, detection module to be used in PET scanners dedicated to human brain and breast, and small animal studies. A new computer controlled gantry allows the system to be used for PET and SPECT applications. Silicon 8x8 detector arrays have been developed by CMRP and will be optically coupled scintillation crystals and readout using the VIKING tM hybrid preamplifier chip to form the basis of the new module Characterisation of the pixel photodiode array has been performed to check the uniformity of the response of the array. This characterisation has been done using a pulsed, near infra-red laser diode system and alpha particles

Cyclotrons for isotope production

International Nuclear Information System (INIS)

Milton, B.F.; Stevenson, N.R.

1995-06-01

Cyclotrons continue to be efficient accelerators for radioisotope production. In recent years, developments in the accelerator technology have greatly increased the practical beam current in these machines while also improving the overall system reliability. These developments combined with the development of new isotopes for medicine and industry, and a retiring of older machines indicates a strong future for commercial cyclotrons. In this paper we will survey recent developments in the areas of cyclotron technology, and isotope production, as they relate to the new generation of commercial cyclotrons. We will also discuss the possibility of systems capable of extracted energies up to 100 MeV and extracted beam currents of up to 2.0 mA. (author). 6 refs., 2 tabs., 3 figs

Development of Beam Diagnostic Tools for Monitoring Cyclotron Beams at Production Intensities

Energy Technology Data Exchange (ETDEWEB)

Jensen, Mikael [Hevesy Laboratory, Risoe-DTU National Laboratory, DK-4000 Roskilde (Denmark)

2009-07-01

This final report for the IAEA-CRP on “Improved High Current Liquid and Gas Targets for Cyclotron Produced Radioisotopes” reports the progress made as part of the Danish participation in the above CRP. Some of the work is the result of international, multi-institutional collaboration and/or research student education, and credit is hereby given to my former students Helge Thisgaard and Jesper Jørgensen, Katie Gagnon, student of Tom Ruth at Triumf, Canada, and, last but not least, to Tom himself. The people at the Edmonton PET centre, for beam time. David Schlyer and Rick Carson of BNL for access to the Tandem accelerator calibration shots. (author)

Development of Beam Diagnostic Tools for Monitoring Cyclotron Beams at Production Intensities

International Nuclear Information System (INIS)

Jensen, Mikael

2009-01-01

This final report for the IAEA-CRP on “Improved High Current Liquid and Gas Targets for Cyclotron Produced Radioisotopes” reports the progress made as part of the Danish participation in the above CRP. Some of the work is the result of international, multi-institutional collaboration and/or research student education, and credit is hereby given to my former students Helge Thisgaard and Jesper Jørgensen, Katie Gagnon, student of Tom Ruth at Triumf, Canada, and, last but not least, to Tom himself. The people at the Edmonton PET centre, for beam time. David Schlyer and Rick Carson of BNL for access to the Tandem accelerator calibration shots. (author)

PET and SPECT in medically non-refractory complex partial seizures. Temporal asymmetries of glucose consumption, Benzodiazepine receptor density

International Nuclear Information System (INIS)

Matheja, P.; Kuwert, T.; Wolf, K.; Schober, O.; Stodieck, S.R.G.; Diehl, B.; Ringelstein, E.B.; Schuierer, G.

1998-01-01

Aim: In contrast to medically refractory complex partial seizures (CPS), only limited knowledge exists on cerebral perfusion and metabolism in medically non-refractory CPS. The aim of this study was to investigate the frequency of temporal asymmetries in regional cerebral glucose consumption (rCMRGlc), regional cerebral blood flow (rCBF), and regional cerebral benzodiazepine receptor density (BRD) in this group of patients. Methods: The study included 49 patients with medically non-refractory cryptogenic CPS (age: 36.0±16.1 years). rCMRGlc was studied with F-18-FDG-PET (FDG), rCBF with Tc-99m-ECD-SPECT (ECD), and BRD with I-123-iomazenil-SPECT (IMZ). All studies were performed interictally and within four weeks in each patient. Duration of epilepsy ranged from 0.1 to 42 years (median 4.0 years). SPECT was performed with the triple-headed SPECT camera Multispect 3, PET with the PET camera ECAT EXACT 47. Using linear profiles, glucose consumption, as well as uptake of ECD and IMZ, were measured in four temporal regions of interest (ROIs), and asymmetry indices were calculated (ASY). The results were compared to 95% confidence intervals determined in control subjects. Results: Thirty-five of the 49 (71%) patients had at least one significantly elevated ASY; temporal rCMRGlc was asymmetrical in 41% of the patients, temporal BRD in 29%, and temporal rCBF in 24%. One patient had an asymmetry of all three variables, two of temporal rCMRGlc and BRD, three of temporal rCMRGlc and rCBF, and another four of rCBF and BRD. Fourteen patients had an isolated temporal asymmetry in rCMRGlc, seven in BRD, and four in rCBF. A discrepancy in lateralization between the three modalities was not observed. Conclusion: The majority of patients with medically non-refractory CPS have focal abnormalities of blood flow and metabolism in their temporal lobe. In this group of patients, FDG-PET demonstrates abnormalities with the highest frequency of the three modalities studied, followed by IMZ

Isochronous cyclotron data base description

International Nuclear Information System (INIS)

Kiyan, I.N.; Vorozhtsov, S.B.; Tarashkevich, R.

2004-01-01

The relational data base of the control parameters of the isochronous cyclotron, Isochronous Cyclotron Data Base (ICDB), is described. The relational data base under consideration, written in Transact SQL for the MS SQL Server 2000 with the use of MS Enterprise Manager and MS Query Analyzer, was installed on the server of the AIC144 isochronous cyclotron in Krakow, which operates under the control of the operating system MS Windows Server 2003 (Standard Edition). The interface of the data base under considerations is written in C++ with the use of Visual C++ .NET and is built in the Cyclotron Operator Help Program (COHP), which is used for modeling the operational modes of the isochronous cyclotron. Communication between the COHP and the relational data base is realised on the base of the Open Data Base Connectivity protocol. The relational data base of the control parameter of the isochronous cyclotron is intended: firstly, for systematization and automatic use of all measured and modelled magnetic field maps in the process of modeling the operational modes; secondly, for systematization and convenient access to the stored operational modes; thirdly, for simplifying the operator's work. The relational data base of the control parameter of the isochronous cyclotron reflects its physical structure and the logic of its operator's work. (author)

Gamma camera based FDG PET in oncology

International Nuclear Information System (INIS)

Park, C. H.

2002-01-01

Positron Emission Tomography(PET) was introduced as a research tool in the 1970s and it took about 20 years before PET became an useful clinical imaging modality. In the USA, insurance coverage for PET procedures in the 1990s was the turning point, I believe, for this progress. Initially PET was used in neurology but recently more than 80% of PET procedures are in oncological applications. I firmly believe, in the 21st century, one can not manage cancer patients properly without PET and PET is very important medical imaging modality in basic and clinical sciences. PET is grouped into 2 categories; conventional (c) and gamma camera based ( CB ) PET. CB PET is more readily available utilizing dual-head gamma cameras and commercially available FDG to many medical centers at low cost to patients. In fact there are more CB PET in operation than cPET in the USA. CB PET is inferior to cPET in its performance but clinical studies in oncology is feasible without expensive infrastructures such as staffing, rooms and equipments. At Ajou university Hospital, CBPET was installed in late 1997 for the first time in Korea as well as in Asia and the system has been used successfully and effectively in oncological applications. Our was the fourth PET operation in Korea and I believe this may have been instrumental for other institutions got interested in clinical PET. The following is a brief description of our clinical experience of FDG CBPET in oncology

The Cyclotron Center of the Slovak Republic

International Nuclear Information System (INIS)

Podhorsky, D.; Ruzicka, J.; Macasek, F.; Makaiova, I.; Saro, S.; Kristiak, J.; Fulup, M.

2001-01-01

The Cyclotron Center of the Slovak Republic was established at the beginning of August 1999 - within the Slovak-Office of Standards, Metrology and Testing (SOSMT), in Bratislava, Slovak Republic. It will have two cyclotrons - a large heavy and light cyclotron DC-72, which will be constructed by the Joint Institute for Nuclear Research (JINR), Dubna, Russian Federation, and a small commercial light ion cyclotron IBA 18/9. The heavy ion source of the electron resonance type (DECRS-2M) will be used for low and medium energy experiments in physics. The small electron accelerator is planned for different applications, including improving the properties of plastics, increasing the resistance of cables to fire and temperature, the sterilization of medical disposables in the CC SR. The main purpose of the Cyclotron Center of the Slovak Republic (CC SR) is to catch the present approach and trends in the area of improving of inhabitants life and health quality using the progressive technology, which is introduced by bringing into practice of the physical equipment - accelerators, producing beams of high energy particles. Experts of nuclear physics and of the related branches have no experimental basis in Slovakia, as after dissolution of the former the Czech and Slovak Federal Republic all bigger nuclear equipment were left in the Czech Republic. The Slovak Republic is one of the European countries where cancer and cardiovascular diseases have a rapidly increasing tendency (the rate of new oncological cases is approximately 20,000/year at the population of 5 million inhabitants) - early diagnostics of population is necessary to be updated urgently. The Slovak Republic use a great part of electricity (about 60 %) from its own nuclear power stations and thus it is in need of education of rising generations of experts from different nuclear fields. The Government of the Slovak republic on June 18, 1996 approved the strategic aim of building up the Cyclotron Laboratory at the

Fourier Transform Ion Cyclotron Resonance Mass Spectrometry at the Cyclotron Frequency.

Science.gov (United States)

Nagornov, Konstantin O; Kozhinov, Anton N; Tsybin, Yury O

2017-04-01

The phenomenon of ion cyclotron resonance allows for determining mass-to-charge ratio, m/z, of an ensemble of ions by means of measurements of their cyclotron frequency, ω c . In Fourier transform ion cyclotron resonance mass spectrometry (FT-ICR MS), the ω c quantity is usually unavailable for direct measurements: the resonant state is located close to the reduced cyclotron frequency (ω + ), whereas the ω c and the corresponding m/z values may be calculated via theoretical derivation from an experimental estimate of the ω + quantity. Here, we describe an experimental observation of a new resonant state, which is located close to the ω c frequency and is established because of azimuthally-dependent trapping electric fields of the recently developed ICR cells with narrow aperture detection electrodes. We show that in mass spectra, peaks close to ω + frequencies can be reduced to negligible levels relative to peaks close to ω c frequencies. Due to reduced errors with which the ω c quantity is obtained, the new resonance provides a means of cyclotron frequency measurements with precision greater than that achieved when ω + frequency peaks are employed. The described phenomenon may be considered for a development into an FT-ICR MS technology with increased mass accuracy for applications in basic research, life, and environmental sciences. Graphical Abstract ᅟ.

PET-COMPTON System. Comparative evaluation with PET System using Monte Carlo Simulation

International Nuclear Information System (INIS)

Diaz Garcia, Angelina; Arista Romeu, Eduardo; Abreu Alfonso, Yamiel; Leyva Fabelo, Antonio; Pinnera HernAndez, Ibrahin; Bolannos Perez, Lourdes; Rubio Rodriguez, Juan A.; Perez Morales, Jose M.; Arce Dubois, Pedro; Vela Morales, Oscar; Willmott Zappacosta, Carlos

2012-01-01

Positron Emission Tomography (PET) in small animals has actually achieved spatial resolution round about 1 mm and currently there are under study different approaches to improve this spatial resolution. One of them combines PET technology with Compton Cameras. This paper presents the idea of the so called PET-Compton systems and has included comparative evaluation of spatial resolution and global efficiency in both PET and PET-Compton system by means of Monte Carlo simulations using Geant4 code. Simulation was done on a PET-Compton system made-up of LYSO-LuYAP scintillating detectors of particular small animal PET scanner named Clear-PET and for Compton detectors based on CdZnTe semiconductor. A group of radionuclides that emits a positron (e+) and quantum almost simultaneously and fulfills some selection criteria for their possible use in PET-Compton systems for medical and biological applications were studied under simulation conditions. By means of analytical reconstruction using SSRB (Single Slide Rebinning) method were obtained superior spatial resolution in PET-Compton system for all tested radionuclides (reaching sub-millimeter values of for 22Na source). However this analysis done by simulation have shown limited global efficiency values in PET-Compton system (in the order of 10 -5 -10 -6 %) instead of values around 5*10 -1 % that have been achieved in PET system. (author)

Analysis of human cerebral functions using positron emission tomography (PET)

International Nuclear Information System (INIS)

Shibasaki, Takashi

1984-01-01

Positron emission tomography has two major advantages to analyse human cerebral functions in vivo. First, we can see the distribution of a variety of substance in the living (and doing something) human brain. Positron emitters, 11 C, 13 N, 15 O and 18 F, are made by medical cyclotron and are elements of natural substrates or easily tagged to substrate. Second, the distribution of the tracer is calculated to make a quantitative functional map in a reasonable spatial resolution over the entire brain in the same time. Not only cortical areas but also deeper structures show regional cerebral blood flow (rCBF) or local cerebral metabolic rates (LCMRs). Nowadays, PET is put to practical use for determination of mainly rCBF, LCMR for glucose (LCMRsub(glu)), LCMR for oxygen (LCMRsub(o2)) and regional cerebral blood volume (rCBV). There have been many other pilot studies, such as estimation of distribution of given neurotransmitters or modulators in the brain which also confirms the substances' role in the neuronal function, and observation of protein synthesis relating to memory function. (J.P.N.)

Performance of the RI exhaust filter at Chosun university cyclotron facility and {sup 18}F emission reduction

Energy Technology Data Exchange (ETDEWEB)

Jeong, Cheol Ki; Jang, Han; Lee, Goung Jin [Dept. of Nuclear Engineering, Chosun University, Gwangju (Korea, Republic of)

2017-03-15

Recently, the number of PET cyclotrons has increased in Korea. A cyclotron mainly produces {sup 18}F, which is used for the production of [{sup 18}F]FDG, a cancer diagnostic radiopharmaceutical. For radiation protection, the discharge control standard under the Nuclear Safety Act limits the radioactive concentration of {sup 18}F in the exhaust discharged from a nuclear power utilization facility to below 2,000 Bq m-3. However, the radioactive concentration of 18F discharged during [18F]FDG production at the cyclotron facility at Chosun University is maintained at about 1,500 Bq m{sup -3} on average, which is 75% of the concentration limit of the discharge control standard, and temporarily exceeds the standard as per the real-time monitoring results. This study evaluated the performance of the exhaust flter unit of the cyclotron facility at Chosun University by assessing the concentration of {sup 18}F in the exhaust, and an experiment was conducted on the discharge reduction, where {sup 18}F is discharged without reacting with the FDG precursors during [{sup 18}F]FDG synthesis and is immediately captured by the [{sup 18}F]FDG automatic synthesis unit. Based on the performance evaluation results of the exhaust flter at the cyclotron facility of Chosun University, the measured capture effciency before and after the flter was found to be 92%. Furthermore, the results of the discharge reduction experiment, where the exhaust {sup 18}F was immediately captured by the [{sup 18}F]FDG synthesizer, showed a very satisfactory 94.3% reduction in the concentration of discharge compared to the existing discharge concentration.

All-magnetic extraction for cyclotron beam reacceleration

Science.gov (United States)

Hudson, E.D.; Mallory, M.L.

1975-07-22

An isochronous cyclotron can be modified to provide an initial electron stripping stage, a complete acceleration of the stripped ions through the cyclotron to a first energy state, means for returning the ions to an intermediate cyclotron orbit through a second stripping stage, further acceleration of the now higher energy stripped ions through the cyclotron to their final energy, and final extraction of the ions from the cyclotron. (auth)

Clinical importance of re-interpretation of PET/CT scanning in patients referred to a tertiary care medical centre

DEFF Research Database (Denmark)

Löfgren, Johan; Loft, Annika; Barbosa de Lima, Vinicius Araújo

2017-01-01

had an external F-18-FDG PET/CT scan were included. Only information that had been available at the time of the initial reading at the external hospital was available at re-interpretation. Teams with one radiologist and one nuclear medicine physician working side by side performed the re......PURPOSE: To evaluate, in a controlled prospective manner with double-blind read, whether there are differences in interpretations of PET/CT scans at our tertiary medical centre, Rigshospitalet, compared to the external hospitals. METHODS: Ninety consecutive patients referred to our department who...

PET/MRI in cancer patients

DEFF Research Database (Denmark)

Kjær, Andreas; Loft, Annika; Law, Ian

2013-01-01

Combined PET/MRI systems are now commercially available and are expected to change the medical imaging field by providing combined anato-metabolic image information. We believe this will be of particular relevance in imaging of cancer patients. At the Department of Clinical Physiology, Nuclear...... described include brain tumors, pediatric oncology as well as lung, abdominal and pelvic cancer. In general the cases show that PET/MRI performs well in all these types of cancer when compared to PET/CT. However, future large-scale clinical studies are needed to establish when to use PET/MRI. We envision...... that PET/MRI in oncology will prove to become a valuable addition to PET/CT in diagnosing, tailoring and monitoring cancer therapy in selected patient populations....

Use of maze in cyclotron hoppers; Utilizacao de labirinto em bunker de ciclotron

Energy Technology Data Exchange (ETDEWEB)

Fernandes, Fernando A.; Alves, Juliano S.; Fochesatto, Cintia; Cerioli, Luciane; Borges, Joao Alfredo; Gonzalez, Delfin; Silva, Daniel C., E-mail: fernandofernandes@biofarmaco.com.br [Delfin Farmacos e Derivados (Biofarmaco Marcadores Moleculares), Lauro de Freitas, BA (Brazil)

2013-07-01

Introduction: the increasing number of cyclotrons in Brazil due to constitutional amendment 49 /06 that enabled the production of radiopharmaceuticals with a short half - life by private companies. The radionuclides used for PET - CT require production centers near or within the diagnostic centers. In order to minimize maintenance and operating risks, gaining efficiency, our facility was the first in Brazil to use the access to a cyclotron bunker via maze, rather than armored door stopper type. Materials: the design calculations were based on the Monte Carlo method (MCNP5 - Monte Carlo N-Particletransportcode version 5). At the ends of the labyrinth are installed a door of polyethylene, for thermalization of neutrons, and other of wood for limiting access. Both legs of the maze have wall thickness of 100cm. In inspection Brazilian CNEN realize measures of dose rate for neutrons and gamma 9 points: 7 around the bunker, 1 over the bunker and 1 in the exhaust with the cyclotron operating with maximum load, double beam of 50uA for 2 hours. After commissioning were carried out around the bunker, the following measures: cumulative dose in three months with dosimeters for neutron rate dose with a gas proportional detector type filled with {sup 3}He and polyethylene neutron moderator and dose rate with a Geiger - Mueller detector for gamma radiation. Readings with neutron detectors were classified as background radiation and dose rates were always below the limits established in standard EN 3.01, and the calculation of the predicted regardless of the intensity of irradiation inside the bunker. Conclusion: the use of labyrinths as a way to access the bunkers cyclotron has been shown to be effective as the radiation shielding and efficient by allowing quick and easy access, virtually eliminating the maintenance.

Clinical application and progress of PET and PET-CT for differential diagnosis of the benign or malignant pulmonary nodules

International Nuclear Information System (INIS)

Wang Xuemei; Wang Meiling; Wang Xiangcheng

2010-01-01

To differential diagnosis the benign or malignant of pulmonary nodules is a medical difficult problem. As the development of medical imaging equipment and technology, PET-CT can identified benign or malignant lesions of pulmonary nodules though changes of metabolism. Researches about PET-CT for differential diagnosis pulmonary nodules benign or malignant are reviewed. (authors)

Conceptual design of the RF accelerating cavities for a superconducting cyclotron

International Nuclear Information System (INIS)

Maggiore, M.; Calabretta, L.; Di Giacomo, M.; Rifuggiato, D.; Battaglia, D.; Piazza, L.

2006-01-01

A superconducting cyclotron accelerating ions up to 250 A MeV, for medical applications and radioactive ions production is being studied at Laboratori Nazionali del Sud in Catania. The radio frequency (RF) system, working in the fourth harmonic, is based on four normal conducting radio frequency cavities operating at 93 MHz. This paper describes an unusual multi-stem cavity design, performed with 3D electromagnetic codes. Our aim is to obtain a cavity, completely housed inside the cyclotron, with a voltage distribution ranging from 65 kV in the injection region to a peak value of 120 kV in the extraction region, and having a low power consumption

Computer design of a compact cyclotron

International Nuclear Information System (INIS)

Bing Wang; Huanfeng Hao; Qinggao Yao; Jinquan Zhang; Mingtao Song; Vorozhtsov, S.B.; Smirnov, V.L.; Hongwei Zhao

2011-01-01

Here we present results of the computer design of the structural elements of a compact cyclotron by the example of HITFiL cyclotron selected as the driving accelerator that is under construction at the Institute of Modern Physics (Lanzhou, China). In the article a complex approach to modeling of the compact cyclotron, including calculation of electromagnetic fields of the structural elements and beam dynamics calculations, is described. The existing design data on the axial injection, magnetic, acceleration and extraction systems of the cyclotron are used as a starting point in the simulation. Some of the upgrades of the cyclotron structural elements were proposed, which led to substantial improvement of the beam quality and transmission

Startup work on Inshas cyclotron

International Nuclear Information System (INIS)

Vorogushin, M.F.; Strokach, A.P.; Shikhov, V.Ya.; Galchuk, A.V.; Soliman, A.N.; El-Abyad, M.; Comsan, M.N.H.; Saleh, Z.A.; Azzam, A.N.

2001-01-01

Startup works on the MGC-20 variable energy cyclotron in the Inshas Nuclear Research Center (Egypt) are described. The cyclotron is intended for acceleration of hydrogen and helium ions in a wide energy range (for protons - from 5 to 20 MeV). Main units of the cyclotron and results of computer experimental acceleration of protons to 18 MeV are described. The prospects of furthers investigations are presented [ru

Contemporary hygienic and engineering requirements to the projecting and exploitation of the positron-emission tomography in medicine

International Nuclear Information System (INIS)

Chekmarev, O.; Paltseva, A.

2004-01-01

The positron-emission tomography (PET) centres, attached to a large medical establishment as a rule include except PET a compact cyclotron for producing positron-radiant ultra-temporary product radionuclides (carbon-11, Nitrogen-14, oxygen-15, fluorine-18 and etc.) based on water and gaseous targets. At present there are no information about regulating and setting up such medical centres, moreover, requirements which must be presented to the Sanitary Inspection Agency at the documents examination are incompletely represented. During 2001-2003 years specialists of the Moscow Medical Centre (MMC) have been reviewing the hygienic expert examination of the 5 versions of the PET's cabinets installation in therapeutic and prophylactic offices. One of the projects for operating ultra-temporary products is submitted in this report. It foresees the usage of proton beam of the self-protected cyclotron RDS/111 (CTJ PET System (USA)). Its energy of irradiation (proton beam) is 11 MeV. The cyclotron is placed in the additional building of the radiological trunk on the territory of the Moscow Clinical hospital. The technological process of producing the ultra-temporary radionuclides is presented. The block of the radiodiagnostic research include: a treatment room for PET; an operating room; an area for information handling; a treatment room for intake of the radio-pharm-preparations; a filling room; a laboratory for express-analysis of blood before and after research; a WC for patients (with radio-pharm-preparations); and at last - an area for transient (30 - 40 min.) staying for the patients in the lay position before the research. All probable accidents, which can happen in the case of any technology violation, are discussed. There were worked out special requirements to the clarification tanks equipment for liquid radioactive waste and to the time of being a patient in the department after diagnostic researches using fluorine-18

Minicyclotron-based technology for the production of positron-emitting labelled radiopharmaceuticals

International Nuclear Information System (INIS)

Barrio, J.R.; Bida, G.; Satyamurthy, N.; Padgett, H.C.; MacDonald, N.S.; Phelps, M.E.

1983-01-01

The use of short-lived positron emitters such as carbon 11, fluorine 18, nitrogen 13, and oxygen 15, together with positron-emission tomography (PET) for probing the dynamics of physiological and biochemical processes in the normal and diseased states in man is presently an active area of research. One of the pivotal elements for the continued growth and success of PET is the routine delivery of the desired positron emitting labelled compounds. To date, the cyclotron remains the accelerator of choice for production of medically useful radionuclides. The development of the technology to bring the use of cyclotrons to a clinical setting is discussed

Minicyclotron-based technology for the production of positron-emitting labelled radiopharmaceuticals

Energy Technology Data Exchange (ETDEWEB)

Barrio, J.R.; Bida, G.; Satyamurthy, N.; Padgett, H.C.; MacDonald, N.S.; Phelps, M.E.

1983-01-01

The use of short-lived positron emitters such as carbon 11, fluorine 18, nitrogen 13, and oxygen 15, together with positron-emission tomography (PET) for probing the dynamics of physiological and biochemical processes in the normal and diseased states in man is presently an active area of research. One of the pivotal elements for the continued growth and success of PET is the routine delivery of the desired positron emitting labelled compounds. To date, the cyclotron remains the accelerator of choice for production of medically useful radionuclides. The development of the technology to bring the use of cyclotrons to a clinical setting is discussed. (ACR)

New horizons in cardiac innervation imaging. Introduction of novel 18F-labeled PET tracers

International Nuclear Information System (INIS)

Kobayashi, Ryohei; Chen, Xinyu; Werner, Rudolf A.; Lapa, Constantin; Javadi, Mehrbod S.; Higuchi, Takahiro

2017-01-01

Cardiac sympathetic nervous activity can be uniquely visualized by non-invasive radionuclide imaging techniques due to the fast growing and widespread application of nuclear cardiology in the last few years. The norepinephrine analogue 123 I-meta-iodobenzylguanidine ( 123 I-MIBG) is a single photon emission computed tomography (SPECT) tracer for the clinical implementation of sympathetic nervous imaging for both diagnosis and prognosis of heart failure. Meanwhile, positron emission tomography (PET) imaging has become increasingly attractive because of its higher spatial and temporal resolution compared to SPECT, which allows regional functional and dynamic kinetic analysis. Nevertheless, wider use of cardiac sympathetic nervous PET imaging is still limited mainly due to the demand of costly on-site cyclotrons, which are required for the production of conventional 11 C-labeled (radiological half-life, 20 min) PET tracers. Most recently, more promising 18 F-labeled (half-life, 110 min) PET radiopharmaceuticals targeting sympathetic nervous system have been introduced. These tracers optimize PET imaging and, by using delivery networks, cost less to produce. In this article, the latest advances of sympathetic nervous imaging using 18 F-labeled radiotracers along with their possible applications are reviewed. (orig.)

Requirement for radiation shields of transportation pipe for on line inhalation gases from compact cyclotron in positron emission tomography

International Nuclear Information System (INIS)

Hachiya, Takenori; Hagami, Eiichi; Shoji, Yasuaki; Aizawa, Yasuo; Kanno, Iwao; Uemura, Kazuo; Handa, Masahiko; Mori, Junichi; Fukagawa, Akihisa.

1989-01-01

In the unit housing of a compact cyclotron and positron emission CT (PET), positron emitting gas such as 15 O, 11 C, C 15 O 2 , C 15 O etc. is supplied from a cyclotron to a PET room through a transportation pipe with an appropriate shield to reduce positron annihilation radiation. This paper discribes the effect of lead and concrete shields with various thickness. Using lead or concrete shield blocks with various thicknesses, radiation leakage through the shield was measured by an ionization chamber type survey meter during continuous and constant supply of 15 O gas of 1.85 GBq/min concentration which is the maximum dose for clinical use. The leakage radiation measured was 213.7, 56.0, 15.3, 5.0 μSv/week for lead shield with 1, 2, 3, and 4 cm thickness, respectively, and 193.3, 30.5 and 5.1 μSv/week for concrete shields with thickness of 10, 20, and 30 cm, respectively. The present study shows that to keep less than 300 μSv/week, which is the permissible dose rate of the boundary zone around the radiation controlled area by Japan Science and Technology Agency, it is required to use more than 8 mm thick lead shield or 7 cm thick concrete for continuous supply of 1.85 GBq/min 15 O gas. (author)

How much can a negative FDG-PET be trusted?

International Nuclear Information System (INIS)

Wang Shuxia

2004-01-01

Purpose: False-negative FDG-PET constituted 22.7% of all clinically identified negative PET in a ten year retrospective review about FDG-PET on irradiated brain tumour. Uncovering possible influencing factors of false-negative FDG-PET may have significant value. Material and methods: 10 patients with a first negative and then a second positive PET during very short time separation and 6 patients with surgically confirmed false-negative PET were traced. Histological type, irradiation parameter, steroids effect were discussed. To define temporary irradiation effect on FDG uptake, interval between radiation treatment to PET examination of these two groups were compared with 24 surgically confirmed true-positive PET, 5 surgically confirmed true-negative PET Results: 80% negative-positive PET transformation happened within 31 weeks. No statistically significant difference with regard to time from irradiation could be found between groups. Steroids medication closely before PET examination was about the same before the first negative and second positive PET scan. 5/6 surgically confirmed false-negative PET patients did not take steroids before PET examination. Conclusion: Tumour histology type, temporary irradiation effect and steroids medication did not constitute the reasons for false negative PET in our patient series. PET could not identify tumour relapse in the very early stage. Therefore, if clinically indicated, second FDG-PET might be a better selection to pick up tumour relapse instead of exploratory surgery or biopsy. In that case, the suitable time point for the second PET could be within 31 weeks after the first PET examination. Keywords: false-negative, FDG-PET, influencing factor, irradiation effect, steroids. (author)

Status report on electron cyclotron resonance ion sources at the Heavy Ion Medical Accelerator in Chiba

CERN Document Server

Kitagawa, A; Sekiguchi, M; Yamada, S; Jincho, K; Okada, T; Yamamoto, M; Hattori, T G; Biri, S; Baskaran, R; Sakata, T; Sawada, K; Uno, K

2000-01-01

The Heavy Ion Medical Accelerator in Chiba at the National Institute of Radiological Sciences (NIRS) is not only dedicated to cancer therapy, it is also utilized with various ion species for basic experiments of biomedical science, physics, chemistry, etc. Two electron cyclotron resonance (ECR) ion sources are installed for production of gaseous ions. One of them, the NIRS-ECR, is a 10 GHz ECR ion source, and is mainly operated to produce C/sup 4+/ ions for daily clinical treatment. This source realizes good reproducibility and reliability and it is easily operated. The other source, the NIRS-HEC, is an 18 GHz ECR ion source that is expected to produce heavier ion species. The output ion currents of the NIRS-ECR and the NIRS-HEC are 430e mu A for C/sup 4+/ and 1.1e mA for Ar/sup 8+/, respectively. (14 refs).

Medical effects of poly-ethylene terephthalate (PET) non-woven ...

African Journals Online (AJOL)

In this study, bamboo activated charcoal was mixed with acrylic resin in various proportions and deposited on poly-ethylene terephthalate (PET) non-woven fabrics. A series of characterizations were carried out to estimate the performances of PET non-woven fabrics such as far infrared ray emission, heat retention, negative ...

Preparation of ⁶⁸Ga-labelled DOTA-peptides using a manual labelling approach for small-animal PET imaging.

Science.gov (United States)

Romero, Eduardo; Martínez, Alfonso; Oteo, Marta; García, Angel; Morcillo, Miguel Angel

2016-01-01

(68)Ga-DOTA-peptides are a promising PET radiotracers used in the detection of different tumours types due to their ability for binding specifically receptors overexpressed in these. Furthermore, (68)Ga can be produced by a (68)Ge/(68)Ga generator on site which is a very good alternative to cyclotron-based PET isotopes. Here, we describe a manual labelling approach for the synthesis of (68)Ga-labelled DOTA-peptides based on concentration and purification of the commercial (68)Ga/(68)Ga generator eluate using an anion exchange-cartridge. (68)Ga-DOTA-TATE was used to image a pheochromocytoma xenograft mouse model by a microPET/CT scanner. The method described provides satisfactory results, allowing the subsequent (68)Ga use to label DOTA-peptides. The simplicity of the method along with its implementation reduced cost, makes it useful in preclinical PET studies. Copyright © 2015 Elsevier Ltd. All rights reserved.

Positron emission tomography. Present status and Romanian perspectives

International Nuclear Information System (INIS)

Constantinescu, B.; Lungu, V.

1995-01-01

Basic principles of the positron emission tomography (PET) are summarised. The main PET methods using short-lived radioisotopes (i.e. 11 C, 13 N, 15 O, 18 F) are briefly reviewed. Three types of particle accelerators for radioisotopes production and medical uses (including radiotherapy), corresponding to the proton energy (E p p p < 200 MeV) are presented. PET imaging equipment and procedures are discussed. Main radiopharmaceuticals based on beta decay for PET studies and their role in medicine is also described. Finally, perspectives for a PET program in Romania (Cyclotron + Radiochemistry + Tomograph ) are discussed. (author)

A line-of-sight electron cyclotron emission receiver for electron cyclotron resonance heating feedback control of tearing modes

DEFF Research Database (Denmark)

Oosterbeek, J.W.; Bürger, A.; Westerhof, E.

2008-01-01

An electron cyclotron emission (ECE) receiver inside the electron cyclotron resonance heating (ECRH) transmission line has been brought into operation. The ECE is extracted by placing a quartz plate acting as a Fabry-Perot interferometer under an angle inside the electron cyclotron wave (ECW) bea...

New horizons in cardiac innervation imaging. Introduction of novel {sup 18}F-labeled PET tracers

Energy Technology Data Exchange (ETDEWEB)

Kobayashi, Ryohei [University Hospital of Wuerzburg, Department of Nuclear Medicine, Wuerzburg (Germany); Nihon Medi-Physics Co., Ltd., Research Centre, Chiba (Japan); Chen, Xinyu [University Hospital of Wuerzburg, Department of Nuclear Medicine, Wuerzburg (Germany); University Hospital of Wuerzburg, Comprehensive Heart Failure Center, Wuerzburg (Germany); Werner, Rudolf A. [University Hospital of Wuerzburg, Department of Nuclear Medicine, Wuerzburg (Germany); University Hospital of Wuerzburg, Comprehensive Heart Failure Center, Wuerzburg (Germany); Johns Hopkins School of Medicine, The Russell H Morgan Department of Radiology and Radiological Sciences, Baltimore, MD (United States); Lapa, Constantin [University Hospital of Wuerzburg, Department of Nuclear Medicine, Wuerzburg (Germany); Javadi, Mehrbod S. [Johns Hopkins School of Medicine, The Russell H Morgan Department of Radiology and Radiological Sciences, Baltimore, MD (United States); Higuchi, Takahiro [University Hospital of Wuerzburg, Department of Nuclear Medicine, Wuerzburg (Germany); University Hospital of Wuerzburg, Comprehensive Heart Failure Center, Wuerzburg (Germany); National Cerebral and Cardiovascular Center, Department of Biomedical Imaging, Research Institute, Suita (Japan)

2017-12-15

Cardiac sympathetic nervous activity can be uniquely visualized by non-invasive radionuclide imaging techniques due to the fast growing and widespread application of nuclear cardiology in the last few years. The norepinephrine analogue {sup 123}I-meta-iodobenzylguanidine ({sup 123}I-MIBG) is a single photon emission computed tomography (SPECT) tracer for the clinical implementation of sympathetic nervous imaging for both diagnosis and prognosis of heart failure. Meanwhile, positron emission tomography (PET) imaging has become increasingly attractive because of its higher spatial and temporal resolution compared to SPECT, which allows regional functional and dynamic kinetic analysis. Nevertheless, wider use of cardiac sympathetic nervous PET imaging is still limited mainly due to the demand of costly on-site cyclotrons, which are required for the production of conventional {sup 11}C-labeled (radiological half-life, 20 min) PET tracers. Most recently, more promising {sup 18}F-labeled (half-life, 110 min) PET radiopharmaceuticals targeting sympathetic nervous system have been introduced. These tracers optimize PET imaging and, by using delivery networks, cost less to produce. In this article, the latest advances of sympathetic nervous imaging using {sup 18}F-labeled radiotracers along with their possible applications are reviewed. (orig.)

Impedance matching network systems using stub-lines of 20 kW CW RF amplifier for SKKUCY-9 compact cyclotron

International Nuclear Information System (INIS)

Lee, Seung Hyun; Song, Ho Seung; Kim, Jeong Hwan; Cong, Truong Van; Kim, Hui Su; Yeon, Yeong Heum; Lee, Yong seok; Chai, Jong Seo

2015-01-01

The SKKUCY-9 is a compact cyclotron for radioactive isotopes (RI) production of positron emission tomography (PET). Charged particles such as H-ions are accelerated azimuthally within a high intensity electric field (E-field) generated from a radio frequency (RF) system in cyclotron. A high power RF signal is transmitted from an RF amplifier to an RF resonating cavity. The RF system of the SKKUCY-9 operates in continuous wave (CW) mode. If an ion beam were accelerated in the cyclotron, the vacuum level and permittivity would be changed because of beam loading. It causes an impedance shift of the RF resonating cavity. This impedance mismatch generates reflected power that decreases the RF transmitting power. To prevent this situation, an impedance matching system is necessary. This paper describes the impedance matching system of a 20 kW RF amplifier in an SKKUCY-9 compact cyclotron. The impedance matching circuit was designed using both an input stage and output stage, which are divided between the cathode and anode in a vacuum tube that is used as an amplifying device. The equivalent circuit of the matching system is made of passive elements. The characteristic results of designed circuit were calculated using a Smith chart. In assembling, the inductors were replaced by movable stub-line structures. The dimensions of the stub-line structures were optimized with equations and the measurement results. The experiment was performed to find the result values of matching circuit impedance and RF power amplitude

Method and apparatus for ion cyclotron spectrometry

Science.gov (United States)

Dahl, David A [Idaho Falls, ID; Scott, Jill R [Idaho Falls, ID; McJunkin, Timothy R [Idaho Falls, ID

2010-08-17

An ion cyclotron spectrometer may include a vacuum chamber that extends at least along a z-axis and means for producing a magnetic field within the vacuum chamber so that a magnetic field vector is generally parallel to the z-axis. The ion cyclotron spectrometer may also include means for producing a trapping electric field within the vacuum chamber that includes at least a first section that induces a first magnetron effect that increases a cyclotron frequency of an ion and at least a second section that induces a second magnetron effect that decreases the cyclotron frequency of an ion. The cyclotron frequency changes induced by the first and second magnetron effects substantially cancel one another so that an ion traversing the at least first and second sections will experience no net change in cyclotron frequency.

Commercial compact cyclotrons in the 90's

International Nuclear Information System (INIS)

Milton, B.F.

1995-09-01

Cyclotrons continue to be efficient accelerators for radio-isotope production. In recent years, developments in the accelerator technology have greatly increased the practical beam current in these machines while also improving the overall system reliability. These developments combined with the development of new isotopes for medicine and industry, and a retiring of older machines indicate a strong future for commercial cyclotrons. In this paper we will survey recent developments in the areas of cyclotron technology, as they relate to the new generation of commercial cyclotrons. Design criteria for the different types of commercial cyclotrons will be presented, with reference to those demands that differ from those in a research oriented cyclotron project. We will also discuss the possibility of systems designed for higher energies and capable of extracted beam currents of up to 2.0 mA. (author)

Commercial compact cyclotrons in the 90's

International Nuclear Information System (INIS)

Milton, B.F.

1995-09-01

Cyclotrons continue to be efficient accelerators for radio-isotope production. In recent years, developments in the accelerator technology have greatly increased the practical beam current in these machines while also improving the overall system reliability. These developments combined with the development of new isotopes for medicine and industry, and a retiring of older machines indicate a strong future for commercial cyclotrons. In this paper the authors will survey recent developments in the areas of cyclotron technology, as they relate to the new generation of commercial cyclotrons. Design criteria for the different types of commercial cyclotrons will be presented, with reference to those demands that differ from those in a research oriented cyclotron project. The authors also discuss the possibility of systems designed for higher energies and capable of extracted beam currents of up to 2.0 mA

Are Pets in the Bedroom a Problem?

Science.gov (United States)

Krahn, Lois E; Tovar, M Diane; Miller, Bernie

2015-12-01

The presence of pets in the bedroom can alter the sleep environment in ways that could affect sleep. Data were collected by questionnaire and interview from 150 consecutive patients seen at the Center for Sleep Medicine, Mayo Clinic in Arizona. Seventy-four people (49%) reported having pets, with 31 (41% of pet owners) having multiple pets. More than half of pet owners (56%) allowed their pets to sleep in the bedroom. Fifteen pet owners (20%) described their pets as disruptive, whereas 31 (41%) perceived their pets as unobtrusive or even beneficial to sleep. Health care professionals working with patients with sleep concerns should inquire about the presence of companion animals in the sleep environment to help them find solutions and optimize their sleep. Copyright © 2015 Mayo Foundation for Medical Education and Research. Published by Elsevier Inc. All rights reserved.

Overview of the future upgrade of the INFN-LNS superconducting cyclotron

Science.gov (United States)

Calabretta, Luciano; Calanna, Alessandra; Cuttone, Giacomo; D'Agostino, Grazia; Rifuggiato, Danilo; Domenico Russo, Antonio

2017-06-01

The LNS Superconducting Cyclotron, named “Ciclotrone Superconduttore” (CS), has been in operation for more than 20 years. A wide range of ion species from hydrogen to lead, with energy in the range 10 to 80 AMeV, have been delivered to users. The maximum beam power is limited to 100 W due to the beam dissipation on the electrostatic deflectors. To fulfil the demand of users aiming at studying rare processes in nuclear physics, an upgrade of the cyclotron is necessarily intended to increase the intensity of ion beams with mass lower than 40 a.m.u. up to a power 10 kW. This will be achieved by means of extraction by stripping. This solution needs to replace the cryostat including the superconducting coils. The present capability of the cyclotron will be maintained, i.e. all the ion species allowed by the operating diagram will be available, being extracted by electrostatic extraction. In addition to the high power beams for nuclear physics, it will be possible to produce medical radioisotopes like 211At using an internal target.

Ion-cyclotron-resonance- and Fourier-transform-ion-cyclotron-resonance spectroscopy: technology and application

International Nuclear Information System (INIS)

Luederwald, I.

1977-01-01

Instrumentation and technology of Ion-Cyclotron-Resonance and Fourier-Transform-Ion-Cyclotron-Resonance Spectroscopy are described. The method can be applied to studies of ion/molecule reactions in gas phase, to obtain thermodynamic data as gas phase acidity or basicity, proton and electron affinity, and to establish reaction mechanisms and ion structures. (orig.) [de

Health physics considerations at a neutron therapy facility cyclotron

International Nuclear Information System (INIS)

Kleck, J.H.; Krueger, D.J.; Mc Laughlin, J.E.; Smathers, J.B.

1987-01-01

The U.C.L.A. Neutron Therapy Facility (NTF) is one of four such facilities in the United States currently involved in NCI sponsored trials of neutron therapy and reflects the present interest in the use of high energy neutron beams for treating certain types of human cancers. The NTF houses a CP-45 negative ion cyclotron which accelerates a 46 MeV proton beam for production of neutrons from a beryllium target. In addition to patient treatment, the NTF is involved in the production of positron emitting radioisotopes for diagnostic use in Positron Emission Tomography (PET). The activation of therapy treatment collimators, positron and neutron target systems, and a high and rapidly varying external radiation environment in a clinical setting have contributed to the need for a comprehensive radiation control program in which patient care is balanced with the maintenance of occupational exposures to ALARA levels

Multi-technique hybrid imaging in PET/CT and PET/MR: what does the future hold?

International Nuclear Information System (INIS)

Galiza Barbosa, F. de; Delso, G.; Voert, E.E.G.W. ter; Huellner, M.W.; Herrmann, K.; Veit-Haibach, P.

2016-01-01

Integrated positron-emission tomography and computed tomography (PET/CT) is one of the most important imaging techniques to have emerged in oncological practice in the last decade. Hybrid imaging, in general, remains a rapidly growing field, not only in developing countries, but also in western industrialised healthcare systems. A great deal of technological development and research is focused on improving hybrid imaging technology further and introducing new techniques, e.g., integrated PET and magnetic resonance imaging (PET/MRI). Additionally, there are several new PET tracers on the horizon, which have the potential to broaden clinical applications in hybrid imaging for diagnosis as well as therapy. This article aims to highlight some of the major technical and clinical advances that are currently taking place in PET/CT and PET/MRI that will potentially maintain the position of hybrid techniques at the forefront of medical imaging technologies.

High power targets for cyclotron production of 99mTc‡

OpenAIRE

Zeisler, S. K.; Hanemaayer, V.; Buckley, K. R.; Hook, B. K.; MeDiarmid, S.; Klug, J.; Corsaut, J.; Kovacs, M.; Cockburn, N.; Exonomou, C.; Harper, R.; Valliant, J. F.; Ruth, T. J.; Schaffer, P.

2015-01-01

Introduction Technetium-99m, supplied in the form of 99Mo/99mTc generators, is the most widely used radioisotope for nuclear medical imaging. The parent isotope 99Mo is currently produced in nuclear reactors. Recent disruptions in the 99Mo supply chain [1] prompted the development of methods for the direct accelerator-based production of 99mTc. Our approach involves the 100Mo(p,2n)99mTc reaction on isotopically enriched molybdenum using small medical cyclotrons (Ep ≤ 20 MeV), which is ...

20 years Rossendorf cyclotron

International Nuclear Information System (INIS)

1978-08-01

On the occasion of the 20th anniversary of initiating of the Rossendorf cyclotron accounts are given of most important works and results in the field of accelerator engineering and utilization of this machine. The reports show the trend of development and actual spectrum of application. The enclosed literature lists give a survey of technical and experimental works at cyclotron. (author)

PET/CT applications in oncology

International Nuclear Information System (INIS)

Oliva González, Juan Perfecto; Martínez Ramírez, Aldo; Baum, Richard Paul

2017-01-01

PET means Positron Emission Tomography, it is a nuclear medicine technique in which radiopharmaceuticals labeled with positron emitters are used to obtain biochemical-metabolic images of the human body. The use of PET / CT contributes to obtain multimodal images that combine anatomical and metabolic information, allowing a more reliable diagnosis of a tumor or local or distant metastases in an organ or tissue. Other multimodal devices combine metabolic imaging with nuclear magnetic resonance. PET/CT is mainly used in Oncology (85-90%), Neurology, Cardiology, Inflammation and Infection although it is currently also used in different medical and surgical pathologies. The present work is aimed at showing what PET/CT is and how useful it is in Oncology. (author)

In-house cyclotron production of high-purity Tc-99m and Tc-99m radiopharmaceuticals.

Science.gov (United States)

Martini, Petra; Boschi, Alessandra; Cicoria, Gianfranco; Zagni, Federico; Corazza, Andrea; Uccelli, Licia; Pasquali, Micòl; Pupillo, Gaia; Marengo, Mario; Loriggiola, Massimo; Skliarova, Hanna; Mou, Liliana; Cisternino, Sara; Carturan, Sara; Melendez-Alafort, Laura; Uzunov, Nikolay M; Bello, Michele; Alvarez, Carlos Rossi; Esposito, Juan; Duatti, Adriano

2018-05-30

In the last years, the technology for producing the important medical radionuclide technetium-99m by cyclotrons has become sufficiently mature to justify its introduction as an alternative source of the starting precursor [ 99m Tc][TcO 4 ] - ubiquitously employed for the production of 99m Tc-radiopharmaceuticals in hospitals. These technologies make use almost exclusively of the nuclear reaction 100 Mo(p,2n) 99m Tc that allows direct production of Tc-99m. In this study, it is conjectured that this alternative production route will not replace the current supply chain based on the distribution of 99 Mo/ 99m Tc generators, but could become a convenient emergency source of Tc-99m only for in-house hospitals equipped with a conventional, low-energy, medical cyclotron. On this ground, an outline of the essential steps that should be implemented for setting up a hospital radiopharmacy aimed at the occasional production of Tc-99m by a small cyclotron is discussed. These include (1) target production, (2) irradiation conditions, (3) separation/purification procedures, (4) terminal sterilization, (5) quality control, and (6) Mo-100 recovery. To address these issues, a comprehensive technology for cyclotron-production of Tc-99m, developed at the Legnaro National Laboratories of the Italian National Institute of Nuclear Physics (LNL-INFN), will be used as a reference example. Copyright © 2018 Elsevier Ltd. All rights reserved.

C235-V3 cyclotron for a proton therapy center to be installed in the hospital complex of radiation medicine (Dimitrovgrad)

Science.gov (United States)

Galkin, R. V.; Gurskii, S. V.; Jongen, Y.; Karamysheva, G. A.; Kazarinov, M. Yu.; Korovkin, S. A.; Kostromin, S. A.; Calderan, J.-M.; Cahay, P.; Mokrenko, S. P.; Morozov, N. A.; Nkongolo, H.; Ol'shevskii, A. G.; Paradis, Y.; Petrov, D. S.; Romanov, V. M.; Samsonov, E. V.; Syresin, E. M.; Shakun, A. N.; Shakun, N. G.; Shirkov, G. D.; Shirkov, S. G.

2014-06-01

Proton therapy is an effective method of treating oncologic diseases. In Russia, construction of several centers for proton and ion therapy is slated for the years to come. A proton therapy center in Dimitrovgrad will be the first. The Joint Institute for Nuclear Research (Russia) in collaboration with Ion Beam Application (IBA) (Belgium) has designed an C235-V3 medical proton cyclotron for this center. It outperforms previous versions of commercial IBA cyclotrons, which have already been installed in 11 oncologic hospital centers in different countries. Experimental and calculation data for the beam dynamics in the C235-V3 medical cyclotron are presented. Reasons for beam losses during acceleration are considered, the influence of the magnetic field radial component in the midplane of the accelerator and main resonances is studied, and a beam extraction system is designed. In 2011-2012 in Dubna, the cyclotron was mounted, its magnetic field was properly configured, acceleration conditions were optimized, and beam extraction tests were carried out after which it was supplied to Dimitrovgrad. In the C235-V3 cyclotron, an acceleration efficiency of 72% and an extraction efficiency of 62% have been achieved without diaphragming to form a vertical profile of the beam.

Application of superconductivity in cyclotron construction

International Nuclear Information System (INIS)

Blosser, H.G.

1982-01-01

This paper reviews major concepts and design features of the new class of cyclotrons which use superconducting coils to provide main magnet excitation. The discussion begins with a brief historical review tracing the evolution of these ''superconducting'' cyclotrons and the impact of this application of superconductivity in pushing back traditional cyclotron construction limits. This is followed by a review of the principal phenomena which come into play to set new limits on the operating regime, and the nature of these limits, some of which arise from orbit properties and some of which result from construction intricacies in the coil and in the rf system. Conclusions anticipate a future widely encompassing role in the application of superconductivity to cyclotron

Design of an Automated System for Synthesis of [18 F] FDG for PET Investigation at IFIN-HH Bucharest

International Nuclear Information System (INIS)

Craciun, Liviu Stefan; Cimpeanu, Catalina; Constantinescu, Olimpiu; Dudu, Dorin; Ionescu, Cristina; Negoita, Nicolae; Racolta, Petru Mihai; Rusen, Ion

2009-01-01

A novel apparatus constructed at IFIN-HH is described for automated synthesis of radiopharmaceuticals labeled with 18 F for use in positron emission tomography (PET) investigations. [18 F] fluoride was produced at the IFIN-HH cyclotron by irradiation of H 2 O enriched 97% in 18 O with 13 MeV deuterons, or 8 MeV protons. The irradiated H 2 O was transferred (injected) into the radiochemical fully-automated processing systems which ensured the separation of 18 F from H 2 O, the labeling with 18 F, and finally purified by filtration with selective absorbants. The system is easy to operate and contains a programmable logical controller that manages the entire operation program stored in its internal memory. The computer is used to assist the operator during the different steps of synthesis and to allow visualization of the process and printing the report. The device was used for used for the production of 2-[18 F] FLUORO-2-DEOXY-D-GLUCOSE at the IFIN-HH cyclotron, one of the most used radiopharmaceutical in PET investigations. The synthesis module is configured so that is flexible enough to accomplish other nucleophile reactions of labeling with short lived radioisotopes.

Design of an Automated System for Synthesis of [18 F] FDG for PET Investigation at IFIN-HH Bucharest

Science.gov (United States)

Craciun, Liviu Stefan; Cimpeanu, Catalina; Constantinescu, Olimpiu; Dudu, Dorin; Ionescu, Cristina; Negoita, Nicolae; Racolta, Petru Mihai; Rusen, Ion

2009-03-01

A novel apparatus constructed at IFIN-HH is described for automated synthesis of radiopharmaceuticals labeled with 18F for use in positron emission tomography (PET) investigations. [18 F] fluoride was produced at the IFIN-HH cyclotron by irradiation of H2O enriched 97% in 18O with 13 MeV deuterons, or 8 MeV protons. The irradiated H2O was transferred (injected) into the radiochemical fully-automated processing systems which ensured the separation of 18F from H2O, the labeling with 18F, and finally purified by filtration with selective absorbants. The system is easy to operate and contains a programmable logical controller that manages the entire operation program stored in its internal memory. The computer is used to assist the operator during the different steps of synthesis and to allow visualization of the process and printing the report. The device was used for used for the production of 2-[18 F] FLUORO-2-DEOXY-D-GLUCOSE at the IFIN-HH cyclotron, one of the most used radiopharmaceutical in PET investigations. The synthesis module is configured so that is flexible enough to accomplish other nucleophile reactions of labeling with short lived radioisotopes.

PET/CT Facility at Radiation Medicine Centre, BARC

International Nuclear Information System (INIS)

Baghel, Nawab Singh; Banerjee, Sharmila

2017-01-01

Positron Emission Tomography (PET) integrated with Computed Tomography in a single unit (PET/CT) has become an established and valued imaging modality in the clinical arena. Integrated PET/CT has been shown to be more accurate for lesion localisation and characterisation than either PET or CT alone. Image fusion brings together two image datasets with the intention of registering them as closely as possible. Generally, the two image datasets would have been produced on different types of medical imaging devices. Various problems can evolve when using two geographically remote imaging devices. To overcome this, in recent times there has been a move towards the integration of the two medical imaging devices into one physical unit. The use of one imaging unit to produce two different image datasets is known as hybrid imaging

Feasibility Study for a Two-Energy Compact Medical Cyclotron Controlled by Two Pairs of Main Coils

International Nuclear Information System (INIS)

Blum, D.; Breckow, J.; Zink, K.

2013-01-01

At Paul Scherrer Institute, Villigen, Switzerland, protons are accelerated for the proton therapy by a 250 MeV isochronous cyclotron. As for radiotherapy less energy is required (about 70 MeV) a carbon degrader reduces the extracted beam energy. This involves the increase of emittance, decrease of transmission, more activated components and a higher dose for the staff. By extracting a lower energy beam from the cyclotron, less degrade would be necessary and the above mentioned side-effects could be minimized. A possible solution could be to extract two energies from the cyclotron, 250 MeV for very deep located tumours and 230-235 MeV for others. A technically easy and affordable solution for this problem might be a two-energy cyclotron controlled by just two pairs of main coils. The feasibility of this solution has been analysed in this study. The compounded magnetic flux density B is the sum of the coil's and the iron's flux density. The amount caused by a coil is mainly responsible for the shape of the compounded flux density. Therefore a split of the coil pair was simulated to obtain more possibilities in the adjustment of a lower-energy beam to its ideal isochronous shape. The result is a simulated isochronous 240 MeV beam which was found with an tangential split of the coil pair, their repositioning and the increasing of current in the first coil pair and decreasing in the other one. The tangential split seemed to reduce the problem of the irons linear share of B. This feasibility study is seen as a first step before using 3D-capable software which considers a higher spatial resolution and the influence of temperature.(author)

Positron emitting pharmaceuticals

International Nuclear Information System (INIS)

Rajan, M.G.R.

2012-01-01

Positron Emission Tomography (PET) imaging of physiology at the molecular level bridges the gap between laboratory science and clinical medicine by providing the most specific and sensitive means for imaging molecular pathways and interactions in tissues of man. PET-imaging requires the use Positron Emitting Radiopharmaceuticals (PRPs), which are radioactively labeled 'true metabolites' i.e., sugars, amino acids, fatty acids etc., essentially made of H, C, N and O which the cells in the body can metabolize. The PET-isotopes: 11 C, 15 O, 13 N and 18 F (instead of H) are cyclotron produced and are short-lived, which places several constraints on the synthesis time for the PRPs, quality control and their clinical use as compared to the conventional 99m Tc- and other SPECT-RPs widely used in nuclear medicine. There are large number of published reports showing the utility of several PRPs labeled with 18 F (T 1/2 = 110 min) and 11 C (T 1/2 = 20 min). A few PRPs have been labeled with 13 N (T 1/2 = 10 min). 15 O (T 1/2 = 2min) is used mostly as H 2 15 O, C 15 or C 15 O 2 . 18 F-radiopharmaceuticals can be made at a medical cyclotron facility and sent to PET -imaging centres, which can be reached in a couple of hours. The sensitivity of PET -imaging has encouraged R and D in several other PRPs, labeled with viz., 68 Ga (generator produced, T 1/2 68 min), 124 I (cyclotron, T 1/2 4.2 d), 82 Rb (generator, T 1/2 75s), 64 Cu (cyclotron, T 1/2 12h), and 94m Tc (cyclotron, T 1/2 52 min). Due to its relevance in several diseases, particularly cancer, PET-imaging has made major scientific contribution to drug development, particularly for neurological diseases and cancer treatment. (author)

A new cyclotron for biomedical research

International Nuclear Information System (INIS)

Wolber, G.

1988-01-01

This paper presents the rationale for replacing the old AEG Compact Cyclotron (built in 1969/71) of the Institute for Radiology and Pathophysiology at the German Cancer Research Center by a 30 MeV H - /15 MeV D - cyclotron. A status report is followed by the scientific and technical reasoning as well as budgetary and organizational considerations. In the appendix we tried to explain the function of a cyclotron in a simple and comprehensive manner. (orig.) [de

Cyclotron Phase-Coherent Ion Spatial Dispersion in a Non-Quadratic Trapping Potential is Responsible for FT-ICR MS at the Cyclotron Frequency

Science.gov (United States)

Nagornov, Konstantin O.; Kozhinov, Anton N.; Tsybin, Yury O.

2018-01-01

Fourier transform ion cyclotron resonance mass spectrometry (FT-ICR MS) at the cyclotron frequency instead of the reduced cyclotron frequency has been experimentally demonstrated using narrow aperture detection electrode (NADEL) ICR cells. Here, based on the results of SIMION simulations, we provide the initial mechanistic insights into the cyclotron frequency regime generation in FT-ICR MS. The reason for cyclotron frequency regime is found to be a new type of a collective motion of ions with a certain dispersion in the initial characteristics, such as pre-excitation ion velocities, in a highly non-quadratic trapping potential as realized in NADEL ICR cells. During ion detection, ions of the same m/z move in phase for cyclotron ion motion but out of phase for magnetron (drift) ion motion destroying signals at the fundamental and high order harmonics that comprise reduced cyclotron frequency components. After an initial magnetron motion period, ion clouds distribute into a novel type of structures - ion slabs, elliptical cylinders, or star-like structures. These structures rotate at the Larmor (half-cyclotron) frequency on a plane orthogonal to the magnetic field, inducing signals at the true cyclotron frequency on each of the narrow aperture detection electrodes. To eliminate the reduced cyclotron frequency peak upon dipolar ion detection, a number of slabs or elliptical cylinders organizing a star-like configuration are formed. In a NADEL ICR cell with quadrupolar ion detection, a single slab or an elliptical cylinder is sufficient to minimize the intensity of the reduced cyclotron frequency components, particularly the second harmonic. [Figure not available: see fulltext.

Ernest Orlando Lawrence (1901-1958), Cyclotron and Medicine

Energy Technology Data Exchange (ETDEWEB)

Chu, William T.

2005-09-01

, constructed a 13-cm diameter model that had all the features of early cyclotrons, accelerating protons to 80,000 volts using less than 1,000 volts on a semi-circular accelerating electrode, now called the ''dee''. Following the discovery by J. D. Cockcroft and E. T. S. Walton of how to produce larger currents at higher voltages, Lawrence constructed the first two-dee 27-Inch (69-cm) Cyclotron, which produced protons and deuterons of 4.8 MeV. The 27-Inch Cyclotron was used extensively in early investigations of nuclear reactions involving neutrons and artificial radioactivity. In 1939, working with William Brobeck, Lawrence constructed the 60-Inch (150-cm) Cyclotron, which accelerated deuterons to 19 MeV. It was housed in the Crocker Laboratory, where scientists first made transmutations of some elements, discovered several transuranic elements, and created hundreds of radioisotopes of known elements. At the Crocker Laboratory the new medical modality called nuclear medicine was born, which used radioisotopes for diagnosis and treatment of human diseases. In 1939 Lawrence was awarded the Nobel Prize in Physics, and later element 103 was named ''Lawrencium'' in his honor.

Cyclotron method for heavy ion acceleration

International Nuclear Information System (INIS)

Gikal, B.N.; Gul'bekyan, G.G.; Kutner, V.B.; Oganesyan, R.Ts.

1984-01-01

Studies on heavy ion beams in a wide range of masses (up to uranium) and energies disclose essential potential opportunities for solution of both fundamental scientific and significant economical problems. A cyclotron method for heavy ion acceleration is considered. Development of low and medium energy heavy ion accelerators is revealed. The design of a complex comprising two isochronous cyclotrons which is planned to be constrdcted 1n the JINR is described. The cyclotron complex includes the U-400 and the U-400 M cyclotrons and it is intended for acceleration of both 35-20 MeV/nucleon superheavy ions such as Xe-U and 120 MeV/nucleon light ions. Certain systems of the accelerators are described. Prospects of the U-400 and the U-400 M development are displayed

Solid targets for production of radioisotopes with cyclotron; Blancos solidos para produccion de radioisotopos con ciclotron

Energy Technology Data Exchange (ETDEWEB)

Paredes G, L.; Balcazar G, M. [Instituto Nacional de Investigaciones Nucleares, Direccion de Investigacion Tecnologica, A.P. 18-1027, 11801 Mexico D.F. (Mexico)

1999-07-01

The design of targets for production of radioisotopes and radiopharmaceuticals of cyclotron to medical applications requires a detailed analysis of several variables such as: cyclotron operation conditions, choice of used materials as target and their physicochemical characteristics, activity calculation, the yielding of each radioisotope by irradiation, the competition of nuclear reactions in function of the projectiles energy and the collision processes amongst others. The objective of this work is to determine the equations for the calculation for yielding of solid targets at the end of the proton irradiation. (Author)

Beam Current Increase and Cathode Lifetime Improvement of KOTRON-13 Ion Source

International Nuclear Information System (INIS)

Lee, W. K.; Chae, S. K.; Song, J. Y.; Im, G. S.; Cho, B. O.

2010-01-01

Technology of cyclotron has been actively developed to meet the increasing requirement output of medical radioactive isotopes for PET. KOTRON-13 is produced with low negative hydrogen ion beam current owing to the low efficiency of proton beam current compared with foreign cyclotron. In the defect there from, the lifetime of cathode is around 5,000min, which requires frequent maintenance period, and the target beam current is maximum 50uA at a poor efficiency compared with the inflow quantity of hydrogen gas and that of inflicting arc current. Considering above affairs, we have to improve the PIG ion source extraction efficiency of KOTRON-13 in order to lift beam current. Mostly the ion source of cyclotron less than 30Mev comes from the use of PIG ion source mainly with the method of cold cathode or hot cathode. However, the cyclotron of 30Mev grade of EBCO or IBA uses the external ion source and uses ion source with cusp type of good withdrawal efficiency. This type requires high voltage, and transports ion from ion source to cyclotron, which requires precise transportation equipment. And entering cyclotron requires a high quality of inflictor with a high defect rate, but high current cyclotron has no choice but to use ion source of such a method. But the cyclotron using PET with the beam current less than 100uA uses PIG ion source of KOTRON-13 with a reasonable maintenance cost

Positron emission tomography: Physics, instrumentation, and image analysis

International Nuclear Information System (INIS)

Porenta, G.

1994-01-01

Positron emission tomography (PET) is a noninvasive diagnostic technique that permits reconstruction of cross-sectional images of the human body which depict the biodistribution of PET tracer substances. A large variety of physiological PET tracers, mostly based on isotopes of carbon, nitrogen, oxygen, and fluorine is available and allows the in vivo investigation of organ perfusion, metabolic pathways and biomolecular processes in normal and diseased states. PET cameras utilize the physical characteristics of positron decay to derive quantitative measurements of tracer concentrations, a capability that has so far been elusive for conventional SPECT (single photon emission computed tomography) imaging techniques. Due to the short half lives of most PET isotopes, an on-site cyclotron and a radiochemistry unit are necessary to provide an adequate supply of PET tracers. While operating a PET center in the past was a complex procedure restricted to few academic centers with ample resources. PET technology has rapidly advanced in recent years and has entered the commercial nuclear medicine market. To date, the availability of compact cyclotrons with remote computer control, automated synthesis units for PET radiochemistry, high-performance PET cameras, and userfriendly analysis workstations permits installation of a clinical PET center within most nuclear medicine facilities. This review provides simple descriptions of important aspects concerning physics, instrumentation, and image analysis in PET imaging which should be understood by medical personnel involved in the clinical operation of a PET imaging center. (author)

Solid targetry for compact cyclotrons

International Nuclear Information System (INIS)

Comor, J.

2004-01-01

In this presentation authors present experimental results of solid targetry for compact cyclotrons. It is concluded: Solid targetry is not restricted to large accelerator centers anymore; Small and medium scale radioisotope production is feasible with compact cyclotrons; The availability of versatile solid target systems is expected to boost the radiochemistry of 'exotic' positron emitters

Ponderomotive force near cyclotron resonance

Energy Technology Data Exchange (ETDEWEB)

Kono, Mitsuo; Sanuki, Heiji

1987-01-01

The ponderomotive force, which is involved in the excitation of macroscopic behaviors of plasma caused by wave motion, plays an important role in various non-linear wave motion phenomena. In the present study, equations for the pondermotive force for plasma in a uniform magnetic field is derived using a renormalization theory which is based on the Vlasov equation. It is shown that the pondermotive force, which diverges at the cyclotron resonence point according to adiabatic approximation, can be expressed by a non-divergent equation by taking into account the instability of the cyclotron orbit due to high-order scattering caused by a wave. This is related with chaotic particle behaviors near cyclotron resonance, where the pondermotive force is small and the diffusion process prevails. It is assumed here that the amplitude of the high-frequency electric field is not large and that the broadening of cyclotron levels is smaller than the distance between the levels. A global chaos will be created if the amplitude of the electric field becomes greater to allow the broadening to exceed the distance between the levels. (Nogami, K.).

Cyclotron transitions of bound ions

Science.gov (United States)

Bezchastnov, Victor G.; Pavlov, George G.

2017-06-01

A charged particle in a magnetic field possesses discrete energy levels associated with particle rotation around the field lines. The radiative transitions between these levels are the well-known cyclotron transitions. We show that a bound complex of particles with a nonzero net charge displays analogous transitions between the states of confined motion of the entire complex in the field. The latter bound-ion cyclotron transitions are affected by a coupling between the collective and internal motions of the complex and, as a result, differ from the transitions of a "reference" bare ion with the same mass and charge. We analyze the cyclotron transitions for complex ions by including the coupling within a rigorous quantum approach. Particular attention is paid to comparison of the transition energies and oscillator strengths to those of the bare ion. Selection rules based on integrals of collective motion are derived for the bound-ion cyclotron transitions analytically, and the perturbation and coupled-channel approaches are developed to study the transitions quantitatively. Representative examples are considered and discussed for positive and negative atomic and cluster ions.

Cyclotron for medicine and research; Zyklotron fuer Medizin und Forschung

Energy Technology Data Exchange (ETDEWEB)

Anon.

2012-11-01

35 tons, weighs the major medical device, which has been delivered in early may at the Julic campus. A heavy-duty crane hoisted the new compact cyclotron to its destination, an underground concrete bunker. There it will from summer 2013 produce radionuclides for the synthesis of radiopharmaca, by which it is possible among others to detect tumors, to pursue metabolic processes, and to investigate the mechanisms of action of drugs.

Injuries, envenomations and stings from exotic pets.

Science.gov (United States)

Warwick, Clifford; Steedman, Catrina

2012-07-01

A variety of exotic vertebrate and invertebrate species are kept as 'pets' including fishes, amphibians (for example, frogs and toads), reptiles (turtles, crocodiles, lizards and snakes), birds, mammals (for example, primates, civets, and lions), and invertebrates (for example spiders, scorpions, and centipedes), and ownership of some of these animals is rising. Data for 2009-2011 suggest that the number of homes with reptiles rose by approximately 12.5%. Recent surveys, including only some of these animals, indicated that they might be present in around 18.6% of homes (equal to approximately 42 million animals of which around 40 million are indoor or outdoor fish). Many exotic 'pets' are capable of causing injury or poisoning to their keepers and some contacts prove fatal. We examined NHS Health Episode Statistics for England using selected formal categories for hospital admissions and bed days for 2004-2010 using the following categories of injury, envenomation or sting; bitten or struck by crocodile or alligator; bitten or crushed by other reptiles: contact with venomous snakes and lizards; contact with scorpions. Between 2004 and 2010 these data conservatively show a total of 760 full consultation episodes, 709 admissions and 2,121 hospital bed days were associated with injuries probably from exotic pets. Injuries, envenomations and stings from exotic pets constitute a small but important component of emerging medical problems. Greater awareness of relevant injuries and medical sequelae from exotic pet keeping may help medics formulate their clinical assessment and advice to patients.

arXiv Cyclotrons: Magnetic Design and Beam Dynamics

CERN Document Server

Zaremba, Simon

Classical, isochronous, and synchro-cyclotrons are introduced. Transverse and longitudinal beam dynamics in these accelerators are covered. The problem of vertical focusing and iscochronism in compact isochronous cyclotrons is treated in some detail. Different methods for isochronization of the cyclotron magnetic field are discussed. The limits of the classical cyclotron are explained. Typical features of the synchro-cyclotron, such as the beam capture problem, stable phase motion, and the extraction problem are discussed. The main design goals for beam injection are explained and special problems related to a central region with an internal ion source are considered. The principle of a Penning ion gauge source is addressed. The issue of vertical focusing in the cyclotron centre is briefly discussed. Several examples of numerical simulations are given. Different methods of (axial) injection are briefly outlined. Different solutions for beam extraction are described. These include the internal target, extracti...

Project of a PET center at IEN-Rio de Janeiro

International Nuclear Information System (INIS)

Santos, G.R.; Suita, J.C.

2001-01-01

Full text: The Institute of Nuclear Engineering plans to establish a cyclotron-PET facility for production of positron emitting radionuclide for nuclear medicine. Indeed, this facility is part of a bigger project: the first PET Center in Brazil. It is envisioned that this Center would play a central role in the introduction to the region modern technologies in nuclear medicine based on PET radiopharmaceuticals. The problem to be addressed is to gather sufficient conditions to setting up the PET Center. Specifically, the IAEA's assistance would be indispensable to financing the proper equipment's for positron emitter radioisotopes' production, synthesis, labeling, and quality control. The IAEA's assistance would be also valuable in personnel training, as well as researcher's interchange and technical cooperation. With the IAEA's assistance, the PET Center project, already started, would gain a considerable impulse to its conclusion. The IAEA would be of greatly contributing to the improvement of the Brazilians' health care. This contribution takes account that the lEN's PET Center would be offering last generation exams and diagnosis, based on nuclear techniques. Therefore, the IEN is requesting the co-operation of the IAEA to set-up such a facility. The way of that requesting is strictly ordinary, and follows the logical framework structure for project elaboration. The first version of that project is now presented in its original form. From that is possible to extract a resumed table with the fundamental of logical framework, as well as consistence verification by a characteristic check list. Obviously some improvements must be done, and it will be performed before deadline. This way, by the end of 2004, the IEN hopes to be contributing in many application areas, and with Brazilian's health care system, by making available last generation techniques of diagnosis, becoming a center of reference in Latin America. (author)

Routine production of 18F using 16.5 MeV cyclotron for synthesis of 2-(18F)fluro-2-deoxy-d-glucose (FDG)

International Nuclear Information System (INIS)

Abd Jalil Abd Hamid; Soni, P.S.; Rajan, M.G.R.

2006-01-01

A medium energy cyclotron with maximum of 75 mA beam current is capable of producing most common Positron Emission Tomography (PET) radionuclides in sufficient quantities. The cyclotron has two targets for production of Flourine-18. One is high yield target system (HYT) (1.2 mL) and the other is HYT Generation II (Gen-II) (2.2 mL) and capable of producing 110 and 170 GBq respectively. Enriched 18 O water (>95%) is used for the routine production of Flourine-18 using the 18 O(p,n) 18 F nuclear reaction and irradiated under helium gas pressurized at 59-65 kPa at a beam current of 35 mA - 55 mA for 20-67 minutes. The [ 18 F]fluoride ion produced are used for the synthesis of 2-fluoro-2-deoxy-D-glucose (2-[ 18 F]FDG). Various factors that may effect the production of PET radionuclides and one such factor includes the silver target body often introduce impurity such as silver oxides in form of black particles that can impede the (ID 0.75 mm) delivery line. Such contaminants would reduce the quantity of the available useful radioisotopes, and hinder the subsequent radiopharmaceutical processes. Used of HYT and HYT Gen-II for the routine production of 18 F- in few ten GBq quantities were reported

Synchro-cyclotron

CERN Multimedia

CERN PhotoLab

1972-01-01

The electromagnetic coil which forms the first section of the proton extraction channel in the improved synchro-cyclotron. The photograph shows the positioning gear and the current septum. An extraction efficiency above 50% is expected.

Compact superconducting cyclotron C400 for hadron therapy

Energy Technology Data Exchange (ETDEWEB)

Jongen, Y.; Abs, M.; Blondin, A.; Kleeven, W.; Zaremba, S.; Vandeplassche, D. [IBA, Chemin du Cyclotron 3, B-1348 Louvain-la-Neuve (Belgium); Aleksandrov, V.; Gursky, S.; Karamyshev, O. [JINR, Joliot-Curie 6, 141980 Dubna, Moscow region (Russian Federation); Karamysheva, G., E-mail: gkaram@nu.jinr.r [JINR, Joliot-Curie 6, 141980 Dubna, Moscow region (Russian Federation); Kazarinov, N.; Kostromin, S.; Morozov, N.; Samsonov, E.; Shirkov, G.; Shevtsov, V.; Syresin, E.; Tuzikov, A. [JINR, Joliot-Curie 6, 141980 Dubna, Moscow region (Russian Federation)

2010-12-01

The compact superconducting isochronous cyclotron C400 has been designed by the IBA-JINR collaboration. It will be the first cyclotron in the world capable of delivering protons, carbon and helium ions for cancer treatment. The cyclotron construction is started this year within the framework of the Archade project (Caen, France). {sup 12}C{sup 6+} and {sup 4}He{sup 2+} ions will be accelerated to 400 MeV/uu energy and extracted by the electrostatic deflector, H{sub 2}{sup +} ions will be accelerated to the energy of 265 MeV/uu and extracted by stripping. The magnet yoke has a diameter of 6.6 m, the total weight of the magnet is about 700 t. The designed magnetic field corresponds to 4.5 T in the hills and 2.45 T in the valleys. Superconducting coils will be enclosed in a cryostat; all other parts of the cyclotron will be warm. Three external ion sources will be mounted on the switching magnet on the injection line located below the cyclotron. The main parameters of the cyclotron, its design, the current status of the development work on the cyclotron systems are presented.

Radiation dose of staff during positron emission tomography study

Energy Technology Data Exchange (ETDEWEB)

Hachiya, Takenori; Shoji, Yasuaki; Hagami, Eiichi; Aizawa, Yasuo; Onodera, Hiroshi; Kan, Mikio; Sasaki, Nobuo; Toyoshima, Eiji; Sugawara, Shigeki

1989-04-01

In this paper, the radiation dose of the PET staff including blood sampling operators (medical doctors), PET operators (radio technologists), nurses, blood analysts (medical technologists), radiochemists and cyclotron operators in the cyclotron-PET unit was evaluated. The dose was measured using the film-badges for whole body and TLD ring-badges for fingers. These data were obtained from June, 1986 to May, 1987. In the average dose per month, those with the highest dose were radiochemists. The whole body dose was 1.08 mSv (108 mrem) for /gamma/-ray, 520 /mu/Sv (52 mrem) for /beta/-ray and the dose for fingers, 7.6mSv (760 mrem). The total dose per year both for /gamma/ and /beta/-ray was 19.2 mSv (1.92 rem) for whole body and 91.2 mSv (9.12 rem) for fingers. The staff with the lowest whole body dose for /gamma/-ray per month was blood analysts whose dose was 30 /mu/Sv (3 mrem). For the staff consisting of doctors, radiotechnologists and nurses, the whole body dose per month was 70-170/mu/Sv (7-17 mrem) for /gamma/-ray, 20 /mu/Sv (2 mrem) for /beta/-ray and the dose for fingers per month was 210-540 /mu/Sv (21-54 mrem). For cyclotron operators, the dose was 90 /mu/Sv (9 mrem) for /gamma/-ray, 30 /mu/Sv (3 mrem) for /beta/-ray and the dose for fingers was 160 /mu/Sv (16 mrem). For cyclotron operators and radiochemists, the whole body dose for the neutron ray was measured by solid state nuclear track detector (SSNTD), but the dose was found to be negligible. (author).

SU-F-I-55: Performance Evaluation of Digital PET/CT: Medical Physics Basis for the Clinical Applications

Energy Technology Data Exchange (ETDEWEB)

Zhang, J; Knopp, MV [The Ohio State University, Columbus, OH (United States); Miller, M [Philips Healthcare, Highland Heights, OH (United States)

2016-06-15

Purpose: Replacement of conventional PMT-based detector with next generation digital photon counting (DPC) detector is a technology leap for PET imaging. This study evaluated the performance and characteristics of the DPC system and its stability within a 1 year time window following its installation focusing on the medical physics basis for clinical applications. Methods: A digital PET/CT scanner using 1:1 coupling of 23,040 crystal: detector elements was introduced and became operational at OSU. We tested and evaluated system performance and characteristics using NEMA NU2-2012. System stabilities in timing resolution, energy resolution, detector temperature and humidity (T&H) were monitored over 1-yr. Timing, energy and spatial resolution were characterized across clinically relevant count rate range. CQIE uniformity PET and NEMA IEC-Body PET with hot spheres varying with sizes and contrasts were performed. PET reconstructed in standard(4mm), High(2mm) and Ultra-High(1mm) definitions were evaluated. Results: NEMA results showed PET spatial resolution (mm-FWHM) from 4.01&4.14 at 1cm to 5.82&6.17 at 20cm in transverse & axial. 322±3ps timing and 11.0% energy resolution were measured. 5.7kcps/MBq system sensitivity with 24kcps/MBq effective sensitivity was obtained. The peak-NECR was ∼171kcps with the effective peak-NECR >650kcps@50kBq/mL. Scatter fraction was ∼30%, and the maximum trues was >900kcps. NEMA IQ demonstrated hot sphere contrast ranging from ∼62%±2%(10mm) to ∼88%±2%(22mm), cold sphere contrast of ∼86%±2%(28mm) and ∼89%±3%(37mm) and excellent uniformity. Monitoring 1-yr stability, it revealed ∼1% change in timing, ±0.4% change in energy resolution, and <10% variations in T&H. CQIE PET gave <3% SUV variances in axial. 60%–100% recovery coefficients across sphere sizes and contrast levels were achieved. Conclusion: Characteristics and stability of the next generation DPC PET detector system over an 1-yr time window was excellent and

SU-F-I-55: Performance Evaluation of Digital PET/CT: Medical Physics Basis for the Clinical Applications

International Nuclear Information System (INIS)

Zhang, J; Knopp, MV; Miller, M

2016-01-01

Purpose: Replacement of conventional PMT-based detector with next generation digital photon counting (DPC) detector is a technology leap for PET imaging. This study evaluated the performance and characteristics of the DPC system and its stability within a 1 year time window following its installation focusing on the medical physics basis for clinical applications. Methods: A digital PET/CT scanner using 1:1 coupling of 23,040 crystal: detector elements was introduced and became operational at OSU. We tested and evaluated system performance and characteristics using NEMA NU2-2012. System stabilities in timing resolution, energy resolution, detector temperature and humidity (T&H) were monitored over 1-yr. Timing, energy and spatial resolution were characterized across clinically relevant count rate range. CQIE uniformity PET and NEMA IEC-Body PET with hot spheres varying with sizes and contrasts were performed. PET reconstructed in standard(4mm), High(2mm) and Ultra-High(1mm) definitions were evaluated. Results: NEMA results showed PET spatial resolution (mm-FWHM) from 4.01&4.14 at 1cm to 5.82&6.17 at 20cm in transverse & axial. 322±3ps timing and 11.0% energy resolution were measured. 5.7kcps/MBq system sensitivity with 24kcps/MBq effective sensitivity was obtained. The peak-NECR was ∼171kcps with the effective peak-NECR >650kcps@50kBq/mL. Scatter fraction was ∼30%, and the maximum trues was >900kcps. NEMA IQ demonstrated hot sphere contrast ranging from ∼62%±2%(10mm) to ∼88%±2%(22mm), cold sphere contrast of ∼86%±2%(28mm) and ∼89%±3%(37mm) and excellent uniformity. Monitoring 1-yr stability, it revealed ∼1% change in timing, ±0.4% change in energy resolution, and <10% variations in T&H. CQIE PET gave <3% SUV variances in axial. 60%–100% recovery coefficients across sphere sizes and contrast levels were achieved. Conclusion: Characteristics and stability of the next generation DPC PET detector system over an 1-yr time window was excellent and

Advanced Accelerators for Medical Applications

Science.gov (United States)

Uesaka, Mitsuru; Koyama, Kazuyoshi

We review advanced accelerators for medical applications with respect to the following key technologies: (i) higher RF electron linear accelerator (hereafter “linac”); (ii) optimization of alignment for the proton linac, cyclotron and synchrotron; (iii) superconducting magnet; (iv) laser technology. Advanced accelerators for medical applications are categorized into two groups. The first group consists of compact medical linacs with high RF, cyclotrons and synchrotrons downsized by optimization of alignment and superconducting magnets. The second group comprises laser-based acceleration systems aimed of medical applications in the future. Laser plasma electron/ion accelerating systems for cancer therapy and laser dielectric accelerating systems for radiation biology are mentioned. Since the second group has important potential for a compact system, the current status of the established energy and intensity and of the required stability are given.

Cyclotron Production of Technetium-99m

Science.gov (United States)

Gagnon, Katherine M.

Technetium-99m (99mTc) has emerged as the most widely used radionuclide in medicine and is currently obtained from a 99Mo/ 99mTc generator system. At present, there are only a handful of ageing reactors worldwide capable of producing large quantities of the parent isotope, 99Mo, and owing to the ever growing shutdown periods for maintenance and repair of these ageing reactors, the reliable supply 99mTc has been compromised in recent years. With an interest in alternative strategies for producing this key medical isotope, this thesis focuses on several technical challenges related to the direct cyclotron production of 99mTc via the 100Mo(p,2n)99mTc reaction. In addition to evaluating the 100Mo(p,2n)99mTc and 100Mo(p,x)99Mo reactions, this work presented the first experimental evaluation of the 100Mo(p,2n) 99gTc excitation function in the range of 8-18 MeV. Thick target calculations suggested that large quantities of cyclotron-produced 99mTc may be possible. For example, a 6 hr irradiation at 500 μA with an energy window of 18→10 MeV is expected to yield 1.15 TBq of 99mTc. The level of coproduced 99gTc contaminant was found to be on par with the current 99Mo/99mTc generator standard eluted with a 24 hr frequency. Highly enriched 100Mo was required as the target material for 99mTc production and a process for recycling of this expensive material is presented. An 87% recovery yield is reported, including metallic target preparation, irradiation, 99mTc extraction, molybdate isolation, and finally hydrogen reduction to the metal. Further improvements are expected with additional optimization experiments. A method for forming structurally stable metallic molybdenum targets has also been developed. These targets are capable of withstanding more than a kilowatt of beam power and the reliable production and extraction of Curie quantities of 99mTc has been demonstrated. With the end-goal of using the cyclotron-produced 99mTc clinically, the quality of the cyclotron

Study to master "1"8F-FDG radiopharmaceutical production process by Korean Cyclotron KOTRONS 13 MeV at Hanoi Irradiation Center

International Nuclear Information System (INIS)

Nguyen Quang Anh; Tran Manh Thang; Dam Thi Tam; Mai Van Vinh

2016-01-01

A PET Cyclotron center is built in Hanoi Irradiation Center (HIC), VINATOM and expectation put in operation in the middle of 2016. Three main processes in "1"8F-FDG synthesis general process of Samyoung Unitech synthesizer module were studied as: effect of time to water removal process, effect of time to nucleophilic substitution reaction, and effect of temperature and time to hydrolysis process. The optimum parameters are collected and re-installed for "1"8F-FDG synthesizer module to achieve highest yield. The human resource was trained basic to advanced theoretical and practical training programs of 18F-FDG Radiopharmaceutical Production by Vietnamese and Korean senior experts in HICs facility for this project. After training courses, the human resource is able to produce and quality control "1"8F-FDG Radiopharmaceutical in different modules and quality control systems such as GE-MX (GE), Synthera (IBA), and Samyoung Unitech (SYU). "1"8F-FDG Radiopharmaceutical was produced in HIC achieves British Pharmacopeia (BP) standards and tested in animals. Animal PET/CT scanner images show clearly distribution of FDG according to physiological characters. Besides, this project were establishing "1"8F-FDG Radiopharmaceutical Production Process by cyclotron KOTRONS13 and Samyoung Unitech synthesizer module and Quality Assurance, Quality Control Process attain BP standards at Hanoi Irradiation Center; and establishing the training documents for practical production human resource training, "1"8F-FDG radiopharmaceutical Quality Assurance Process, Quality Control Process which attain BP standards. (author)

F-FDG PET/CT (PET/CT) influences management in patients with known or suspected pancreatic cancer

International Nuclear Information System (INIS)

Barber, Thomas W.; Kalff, Victor; Cherk, Martin H.; Yap, Kenneth SK.; Evans, Peter; Kelly, Michael J.

2009-01-01

Full text: Objective: To assess the impact on clinical management of PET/CT in patients with known or suspected pancreatic cancer. Methods: Between April 2006 and September 2008,25 PET/CT scans were performed using a dedicated PET/CT (22 scans) or a coincidence hybrid PET/CT camera (3 scans) in 23 patients with known or suspected pancreatic cancer. 17 scans were performed for initial evaluation and 8 for restaging of disease. The pre-PET/CT management plan and for intent were prospectively recorded in all cases. The post-PET/CT management plan was determined from the medical record and for discussions with treating clinicians. The impact of PET/CT on management was classified as High, Medium, Low or None, defined using ANZAPNM PET data collection project criteria. Follow-up was used to reconcile any discordance between PET/CT and conventional imaging. Results: Overall, PET/CT management impact was classified as high (n equal 7), medium (n equal 4), low (n equal 10) or none (n equal 4). Impact was either high or medium in l l/25 patients (44%) (95% confidence interval; 24 - 64%). Impact was high in 4/17 patients imaged for initial evaluation, predominantly by clarifying equivocal lesions on conventional imaging. In restaged patients, PET/CT impact was high in 3/8, and it correctly modified disease extent in 5/8. In the 16 discordant studies, PET/CT assessment was correct in 10, conventional imaging in 4 and there was insufficient information in 2. Conclusion: PET/CT has high or medium management impact in 44% of patients imaged for known or suspected pancreatic cancer, more commonly during restaging. Discordant PET/CT results were usually correct.

Impact on medical economics of [18F]FDG-PET application in health insurance of diagnosis of tumors unapproved in the present insurance

International Nuclear Information System (INIS)

Honda, Norinari; Ito, Kengo; Torizuka, Kanji

2008-01-01

Medical costs were estimated for the assumed case of approval of [ 18 F]fluorodeoxyglucose positron emission tomography (FDG-PET) and/or PET-CT diagnoses (D) of all tumors which are now unapproved in the national health insurance system. The number of D was predicted to be 275,785 examinations in 2008, based on results of 3 questionnaires to PET facilities in 2004-2006. The average D examination fee was found to be 78,350 Japanese yen when calculated from the proportion of examinations with the fee of 20% reduction and ratio of PET/PET-CT examinations. Frequency of surgical operation was assumed to be reduced by 27% because of precised D for the stage decision of malignant neoplasm. These assumptions resulted in the impact of 3,164,258,753 Japanese yen decrease by D approval in the insurance. Integration of precise D image reading by experts, patients' anamnesis, physical and biochemical findings, and other imaging diagnosis enables the decision of the stage of malignancy more accurate; based on which establishment of rational therapeutic planning is possible; which is important both for saving the cost of medicare and for improving its quality. (R.T.)

Status report on cyclotron operation

International Nuclear Information System (INIS)

Kovacs, P.; Szuecs, I.; Ander, I.; Lakatos, T.; Fenyvesi, A.; Ditroi, F.; Takacs, S.; Tarkanyi, F.

2004-01-01

The operation of the cyclotron in 2003 was again concentrated to 9 months; January, July and August were reserved for maintenance, renewal works and holidays. The overall working time of the accelerator was 4051 hours. The cyclotron was available for users for 3682 hours. In order to improve the circumstances of the irradiations renewal and improvements were done. (N.T.)

Slow wave cyclotron maser

International Nuclear Information System (INIS)

Kho, T.H.; Lin, A.T.

1988-01-01

Cyclotron masers such as Gyrotrons and the Autoresonance Masers, are fast wave devices: the electromagnetic wave's phase velocity v rho , is greater than the electron beam velocity, v b . To be able to convert the beam kinetic energy into radiation in these devices the beam must have an initial transverse momentum, usually obtained by propagating the beam through a transverse wiggler magnet, or along a nonuniform guide magnetic field before entry into the interaction region. Either process introduces a significant amount of thermal spread in the beam which degrades the performance of the maser. However, if the wave phase velocity v rho v b , the beam kinetic energy can be converted directly into radiation without the requirement of an initial transverse beam momentum, making a slow wave cyclotron maser a potentially simpler and more compact device. The authors present the linear and nonlinear physics of the slow wave cyclotron maser and examine its potential for practical application

PET in cancer screening: a controversial imaging

International Nuclear Information System (INIS)

Su Minggang; Tan Tianzhi

2012-01-01

Malignancy has been one of the most dangerous threats to human health. Early diagnosis and treatment are key factors for improving prognosis. Cancer screening is an important way to detect early stage cancer and precancerous lesion. PET has been used increasingly in cancer screening in accordance with the requirement of the public. Though a great number of data show that PET can find some subclinical malignancy, yet as a cancer screening modality, PET is still controversial in contemporary medical practice. The aim of this article is to review the application status and existing problem of PET in cancer screening, and to offer some recognition and view about cancer srceening. (authors)

Isotope separation by ionic cyclotron resonance

International Nuclear Information System (INIS)

Compant La Fontaine, A.; Gil, C.; Louvet, P.

1986-10-01

The principle of the process of isotopic separation by ionic cyclotron resonance is explained succinctly. The theoretical calculation of the isotopic effect is given as functions of the electric and magnetic fields in the frame of single particle approximation and of plasma collective theory. Then, the main parts of the demonstration device which is in operation at the CEA, are described here: the supraconducting magnetic field, the used diagnostics, the principle of the source and the collecting apparatus. Some experimental results are given for chromium. The application of the process to ponderal separation of metal isotopes, as chromium, nickel and molybdenum is discussed in view of production of medical, structural and irradiation isotopes

Rf structure of superconducting cyclotron for therapy application

International Nuclear Information System (INIS)

Takekoshi, Hidekuni; Matsuki, Seishi; Mashiko, Katuo; Shikazono, Naomoto.

1981-01-01

Advantages of fast neutrons in therapeutical application are now widely recognized. Fast neutrons are generated by bombarding a thick beryllium target with high energy protons and deuterons. The AVF cyclotrons which deliver 50 MeV protons and 25 MeV deuterons are commonly used and are commercially available now. At the treatment usually rotational irradiation is taken to prevent an injury to normal tissue from the high LET effect of fast neutrons. The construction cost of both cyclotrons and isocentric irradiation installation are relatively high, so that the spread of neutron therapy is obstructed. A superconducting cyclotron for neutron therapy application was proposed by a Chalk River group. This low cost design allows the installation to be a dedicated facility located in a hospital, and small size allows installations of the complete cyclotron in a rotatable gantry. The design studies of the superconducting cyclotron based on this idea are going on at Kyoto University. The full scale model experiments for a rf structure of the cyclotron were carried out. (author)

PET-CT in oncological patients: analysis of informal care costs in cost-benefit assessment.

Science.gov (United States)

Orlacchio, Antonio; Ciarrapico, Anna Micaela; Schillaci, Orazio; Chegai, Fabrizio; Tosti, Daniela; D'Alba, Fabrizio; Guazzaroni, Manlio; Simonetti, Giovanni

2014-04-01

The authors analysed the impact of nonmedical costs (travel, loss of productivity) in an economic analysis of PET-CT (positron-emission tomography-computed tomography) performed with standard contrast-enhanced CT protocols (CECT). From October to November 2009, a total of 100 patients referred to our institute were administered a questionnaire to evaluate the nonmedical costs of PET-CT. In addition, the medical costs (equipment maintenance and depreciation, consumables and staff) related to PET-CT performed with CECT and PET-CT with low-dose nonenhanced CT and separate CECT were also estimated. The medical costs were 919.3 euro for PET-CT with separate CECT, and 801.3 euro for PET-CT with CECT. Therefore, savings of approximately 13% are possible. Moreover, savings in nonmedical costs can be achieved by reducing the number of hospital visits required by patients undergoing diagnostic imaging. Nonmedical costs heavily affect patients' finances as well as having an indirect impact on national health expenditure. Our results show that PET-CT performed with standard dose CECT in a single session provides benefits in terms of both medical and nonmedical costs.

Commissioning of cryogen delivery system for superconducting cyclotron magnet

International Nuclear Information System (INIS)

Pal, G.; Nandi, C.; Bhattacharyya, T.K.; Chaudhuri, J.; Bhandari, R.K.

2005-01-01

A K-500 superconducting cyclotron is being constructed at VECC Kolkata. The cryogen delivery system distributes liquid helium and liquid nitrogen to the superconducting cyclotron. Liquid helium is required to cool the cyclotron magnet and cryopanels. Liquid nitrogen is used to reduce the capacity of the helium liquefier. This paper describes the system, the current status and the commissioning experiences of cryogen delivery system for cyclotron magnet. (author)

Progress report: Variable Energy Cyclotron Centre, Calcutta

International Nuclear Information System (INIS)

1999-01-01

This volume of the progress report brings out the scientific and technical activities of Variable Energy Cyclotron Centre, Calcutta during the year 1999. This includes brief review of the various R and D activities of the Centre and outside users of the cyclotron from the universities and other research institutes. The operational activities of the cyclotron with ECR ion sources, accelerator oriented research activities, activities on detector, target and electronics are reported. The activities of the Computer and Informatics group are described. The status report of the ongoing projects is also provided. The main activities of the superconducting cyclotron project, radioactive ion beam project, heavy ion experimental facility, advanced computational facility, recovery and analysis of helium from hot springs and material science research are described

10 GHz ECRIS for Warsaw Cyclotron

CERN Document Server

Sudlitz, K

1999-01-01

Cusp type, 10 GHz ECRIS has been built and tested earlier. For obtaining intensive beams, more relevant for cyclotron, cusp geometry has been replaced by hexapole. Discharge chamber (stainless steel, 50 mm diameter, 250 mm long) is an extension of a coaxial line, feeding RF (9,6 GHz, up to 200 W) to the plasma. The NdFeB hexapole (0,52 T on the surface) has been used. The axial magnetic field is created by water cooled coils. The axial injection line dedicated to K160 isochronous heavy ion cyclotron has been constructed. The line consists of Glaser lenses, double focusing magnet, solenoid and mirror type inflector. The system provides sufficient transmission of the beam from ECR ion source to the firsts orbits of the cyclotron for m/q ranging from 7 to 2. After successful initial tests which were done in July 1997 the ECRIS serves as an external source for Warsaw Cyclotron.

Mapping of the flux and estimate of the radiation source term of neutron fields generated by the GE PETtrace-8 cyclotron

International Nuclear Information System (INIS)

Benavente Castillo, Jhonny Antonio

2017-01-01

closest to the experimental results. This radiation source term can be used for the study in the development of new dosimeters, improved shielding and in the support of future decommissioning studies, concerning PET cyclotrons producing 18 F by 18 O(p,n) 18 F nuclear reactions, for the case of proton beams with energies up to 16.5 MeV. (author)

Electron cyclotron harmonic wave acceleration

Science.gov (United States)

Karimabadi, H.; Menyuk, C. R.; Sprangle, P.; Vlahos, L.

1987-01-01

A nonlinear analysis of particle acceleration in a finite bandwidth, obliquely propagating electromagnetic cyclotron wave is presented. It has been suggested by Sprangle and Vlahos in 1983 that the narrow bandwidth cyclotron radiation emitted by the unstable electron distribution inside a flaring solar loop can accelerate electrons outside the loop by the interaction of a monochromatic wave propagating along the ambient magnetic field with the ambient electrons. It is shown here that electrons gyrating and streaming along a uniform, static magnetic field can be accelerated by interacting with the fundamental or second harmonic of a monochromatic, obliquely propagating cyclotron wave. It is also shown that the acceleration is virtually unchanged when a wave with finite bandwidth is considered. This acceleration mechanism can explain the observed high-energy electrons in type III bursts.

Electron cyclotron harmonic wave acceleration

International Nuclear Information System (INIS)

Karimabadi, H.; Menyuk, C.R.; Sprangle, P.; Vlahos, L.; Salonika Univ., Greece)

1987-01-01

A nonlinear analysis of particle acceleration in a finite bandwidth, obliquely propagating electromagnetic cyclotron wave is presented. It has been suggested by Sprangle and Vlahos in 1983 that the narrow bandwidth cyclotron radiation emitted by the unstable electron distribution inside a flaring solar loop can accelerate electrons outside the loop by the interaction of a monochromatic wave propagating along the ambient magnetic field with the ambient electrons. It is shown here that electrons gyrating and streaming along a uniform, static magnetic field can be accelerated by interacting with the fundamental or second harmonic of a monochromatic, obliquely propagating cyclotron wave. It is also shown that the acceleration is virtually unchanged when a wave with finite bandwidth is considered. This acceleration mechanism can explain the observed high-energy electrons in type III bursts. 31 references

83-inch cyclotron research program. Final report

International Nuclear Information System (INIS)

Parkinson, W.C.

1983-07-01

In June of 1960 the US Atomic Energy Commission authorized the construction of a modern variable energy cyclotron facility at The University of Michigan to be used for research in nuclear spectroscopy. The Legislature of the State of Michigan made available funds for construction of a building to house the 83-inch cyclotron and auxiliary equipment as well as the University's remodeled 42-inch cyclotron. The research program centered around the 83-inch cyclotron was funded by the AEC and its successors, the Energy Research and Development Administration (ERDA) and the Department of Energy (DOE), from September 1964 through March 1977. The program represented a continuation of the research effort using the 42-inch cyclotron facility which had been supported continuously by the AEC since February 1950. This final report to DOE briefly describes the research facility, the research program, and highlights the principal accomplishments of the effort. It begins with a historical note to place this effort within the context of nuclear physics research in the Department of Physics of the University of Michigan

Recycling and recommissioning a used biomedical cyclotron

International Nuclear Information System (INIS)

Carroll, L.R.; Ramsey, F.; Armbruster, J.; Montenero, M.

2001-01-01

Biomedical Cyclotrons have a very long life, but there eventually comes a time when any piece of equipment has to be retired from service. From time to time, we have the opportunity to help find new homes for used cyclotrons which, with relatively modest overhaul and refurbishment, can have many additional years of productive service, and thus represent a very valuable asset. The reasons for retiring a cyclotron vary, of course, but in our experience it is often due to an institution's changing priorities or changing needs, rather than the due to any fundamental age-related deficiency in the cyclotron itself. In this paper we will report on the relocation and successful restoration of a used TCC CP-42 cyclotron, which was moved from M.D. Anderson Hospital in Houston to Denton, Texas in early 1998, where it is presently being used for R and D and commercial production of biomedical isotopes. Ownership of the machine has been transferred to the University of North Texas; facility, manpower, and operational resources are provided by International Isotopes, Inc

PET studies in epilepsy

Science.gov (United States)

Sarikaya, Ismet

2015-01-01

Various PET studies, such as measurements of glucose, serotonin and oxygen metabolism, cerebral blood flow and receptor bindings are availabe for epilepsy. 18Fluoro-2-deoxyglucose (18F-FDG) PET imaging of brain glucose metabolism is a well established and widely available technique. Studies have demonstrated that the sensitivity of interictal FDG-PET is higher than interictal SPECT and similar to ictal SPECT for the lateralization and localization of epileptogenic foci in presurgical patients refractory to medical treatments who have noncontributory EEG and MRI. In addition to localizing epileptogenic focus, FDG-PET provide additional important information on the functional status of the rest of the brain. The main limitation of interictal FDG-PET is that it cannot precisely define the surgical margin as the area of hypometabolism usually extends beyond the epileptogenic zone. Various neurotransmitters (GABA, glutamate, opiates, serotonin, dopamine, acethylcholine, and adenosine) and receptor subtypes are involved in epilepsy. PET receptor imaging studies performed in limited centers help to understand the role of neurotransmitters in epileptogenesis, identify epileptic foci and investigate new treatment approaches. PET receptor imaging studies have demonstrated reduced 11C-flumazenil (GABAA-cBDZ) and 18F-MPPF (5-HT1A serotonin) and increased 11C-cerfentanil (mu opiate) and 11C-MeNTI (delta opiate) bindings in the area of seizure. 11C-flumazenil has been reported to be more sensitive than FDG-PET for identifying epileptic foci. The area of abnormality on GABAAcBDZ and opiate receptor images is usually smaller and more circumscribed than the area of hypometabolism on FDG images. Studies have demonstrated that 11C-alpha-methyl-L-tryptophan PET (to study synthesis of serotonin) can detect the epileptic focus within malformations of cortical development and helps in differentiating epileptogenic from non-epileptogenic tubers in patients with tuberous sclerosis complex

Report of the consultants' meeting on target and processing technologies for cyclotron production of radionuclides

International Nuclear Information System (INIS)

1999-11-01

is not widely available. New target technology could make this radionuclide available from even low energy cyclotrons. The same technology can be applied to the production of I-124, which is a PET radionuclide, which also has potential as a therapeutic agent. Pd-103 has become an extremely important radionuclide for the treatment of prostate cancer when incorporated into sealed sources. The target preparation technology requires further research including the chemical processing of the target materials. The entire above target systems use either enriched or very expensive target materials thus the importance of target recover procedures is recognised. This technology has direct application in other target systems

New perspective in high tech radiotherapy planning using PET/CT images (Radiation oncologist's view on PET/CT usage)

International Nuclear Information System (INIS)

Hadjieva, T.; Bildirev, N.; Koleva, I.; Zahariev, Z.; Vasileva, V.; Encheva, E.; Sultanov, B.

2010-01-01

Biological images provided by 18F-FDG PET in combination with structural X ray picture currently offer the most accurate available information on tumour staging, curative antitumour effect for prognosis, impairment of organ function after treatment, as well as primary tumour detection in unknown primary metastatic disease. The authors as radiation oncologists critically have analyzed numerous clinical trials and two guidelines to prove PET/ CT benefit in radiotherapy practice. At present they found lack of scientific evidence to confirm that patient outcomes are superior as a result of the use of PET in RT planning. PET/CT offers a best image for tumour delineation only in some cases of lung cancer, mediastinal lymph nodes and malignant lymphomas. 11C methionin PET adds additional information on postoperative MRI image for brain tumours. Inflammation as postradiation phenomenon, as well as physiological organ movements leads to false-positive PET signal. High tech radiotherapy methods require delineation on precise images given after multidisciplinary team expertise - a practice that is possible only in clinical trials, These unsolved problems have raised many ethical challenges in medical, scientific and social aspect, if wide and routine use of FDG-PET u PET/CT is advocated. (authors)

DosedPet application for Nuclear Medicine: Calculation of the volume of medication needed for PET/CT patient

International Nuclear Information System (INIS)

Nascimento, Pedro Augusto do; Rodrigues, Araken dos S. Werneck

2016-01-01

This paper presents the application (APP) DosePet that calculates the amount of medicament for PET / CT in patients according to the predetermined radiation dose. The software has been designed using the web MIT App Inventor2 tool for Android platform. The application allows the workers to simulate the amount of radiation still existing in the facilities after the applications, increasing security and reducing exposures, and enable greater efficiency in the use of the radiopharmaceutical. (author)

Method and apparatuses for ion cyclotron spectrometry

Science.gov (United States)

Dahl, David A [Idaho Falls, ID; Scott, Jill R [Idaho Falls, ID; McJunkin, Timothy R [Idaho Falls, ID

2012-03-06

An ion cyclotron spectrometer may include a vacuum chamber that extends at least along a z-axis and means for producing a magnetic field within the vacuum chamber so that a magnetic field vector is generally parallel to the z-axis. The ion cyclotron spectrometer may also include means for producing a trapping electric field within the vacuum chamber. The trapping electric field may comprise a field potential that, when taken in cross-section along the z-axis, includes at least one section that is concave down and at least one section that is concave up so that ions traversing the field potential experience a net magnetron effect on a cyclotron frequency of the ions that is substantially equal to zero. Other apparatuses and a method for performing ion cyclotron spectrometry are also disclosed herein.

Cyclotron radiation by a multi-group method

International Nuclear Information System (INIS)

Chu, T.C.

1980-01-01

A multi-energy group technique is developed to study conditions under which cyclotron radiation emission can shift a Maxwellian electron distribution into a non-Maxwellian; and if the electron distribution is non-Maxwellian, to study the rate of cyclotron radiation emission as compared to that emitted by a Maxwellian having the same mean electron density and energy. The assumptions in this study are: the electrons should be in an isotropic medium and the magnetic field should be uniform. The multi-group technique is coupled into a multi-group Fokker-Planck computer code to study electron behavior under the influence of cyclotron radiation emission in a self-consistent fashion. Several non-Maxwellian distributions were simulated to compare their cyclotron emissions with the corresponding energy and number density equivalent Maxwellian distribtions

Low energy cyclotron for radiocarbon dating

International Nuclear Information System (INIS)

Welch, J.J.

1984-12-01

The measurement of naturally occurring radioisotopes whose half lives are less than a few hundred million years but more than a few years provides information about the temporal behavior of geologic and climatic processes, the temporal history of meteoritic bodies as well as the production mechanisms of these radioisotopes. A new extremely sensitive technique for measuring these radioisotopes at tandem Van de Graaff and cyclotron facilities has been very successful though the high cost and limited availability have been discouraging. We have built and tested a low energy cyclotron for radiocarbon dating similar in size to a conventional mass spectrometer. These tests clearly show that with the addition of a conventional ion source, the low energy cyclotron can perform the extremely high sensitivity 14 C measurements that are now done at accelerator facilities. We found that no significant background is present when the cyclotron is tuned to accelerate 14 C negative ions and the transmission efficiency is adequate to perform radiocarbon dating on milligram samples of carbon. The internal ion source used did not produce sufficient current to detect 14 C directly at modern concentrations. We show how a conventional carbon negative ion source, located outside the cyclotron magnet, would produce sufficient beam and provide for quick sampling to make radiocarbon dating milligram samples with a modest laboratory instrument feasible

18F-DOPA PET and enhanced CT imaging for congenital hyperinsulinism: initial UK experience from a technologist's perspective.

Science.gov (United States)

Meintjes, Marguerite; Endozo, Raymond; Dickson, John; Erlandsson, Kjel; Hussain, Khalid; Townsend, Caroline; Menezes, Leon; Bomanji, Jamshed

2013-06-01

Congenital hyperinsulinism (CHI) is the most common cause of persistent hypoglycaemia in infants and children. Histologically, there are two subgroups, diffuse and focal. The aim of this study was to evaluate the accuracy of (18)F-fluoro-L-dihydroxyphenylalanine ((18)F-DOPA) PET/computed tomography (CT) and contrast-enhanced CT in distinguishing between focal and diffuse lesions in infants with CHI who are unresponsive to medical therapy. In addition, this paper describes the detailed protocol used for imaging and analysis of (18)F-DOPA PET/CT images in our clinical practice. Twenty-two (18)F-DOPA PET/CT and contrast-enhanced CT imaging studies were carried out on 18 consecutive patients (nine boys and nine girls) with CHI (median age, 2 years and 1 month; range, 1-84 months) who had positive dominant ABCC8 mutation genetic results or negative ABCC8/t results but did not respond to first-line medical therapy with high-dose diazoxide. (18)F-DOPA was produced by the cyclotron unit of Woolfson Molecular Imaging Centre, Manchester, and transported to our centre in central London after synthesis and implementation of quality control measures. (18)F-DOPA was administered intravenously at a dose of 4 MBq/kg, and iodine contrast medium was injected intravenously at a dose of 1.5 ml/kg. Single bed position PET/CT images of the pancreas were acquired under light sedation with oral chloral hydrate. Four PET dynamic data acquisition scans were taken 20, 40, 50 and 60 min after injection for a duration of 10 min each. The results were assessed by visual interpretation and quantitative measurements of standardized uptake values (SUVs) in the head, body, and tail of the pancreas. Of the 18 patients, 13 showed diffuse and five showed focal (18)F-DOPA PET pancreatic uptake. Three regions of interest were drawn over the head, body and tail of the pancreas to calculate the SUV(max). Using the formula - highest SUV(max)/next highest SUV(max) - a ratio was calculated. Five patients had

Operation of the Karlsruhe Isochronous Cyclotron in 1975

International Nuclear Information System (INIS)

Schulz, F.; Schweickert, H.

1976-06-01

The operation of the Karlsruhe Isochronous Cyclotron in 1975 is briefly surveyed. The main reasons for a very short period for maintenance, repair and installation, and several additional efforts to improve the reliability of the accelerator installation, are discussed. The status and the results of several technical developments for the cyclotron are described: 1) the axial injection system; 2) computer aided cyclotron operation; 3) ion source development; 4) capacitive current measurement at the external beam; 5) new correction coils for the cyclotron; 6) improvement of the neutron time-of-flight spectrometer. As there is an increasing interest in using this type of accelerator for research in fields other than nuclear physics, it was felt appropriate to present short surveys on investigations at our cyclotron in 1975 in the fields of: 1) solid state physics; 2) engineering; 3) materials research; 4) nuclear medicine; 5) nuclear chemistry. (orig.) [de

Present and future superconducting cyclotrons

International Nuclear Information System (INIS)

Nolen, J.A. Jr.

1987-01-01

This paper begins with a brief review of the status of present superconducting (SC) cyclotron projects, including the two which are currently operating and the six which are under construction. The next section summarizes the main features shared by five of these machines, while the third section presents recent developments and new concepts introduced in the other three ''second generation'' SC cyclotrons. Projects in early stages of development are discussed in the fourth section

NIRS-Chiba isochronous cyclotron 1975

International Nuclear Information System (INIS)

Ogawa, H.; Kumamoto, Y.; Yamada, T.; Hiramoto, T.

1976-02-01

The cyclotron facility installed according to the recommendation of the Atomic Energy Committee of Japan is used for neutron therapy and production of short-lived radioisotopes. Construction on the facility was started in the autumn of 1972, and completed in March 1974. Described are the following: beam transport and the experimental hall, machine research and improvement, machine time sharing and the particles and energies, characteristics of the cyclotron, and facility personnel. (auth.)

Knowledge based operation assist system for JAERI AVF cyclotron

International Nuclear Information System (INIS)

Agematsu, T.; Okumura, S.; Yokota, W.; Arakawa, K.; Murakami, T.; Okamura, T.

1992-01-01

We have developed two operation assist systems for easy and rapid operation of the JAERI AVF cyclotron. One is a knowledge based expert system guiding the sequence of parameter adjustment to inexperienced cyclotron operators. The other is a real-time simulation of the beam trajectories which are calculated from actual operating parameters. It graphically indicates feasible setting range of parameters that satisfies the acceptance of the cyclotron. These systems provide a human interface to adjust the parameters of the cyclotron. (author)

Radiation protection in newer medical imaging techniques: PET/CT

International Nuclear Information System (INIS)

2008-01-01

A major part of patient exposure now arises from practices that barely existed two decades ago, and the technological basis for their successful dissemination only began to flourish in the last decade or so. Hybrid imaging systems, such as the combination of computed tomography (CT) and positron emission tomography (PET), are an example of a technique that has only been introduced in the last decade. PET/CT has established a valuable place for itself in medical research and diagnosis. However, it is an application that can result in high patient and staff doses. For practitioners and regulators, it is evident that innovation has been driven both by the imaging industry and by an increasing array of new applications generated and validated in the clinical environment. Regulation, industrial standardization, safety procedures and advice on best practices lag (inevitably) behind the industrial and clinical innovations. This series of Safety Reports (Nos 58, 60 and 61) is designed to help fill the growing vacuum, by bringing up to date and timely advice from experienced practitioners to bear on the problems involved. The advice in this report has been developed within the IAEA's statutory responsibility to establish standards for the protection of people against exposure to ionizing radiation and to provide for the worldwide application of these standards. The Fundamental Safety Principles and the International Basic Safety Standards for Protection against Ionizing Radiation and for the Safety of Radiation Sources (BSS) were issued by the IAEA and co-sponsored by organizations including the Food and Agriculture Organization of the United Nations (FAO), the International Labour Organisation (ILO), the OECD Nuclear Energy Agency (OECD/NEA), the Pan American Health Organization (PAHO) and the World Health Organization (WHO), and require the radiation protection of patients undergoing medical exposures through justification of the procedures involved and through

Possibilities of FDG-PET in diagnosis of urological tumors

International Nuclear Information System (INIS)

Kawamoto, Ken; Nakagawa, Masayuki

2004-01-01

The aim of this study was to determine the value of 18 F-fluorodeoxyglucose positron emission tomography (FDG-PET) in evaluating patients with urological tumors. FDG-PET scans were taken in 116 patients with urological diseases. The number of patients with prostatic disease, renal disease and adrenal disease was 86 (74.1%), 10 and 10, respectively. Seven patients with bladder tumors who had previously undergone either cystectomy or transurethral resection of bladder cancer (TUR-Bt) received FDG-PET scan for medical check-up. Three patients with testicular disease were also included in this series. In patients with prostatic disease, 41 patients were already diagnosed as having prostate cancer and FDG-PET was performed for medical check-up. Forty-five patients were suspected of having prostate cancer because of the FDG accumulation and/or a rise in serum prostatic specific antigen (PSA). Of these patients, 9 were diagnosed as having prostate cancer by biopsy. Serum PSA levels were elevated in all 9 patients, however FDG-PET findings were false-negative in 4 of the 9 patients. In patients with renal disease, 2 of the 4 patients suspected of having renal cell carcinoma actually had benign diseases. In one patient with a renal mass, FDG-PET was false-negative. All 6 patients with metastatic adrenal tumors showed positive findings in FDG-PET, and the patients with nonhypersecreting adrenal masses showed negative findings in FDG-PET. In three patients with seminoma, viable metastatic foci were successfully detected by FDG-PET after chemotherapy. In the present study, FDG-PET was not superior to tumor markers, such as serum PSA and conventional imaging modalities for the detection of prostate cancer and renal cell carcinoma. However, in patients with nonhypersecreting adrenal masses or a metastatic adrenal tumor, FDG-PET may provide significant functional information for tissue characterization. Moreover FDG-PET can be useful for the detection of residual viable carcinoma

Isochronous cyclotron for thermonuclear reactors driving

International Nuclear Information System (INIS)

Alenitskij, Yu.G.

1998-01-01

The main requirements to an accelerator as a part of an electronuclear power plant are considered. The range of the parameters of the accelerated proton and deuteron beams, for which the isochronous cyclotron is the most profitable, is proposed. An opportunity of using the cyclotron to drive the research reactors of various types is considered

Cyclotron to Oslo University

International Nuclear Information System (INIS)

Sandstad, J.

1978-01-01

The new cyclotron was delivered to Oslo University on September 21st 1978, and was mannfactured by A/B Scandtronix of Uppsala, Sweden. The contract price was 6,8 million Norwegian kroner and installation will cost a further 4 million. The main specifications are given. The energy will be 36 MeV for protons and alpha particles, 18 MeV deuterons and 48 MeV for helium 3. The principle of a cyclotron is briefly described. While the primary purpose of the machine is nuclear research it is also planned to produce short-lived radioisotopes, primarily iodine 123. (JIW)

Cyclotron for industrial production of radioisotopes: relevants characteristics

International Nuclear Information System (INIS)

Lima, Wanderley de

1997-01-01

The industrial production of radioisotopes requests cyclotrons with easy maintenance services, high productivity and low operation costs. To obtain this performance the experts on the have achieved excellent results, taking advantage of modern resources in calculation and modeling. Only by the maximum exploitation of the azimutal variation of the magnetic field, a physical concept introduced in 1967 with the isocronous cyclotrons, it was possible to construct cyclotrons with only 30% of the electrical consumption required by the former cyclotrons. On the other hand, the acceleration of negative ions enable the 100% accelerated beam utilization, without internal energy dissipation, obtaining beam intensities up to 1mA in continuous running which represents an increased factor of 15. Other construction parameters were optimized aiming at reliability and reduction in the components activation. Concerning energy consumption and the beam intensity supplied, a present cyclotron with 30 MeV and 300μA of protons current is 15 times more efficient than its precedent. (author). 6 refs., 1 fig., 2 tabs

Present situation of 'baby cyclotron'

International Nuclear Information System (INIS)

Yamada, Teruo

1981-01-01

A ''baby cyclotron'' has been developed by the Japan Steel Works, Ltd. Its No. 1 model (proton 9.4 MeV) was delivered to the Nakano Hospital of National Sanatorium in March, 1979. It is being used successfully for the production of 11 C, 13 N and 15 O and labeled compounds. The proton or deuteron particles accelerated in the cyclotron collide on target materials. The target box, which is automatically changeable, is directly installed to the accelerating box, thereby taking the safety measures for any leaking radiation. The following matters are described: the production of short-lived radioisotopes (RI yields and treatment); the processes of production in the Nakano Hospital, with No. 1 baby cyclotron, including the photosynthesis of labeled compounds such as 11 C-labeled glucose; the research on the automation in the synthesis of organic labeled compounds like 11 C-palmitic acid. (J.P.N.)

Cryogenic system for VECC K500 superconducting cyclotron

CERN Document Server

Pal, G; Bhattacharyya, T K; Bhandari, R K

2009-01-01

VEC Centre, Kolkata in India is at an advanced stage of commissioning a K500 superconducting cyclotron. The superconducting coil of the magnet for cyclotron is cooled by liquid helium. Three liquid helium cooled cryopanels, placed inside the Dees of the radiofrequency system, maintain the vacuum in the acceleration region of the superconducting cyclotron. The cryogenic system for magnet for cyclotron has been tested by cooling the coil and energizing the magnet. The cryogenic system for cryopanels has also been tested. Heater and temperature sensor were placed on the liquid helium cold head for cryopanel. The temperature of the cold head was observed to be below 20 K upto a heat load of 11.7 watt.

Special radiation protection aspects of medical accelerators

CERN Document Server

Silari, Marco

2001-01-01

Radiation protection aspects relevant to medical accelerators are discussed. An overview is first given of general safety requirements. Next. shielding and labyrinth design are discussed in some detail for the various types of accelerators, devoting more attention to hadron machines as they are far less conventional than electron linear accelerators. Some specific aspects related to patient protection are also addressed. Finally, induced radioactivity in accelerator components and shielding walls is briefly discussed. Three classes of machines are considered: (1) medical electron linacs for 'conventional' radiation therapy. (2) low energy cyclotrons for production of radionuclides mainly for medical diagnostics and (3) medium energy cyclotrons and synchrotrons for advanced radiation therapy with protons or light ion beams (hadron therapy). (51 refs).

Variable-Energy Cyclotron for Proton Therapy Application

CERN Document Server

Alenitsky, Yu G; Vorozhtsov, A S; Glazov, A A; Mytsyn, G V; Molokanov, A G; Onishchenko, L M

2004-01-01

The requirements to characteristics of the beams used for proton therapy are considered. The operation and proposed cyclotrons for proton therapy are briefly described. The technical decisions of creation of the cyclotron with energy variation in the range 70-230 MeV and with current up to 100 nA are estimated. Taking into account the fact, that the size and cost of the cyclotron are approximately determined by the maximum proton energy, it is realistically offered to limit the maximum proton energy to 190 MeV and to elaborate a cyclotron project with a warm winding of the magnet for acceleration of H^{-} ions. The energy of the extracted protons for each run is determined by a stripped target radius in the vacuum chamber of the accelerator, and the radiation dose field for the patient is created by the external devices using the developed techniques.

Guidelines on preparation of documentation required in PET radiopharmaceutical manufacturing

International Nuclear Information System (INIS)

2001-01-01

This article made by the Nuclear Pharmacy Working Group, subcommittee on Medical Application of Cyclotron-Produced Radionuclides, Medical Science and Pharmaceutical Committee, Japan Radioisotope Association, described the actual examples of Standards, Standard Operating Procedure, Documents and so on for the purpose of operation along the Standards of Compounds Labeled with Positron Nuclides Approved as Established Techniques for Medical Use (2001 Revision). Examples were the organization for manufacturing and management, standard format of the product (for [ 18 F]2-deoxy-2-fluoro-D-glucose), standard for process control of manufacture, standard for control of manufacturing and hygiene, standard for quality, and standard operating procedures for entering and leaving the manufacturing facility, for the clean-bench and for the test of floating micro-particles. The second item involved the definition of the cyclotron target ( 18 O), generation of 18 F by the reaction (p, n), purification of the product, and prescription: the third item; storage of the product and manufacturing process control: and the fourth; education and training of personnel, and health management. (K.H.)

PET-CT findings in patients with polymyalgia rheumatica without symptoms of cranial ischaemia

DEFF Research Database (Denmark)

Lund-Petersen, Alexander; Voss, Anne; Laustrup, Helle

2017-01-01

Introduction: Polymyalgia rheumatica (PMR) is an inflammatory disorder that affects the lderly. At present, evidence is limited regarding the usefulness of positron emission tomography-computed tomography (PET-CT) in the diagnosis of PMR. This study aimed to compare patient characteristics...... and symptoms with PET-CT findings in a Danish population of PMR patients without clinical symptoms of giant cell arteritis. Methods: The medical records of 50 Danish PET-CT-scanned patients with PMR were reviewed. Symptoms, characteristics and PET-CT findings were registered from the medical records. Results...... of the following three locations: the shoulder, the hip and the spinous processes. Vascular FDG uptake was seen in 7% of the patients. No significant correlations between any symptoms and any PET-CT findings were found. C-reactive protein was significantly lower in patients receiving glucocorticoids...

Ramifide resonators for cyclotrons

International Nuclear Information System (INIS)

Smirnov, Yu.V.

2000-01-01

The resonators with the conductors ramified form for cyclotrons are systematized and separated into the self-contained class - the ramified resonators for cyclotrons (Carr). The ramified resonators are compared with the quarter-wave and half-wave nonramified resonators, accomplished from the transmitting lines fragments. The CRR are classified into two types: ones with the additional structural element, switched in parallel and in series. The CRR may include several additional structural elements. The CRR calculations may be concluded by analytical methods - the method of matrix calculation or the method of telegraph equations and numerical methods - by means of the ISFEL3D, MAFIA and other programs [ru

Status Report on Cyclotron Operation

International Nuclear Information System (INIS)

Kovacs, P.; Szuecs, I.; Ander, I.; Lakatos, T.; Tarkanyi, F.

2004-01-01

Complete text of publication follows. The operation of the cyclotron in 2004 was concentrated to the usual 9 months; January, July and August were reserved for maintenance and holidays. The overall working time of the accelerator was 3554 hours, the time used for systematic maintenance was 450 hours. The breakdown periods amounted to 70 hours last year, included in it a 50 hours repair of RF control module under guarantee. The cyclotron was available for users during 3034 hours. The effectively used beam-on-target time statistics is summarized in Table 1. Developments: A new measuring site with a HPGe detector based gamma spectrometer is under installation in the basement of the Cyclotron Laboratory. A two channel pneumatic rabbit system is also under development to enable fast transport of samples between the new measuring site and two irradiation sites (the low intensity fast neutron irradiation site and the beam line used for Thin Layer Activation). (author)

A survey of attitudes toward responsible pet ownership.

Science.gov (United States)

Selby, L A; Rhoades, J D; Hewett, J E; Irvin, J A

1979-01-01

The concerns of medical and community officials about responsible pet ownership have increased. Before a practical solution can be found for irresponsible ownership and community health problems associated with pet populations, the public's attitudes on issues related to responsible pet ownership must be determined. Such issues include attitudes on dog and cat overpopulation, potential public health problems associated with pet populations, and methods of controlling pet populations and stray animals. Responses to a questionnaire were used to evaluate the attitudes of 910 pet owners and nonowners toward factors comprising responsible pet ownership. The median age of the respondents was 33 years; 414 (45 percent) were men, and 496 (55 percent) were women. At the time of the study, 18 percent owned a cat and a dog, 35 percent owned only a dog, 11 percent showed only a cat, and 36 percent were nonowners. Not only the sex of the respondent but also the category of pet ownership affected opinions on overpopulation of dogs and cats, nuisance and pollution problems associated with these animals, and methods of controlling pet populations in the community. For example, owners agreed strongly on family planning for pets, but a majority of male owners stated that they would not have their dogs neutered. PMID:572978

Cyclotron-based neutron source for BNCT

Energy Technology Data Exchange (ETDEWEB)

Mitsumoto, T.; Yajima, S.; Tsutsui, H.; Ogasawara, T.; Fujita, K. [Sumitomo Heavy Industries, Ltd (Japan); Tanaka, H.; Sakurai, Y.; Maruhashi, A. [Kyoto University Research Reactor Institute (Japan)

2013-04-19

Kyoto University Research Reactor Institute (KURRI) and Sumitomo Heavy Industries, Ltd. (SHI) have developed a cyclotron-based neutron source for Boron Neutron Capture Therapy (BNCT). It was installed at KURRI in Osaka prefecture. The neutron source consists of a proton cyclotron named HM-30, a beam transport system and an irradiation and treatment system. In the cyclotron, H- ions are accelerated and extracted as 30 MeV proton beams of 1 mA. The proton beams is transported to the neutron production target made by a beryllium plate. Emitted neutrons are moderated by lead, iron, aluminum and calcium fluoride. The aperture diameter of neutron collimator is in the range from 100 mm to 250 mm. The peak neutron flux in the water phantom is 1.8 Multiplication-Sign 109 neutrons/cm{sup 2}/sec at 20 mm from the surface at 1 mA proton beam. The neutron source have been stably operated for 3 years with 30 kW proton beam. Various pre-clinical tests including animal tests have been done by using the cyclotron-based neutron source with {sup 10}B-p-Borono-phenylalanine. Clinical trials of malignant brain tumors will be started in this year.

Technical report on analysis and purification of used O-18 cyclotron target water

International Nuclear Information System (INIS)

Kim, T. S.; Jeong, D. Y.; Kim, J. W.; Ko, K. H.; Lim, K; Kim, C. J.; Park, K. B.

2004-01-01

F-18-labeled 2-[ 18 F]fluoro-deoxy-glucose( 18 F-FDG), which is used for PET diagnosis, is generally synthesized by using the nucleophilic substitution method. If 18 O-H 2 O is irradiated by the protons accelerated in a cyclotron, 18F-fluoride is produced by means of nuclear reaction of 18O(p,n)18F. However, 18 O-H 2 O is very expensive and its timely procurement might be difficult because of its frequent world market fluctuations. Therefore, 18 O-H 2 O used for the production of 18 F-FDG should be reused efficiently. When the target 18 O-H 2 O flows the tubes in the synthetic apparatus and ion-exchange resin, it is contaminated by the organic substances such as ethanol, methanol, and acetonitrile, etc. If the recovered target water containing many of these impurities is reused as target water in a cyclotron, abnormal increases of the pressure in the target chamber during irradiation and reduction of the target chamber life-span may occur. As a result, production yield of 18F-fluoride would be decreased, and also the yield of 18 F-FDG. Therefore, organic substances and various metallic ions contained in recovered 18 O-H 2 O must be eliminated prior to its reuse. Moreover, the loss of 18 O-H 2 O during the purification process must be minimized to use the target water economically

NORTICA - a new code for cyclotron analysis

International Nuclear Information System (INIS)

Gorelov, D.; Johnson, D.; Marti, F.

2001-01-01

The new package NORTICA (Numerical ORbit Tracking In Cyclotrons with Analysis) of computer codes for beam dynamics simulations is under development at NSCL. The package was started as a replacement for the code MONSTER developed in the laboratory in the past. The new codes are capable of beam dynamics simulations in both CCF (Coupled Cyclotron Facility) accelerators, the K500 and K1200 superconducting cyclotrons. The general purpose of this package is assisting in setting and tuning the cyclotrons taking into account the main field and extraction channel imperfections. The computer platform for the package is Alpha Station with UNIX operating system and X-Windows graphic interface. A multiple programming language approach was used in order to combine the reliability of the numerical algorithms developed over the long period of time in the laboratory and the friendliness of modern style user interface. This paper describes the capability and features of the codes in the present state

NORTICA—a new code for cyclotron analysis

Science.gov (United States)

Gorelov, D.; Johnson, D.; Marti, F.

2001-12-01

The new package NORTICA (Numerical ORbit Tracking In Cyclotrons with Analysis) of computer codes for beam dynamics simulations is under development at NSCL. The package was started as a replacement for the code MONSTER [1] developed in the laboratory in the past. The new codes are capable of beam dynamics simulations in both CCF (Coupled Cyclotron Facility) accelerators, the K500 and K1200 superconducting cyclotrons. The general purpose of this package is assisting in setting and tuning the cyclotrons taking into account the main field and extraction channel imperfections. The computer platform for the package is Alpha Station with UNIX operating system and X-Windows graphic interface. A multiple programming language approach was used in order to combine the reliability of the numerical algorithms developed over the long period of time in the laboratory and the friendliness of modern style user interface. This paper describes the capability and features of the codes in the present state.

Intensity limits of the PSI Injector II cyclotron

Science.gov (United States)

Kolano, A.; Adelmann, A.; Barlow, R.; Baumgarten, C.

2018-03-01

We investigate limits on the current of the PSI Injector II high intensity separate-sector isochronous cyclotron, in its present configuration and after a proposed upgrade. Accelerator Driven Subcritical Reactors, neutron and neutrino experiments, and medical isotope production all benefit from increases in current, even at the ∼ 10% level: the PSI cyclotrons provide relevant experience. As space charge dominates at low beam energy, the injector is critical. Understanding space charge effects and halo formation through detailed numerical modelling gives clues on how to maximise the extracted current. Simulation of a space-charge dominated low energy high intensity (9.5 mA DC) machine, with a complex collimator set up in the central region shaping the bunch, is not trivial. We use the OPAL code, a tool for charged-particle optics calculations in large accelerator structures and beam lines, including 3D space charge. We have a precise model of the present (production) Injector II, operating at 2.2 mA current. A simple model of the proposed future (upgraded) configuration of the cyclotron is also investigated. We estimate intensity limits based on the developed models, supported by fitted scaling laws and measurements. We have been able to perform more detailed analysis of the bunch parameters and halo development than any previous study. Optimisation techniques enable better matching of the simulation set-up with Injector II parameters and measurements. We show that in the production configuration the beam current scales to the power of three with the beam size. However, at higher intensities, 4th power scaling is a better fit, setting the limit of approximately 3 mA. Currents of over 5 mA, higher than have been achieved to date, can be produced if the collimation scheme is adjusted.

Considerations, measurements and logistics associated with low-energy cyclotron decommissioning

International Nuclear Information System (INIS)

Sunderland, J. J.; Erdahl, C. E.; Bender, B. R.; Sensoy, L.; Watkins, G. L.

2012-01-01

The University of Iowa’s 20-year-old 17 MeV Scanditronix cyclotron underwent decommissioning in the summer of 2011. To satisfy local, state and federal regulations defining removal, transportation and long-term safe and environmentally secure disposal of the 22 ton activated cyclotron, a series of nuclear spectroscopic measurements were performed to characterize the nature and extent of proton and neutron activation of the 22-ton cyclotron, its associated targets, and the concrete wall that was demolished to remove the old cyclotron. Neutron activation of the concrete wall was minimal and below exempt concentrations resulting in standard landfill disposal. The cyclotron assessment revealed the expected array of short and medium-lived radionuclides. Subsequent calculations suggest that meaningful levels residual activity will have decayed virtually to background after 15 years, with the total residual activity of the entire cyclotron dropping below 37 MBq (1 mCi).

Silicon Photomultipliers and Monolithic Scintillators for Time-of-Flight PET

NARCIS (Netherlands)

Seifert, S.

2012-01-01

Positron emission tomography (PET) is a nuclear medical imaging modality. Its aim is to visualize the 3-dimensional distribution of a radiopharmaceutical (also called the tracer) within a patient (clinical PET) or test-animal (in case of preclinical investigations). The information that can be

Usefulness of PET in non-lesional temporal lobe epilepsy

International Nuclear Information System (INIS)

Bertuluchi, M.; Arganaraz, R.; Buznick, J.; Pomata, H.

2011-01-01

Objective. To evaluate the usefulness of PET in patients with refractory non-lesional temporal lobe epilepsy. Material and methods. We present three patients with features of temporal lobe epilepsy refractory to medication, where high definition MRI was normal. Results. These patients had PET hypometabolism in the temporal areas related to clinical and neurophysiological findings. Two of these patients were implanted with subdural grids to confirm the diagnosis and the third was operated directly based on the findings of PET. Encourage the presentation of the importance in recent years is acquiring the PET. Conclusion. In those patients in clinical neurophysiology and epilepsy with suspected temporal lobe, but in the MRI images show no structural lesions, PET can play an important role defining the diagnosis. (authors)

An in-beam PET system for monitoring ion-beam therapy: test on phantoms using clinical 62 MeV protons

Science.gov (United States)

Camarlinghi, N.; Sportelli, G.; Battistoni, G.; Belcari, N.; Cecchetti, M.; Cirrone, G. A. P.; Cuttone, G.; Ferretti, S.; Kraan, A.; Retico, A.; Romano, F.; Sala, P.; Straub, K.; Tramontana, A.; Del Guerra, A.; Rosso, V.

2014-04-01

Ion therapy allows the delivery of highly conformal dose taking advantage of the sharp depth-dose distribution at the Bragg-peak. However, patient positioning errors and anatomical uncertainties can cause dose distortions. To exploit the full potential of ion therapy, an accurate monitoring system of the ion range is needed. Among the proposed methods to monitor the ion range, Positron Emission Tomography (PET) has proven to be the most mature technique, allowing to reconstruct the β+ activity generated in the patient by the nuclear interaction of the ions, that can be acquired during or after the treatment. Taking advantages of the spatial correlation between positron emitters created along the ions path and the dose distribution, it is possible to reconstruct the ion range. Due to the high single rates generated during the beam extraction, the acquisition of the β+ activity is typically performed after the irradiation (cyclotron) or in between the synchrotron spills. Indeed the single photon rate can be one or more orders of magnitude higher than normal for cyclotron. Therefore, acquiring the activity during the beam irradiation requires a detector with a very short dead time. In this work, the DoPET detector, capable of sustaining the high event rate generated during the cyclotron irradiation, is presented. The capability of the system to acquire data during and after the irradiation will be demonstrated by showing the reconstructed activity for different PMMA irradiations performed using clinical dose rates and the 62 MeV proton beam at the CATANA-LNS-INFN. The reconstructed activity widths will be compared with the results obtained by simulating the proton beam interaction with the FLUKA Monte Carlo. The presented data are in good agreement with the FLUKA Monte Carlo.

An in-beam PET system for monitoring ion-beam therapy: test on phantoms using clinical 62 MeV protons

International Nuclear Information System (INIS)

Camarlinghi, N; Sportelli, G; Belcari, N; Cecchetti, M; Ferretti, S; Kraan, A; Retico, A; Straub, K; Guerra, A Del; Rosso, V; Battistoni, G; Sala, P; Cirrone, G A P; Cuttone, G; Romano, F; Tramontana, A

2014-01-01

Ion therapy allows the delivery of highly conformal dose taking advantage of the sharp depth-dose distribution at the Bragg-peak. However, patient positioning errors and anatomical uncertainties can cause dose distortions. To exploit the full potential of ion therapy, an accurate monitoring system of the ion range is needed. Among the proposed methods to monitor the ion range, Positron Emission Tomography (PET) has proven to be the most mature technique, allowing to reconstruct the β + activity generated in the patient by the nuclear interaction of the ions, that can be acquired during or after the treatment. Taking advantages of the spatial correlation between positron emitters created along the ions path and the dose distribution, it is possible to reconstruct the ion range. Due to the high single rates generated during the beam extraction, the acquisition of the β + activity is typically performed after the irradiation (cyclotron) or in between the synchrotron spills. Indeed the single photon rate can be one or more orders of magnitude higher than normal for cyclotron. Therefore, acquiring the activity during the beam irradiation requires a detector with a very short dead time. In this work, the DoPET detector, capable of sustaining the high event rate generated during the cyclotron irradiation, is presented. The capability of the system to acquire data during and after the irradiation will be demonstrated by showing the reconstructed activity for different PMMA irradiations performed using clinical dose rates and the 62 MeV proton beam at the CATANA-LNS-INFN. The reconstructed activity widths will be compared with the results obtained by simulating the proton beam interaction with the FLUKA Monte Carlo. The presented data are in good agreement with the FLUKA Monte Carlo

Validating the Patient Experience with Treatment and Self-Management (PETS), a patient-reported measure of treatment burden, in people with diabetes.

Science.gov (United States)

Rogers, Elizabeth A; Yost, Kathleen J; Rosedahl, Jordan K; Linzer, Mark; Boehm, Deborah H; Thakur, Azra; Poplau, Sara; Anderson, Roger T; Eton, David T

2017-01-01

To validate a comprehensive general measure of treatment burden, the Patient Experience with Treatment and Self-Management (PETS), in people with diabetes. We conducted a secondary analysis of a cross-sectional survey study with 120 people diagnosed with type 1 or type 2 diabetes and at least one additional chronic illness. Surveys included established patient-reported outcome measures and a 48-item version of the PETS, a new measure comprised of multi-item scales assessing the burden of chronic illness treatment and self-care as it relates to nine domains: medical information, medications, medical appointments, monitoring health, interpersonal challenges, health care expenses, difficulty with health care services, role activity limitations, and physical/mental exhaustion from self-management. Internal reliability of PETS scales was determined using Cronbach's alpha. Construct validity was determined through correlation of PETS scores with established measures (measures of chronic condition distress, medication satisfaction, self-efficacy, and global well-being), and known-groups validity through comparisons of PETS scores across clinically distinct groups. In an exploratory test of predictive validity, step-wise regressions were used to determine which PETS scales were most associated with outcomes of chronic condition distress, overall physical and mental health, and medication adherence. Respondents were 37-88 years old, 59% female, 29% non-white, and 67% college-educated. PETS scales showed good reliability (Cronbach's alphas ≥0.74). Higher PETS scale scores (greater treatment burden) were correlated with more chronic condition distress, less medication convenience, lower self-efficacy, and worse general physical and mental health. Participants less (versus more) adherent to medications and those with more (versus fewer) health care financial difficulties had higher mean PETS scores. Medication burden was the scale that was most consistently associated with

An experimental study on cyclotron-Cherenkov radiation

Energy Technology Data Exchange (ETDEWEB)

Lee, C Y; Masuzaki, M; Yoshida, H; Toyosugi, N; Kamada, K; Ando, R [Kanazawa Univ. (Japan). Department of Physics

1997-12-31

Dielectric-loaded cylindrical waveguide configurations with an injected electron beam in which the growth rate of the cyclotron-Cherenkov instability surpasses that of the Cherenkov instability were sought by numerical treatment, and one configuration of this kind was found. This configuration consists of a metallic core and an outer metallic cylinder with a dielectric liner on the inner surface. Based on the calculations, an experimental device was designed and assembled to investigate experimentally radiation due to the cyclotron-Cherenkov instability. Beam propagation in the dielectric-loaded coaxial waveguide and microwave radiation due to the cyclotron-Cherenkov instability and the Cherenkov instability were studied. (author). 6 figs., 10 refs.

The booster linac of the Sparkle Company 18 MeV Cyclotron: main design elements

International Nuclear Information System (INIS)

Picardi, L.; Ronsivalle, C.

2009-01-01

The Sparkle Company (Casarano, Le) that is setting up a centre for production and research on radioisotopes for medical use, has requested to the ENEA Accelerator Laboratory a specific design of a linear accelerator for boosting the energy of its commercial cyclotron from 18 to 24 MeV, with the aim of implementing a small proton irradiation facility for radiobiology studies. This is the first case of coupling a cyclotron beam to a linac, that, if successful, can give rise to a new class of accelerators for proton therapy. The linac can accelerate only a very small portion of the cyclotron beam, due to the intrinsic mismatching of the two kind of accelerators both in the vertical and in the longitudinal phase planes. A beam transport line has been studied that besides matching at best the beam to the linac in the transverse plane, is equipped with a chopping system to lower drastically the primary beam power in order to protect the linac structure. The linac is SCDTL type, and operates at 3 GHz. In the following the results of the design are presented. [it

Cyclotron Development and Technical Aspects on Accelerator Based Laboratory Development

International Nuclear Information System (INIS)

Sunarhadijoso

2000-01-01

BATAN is planning to establish an accelerator-based laboratory at P3TM Yogyakarta as an effort in the development and use of accelerator technology for improving industrial performance and public welfare. This paper reviews several aspects of cyclotron technology and describes the combination of a linear accelerator - cyclotron system as an alternative to be considered in the planing of the laboratory. The progress of cyclotron technology is discussed covering three generations, i.e. conventional cyclotron, synchrocyclotron and AVF cyclotron generations. The planning should not consider the accelerator application for radioisotope production because it is established in Serpong with the existing negative ion cyclotron. The proposed facility at P3TM may comprise two linear accelerators coupled with a positive ion cyclotron of synchrocyclotron generation. In fact, the attachment of the synchrocyclotron unit is flexible and it can be installed subsequently if the higher energy particle beam, which can not be produced by the linear accelerators, is extremely needed. Some technical aspects related to ion beam application, building construction and infrastructure, human resources, and specification of function test are discussed for additional information in the implementation of the planning. (author)

Optimization of the procedure for verification of the response on activity of activimeters in PET production units using {sup 1}3N; Optimizacion del procedimiento de verificacion de la respuesta en actividad de activimetros en unidades de produccion PET usando {sup 1}3N

Energy Technology Data Exchange (ETDEWEB)

Verde Velasco, J. M.; Lopez Lorenzo, B.; Ruiz Guijarro, J. A.; Montes Fuentes, C.

2013-07-01

The Spanish Protocol for quality control in medicine nuclear1 establishes the need to control regular activity of the calibrators of dose response. This Protocol establishes the use of 99mTc for performing this test. In the case of a PET facility this methodology is feasible not to dispose of the radionuclide in the installation. We propose an alternative methodology for carrying out this test of fast, cheap and efficient form in a facility that has cyclotron. (Author)

Suppression of cyclotron instability in Electron Cyclotron Resonance ion sources by two-frequency heating

International Nuclear Information System (INIS)

Skalyga, V.; Izotov, I.; Mansfeld, D.; Kalvas, T.; Koivisto, H.; Komppula, J.; Kronholm, R.; Laulainen, J.; Tarvainen, O.

2015-01-01

Multiple frequency heating is one of the most effective techniques to improve the performance of Electron Cyclotron Resonance (ECR) ion sources. The method increases the beam current and average charge state of the extracted ions and enhances the temporal stability of the ion beams. It is demonstrated in this paper that the stabilizing effect of two-frequency heating is connected with the suppression of electron cyclotron instability. Experimental data show that the interaction between the secondary microwave radiation and the hot electron component of ECR ion source plasmas plays a crucial role in mitigation of the instabilities

Initial operation of the cyclotron CYTRACK

International Nuclear Information System (INIS)

Denisov, Yu.N.; Dolya, S.N.; Kalinichenko, V.V.; Karamysheva, G.A.; Kostromin, S.A.; Fedorenko, S.B.

2005-01-01

The industrial cyclotron CYTRACK is dedicated to produce the track membranes. It is the basic instrument for the industry of membrane products to be consumed in medicine, biotechnology, pharmacology, microelectronics and many other industries. Cyclotron CYTRACK started working in August 2002. Argon ions were accelerated to the project energy - 2.4 MeV/nucleon, the extracted beam intensity was about 200 nA, the extraction efficiency totaled ∼50%

Imaging and PET - PET/CT imaging

International Nuclear Information System (INIS)

Von Schulthess, G.K.; Hany, Th.F.

2008-01-01

PET/CT has grown because the lack of anatomic landmarks in PET makes 'hardware-fusion' to anatomic cross-sectional data extremely useful. Addition of CT to PET improves specificity, but also sensitivity, and adding PET to CT adds sensitivity and specificity in tumor imaging. The synergistic advantage of adding CT is that the attenuation correction needed for PET data can also be derived from the CT data. This makes PET-CT 25-30% faster than PET alone, leading to higher patient throughput and a more comfortable examination for patients typically lasting 20 minutes or less. FDG-PET-CT appears to provide relevant information in the staging and therapy monitoring of many tumors, such as lung carcinoma, colorectal cancer, lymphoma, gynaecological cancers, melanoma and many others, with the notable exception of prostatic cancer. for this cancer, choline derivatives may possibly become useful radiopharmaceuticals. The published literature on the applications of FDG-PET-CT in oncology is still limited but several designed studies have demonstrated the benefits of PET-CT. (authors)

Evaluation of PET Scanner Performance in PET/MR and PET/CT Systems: NEMA Tests.

Science.gov (United States)

Demir, Mustafa; Toklu, Türkay; Abuqbeitah, Mohammad; Çetin, Hüseyin; Sezgin, H Sezer; Yeyin, Nami; Sönmezoğlu, Kerim

2018-02-01

The aim of the present study was to compare the performance of positron emission tomography (PET) component of PET/computed tomography (CT) with new emerging PET/magnetic resonance (MR) of the same vendor. According to National Electrical Manufacturers Association NU2-07, five separate experimental tests were performed to evaluate the performance of PET scanner of General Electric GE company; SIGNATM model PET/MR and GE Discovery 710 model PET/CT. The main investigated aspects were spatial resolution, sensitivity, scatter fraction, count rate performance, image quality, count loss and random events correction accuracy. The findings of this study demonstrated superior sensitivity (~ 4 folds) of PET scanner in PET/MR compared to PET/CT system. Image quality test exhibited higher contrast in PET/MR (~ 9%) compared with PET/CT. The scatter fraction of PET/MR was 43.4% at noise equivalent count rate (NECR) peak of 218 kcps and the corresponding activity concentration was 17.7 kBq/cc. Whereas the scatter fraction of PET/CT was found as 39.2% at NECR peak of 72 kcps and activity concentration of 24.3 kBq/cc. The percentage error of the random event correction accuracy was 3.4% and 3.1% in PET/MR and PET/CT, respectively. It was concluded that PET/MR system is about 4 times more sensitive than PET/CT, and the contrast of hot lesions in PET/MR was ~ 9% higher than PET/CT. These outcomes also emphasize the possibility to achieve excellent clinical PET images with low administered dose and/or a short acquisition time in PET/MR.

Electron cyclotron emission measurements during 28 GHz electron cyclotron resonance heating in Wendelstein WVII-A stellarator

International Nuclear Information System (INIS)

Hartfuss, H.J.; Gasparino, U.; Tutter, M.; Brakel, R.; Cattanei, G.; Dorst, D.; Elsner, A.; Engelhardt, K.; Erckmann, V.; Grieger, G.; Grigull, P.; Hacker, H.; Jaeckel, H.; Jaenicke, R.; Junker, J.; Kick, M.; Kroiss, H.; Kuehner, G.; Maassberg, H.; Mahn, C.; Mueller, G.; Ohlendorf, W.; Rau, F.; Renner, H.; Ringler, H.; Sardei, F.; Weller, A.; Wobig, H.; Wuersching, E.; Zippe, M.; Kasparek, W.; Mueller, G.A.; Raeuchle, E.; Schueller, P.G.; Schwoerer, K.; Thumm, M.

1987-11-01

Electron cyclotron emission measurements have been carried out on electron cyclotron resonance heated plasmas in the WENDELSTEIN VII-A Stellarator. Blackbody radiation from the thermalized plasma main body as well as radiation from a small amount of weakly relativistic suprathermal electrons has been detected. In addition sideband emission has been observed near the second harmonic of the heating line source. Harmonic generation and parametric wave decay at the upper hybrid layer may be a reasonable explanation. (orig.)

[Cyclotron based nuclear science

International Nuclear Information System (INIS)

1989-06-01

This report contains papers on the following topics: Heavy ion reactors, nuclear structure and fundamental interactions; atomic and materials studies; nuclear theory; and superconducting cyclotron and instrumentation

Optimization of the procedure for verification of the response on activity of activimeters in PET production units using 13N

International Nuclear Information System (INIS)

Verde Velasco, J. M.; Lopez Lorenzo, B.; Ruiz Guijarro, J. A.; Montes Fuentes, C.

2013-01-01

The Spanish Protocol for quality control in medicine nuclear1 establishes the need to control regular activity of the calibrators of dose response. This Protocol establishes the use of 99mTc for performing this test. In the case of a PET facility this methodology is feasible not to dispose of the radionuclide in the installation. We propose an alternative methodology for carrying out this test of fast, cheap and efficient form in a facility that has cyclotron. (Author)

A small low energy cyclotron for radioisotope measurements

International Nuclear Information System (INIS)

Bertsche, K.J.

1989-11-01

Direct detection of 14 C by accelerator mass spectrometry has proved to be a much more sensitive method for radiocarbon dating than the decay counting method invented earlier by Libby. A small cyclotron (the ''cyclotrino'') was proposed for direct detection of radiocarbon in 1980. This combined the suppression of background through the use of negative ions, which had been used effectively in tandem accelerators, with the high intrinsic mass resolution of a cyclotron. Development of a small electrostatically-focused cyclotron for use as a mass spectrometer was previously reported but the sensitivity needed for detection of 14 C at natural abundance was not achieved. The major contributions of this work are the integration of a high current external ion source with a small flat-field, electrostatically-focused cyclotron to comprise a system capable of measuring 14 C at natural levels, and the analysis of ion motion in such a cyclotron, including a detailed analysis of phase bunching and its effect on mass resolution. A high current cesium sputter negative ion source generates a beam of carbon ions which is pre-separated with a Wien filter and is transported to the cyclotron via a series of electrostatic lenses. Beam is injected radially into the cyclotron using electrostatic deflectors and an electrostatic mirror. Axial focusing is entirely electrostatic. A microchannel plate detector is used with a phase-grated output. In its present form the system is capable of improving the sensitivity of detecting 14 C in some biomedical experiments by a factor of 10 4 . Modifications are discussed which could bring about an additional factor of 100 in sensitivity, which is important for archaeological and geological applications. Possibilities for measurements of other isotopes, such as 3 H, and 10 Be, and 26 Al, are discussed. 70 refs

U-2g0 cyclotron operational experience and improvement

International Nuclear Information System (INIS)

Gigal, B.N.; Gul'bekyan, G.G.; Kozlov, S.I.; Oganesyan, R.Ts.

1983-01-01

Brief description of main syste's of the U-200 isochronous 2-m cyclotron put into opera ion in 1968 is given and its operational characteristics a e presented. The cyclotron is used for conducting inve tigations in the field of nuclear physics. Ions from d uterium to argon have been accelerated in the cyclotro'. Annual time of target irradiation constitutes 2000-4000. The specific features of the cyclotron are: high l vel of a magnetic field (of about 20 kOe), possibili y of acceleration of ions with different mass-to-charge ratio a low correcting winding power, simple and high-e fective beam extraction by the method of charge exchange on a thin target allowing to vary smoothly energy of extracted ons. An experience in the U-200 cyclotron development and o eration is used as the basis for designing and choosing basic parameters of the U-200P, U-250, U-400 heavy ion cyclotrons

Electron-Cyclotron Waves

NARCIS (Netherlands)

Westerhof, E.

1994-01-01

The essential elements of the theory of electron cyclotron waves are reviewed, The two main electro-magnetic modes of propagation are identified and their dispersion and absorption properties are discussed. The importance of the use of the relativistic resonance condition is stressed.

High-resolution PET [Positron Emission Tomography] for Medical Science Studies

Science.gov (United States)

Budinger, T. F.; Derenzo, S. E.; Huesman, R. H.; Jagust, W. J.; Valk, P. E.

1989-09-01

One of the unexpected fruits of basic physics research and the computer revolution is the noninvasive imaging power available to today's physician. Technologies that were strictly the province of research scientists only a decade or two ago now serve as the foundations for such standard diagnostic tools as x-ray computer tomography (CT), magnetic resonance imaging (MRI), magnetic resonance spectroscopy (MRS), ultrasound, single photon emission computed tomography (SPECT), and positron emission tomography (PET). Furthermore, prompted by the needs of both the practicing physician and the clinical researcher, efforts to improve these technologies continue. This booklet endeavors to describe the advantages of achieving high resolution in PET imaging.

Lower-hybrid absorption at the ion cyclotron harmonics

International Nuclear Information System (INIS)

Puri, S.

1975-01-01

In the presence of magnetic field gradients, the lower-hybrid wave can be absorbed through linear collisionless damping at the location of cyclotron or cyclotron harmonic resonances acting as singular turning points in the path of the advancing wave-front. (Auth.)

In-beam PET at high-energy photon beams: a feasibility study

Science.gov (United States)

Müller, H.; Enghardt, W.

2006-04-01

For radiation therapy with carbon ion beams, either for the stable isotope 12C or for the radioactive one 11C, it has been demonstrated that the β+-activity distribution created or deposited, respectively, within the irradiated volume can be visualized by means of positron emission tomography (PET). The PET images provide valuable information for quality assurance and precision improvement of ion therapy. Dedicated PET scanners have been integrated into treatment sites at the Heavy Ion Medical Accelerator at Chiba (HIMAC), Japan, and the Gesellschaft für Schwerionenforschung (GSI), Germany, to make PET imaging feasible during therapeutic irradiation (in-beam PET). A similar technique may be worthwhile for radiotherapy with high-energy bremsstrahlung. In addition to monitoring the dose delivery process which in-beam PET has been primarily developed for, it may be expected that radiation response of tissue can be detected by means of in-beam PET. We investigate the applicability of PET for treatment control in the case of using bremsstrahlung spectra produced by 15-50 MeV electrons. Target volume activation due to (γ, n) reactions at energies above 20 MeV yields moderate β+-activity levels, which can be employed for imaging. The radiation from positrons produced by pair production is not presently usable because the detectors are overloaded due to the low duty factor of medical electron linear accelerators. However, the degradation of images caused by positron motion between creation and annihilation seems to be tolerable.

Cyclotron Produced Radionuclides: Guidance on Facility Design and Production of [18F]Fluorodeoxyglucose (FDG)

International Nuclear Information System (INIS)

2012-01-01

Positron emission tomography (PET) has advanced rapidly in recent years and is becoming an indispensable imaging modality for the evaluation and staging of cancer patients. A key component of the successful operation of a PET centre is the on-demand availability of radiotracers (radiopharmaceuticals) labelled with suitable positron emitting radioisotopes. Of the hundreds of positron labelled radiotracers, 2-[ 18 F]-fluoro-2-deoxy-D-glucose (FDG) is the most successful and widely used imaging agent in PET today. While FDG is utilized largely in oncology for the management of cancer patients, its applications in neurology and cardiology are also steadily growing. A large number of PET facilities have been established in Member States over the past few years, and more are being planned. The design and operation of a facility for the production of FDG requires attention to detail, in particular the application of good manufacturing practices (GMP) guidelines and quality assurance. The product must conform to the required quality specifications and must be safe for human use. This book is intended to be a resource manual with practical information for planning and operating an FDG production facility, including design and implementation of the laboratories, facility layout, equipment, personnel and FDG quality assessment. GMP and quality management are discussed only briefly, since these topics are covered extensively in the IAEA publication Cyclotron Produced Radionuclides: Guidelines for Setting up a Facility (Technical Reports Series No. 471). It should be noted that manufacturing processes and quality specifications for FDG are not currently globally harmonized, and these do vary to some extent. However, there is no disagreement over the need to ensure that the product is manufactured in a controlled manner, that it conforms to applicable quality specifications and that it is safe for human use. Administrators, managers, radiopharmaceutical scientists, production

Stability and nonlinear dynamics of gyrotrons at cyclotron harmonics

International Nuclear Information System (INIS)

Saraph, G.P.; Nusinovich, G.S.; Antonsen, T.M. Jr.; Levush, B.

1992-01-01

Gyrotrons operating at higher harmonics of the cyclotron frequency can overcome the frequency limitations caused by achievable strength of the magnetic field. However, the excitation of modes at the fundamental frequency exhibit a major problem for stable operation of harmonic gyrotron at high power with high efficiency. Therefore the issues of stability of gyrotron operation at the cyclotron harmonics and nonlinear dynamics of mode interaction are of great importance. The results of the authors stability analysis and multimode simulation are presented here. A detailed nonlinear theory of steady state single mode operation at cyclotron harmonics has been presented previously, taking into account beam-wave coupling and nonlinear gain function at cyclotron harmonics. A set of equations describing low gain regime interaction of modes resonant at different cyclotron harmonics was studied before. The multifrequency time-dependent nonlinear analysis presented here is based on previous gyrotron studies and beam-wave interaction at cyclotron harmonics. The authors have determined the parameter space for stable single mode operation at the second harmonic. The nonlinear dynamics of mode evolution and mode interaction for a harmonic gyrotron is presented. A new nonlinear effect in which the parasite at the fundamental harmonic helps excite the operating mode at the second harmonic has been demonstrated

Fabrication of beam diagnostic components for Superconducting Cyclotron at Kolkata

International Nuclear Information System (INIS)

Roy, S.; Bhattacharya, S.; Das, T.; Bhattacharyya, T.K.; Pal, S.; Pal, G.; Mallik, C.; Bhandari, R.K.

2009-01-01

The viewer probe and main probe are used for determining the position and current of charged particles as it is accelerated inside the superconducting cyclotron. The viewer probe is used to visually observe the shape of the charged particle beam inside the cyclotron with the help of a borescope. The main probe measures the distribution of charged particles. The viewer probe and main probe are bellow sealed. They can be positioned with an accuracy of 0.5 mm at different radii within the superconducting cyclotron. M9 slit is placed after the exit flange of the cyclotron. It determines the position of the beam leaving the cyclotron. The beam line has slits, faraday cup, beam viewers, collimators, etc. for beam diagnostics. This paper presents the mechanical design and details of beam diagnostic components. (author)

Accelerator physics and nuclear energy education in INRNE-BAS

International Nuclear Information System (INIS)

Tonev, D.; Goutev, N.; Georgiev, L. S.

2015-01-01

Presently Bulgaria has no research nuclear facility, neither a research reactor, nor an accelerator. With the new cyclotron laboratory in Sofia the Institute for Nuclear Research and Nuclear Energy at the Bulgarian Academy of Sciences will restart the experimental research program not only in the fi eld of nuclear physics, but also in many interdisciplinary fields related to nuclear physics. The cornerstone of the cyclotron laboratory is a cyclotron TR24, which provides a proton beam with a variable energy between 15 and 24 MeV and current of up to 0.4 mA. The TR24 accelerator allows for the production of a large variety of radioisotopes for medical applications and development of radiopharmaceuticals. The new cyclotron facility will be used for research in radiopharmacy, radiochemistry, radiobiology, nuclear physics, solid state physics, applied research, new materials and for education in all these fields including especially nuclear energy. Keywords: Cyclotron, PET/CT, radiopharmacy

MC-50 AVF cyclotron operation

Energy Technology Data Exchange (ETDEWEB)

Chae, Jong Seo; Lee, Dong Hoon; Kim, You Seok; Park, Chan Won; Lee, Yong Min; Hong, Sung Seok; Lee, Min Yong

1995-12-01

The first cyclotron in Korea, MC-59 cyclotron is used for neutron irradiation, radionuclide development, production and material and biomedical research. 50.5MeV and 35MeV proton beam have been extracted with 20-70 .mu.A. A total of beam extraction time are 1095.7 hours. 206.5 hours are used for the developments and 663.8 hours are for radionuclide production and development and 225.4 hours for application researches. The shutdown days are 23days. Fundamental data for failure decrement and efficient beam extraction were composed and maintenance technologies were developed. (author). 8 tabs., 17 figs., 10 refs.

MC-50 AVF cyclotron operation

International Nuclear Information System (INIS)

Kim, Yu Seok; Chai, Jong Seo; Bak, Seong Ki; Park, Chan Won; Jo, Young Ho; Hong, Seong Seok; Lee, Min Yong; Jang Ho Ha

2000-01-01

The first cyclotron in Korea, MC-50 cyclotron is used for neutron irradiation, radionuclide development, production and material and biomedical research. 50.5MeV and 35MeV proton beam have been extracted with 20-60μA. A total of beam extraction time are 1095.7 hours. 206.5 hours are used for the developments and 663.8 hours are for radionuclide production and development and 225.4 hours for application researches. The shutdown days are 23 days. Fundamental data for failure decrement and efficient beam extraction were composed and maintenance technologies were developed

MC-50 AVF cyclotron operation

Energy Technology Data Exchange (ETDEWEB)

Kim, Yu Seok; Chai, Jong Seo; Bak, Seong Ki; Park, Chan Won; Jo, Young Ho; Hong, Seong Seok; Lee, Min Yong; Jang Ho Ha

2000-01-01

The first cyclotron in Korea, MC-50 cyclotron is used for neutron irradiation, radionuclide development, production and material and biomedical research. 50.5MeV and 35MeV proton beam have been extracted with 20-60{mu}A. A total of beam extraction time are 1095.7 hours. 206.5 hours are used for the developments and 663.8 hours are for radionuclide production and development and 225.4 hours for application researches. The shutdown days are 23 days. Fundamental data for failure decrement and efficient beam extraction were composed and maintenance technologies were developed.

MC-50 AVF cyclotron operation

International Nuclear Information System (INIS)

Chae, Jong Seo; Lee, Dong Hoon; Kim, You Seok; Park, Chan Won; Lee, Yong Min; Hong, Sung Seok; Lee, Min Yong.

1995-12-01